0001213900-22-007623.txt : 20220214 0001213900-22-007623.hdr.sgml : 20220214 20220214170828 ACCESSION NUMBER: 0001213900-22-007623 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cinedigm Corp. CENTRAL INDEX KEY: 0001173204 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-VIDEO TAPE RENTAL [7841] IRS NUMBER: 223720962 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31810 FILM NUMBER: 22634535 BUSINESS ADDRESS: STREET 1: 237 WEST 35TH STREET STREET 2: SUITE 605 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-206-8600 MAIL ADDRESS: STREET 1: 237 WEST 35TH STREET STREET 2: SUITE 605 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Cinedigm Digital Cinema Corp. DATE OF NAME CHANGE: 20091006 FORMER COMPANY: FORMER CONFORMED NAME: Access Integrated Technologies, Inc. d/b/a Cinedigm Digital Cinema Corp. DATE OF NAME CHANGE: 20081202 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS INTEGRATED TECHNOLOGIES INC DATE OF NAME CHANGE: 20020509 10-Q 1 f10q1221_cinedigmcorp.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal period ended: December 31, 2021

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File Number: 001-31810

 

Cinedigm Corp.

(Exact name of registrant as specified in its charter)

 

Delaware   22-3720962
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)
     
237 West 35th Street, Suite 605, New York, NY   10001
(Address of principal executive offices)   (Zip Code)

 

(212) 206-8600

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on
which registered
CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE   CIDM   NASDAQ GLOBAL MARKET

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

  

Large accelerated filer    Accelerated filer    Non-accelerated filer    Smaller reporting company    Emerging Growth Company 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

As of February 11, 2022, 174,871,216 shares of Class A Common Stock, $0.001 par value, were outstanding.

 

 

 

 

 

 

CINEDIGM CORP.

TABLE OF CONTENTS

 

    Page
  PART I - FINANCIAL INFORMATION  
     
Item 1. Condensed Consolidated Financial Statements (Unaudited) 1
  Condensed Consolidated Balance Sheets at December 31, 2021 (Unaudited) and March 31, 2021 1
  Unaudited Condensed Consolidated Statements of Operations for the Three Months and Nine Months ended December 31, 2021 and 2020 2
  Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months and Nine Months ended December 31, 2021 and 2020 3
  Unaudited Condensed Consolidated Statements of (Deficit) Equity for the Three Months and Nine Months ended December 31, 2021 and 2020 4
  Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months ended December 31, 2021 and 2020 6
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 30
Item 4. Controls and Procedures 46
     
  PART II - OTHER INFORMATION  
     
Item 1. Legal Proceedings 48
Item 1A. Risk Factors 48
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 48
Item 3. Defaults Upon Senior Securities 48
Item 4. Mine Safety Disclosures 48
Item 5. Other Information 48
Item 6. Exhibits 49
Exhibit Index 49
Signatures 50

 

i

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

 

CINEDIGM CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except for share and per share data)

  

   December 31,
2021
   March 31,
2021
 
   (Unaudited)     
ASSETS        
Current assets        
Cash and cash equivalents  $20,201   $16,849 
Accounts receivable, net   29,785    21,093 
Inventory   92    166 
Unbilled revenue   2,826    1,377 
Prepaid and other current assets   5,787    3,657 
Total current assets   58,691    43,142 
Restricted cash   
    1,000 
Equity investment in Starrise, a related party, at fair value   7,896    6,443 
Property and equipment, net   2,438    3,500 
Right-of-use assets   16    100 
Intangible assets, net   15,672    9,860 
Goodwill   13,659    8,701 
Other long-term assets   1,182    2,700 
Total assets  $99,554   $75,446 
LIABILITIES AND EQUITY          
Current liabilities          
Accounts payable and accrued expenses  $54,706   $46,627 
Current portion of notes payable (see Note 5)   
    1,956 
Current portion of notes payable, non-recourse (see Note 5)   
    7,786 
Current portion of deferred consideration on purchase of a business   472    
 
Current portion of earnout consideration on purchase of a business   292    
 
Operating lease liabilities, current portion   16    87 
Current portion of deferred revenue   285    924 
Total current liabilities   55,771    57,380 
PPP Loan   
    2,152 
Deferred consideration on purchase of a business, net of current portion   1,538    
 
Earnout consideration on purchase of a business, net of current portion   1,236    
 
Operating lease liabilities, net of current portion       13 
Other long-term liabilities   
    19 
Total liabilities   58,545    59,564 
Commitments and contingencies (see Note 7)   
 
    
 
 
Stockholders’ equity          
Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; and 7 shares issued and outstanding at December 31, 2021 and March 31, 2021. Liquidation preference of $3,648   3,559    3,559 
Common stock, $0.001 par value; Class A stock 275,000,000 and 200,000,000 shares authorized at December 31, 2021 and March 31, 2021, respectively; 176,187,067 and 167,542,404 shares issued and 174,871,216 and 166,228,568 shares outstanding at December 31, 2021 and March 31, 2021, respectively   174    164 
Additional paid-in capital   520,099    499,272 
Treasury stock, at cost; 1,315,851 and 1,313,836 Class A common shares at December 31, 2021 and March 31, 2021, respectively   (11,608)   (11,603)
Accumulated deficit   (469,729)   (474,080)
Accumulated other comprehensive loss   (101)   (68)
Total stockholders’ equity of Cinedigm Corp.   42,394    17,244 
Deficit attributable to noncontrolling interest   (1,385)   (1,362)
Total equity   41,009    15,882 
Total liabilities and equity  $99,554   $75,446 

 

See accompanying Notes to Condensed Consolidated Financial Statements

 

1

 

 

CINEDIGM CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except for share and per share data)

 

   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2021   2020   2021   2020 
Revenues  $14,084   $9,954   $39,202   $23,154 
Costs and expenses:                    
Direct operating (excludes depreciation and amortization shown below)   6,459    4,385    14,423    11,394 
Selling, general and administrative   7,736    5,361    20,938    15,369 
Bad debt (recovery)   (378)   70    (418)   (123)
Depreciation and amortization of property and equipment   336    822    1,425    3,691 
Amortization of intangible assets   695    597    2,238    1,778 
Total operating expenses   14,848    11,235    38,606    32,109 
Income (loss) from operations   (764)   (1,281)   596    (8,955)
Interest expense, net   (97)   (948)   (277)   (3,432)
Gain (loss) on forgiveness of PPP loan and extinguishment of note payable   
    (540)   2,178    (852)
Change in fair value of equity investment in Starrise, a related party   453    (6,751)   1,453    (42,377)
Other expense, net   (22)   (147)   69    (668)
Income (loss) before income taxes   (430)   (9,667)   4,019    (56,284)
Income tax benefit   26    
    576    181 
Net income (loss)   (404)   (9,667)   4,595    (56,103)
Net income attributable to noncontrolling interest   19    23    23    60 
Net income (loss) attributable to controlling interests   (385)   (9,644)   4,618    (56,043)
Preferred stock dividends   (89)   (89)   (267)   (267)
Net income (loss) attributable to common stockholders  $(474)  $(9,733)  $4,351   $(56,310)
Net income (loss) per Class A common stock attributable to common stockholders - basic:  $0.00   $(0.07)  $0.03   $(0.49)
Weighted average number of Class A common stock outstanding: basic   173,167,450    136,866,072    169,413,873    115,347,494 
Net income (loss) per Class A common stock attributable to common stockholders - diluted:  $0.00   $(0.07)  $0.03   $(0.49)
Weighted average number of Class A common stock outstanding: diluted   

173,167,450

    136,866,072    173,017,364    115,347,494 

 

See accompanying Notes to Condensed Consolidated Financial Statements

  

2

 

 

CINEDIGM CORP.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(In thousands)

 

   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2021   2020   2021   2020 
Net income (loss)  $(404)  $(9,667)  $4,595   $(56,103)
Other comprehensive (loss) income: foreign exchange translation   (14)   (76)   (33)   (186)
Comprehensive income (loss)   (418)   (9,743)   4,562    (56,289)
Less: comprehensive income attributable to noncontrolling interest   19    23    23    60 
Comprehensive income (loss) attributable to controlling interests  $(399)  $(9,720)  $4,585   $(56,229)

 

See accompanying Notes to Condensed Consolidated Financial Statements

 

3

 

 

CINEDIGM CORP.

CONSDENSED CONSOLIDATED STATEMENTS OF (DEFICIT) EQUITY

(Unaudited)

(In thousands, except share data)

 

   Series A
Preferred Stock
   Class A
Common Stock
   Treasury   Additional
Paid-In
   Accumulated   Accumulated Other Comprehensive   Total Stockholders’   Non-Controlling   Total 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Loss   Deficit   Interest   Deficit 
Balances as of March 31, 2020   7   $3,559    61,937,593   $62    1,313,836   $(11,603)  $400,784   $(410,904)  $92   $(18,010)  $(1,277)  $(19,287)
Foreign exchange translation       
        
        
    
    
    (80)   (80)   
    (80)
Stock issued in connection with the SPA with certain investors, net       
    10,666,666    11        
    7,139    
    
    7,150    
    7,150 
Issuance of Class A common stock in connection with the Starrise transaction, a related party       
    29,855,081    30        
    11,016    
    
    11,046    
    11,046 
Contributed capital under the Starrise transaction, a related party       
        
        
    17,187    
    
    17,187    
    17,187 
Issuance of stock in connection with settlement of second lien loan       
    329,501    
        
    757    
    
    757    
    757 
Exercise of warrants for Class A common stock       
    236,899    
        
    301    
    
    301    
    301 
Stock-based compensation       
        
        
    177    
    
    177    
    177 
Preferred stock dividends paid with common stock       
    267,079    
        
    89    (89)   
    
    
    
 
Net loss       
        
        
    
    (19,856)   
    (19,856)   (14)   (19,870)
Balances as of June 30, 2020   7    3,559    103,292,819    103    1,313,836    (11,603)   437,450    (430,849)   12    (1,328)   (1,291)   (2,619)
Foreign exchange translation       
        
        
    
    
    (30)   (30)   
    (30)
July 2020 issuance of Class A common stock, net of $695 in issuance costs       
    7,213,334    7        
    10,118    
         10,125    
    10,125 
Common stock issued in connection with conversion of Convertible Notes       
    10,000,000    10        
    14,990    
    
    15,000    
    15,000 
Issuance of common stock for third party professional service   
    
    80,000    
    
    
    71    
    
    71    
    71 
Issuance of Class A common stock to management and employees       
    689,364    1        
    785    
    
    786    
    786 
Issuance of common stock in connection with performance stock units           373,647                                     
Common stock issued to settle second lien loan       
    33,465            
    61    
    
    61    
    61 
Stock-based compensation       
        
        
    178    
    
    178    
    178 
Preferred stock dividends paid with common stock       
    44,913    
        
    89    (89)   
    
    
    
 
Net loss       
        
        
    
    (26,543)   
    (26,543)   (23)   (26,566)
Balances as of September 30, 2020   7   $3,559    121,727,542   $121    1,313,836   $(11,603)  $463,742   $(457,481)  $(18)  $(1,680)  $(1,314)  $(2,994)
Foreign exchange translation       
        
        
    
    
    (76)   (76)       (76)
Common stock issued to settle second lien loan       
    3,228,783    5    
    
    2,185    
    
    2,190    
    2,190 
Preferred stock dividends paid with common stock       
    171,933    
        
    89    (89)   
    
    
    
 
Stock compensation and expenses       
        
        
    794    
    
    794    
    794 
Issuance of Class A common stock to management       
    320,000    
        
    166    
    
    166    
    166 
Issuance of common stock in connection with performance stock units           320,000            
    
    
    
    
    
    
 
Issuance of common stock in connection with ATM raises, net       
    28,405,840    27        
    18,589    
    
    18,616    
    18,616 
Class A common stock to be issued in connection with asset acquisition       
        
        
    1,853    
    
    1,853    
    1,853 
Net loss       
        
        
    
    (9,644)   
    (9,644)   (23)   (9,667)
Balance as of December 31, 2020   7   $3,559    154,174,098   $153    1,313,836   $(11,603)  $487,418   $(467,214)  $(94)  $12,219   $(1,337)  $10,882 

 

See accompanying & Notes to Condensed Consolidated Financial Statements

 

4

 

  

CINEDIGM CORP.

CONDENSED CONSOLIDATED STATEMENTS OF (DEFICIT) EQUITY

(Unaudited)

(In thousands, except share data)

 

   Series A
Preferred
Stock
   Class A
Common Stock
   Treasury   Additional
Paid-In
   Accumulated   Accumulated
Other
Comprehensive
   Total
Stockholders’
Equity
   Non-Controlling   Total
Equity
 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Loss   (Deficit)   Interest   (Deficit) 
Balances as of March 31, 2021   7   $3,559    166,228,568   $164    1,313,836   $(11,603)  $499,272   $(474,080)  $(68)  $17,244   $(1,362)  $15,882 
Foreign exchange translation       
        
        
    
    
    (54)   (54)   
    (54)
Stock-based compensation       
    35,714    
        
    983    
    
    983    
    983 
Issuance of common stock in connection with a business combination       
    1,483,129    2        
    2,504    
    
    2,506    
    2,506 
Preferred stock dividends paid with common stock       
    53,278    
        
    89    (89)   
    
    
    
 
Net income       
        
        
    
    5,187    
    5,187    7    5,194 
Balances as of June 30, 2021   7    3,559    167,800,689    166    1,313,836    (11,603)   502,848    (468,982)   (122)   25,866    (1,355)   24,511 
Foreign exchange translation       
        
        
    
    
    35    35    
    35 
Stock-based compensation       
    132,630    
        
    946    
    
    946    
    946 
Issuance of common stock in connection with business combinations       
    1,179,156    1        
    2,317    
    
    2,318    
    2,318 
Treasury stock in connection with taxes withheld from employees       
    (2,015)   
    2,015    (5)   
    
    
    (5)   
    (5)
Preferred stock dividends                               (89)   
    (89)   
    (89)
Net loss       
        
        
    
    (184)   
    (184)   (11)   (195)
Balances as of September 30, 2021   7    3,559    169,110,460    167    1,315,851    (11,608)   506,111    (469,255)   (87)   28,887    (1,366)   27,521 
Foreign exchange translation        
 
         
 
         
 
    
 
    
 
    (14)   (14)   
 
    (14)
Stock-based compensation        
 
    147,712    
 
         
 
    1,349    
 
    
 
    1,349    
 
    1,349 
Issuance of common stock in connection with equity line purchase  commitment       
    210,084    
        
    
    
    
    
    
    
 
Preferred stock dividends             102,697                   178              178         178 
Issuance of common stock in connection with performance stock units             263                   
             
         
 
Issuance of common stock in connection with ATM raises, net        
 
    5,300,000    7    
 
    
 
    12,371    
 
    
 
    12,378    
 
    12,378 
Preferred stock dividends accrued                                 89    (89)        
         
 
Net loss        
 
         
 
         
 
    
 
    (385)   
 
    (385)   (19)   (404)
Balances as of December 31, 2021   7    3,559    174,871,216    174    1,315,851    (11,608)   520,099    (469,729)   (101)   42,394    (1,385)   41,009 

 

See accompanying Notes to Condensed Consolidated Financial Statements

 

5

 

 

CINEDIGM CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

    Nine Months Ended
December 31,
 
    2021     2020  
Cash flows from operating activities:                
Net income (loss)   $ 4,595     $ (56,103 )
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                
Depreciation and amortization of property and equipment and amortization of intangible assets     3,663       5,469  
Changes in fair value of equity investment in Starrise     (1,464 )     42,377  
(Gain) loss from forgiveness of PPP loan and extinguishment of note payable     (2,178 )     852  
Impairment of advances     782       280  
Loss from sale of property and equipment    
      62  
Amortization of debt issuance costs included in interest expense    
      140  
Provision for doubtful accounts     (397 )     (123 )
Stock-based compensation     3,278       2,172  
Accretion and PIK interest expense added to note payable    
      294  
Interest expense for deferred consideration     30      
 
Interest expense for earnout consideration     67      
 
Other     59      
 
Changes in operating assets and liabilities, net of acquisitions:                
Accounts receivable     (8,164 )     9,820  
Inventory     74       359  
Unbilled revenue     (1,449 )     (1,085 )
Prepaids and other current assets, and other long-term assets    

(1,394

)     1,765  
Accounts payable, accrued expenses, and other liabilities    

7,883

      (21,831 )
Deferred revenue     (639 )     (1,224 )
Net cash provided by (used in) operating activities     4,746       (16,776 )
Cash flows from investing activities:                
Purchases of property and equipment     (292 )     (339 )
Purchase of businesses     (4,750 )    
 
Proceeds from the sale of property and equipment    
      156  
Sale of equity investment in Starrise     11       815  
Purchases of intangible assets    
      (742 )
Net cash used in investing activities     (5,031 )     (110 )
Cash flows from financing activities:                
Payments of notes payable     (7,786 )     (22,365 )
(Payments) proceeds under revolving credit agreement, net     (1,956 )     12,823  
Proceeds from PPP Loan    
      2,152  
Proceeds from issuance of Class A common stock, net     12,378       36,189  
Net cash provided by financing activities     2,636       28,799  
Net change in cash, cash equivalents, and restricted cash     2,352       11,913  
Cash, cash equivalents, and restricted cash at beginning of period     17,849       15,294  
Cash, cash equivalents, and restricted cash at end of period   $ 20,201     $ 27,207  

 

See accompanying Notes to Condensed Consolidated Financial Statements

 

6

 

 

CINEDIGM CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(In thousands, except share information)

 

1. NATURE OF OPERATIONS AND LIQUIDITY

 

Cinedigm Corp. (“Cinedigm,” the “Company,” “we,” “us,” or similar pronouns) was incorporated in Delaware on March 31, 2000. We are (i) a distributor and aggregator of independent movie, television and other short form content managing a library of distribution rights to thousands of titles and episodes released across digital, physical, theatrical, home and mobile entertainment platforms (“Streaming”) and (ii) a servicer of digital cinema assets (“Systems”) for over 4,609 movie screens in both North America and several international countries.

 

We report our financial results in two primary segments as follows: (1) cinema equipment business and (2) content and entertainment business (“Content & Entertainment” or “CEG”). The cinema equipment business segment consists of the non-recourse, financing vehicles and administrators for our digital cinema equipment (the “Systems”) installed in movie theatres throughout North America and Australia. It also provides fee-based support to over 4,609 movie screens as well as directly to exhibitors and other third-party customers in the form of monitoring, billing, collection and verification services. Our Content & Entertainment segment operates in: (1) ancillary market aggregation and distribution of entertainment content and (2) branded and curated over-the-top (“OTT”) digital network business providing entertainment channels and applications.

 

Risks and Uncertainties

 

The COVID-19 pandemic and related economic repercussions created significant volatility and uncertainty impacting the Company’s results for the period. As part of our Content & Entertainment business, the Company sells DVDs and Blu-ray discs at brick-and-mortar stores. Due to the lingering effects of the COVID-19 pandemic in the nine-month period ended December 31, 2021, the sale of physical discs through our retail partners declined although this was partially offset by digital purchases of physical product and increases in streaming views. As part of our Cinema Equipment business, the Company earns revenue when movies are exhibited in theatres. Major studios continued to release tentpole films in the theatrical markets as box office results steadily showed improvement in the three months ended December 31, 2021.  However, the number of wide releases remained below pre-pandemic levels during that quarter as studios continue to shuffle release dates and test theatrical windows.  The Canadian government tightened Movie Theatre restrictions amid a Covid surge due to the Omicron variant as well as shuttering all Quebec theatres during that quarter.  Movie theatres in the U.S. remained open and continued to follow NATO CinemaSafe protocols in an effort to help reinforce consumer confidence in the safety of the theatrical moviegoing experience. 

 

Liquidity

 

We have incurred net losses historically and have an accumulated deficit of $469.7 million and our working capital is $2.9 million as of December 31, 2021. We may continue to generate net losses for the foreseeable future. In addition, we have had debt-related contractual obligations. Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect Loan (as defined below) non-recourse debt amount by paying an aggregate principal amount of $7.8 million. As of December 31, 2021 there was $0 million principal outstanding and there was no availability under the Credit Facility which expired on September 28, 2021. Net cash provided by operating activities for the nine months ended December 31, 2021 was $4.7 million. Based on these conditions and the Company´s financing strategies, the Company entered into the transactions described below:

 

Sale of Cinematic Equipment

 

On March 17, 2021, the Company entered into two separate agreements for the sale of cinematic equipment to American Multi-Cinema, Inc. (“AMC”). The agreements included the sale in tranches of a total of 2,369 cinematic projectors starting in March 2021 and continuing through January 2023 for total cash consideration of $10.8 million. Through December 31, 2021, the Company recognized aggregate revenue for $9.1 million. A portion of the total proceeds were used to paydown the remaining outstanding balance of the Prospect Loan notes payable.

  

7

 

 

Equity Investment in a Related Party

 

On December 27, 2019, the Company entered into, and on February 14, 2020 amended, (see Note 2 - Summary of Significant Accounting Policies), a stock purchase agreement (as so amended, the “Starrise Stock Purchase Agreement”) with BeiTai Investment LP (“BeiTai”), a related party for accounting purposes of Cinedigm and Aim Right Ventures Limited (“Aim Right”), two shareholders of Starrise Media Holdings Limited, a leading Chinese entertainment company (“Starrise”), to buy from them an aggregate of 410,901,000 outstanding Starrise ordinary shares (the “Starrise Share Acquisition”). On February 14, 2020, the Company purchased 162,162,162 of the Starrise ordinary shares from BeiTai and issued BeiTai 21,646,604 shares of its Class A common stock, par value $.001 per share (the “Common Stock”) in consideration therefor. The Starrise shares received were valued at approximately $25 million and the Company issued shares that were valued at approximately $11.2 million. On April 10, 2020, the Company, in accordance with the terms of the Stock Purchase Agreement, terminated its obligation to purchase Starrise ordinary shares from Aim Right under the Starrise Stock Purchase Agreement.

 

On April 10, 2020, the Company entered into another stock purchase agreement (the “April Starrise Stock Purchase Agreement”) with five (5) shareholders of Starrise - Bison Global Investment SPC - Bison Global No. 1 SP, Huatai Investment LP, Antai Investment LP, Mingtai Investment LP and Shangtai Asset Management LP - all of which are related parties to the Company to buy an aggregate of 223,380,000 outstanding Starrise ordinary shares from them and for the Company to issue to them an aggregate of 29,855,081 shares of its Common Stock as consideration therefor (the “April Starrise Share Acquisition”). On April 15, 2020, the April Starrise Share Acquisition was consummated and this transaction was also recorded as an equity investment in Starrise.

 

Starrise’s ordinary shares (HK 1616) are listed on the main board of the Stock Exchange of Hong Kong Limited. Based on the closing price of HKD 0.159 per share on February 11, 2022, calculated at an exchange rate of 7.8 Hong Kong Dollars to 1 US dollar, the market value of Cinedigm’s ownership in Starrise ordinary shares was approximately $7.4 million. 

 

Borrowings

 

On June 22, 2021, the maturity date of the East West Credit Facility (as defined in Note 5 - Notes Payable) with East West Bank was extended from June 30, 2021 to September 28, 2021 and was not extended.

 

On April 15, 2020, the Company received $2.2 million from East West Bank, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts were intended to be eligible for forgiveness, subject to the provisions of the CARES Act, and could be subject to repayment. On July 7, 2021, the Company received notification from the lender that the U.S. Small Business Administration had approved the Company’s PPP Loan forgiveness application for the entire PPP Loan amount and accrued interest effective as of June 30, 2021. The forgiveness of the PPP Loan was recognized as a gain of $2.2 million during the Company’s fiscal quarter ended June 30, 2021.

 

Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect loan non-recourse outstanding debt amount by paying an aggregate principal amount of $7.8 million. Pre-payment of the Prospect Loan was permissible without penalty.

 

Common Stock Purchase Agreement

 

In October 2021, we entered into a Common Stock Purchase Agreement (the “Equity Line Purchase Agreement”) and a Registration Rights Agreement (the “Registration Rights Agreement”) with B. Riley Principal Capital, LLC (“B. Riley Principal Capital”). Pursuant to the Equity Line Purchase Agreement, the Company has the right to sell to B. Riley Principal Capital up to the lesser of (i) $50,000,000 of newly issued shares of Common Stock and (ii) the Exchange Cap (as defined below) (subject to certain conditions and limitations), from time to time during the 24-month period from and after the October 21, 2021. Sales of Common Stock pursuant to the Equity Line Purchase Agreement, and the timing of any sales, are solely at the option of the Company, and the Company is under no obligation to sell any securities to B. Riley Principal Capital under the Equity Line Purchase Agreement. As consideration for B. Riley Principal Capital’s commitment to purchase shares of Common Stock at the Company’s direction upon the terms and subject to the conditions set forth in the Equity Line Purchase Agreement, upon execution of the Equity Line Purchase Agreement, the Company issued 210,084 shares of Common Stock to B. Riley Principal Capital (the “Commitment Shares”). The purchase price of the shares of Common Stock that we elect to sell to B. Riley Principal Capital pursuant to the Equity Line Purchase Agreement will be determined by reference to the volume weighted average price of the Common Stock (“VWAP”) during the applicable purchase date, less a fixed 5% discount to such VWAP. Pursuant to the Registration Rights Agreement, the Company filed a Registration Statement on Form S-1 that was declared effective by the Securities and Exchange Commission on October 21, 2021 (File No. 333-260210) for the resale by B. Riley Principal Capital of up to 25,210,084 shares of Common Stock (including the Commitment Shares) acquired pursuant to the Equity Line Purchase Agreement. During October and November 2021, we sold 5,300,000 shares of Common Stock under the Equity Line Purchase Agreement. Net proceeds from such sales totaled $12.4 million.

 

We believe the combination of: (i) our cash and cash equivalent balances at December 31, 2021 and (ii) expected cash flows from operations, as well as liquidity for our operational and capital needs, for twelve months from the filing of this report will be sufficient to satisfy our contractual obligations, as well as liquidity for our operational and capital needs, for twelve months from the filing of this report. Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. Failure to generate additional revenues, obtain additional capital or manage discretionary spending could have an adverse effect on our financial position, results of operations and liquidity.

 

8

 

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

BASIS OF PRESENTATION AND CONSOLIDATION

 

Our consolidated financial statements include the accounts of Cinedigm and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

Investments in which we do not have a controlling interest or are not the primary beneficiary, but have the ability to exert significant influence, are accounted for under the equity method of accounting. Noncontrolling interests for which we have been determined to be the primary beneficiary are consolidated and recorded as net loss attributable to noncontrolling interest. See Note 3 - Other Interests to the Consolidated Financial Statements for a discussion of our noncontrolling interests.

 

USE OF ESTIMATES

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates include the adequacy of accounts receivable reserves, return reserves, inventory reserves, recovery of advances, assessment of goodwill impairment, long-lived and finite-lived assets impairment and estimated amortization lives, fair value for asset acquisitions and business combinations, valuation allowances for income taxes and stock awards. Actual results could differ from these estimates.

 

CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

 

We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal. Our Prospect Loan required that we maintain specified cash balances that are restricted to repayment of interest thereunder. See Note 5 - Notes Payable for information about our restricted cash balances.

 

Cash, cash equivalents, and restricted cash consisted of the following:

 

   As of 
(in thousands)  December 31,
2021
   March 31,
2021
 
Cash and Cash Equivalents  $20,201   $26,207 
Restricted Cash   
    1,000 
   $20,201   $27,207 

 

EQUITY INVESTMENT IN STARRISE, A RELATED PARTY

 

On February 14, 2020, the Company acquired an approximately 11.5% interest in Starrise, a leading publicly traded Chinese entertainment company whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Starrise that is related to our major shareholders. When we acquired the Starrise stock, our then-majority affiliated stockholders also maintained a significant beneficial interest in Starrise. Upon consummation of the transaction on February 14, 2020, the Company recorded an initial investment of approximately $25 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.2 million, valued as of the date of the issuance of the Common Stock. The difference in value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital.

 

9

 

 

On April 10, 2020, the Company purchased an additional 15% interest in Starrise in a private transaction from shareholders of Starrise that are affiliated with the then-major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Common Stock of $11.0 million, valued at the date of the issuance of the Common Stock. The difference in the value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Starrise.

 

The Company has made an irrevocable election to apply the fair value accounting option under ASC 825-10, Financial Instruments, as it relates to its equity investment in Starrise. The Company’s investment in Starrise is marked to market and recorded at fair value.  The stock is traded on the Hong Kong Stock exchange with readily available pricing that is classified as Level 1 in the fair value hierarchy. The Company has established a policy that consistently uses either the closing price of last active trades or the latest bid price when there is no active trades, unadjusted at the last day of each reporting period, as the most relevant and representative input to the Level 1 fair value measures of its investment holdings.

 

As of December 31, 2021 and March 31, 2021, the value of our equity investment in Starrise, using the readily determinable fair value inputs from the market pricing of the Stock Exchange of Hong Kong, was approximately $7.9 million and $6.4 million, respectively, resulting in a change in fair value of approximately $1.5 million and ($42.4) million for the nine months ended December 31, 2021 and 2020 respectively, on our consolidated statement of operations. On April 1 and May 5, 2021, the Company sold 80,000 and 600,000 Starrise ordinary shares, respectively for a total amount of $11 thousand. At December 31, 2021 and March 31, 2021, the Company owned 362,307,397 and 362,987,397 ordinary shares or 17% and 26% of Starrise, respectively.

 

NON-MONETARY TRANSACTIONS

 

During the three and nine months ended December 31, 2020, the Company entered into agreements with certain vendors to transfer 5,139,762 and 14,184,765 Starrise ordinary shares to satisfy outstanding liabilities with these vendors. Upon the sale of the Starrise shares by the vendors, with certain restrictions on sales unless the Company gave consent to sell, if the proceeds did not satisfy the amount due to the vendor, the Company was liable for the balance owed. Pursuant to such agreements, the Company reduced the amount payable to its vendors by $0.8 million as of December 31, 2020. There were no such transactions during the nine months ended December 31, 2021.

 

There was no gain or loss resulting from these transactions for the three and nine months ended December 31, 2021 and 2020.

 

ACCOUNTS RECEIVABLE

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

We record accounts receivable, long-term in connection with activation fees that we earn from our digital cinema equipment (the “Systems”) deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rate.

 

ADVANCES

 

Advances, which are recorded within prepaid and other current assets on the consolidated balance sheets, represent amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record impairment charges for amounts that we expect may not be recoverable as of the consolidated balance sheet date. Impairments and accelerated amortization related to advances were $0.4 million and $0.3 million, respectively, for the three months ended December 31, 2021 and 2020. Impairments and accelerated amortization related to advances were $0.8 million and $0.3 million, respectively, for the nine months ended December 31, 2021 and 2020.

 

10

 

 

PROPERTY AND EQUIPMENT

 

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:

 

Computer equipment and software   3 - 5 years 
Internal use software   5 years 
Digital cinema projection systems   10 years 
Machinery and equipment   3 - 10 years 
Furniture and fixtures   3 - 6 years 

 

We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software. Post-configuration training and maintenance costs are expensed as incurred.

 

Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the leasehold improvements. Repair and maintenance costs are charged to expense as incurred. Major renewals, improvements and additions are capitalized. Upon the sale or other disposition of any property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and the gain or loss on disposal is included in the consolidated statements of operations.

 

FAIR VALUE MEASUREMENTS

 

The fair value measurement disclosures are grouped into three levels based on valuation factors:

 

  Level 1 – quoted prices in active markets for identical investments

 

  Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)

 

  Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)

 

Assets and liabilities measured at fair value on a recurring basis use the market approach, where prices and other relevant information are generated by market transactions involving identical or comparable assets or liabilities.

 

The equity investment in Starrise is in Hong Kong dollars and was translated into US dollars as of December 31, 2021 and March 31, 2021 at an exchange rate of 7.8 and 7.8 Hong Kong Dollars to 1 US Dollar, respectively. The fair value of this equity investment is measured by the unadjusted market pricing of Starrise on the Stock Exchange of Hong Kong.

 

The earnout consideration on purchase of Bloody Disgusting business (Note 4) is determined according to the probability-based method to the estimated the value of the earnout based on the premise that there are different probabilities to achieve different forecasts and therefore the defined earnout metric targets. Under this method, weighted-average earnout payments for each earnout period were estimated based on the probability of each forecast scenario. The resultant weighted-average earnout payments are discounted to a present value.

 

The following tables summarize the levels of fair value measurements of our financial assets and liabilities as of December 31, 2021 and March 31, 2021:

 

As of December 31, 2021                
                 
(in thousands)  Level 1   Level 2   Level 3   Total 
Assets:                
Equity investment in Starrise, at fair value  $7,896   $
   $
   $7,896 
   $7,896   $
   $
   $7,896 
                     
Liabilities:                    
Current portion of earnout consideration on purchase of a business  $
   $
    292    292 
Earnout consideration on purchase of a business, net of current portion  $
   $
    1,236    1,236 
   $
   $
   $1,528   $1,528 

  

As of March 31, 2021                
                 
(in thousands)  Level 1   Level 2   Level 3   Total 
Restricted cash  $1,000   $
   $
   $1,000 
Equity investment in Starrise, at fair value   6,443    
    
    6,443 
   $7,443   $
   $
   $7,443 

 

11

 

 

Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.

 

IMPAIRMENT OF LONG-LIVED AND FINITE-LIVED ASSETS

 

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. During the three and nine months ended December 31, 2021 and 2020, no impairment charge was recorded from operations for long-lived assets or finite-lived assets.

 

GOODWILL

 

Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.

 

Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.

 

The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test.

 

No goodwill impairment charge was recorded in the nine months ended December 31, 2021 and 2020.

 

Gross amounts of goodwill and accumulated impairment charges that we have recorded are as follows:

 

(In thousands)    
Goodwill at March 31, 2021  $8,701 
Goodwill from business combinations – see Note 4   4,958 
Goodwill at December 31, 2021  $13,659 

 

12

 

 

REVENUE RECOGNITION

 

We determine revenue recognition by:

 

  identifying the contract, or contracts, with the customer;

 

  identifying the performance obligations in the contract;

 

  determining the transaction price;

 

  allocating the transaction price to performance obligations in the contract; and

 

  recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.

 

We recognize revenue in the amount that reflects the consideration we expect to receive in exchange for the services provided, sales of physical products (e.g., DVDs and Blu-ray Discs) or when the content is available for subscription on the digital platform or available on the point-of-sale for transactional and video on demand services which is when the control of the promised products and services is transferred to our customers and our performance obligations under the contract have been satisfied. Revenues that might be subject to various taxes are recorded net of transaction taxes assessed by governmental authorities such as sales value-added taxes and other similar taxes.

 

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less.

 

Cinema Equipment Business

 

Our Cinema Equipment Business consists of financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).

 

We retain ownership of our digital cinema equipment (the “Systems”) and the residual cash flows related to the Systems in Phase I Deployment after the end of the 10-year deployment payment period.

 

For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.

 

The Cinema Equipment Business also provides monitoring, data collection, serial data verification and management services to this segment, as well as to exhibitors who purchase their own equipment, in order to collect virtual print fees (“VPFs”) from motion picture studios and distributors and Alternative Content Fees (“ACFs”) from alternative content providers, and to distribute those fees to theatrical exhibitors (collectively, “Services”).

 

VPFs are earned, net of administrative fees, pursuant to contracts with movie studios and distributors, whereby amounts are payable by a studio to Phase I Deployment and to Phase II Deployment when movies distributed by the studio are displayed on screens utilizing our Systems installed in movie theatres. VPFs are earned and payable to Phase I Deployment based on a defined fee schedule until the end of the VPF term. One VPF is payable for every digital title initially displayed per System. The amount of VPF revenue is dependent on the number of movie titles released and displayed using the Systems in any given accounting period. VPF revenue is recognized in the period the title first plays for general audience viewing in a digital projector equipped movie theatre. The Phase 1 Deployment’s and Phase 2 Deployments performance obligations for revenue recognition are met at this time. 

  

13

 

 

Phase II Deployment’s agreements with distributors require the payment of VPFs, according to a defined fee schedule, for ten years from the date each system is installed; however, Phase II Deployment may no longer collect VPFs once “cost recoupment,” as defined in the contracts with movie studios and distributors, is achieved. Cost recoupment will occur once the cumulative VPFs and other cash receipts collected by Phase II Deployment have equaled the total of all cash outflows, including the purchase price of all Systems, all financing costs, all “overhead and ongoing costs”, as defined, and including service fees, subject to maximum agreed upon amounts during the three-year rollout period and thereafter. Further, if cost recoupment occurs before the end of the eighth contract year, the studios will pay us a one-time “cost recoupment bonus.” The Company evaluated the constraining estimates related to the variable consideration, i.e., the one-time bonus and determined that it is not probable to conclude at this point in time that a significant reversal in the amount of cumulative revenue recognized will occur when the uncertainty associated with the variable consideration is subsequently resolved.

 

Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Cinedigm recognizes revenue once the customer takes possession of the Systems and Cinedigm received the sale proceeds. Such sales were originally contemplated as the conclusion of the digital cinema deployment plan.  Total system sales revenue recognized was $1.3 million and $66 thousand, during the three months ended December 31, 2021 and 2020, respectively. Total system sales revenue recognized was $9.1 million and $157 thousand, during the nine months ended December 31, 2021 and 2020, respectively. Revenues earned in connection with up front exhibitor contributions are deferred and recognized over the expected cost recoupment period.

 

Exhibitors who purchased and own Systems using their own financing in Phase II of the Cinema Equipment Business paid us an upfront activation fee of approximately $2.0 thousand per screen (the “Exhibitor-Buyer Structure”). Upfront activation fees were recognized in the period in which these Systems were delivered and ready for content, as we had no further obligations to the customer after that time and collection was reasonably assured. In addition, we recognize activation fee revenue of between $1.0 thousand and $2.0 thousand on Phase II Deployment Systems and for Systems installed by CDF2 Holdings, a related party, (See Note 3 - Other Interests) upon installation and such fees are generally collected upfront upon installation. Our services division manages and collects VPFs on behalf of exhibitors, for which it earns an administrative fee equal to 10% of the VPFs collected.

 

The Cinema Equipment Business earns an administrative fee of approximately 5% of VPFs collected and, in addition, earns an incentive service fee equal to 2.5% of the VPFs earned by Phase 1 DC. This administrative fee is related to the collection and remittance of the VPF’s and the performance obligation is satisfied at that time the related VPF fees are due which is at the time the movies are displayed on screens utilizing our Systems installed in movie theatres. The service fees are recognized as a point in time revenue when the corresponding VPF fees are due from the movie studios and distributors.

 

Content & Entertainment Business

 

CEG earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or “OTT Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Physical Revenue” or “Base Distribution Business”). Fees earned are typically a percentage based on the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”)   on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the performance obligation is satisfied, which is when the content is available for subscription on the digital platform, at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Physical revenue is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration.

  

14

 

 

Physical goods reserved for sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

CEG also has contracts for the theatrical distribution of third party feature movies and alternative content. CEG’s distribution fee revenue and CEG’s participation in box office receipts are recognized at the time a feature movie and alternative content are viewed. CEG has the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

 

Principal Agent Considerations

 

We determine whether revenue should be reported on a gross or net basis for each revenue stream based on the transfer of control of goods and services. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

 

  which party is primarily responsible for fulfilling the promise to provide the specified good or service; and

 

  which party has discretion in establishing the price for the specified good or service.

 

Shipping and Handling

 

Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in cost of goods sold because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

 

Credit Losses

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

Our CEG segment recognizes accounts receivable, net of an estimated allowance for product returns and customer chargebacks, at the time that it recognizes revenue from a sale. Reserves for product returns and other allowances is variable consideration as part of the transaction price. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

We record accounts receivable, long-term in connection with activation fees that we earn from Systems deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rates.

 

Contract Liabilities

 

We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable.

 

Deferred revenue pertaining to our Content & Entertainment Business includes amounts related to the sale of DVDs with future release dates.

 

Deferred revenue relating to our Cinema Equipment Business pertains to revenues earned in connection with up front exhibitor contributions that are deferred and recognized over the expected cost recoupment period. It also includes unamortized balances in connection with activation fees due from the Systems deployments that have extended payment terms.

 

15

 

 

The ending deferred revenue balance as of December 31, 2021 was $0.3 million. For the three and nine months ended December 31, 2021 and 2020, respectively, the additions to our deferred revenue balance were primarily due to cash payments received or due in advance of satisfying performance obligations, while the reductions to our deferred revenue balance were primarily due to the recognition of revenue upon fulfillment of our performance obligations, both of which were in the ordinary course of business.

 

During the three months ended December 31, 2021 and 2020, $0.3 million and $1.2 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. During the nine months ended December 31, 2021 and 2020, $0.6 million and $2.5 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. As of December 31, 2021, the aggregate amount of contract revenue allocated to unsatisfied performance obligations was $0.3 million. This amount is to be recognized during January and February of 2022.

 

Participations and royalties payable

 

When we use third parties to distribute company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.

 

Disaggregation of Revenue

 

The Company disaggregates revenue into different revenue categories for the Cinema Equipment and CEG Businesses. The Cinema Equipment Business revenue categories are: Phase I Deployment revenue, Phase II Deployment revenue, Services, and Digital System Sales, and the Content & Entertainment Business revenue categories are: Base Distribution Business and OTT Streaming and Digital.

 

The following tables present the Company’s revenue categories for the three and nine months ended December 31, 2021 and 2020 (in thousands):

 

   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2021   2020   2021   2020 
Cinema Equipment Business:                    
Phase I Deployment  $133   $281   $372   $424 
Phase II Deployment   87    367    891    1,067 
Services   506    196    1,171    481 
Digital System Sales   1,334    66    9,110    186 
Total Cinema Equipment Business revenue  $2,060   $910   $11,544   $2,158 
                     
Content & Entertainment Business:                    
Base Distribution Business  $3,668   $4,152   $6,368   $9,218 
OTT Streaming and Digital   8,356    4,892    21,290    11,778 
Total Content & Entertainment Business revenue  $12,024   $9,044   $27,658   $20,996 

 

DIRECT OPERATING COSTS

 

Direct operating costs consist of operating costs such as cost of goods sold, fulfillment expenses, shipping costs, property taxes and insurance on Systems, royalty expenses, impairments of advances, and marketing and direct personnel costs.

 

16

 

 

STOCK-BASED COMPENSATION

 

The Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The Company measures the compensation expense of employee and nonemployee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and nonemployee is required to provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.

 

INCOME TAXES

 

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax bases.

 

Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States.

 

The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10, Income Taxes (Accounting for Uncertainty in Income Taxes), which clarified the accounting for uncertainty in tax positions. This amendment provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.

 

NET INCOME/LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS

 

Basic and diluted net loss per common share has been calculated as follows:

 

Basic and diluted net loss per common share attributable to common stockholders =   Net loss attributable to common stockholders
  Weighted average number of common stock outstanding during the period

 

Stock issued and treasury stock repurchased during the period are weighted for the portion of the period that they are outstanding. Shares issued and any shares that are reacquired during the period are weighted for the portion of the period that they are outstanding.

 

We had net income for the nine months ended December 31, 2021, and therefore the impact of potentially dilutive common shares from outstanding stock options, stock appreciation rights, and warrants, totaling 3,603,491 shares for the nine months ended December 31, 2021, respectively, was included in the computations of diluted earnings per share. For the three months ended December 31, 2021, 12,088,473 potentially dilutive shares have been excluded from the diluted loss per share as their impact would have been antidilutive. We had a net loss for the three months ended December 31, 2021 and therefore no dilution as basic and diluted loss per share are the same for the period. The calculation of diluted net income per share for the nine months ended December 31, 2021 does not include the impact of 8,484,982 potentially dilutive shares relating to stock options, stock appreciation rights, and warrants as their impact would have been anti-dilutive as their exercise prices are above the Company’s average Common Stock price during the period.

 

We incurred net losses for the three and nine months ended December 31, 2020, and therefore the impact of potentially dilutive common shares from outstanding stock options and warrants, totaling 9,040,138 shares as of December 31, 2020, were excluded from the computations of loss per share as their impact would have been anti-dilutive.

 

17

 

 

COMPREHENSIVE INCOME (LOSS)

 

As of the three and nine months ended December 31, 2021 and 2020, comprehensive income (loss) consisted of net loss and foreign currency translation adjustments.

 

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

 

Adopted

 

On December 18, 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The update also simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance to improve consistent application. The amendment in this update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company adopted this guidance on April 1, 2021 and the adoption of this ASU did not have a material impact on our consolidated financial statements.

 

Not yet adopted

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which provides new guidance regarding the measurement and recognition of credit impairment for certain financial assets. Such guidance will impact how the Company determines its allowance for estimated uncollectible receivables and evaluates its available-for-sale investments for impairment. ASU 2016-13 is effective for the Company in the first quarter of fiscal 2023. The Company is currently evaluating the effect that ASU 2016-13 will have on its consolidated financial statements and related disclosures.

 

3. OTHER INTERESTS

 

Investment in CDF2 Holdings

 

We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.

 

CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification Topic 810 (“ASC 810”), “Consolidation.” ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.

 

As of December 31, 2021 and March 31, 2021, our maximum exposure to loss, as it relates to the non-consolidated CDF2 Holdings entity, represents accounts receivable for service fees under a master service agreement with CDF2 Holdings. Such accounts receivable was $0.7 million and $0.3 million as of December 31, 2021 and March 31, 2021, respectively, which are included in accounts receivable, net on the accompanying consolidated balance sheets.

 

The accompanying Consolidated Statements of Operations include $0.5 million and $83 thousand of digital cinema servicing revenue from CDF2 Holdings for the nine months ended December 31, 2021 and 2020, respectively. The accompanying Consolidated Statements of Operations include $0.2 million and $47 thousand of digital cinema servicing revenue from CDF2 Holdings for the three months ended December 31, 2021 and 2020, respectively.

 

Total Stockholders’ Deficit of CDF2 Holdings at December 31, 2021 and March 31, 2021 was $52.9 million and $46.3 million, respectively. We have no obligation to fund the operating loss or the stockholders’ deficit beyond our initial investment of $2.0 million and, accordingly, our investment in CDF2 Holdings as of December 31, 2021 and March 31, 2021 is carried at $0.

 

18

 

 

Majority Interest in CONtv

 

We own an 85% interest in CON TV, LLC, a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the Internet and other consumer digital distribution platforms, such as gaming consoles, set-top boxes, handsets, and tablets.

 

4. BUSINESS COMBINATION

 

FoundationTV, Inc.

 

On May 12, 2021, the Company entered into a stock purchase agreement (the “Foundation Stock Purchase Agreement”) with FoundationTV, Inc. (“FoundationTV”), to buy all of FoundationTV´s issued and outstanding stock in consideration of an aggregate of $5.2 million, of which $0.7 million was paid in cash and 1,483,129 shares of Common Stock, which were valued at $2.5 million, were issued at closing stock price of $1.69 on the closing date of June 9, 2021, and an additional $2.0 million will be paid in eight equal installments of one installment on each six month anniversary of closing over forty-eight months, and a final lump sum payment of $225 thousand on the four year anniversary of the closing, reduced by $0.2 million settlement of a prior relationship. The Foundation Stock Purchase Agreement contained certain conditions to closing, including that the Company obtain approval of its stockholders, applicable lenders, and regulatory authorities, as applicable, and representations and warranties and covenants as are customary for transactions of this type. On June 9, 2021, the FoundationTV acquisition was consummated. The Company incurred transaction costs of $36 thousand during the nine months ended December 31, 2021. As of December 31, 2021, the deferred consideration initially measured by bringing to present value the agreed-upon cash payments discounted by a 3% rate, includes a $0.5 million short-term payable and a long-term payable for $1.5 million.

 

Purchase Price    
Purchase Price  $5,237 
Total purchase price  $5,237 
      
Allocation of purchase price     
Developed technology   3,200 
Goodwill   2,037 
Total allocation of purchase price  $5,237 

 

The developed technology acquired in this transaction has a useful life of 10 years. During the three and nine months ended December 31, 2021, the Company recorded $80 thousand and $160 thousand in amortization expense related to the developed technology acquired in the acquisition.

 

Below is the amortization expense per year for the developed technology acquired in the business combination:

 

2022 (remaining)  $80 
2023   320 
2024   320 
2025   320 
2026   320 
2027   320 
2028   320 
2029   320 
2030   320 
2031   320 
2032   80 
Total  $3,040 

 

19

 

 

Bloody Disgusting, LLC

 

On September 17, 2021, the Company entered into an asset purchase agreement (the “Bloody Disgusting Asset Purchase Agreement”) with Bloody Disgusting, LLC (“Bloody Disgusting”), to buy substantially all of the assets of Bloody Disgusting, in consideration of an aggregate of $7.8 million, of which $4.0 million was paid in cash and 1,039,501 shares of Common Stock, which were valued at $2.3 million, were issued at closing stock price of $2.23 on the closing date of September 17, 2021, and $1.5 million as of the fair value of the earnout liability, related to earnout targets, as defined, to be met as of March 2022, March 2023 and March 2024. The fair value of the earnout liability was estimated considering the weighted probability of scenarios on the earnout metrics possible outcomes during the earnout period. The Bloody Disgusting Asset Purchase Agreement contained certain conditions to closing and representations and warranties and covenants as are customary for transactions of this type. On September 17, 2021, the Bloody Disgusting acquisition was consummated. The Company incurred transaction costs of $40 thousand during the nine months ended December 31, 2021. During the three months ended December 31, 2021, the Company finalized the measurement of the assets acquired.

 

Purchase Price    
Purchase Price  $7,780 
Total purchase price  $7,780 
      
Allocation of purchase price     
Current assets   9 
Advertiser relationships   3,750 
Trade name   1,100 
Goodwill   2,921 
Total allocation of purchase price  $7,780 

 

The advertiser relationships acquired in this transaction has a useful life of 12 years and the trade name acquired has a useful life of 10 years. During the three and nine months ended December 31, 2021, the Company recorded $105 thousand in amortization expense related to the intangible assets acquired.

 

Below is the amortization expense per year for the intangible assets acquired in the business combination:

 

   Advertiser relationships   Trade name   Total 
2022 (remaining)  $78   $28   $106 
2023   313    110    423 
2024   313    110    423 
2025   313    110    423 
2026   313    110    423 
2027   313    110    423 
2028   313    110    423 
2029   313    110    423 
2030   313    110    423 
2031   313    110    423 
2032   313    55    368 
2033   313    
    313 
2034   151    
    151 
Total   3,672    1,073   $4,745 

 

20

 

 

5. NOTES PAYABLE

 

Notes payable consisted of the following:

 

   December 31,
2021
   March 31,
2021
 
(In thousands)  Current
Portion
   Long Term
Portion
   Current
Portion
   Long Term
Portion
 
Prospect Loan  $
   $
   $7,786   $
 
Total non-recourse notes payable   
    
    7,786    
 
Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts  $
   $
   $7,786   $
 
Credit Facility  $
   $
   $1,956   $
 
PPP Loan   
    
    
    2,152 
Total recourse notes payable   
    
    1,956    2,152 
Total recourse notes payable, net of unamortized debt issuance costs and debt discounts  $
   $
   $1,956   $2,152 
Total notes payable, net of unamortized debt issuance costs  $
    —
   $
   $9,742   $2,152 

 

Non-recourse debt is generally defined as debt whereby the lenders’ sole recourse with respect to defaults is limited to the value of the asset, which is collateral for the debt. Certain of our subsidiaries are liable with respect to, and their assets serve as collateral for, certain indebtedness for which our assets and the assets of our other subsidiaries that are not parties to the transaction are generally not liable. We have referred to this indebtedness as “non-recourse debt” because the recourse of the lenders is limited to the assets of specific subsidiaries. Such indebtedness includes the Prospect Loan.

 

Prospect Loan

 

In February 2013, our Cinedigm DC Holdings, LLC (“CDCH”), Access Digital Media, Inc (“AccessDM”) and Access Digital Cinema Phase 2, Corp. (“Phase 2 DC”) subsidiaries entered into a term loan agreement (the “Prospect Loan” or the “Term Loan Agreement”) with Prospect Capital Corporation (“Prospect”), pursuant to which CDCH borrowed $70.0 million. The Prospect Loan included interest at LIBOR plus 9.0% (with a 2.0% LIBOR floor), which was payable in cash, and at an additional 2.50% accrued as an increase to the aggregate principal amount of the Prospect Loan until the Prospect Loan was paid off, at which time all accrued interest became payable in cash.

 

Collections of CDCH accounts receivable were deposited into accounts designated to pay certain operating expenses, principal, interest, fees, costs and expenses relating to the Prospect Loan. On a quarterly basis, if there was excess cash flow, it was used for prepayment of the Prospect Loan. We also maintained a debt service fund under the Prospect Loan for future principal and interest payments. As of December 31, 2021, and March 31, 2021, the debt service fund had a balance of $0 and $1.0 million, respectively, which was classified as part of restricted cash on our Consolidated Balance Sheets.

 

On March 4, 2021, CDCH, AccessDM, Phase 2 DC, Christie/AIX, Inc., Cinedigm Digital Funding I, LLC, certain Lenders, and Prospect Capital Corporation, as administrative agent and collateral agent, entered into Amendment No. 3 (the “Prospect Amendment”) to the Term Loan Agreement. Under the Prospect Amendment, the maturity date of the loan under the Term Loan Agreement was extended to March 31, 2022. As a condition to the effectiveness of the Amendment, CDCH paid $3,500,000 to Prospect to reduce the outstanding principal amount of the Loan.

 

The Prospect Loan was secured by, among other things, a first priority pledge of the stock of CDF2 Holdings, our wholly-owned unconsolidated subsidiary, the stock of AccessDM, owned by DC Holdings, and the stock of our Phase 2 DC subsidiary, and was also guaranteed by AccessDM and Phase 2 DC. We provided limited financial support to the Prospect Loan not to exceed $1.5 million per year in the event financial performance did not meet certain defined benchmarks.

 

The Prospect Loan contained customary representations, warranties, affirmative covenants, negative covenants and events of default.

 

Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect Loan outstanding non-recourse debt amount by paying an aggregate principal amount of $7.8 million. Pre-payment of the Prospect Loan was permissible without penalty.

 

21

 

 

The following table summarizes the activity related to the Prospect Loan:

 

   As of 
(In thousands)  December 31,
2021
   March 31,
2021
 
Prospect Loan, at issuance  $70,000   $70,000 
PIK Interest   8,016    6,397 
Payments to date   (78,016)   (68,611)
Prospect Loan, gross  $
   $7,786 
Less unamortized debt issuance costs and debt discounts   
    
 
Prospect Loan, net   
    7,786 
Less current portion   
    (7,786)
Total long term portion  $
   $
 

 

Credit Facility and Cinedigm Revolving Loans

 

On March 30, 2018, the Company entered into the Loan, Guaranty and Security Agreement, dated as of March 30, 2018, by and between the Company, East West Bank and the Guarantors named therein (the “Credit Facility”) for a maximum of $19.0 million in revolving loans outstanding at any one time with a maturity date of March 31, 2020, which may be extended for two successive one-year periods at the sole discretion of the lender, subject to certain conditions.

 

Interest under the Credit Facility is due monthly at a rate elected by the Company of either 0.5% plus Prime Rate or 3.25% above LIBOR Rate established by the lender.

 

On July 3, 2019, the Company entered into an amendment to the Credit Facility (the “EWB Amendment”). The EWB Amendment reduced the size of the facility to $18.0 million, required certain prepayments and daily cash sweeps from collections of receivables to be made, changed in certain respects how the borrowing base is calculated, and extended the maturity date to June 30, 2020. In connection with the EWB Amendment, three of our subsidiaries became Guarantors under the Credit Facility. On June 25, 2020, the Company and East West Bank amended the Credit Facility to extend the maturity of the Credit Facility to June 30, 2021 and waive events of default provisions. On June 22, 2021, the maturity date of the Credit Facility was extended to September 28, 2021. During this extension period, unless an amendment had been entered into, we were not able to access any additional borrowings under the Credit Facility. The September 28, 2021 expiration date has passed and the agreement was not extended.

 

As of December 31, 2021 and March 31, 2021, there was $0 and $2.0 million outstanding, respectively, and there was no availability under the Credit Facility based on the Company’s borrowing base as of December 31, 2021.

 

PPP Loan

 

On April 15, 2020, the Company received $2.2 million from East West Bank, the Company’s existing lender, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts were intended to be eligible for forgiveness, subject to the provisions of the CARES Act, and could be subject to repayment. On July 7, 2021, the Company received notification from the lender that the U.S. Small Business Administration had approved the Company’s PPP Loan forgiveness application for the entire PPP Loan amount and accrued interest effective June 30, 2021.

 

22

 

 

6. STOCKHOLDERS’ EQUITY

 

COMMON STOCK

 

Authorized Class A Common Stock 

 

On October 11, 2021, the Company filed a Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation, pursuant to which the number of shares of Class A common stock authorized for issuance was increased to 275,000,000 shares.

 

During the nine months ended December 31, 2021, we issued 8,642,648 shares of Common Stock which consist of the sale of shares of our Class A common stock, issuance of Common Stock for business combination, the issuances of Common Stock in payment of preferred stock dividends and in payment of board retainer fees.

 

PREFERRED STOCK

 

Cumulative dividends in arrears on preferred stock were $0.1 million and $0.1 million as of December 31, 2021 and March 31, 2021, respectively. In May 2021 and October 2021, we paid preferred stock dividends in arrears in the form of 53,278 and 102,697 shares of Class A common stock, respectively.

 

TREASURY STOCK

 

We have treasury stock, at cost, consisting of 1,315,851 and 1,313,836 shares of Class A common stock at December 31, 2021 and March 31, 2021, respectively.

 

CINEDIGM’S EQUITY INCENTIVE PLANS

 

Stock Based Compensation Awards

 

Awards issued under our 2000 Equity Incentive Plan (the “2000 Plan”) may be in any of the following forms (or a combination thereof) (i) stock option awards; (ii) stock appreciation rights; (iii) stock or restricted stock or restricted stock units; or (iv) performance awards. The 2000 Plan provides for the granting of incentive stock options (“ISOs”) with exercise prices not less than the fair market value of our Common Stock on the date of grant. ISOs granted to shareholders having more than 10% of the total combined voting power of the Company must have exercise prices of at least 110% of the fair market value of our Common Stock on the date of grant. ISOs and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is subject to the continuous service of the participant. The exercise prices and vesting periods (if any) for non-statutory options are set at the discretion of our compensation committee. On November 1, 2017, upon the consummation of the initial equity investment in Cinedigm by Bison, as a result of which there was a change of control of the Company, all stock options (incentive and non-statutory) and shares of restricted stock were vested immediately and the options became fully exercisable.

 

In connection with the grants of stock options and shares of restricted stock under the 2000 Plan, we and the participants have executed stock option agreements and notices of restricted stock awards setting forth the terms of the grants. The 2000 Plan provided for the issuance of up to 2,380,000 shares of Common Stock to employees, outside directors and consultants.

 

As of December 31, 2021, there were 217,837 stock options outstanding in the 2000 Plan with weighted average exercise price of $14.49 and a weighted average contract life of 1.42 years. As of March 31, 2021, there were 261,587 shares pursuant to stock options outstanding in the Plan with weighted average exercise price of $14.99 and a weighted average contract life of 2.11 years. A total of 43,500 options expired and 250 options forfeited during the three and nine months ended December 31, 2021.

 

23

 

 

Options outstanding under the 2000 Plan as of December 31, 2021 is as follows:

 

As of December 31, 2021 
Range of Prices   Options Outstanding   Weighted Average Remaining Life in Years   Weighted Average Exercise Price   Aggregate Intrinsic Value
(In thousands)
 
 $7.40 - $13.69    5,000    3.50   $7.40   $
 
 $14.00 - $24.40    212,837    1.37    14.65    
 
      217,837             $
 

 

An analysis of all options exercisable under the 2000 Plan as of December 31, 2021 is presented below:

 

Options Exercisable   Weighted Average
Remaining Life in Years
   Weighted Average
Exercise Price
   Aggregate Intrinsic Value
(In thousands)
 
 217,837    1.42   $14.49    
 

 

In August 2017, the Company adopted the 2017 Equity Incentive Plan (the “2017 Plan). The 2017 Plan replaced the 2000 Plan, and applies to employees and directors of, and consultants to, the Company. The 2017 Plan provided for the issuance of up to 2,108,270 shares of Class A common stock, in the form of various awards, including stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance awards and cash awards. The Compensation Committee of the Company’s Board of Directors (the “Board”) is authorized to administer the 2017 Plan and make grants thereunder. The approval of the 2017 Plan did not affect awards already granted under the 2000 Plan. On December 4, 2019, upon shareholder approval, the 2017 Plan was amended to increase the maximum number of shares of Class A common stock authorized for issuance thereunder from 2,108,270 shares to 4,098,270.

 

On October 23, 2020, the Company amended its 2017 Plan to increase the number of shares authorized for issuance thereunder from 4,098,270 to 14,098,270.

 

On October 11, 2021, the Company amended its 2017 Plan to increase the number of shares authorized for issuance thereunder from 14,098,270 to 18,098,270.

 

During the nine months ended December 31, 2021, the Company granted 1,807,625 stock appreciation rights (“SARs”). The SARs were granted under the Company’s 2017 Equity Incentive Plan (the “2017 Plan), except for 600,000 SARs granted to an officer of the Company as an inducement grant. All SARs issued have an exercise price equal to the fair value of the Company’s Class A common stock on the date of grant and a maturity date of 10 years. The SARs were valued on the grant date utilizing an option pricing model, as follows:

 

Grant Date: May 23, 2021 – November 30, 2021

 

Maturity Date: May 23, 2031 – November 30, 2031

 

Exercise price: $1.29 - $2.56

 

Volatility: 110.32% - 114.42%

 

Discount rate: 0.96% - 1.50%

 

Expected term: 66.5 years

 

Stock appreciation rights outstanding under the 2017 Plan as of December 31, 2021 is as follows:

 

As of December 31, 2021 
Range of Prices   SAR´s Outstanding   Weighted Average Remaining Life in Years   Weighted Average Exercise Price   Aggregate Intrinsic Value
(In thousands)
 
 $0.54 - $0.74    5,550,000    8.99   $0.64   $3,131 
 $1.16 - $1.47    2,050,860    8.15    1.37    
 
 $1.71 - $2.10    2,680,738    9.16    1.97    
 
 $2.23 - $2.56    394,375    9.85    2.33    
 
      10,675,973             $3,131 

 

An analysis of all stock appreciation rights exercisable under the 2017 Plan as of December 31, 2021 is presented below:

 

Options Exercisable   Weighted Average
Remaining Life in Years
   Weighted Average
Exercise Price
   Aggregate Intrinsic Value
(In thousands)
 
 2,712,610    7.26   $1.16    775 

 

24

 

 

Employee and director stock-based compensation expense related to our stock-based awards was as follows:

 

   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
(In thousands)  2021   2020   2021   2020 
Selling, general and administrative  $1,349   $960   $3,278   $2,172 
   $1,349   $960   $3,278   $2,172 

 

Total SARs outstanding are as follows:

 

   Nine Months
Ended
December 31,
2021
 
SARs Outstanding March 31, 2021   9,154,933 
Issued   1,807,625 
Forfeited   (286,585)
Total SARs Outstanding December 31, 2021   10,675,923 

 

There was $1 thousand and $1thousand of stock-based compensation recorded for the nine months ended December 31, 2021 and 2020, respectively, related to employees’ restricted stock awards. There was $0 thousand and $1thousand of stock-based compensation recorded for the three months ended December 31, 2021 and 2020, respectively, related to employees’ restricted stock awards.

 

There was $290 thousand and $131 thousand of stock-based compensation for the nine months ended December 31, 2021 and 2020, respectively, related to board of directors. There was $107 thousand and $65 thousand of stock-based compensation for the three months ended December 31, 2021 and 2020, respectively, related to board of directors. During the nine months ended December 31, 2021, the Company issued 245,887 shares to the board of directors.

 

OPTIONS GRANTED OUTSIDE CINEDIGM’S EQUITY INCENTIVE PLAN

 

In October 2013, we issued options outside of the 2000 Plan to 10 individuals who became employees as a result of a business combination. The employees received options to purchase an aggregate of 62,000 shares of our Class A Common Stock at an exercise price of $17.50 per share. The options were fully vested as of October 2017 and expire 10 years from the date of grant, if unexercised. As of December 31, 2021, 12,500 of such options remained outstanding.

  

WARRANTS

 

The following table presents information about outstanding warrants to purchase shares of our Class A common stock as of December 31, 2021. All of the outstanding warrants are fully vested and exercisable.

 

Recipient  Amount
outstanding
   Expiration   Exercise price
per share
 
5-year Warrant issued to BEMG in connection with a term loan agreement   1,400,000    December 2022   $1.80 

 

Warrants for the purchase of 298,519 shares of Common Stock expired unexercised during the nine months ended December 31, 2021.

 

7. COMMITMENTS AND CONTINGENCIES

 

From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities. Although the results of litigation and claims cannot be predicted with certainty, the Company does not believe it is party to any claim or litigation the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business. Regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources and other factors. 

 

We operate from leased properties under non-cancelable operating lease agreements, certain of which contain escalating lease clauses.

 

The Company leases office space under operating leases. The Company’s portfolio of leases is primarily related to real estate and since most of our leases do not provide a readily determinable implicit rate, the Company estimated its incremental borrowing rate to discount the lease payments based on information available at either the implementation date of Topic 842 or at lease commencement for leases entered into thereafter.

 

25

 

 

The table below presents the lease-related assets and liabilities recorded on the balance sheet as of December 31, 2021 and March 31, 2021:

 

(In thousands)  Classification on the Balance Sheet  December 31,
2021
   March 31,
2021
 
Assets           
Noncurrent  Operating lease right-of-use asset  $       16   $     100 
Liabilities             
Current  Operating leases – current portion   16    87 
Noncurrent  Operating leases – long-term portion   
    13 
Total operating lease liabilities     $16   $100 

 

Lease Costs

 

The table below presents certain information related to lease costs for leases:

 

   Nine months Ended   Nine months Ended 
(In thousands)  December 31,
2021
   December 31,
2020
 
Operating lease cost  $             90   $          160 
Total lease cost  $90   $160 

 

Other Information

 

The table below presents supplemental cash flow information related to leases:

 

   Nine months Ended   Nine months Ended 
(In thousands)  December 31,
2021
   December 31,
2020
 
Cash paid for amounts included in the measurement of lease liabilities                13                162 
Operating cash flows used for operating leases  $13   $162 

 

Distribution arrangement minimum guaranty

 

On September 1, 2021 the Company extended a video works distribution arrangement providing a non-refundable and fully-recoupable advance minimum participation guaranty for a total amount of $3.5 million, where $1.5 million is payable no later than November 1, 2021, $1.0 million at the first year anniversary of the arrangement and $0.9 million on the second-year anniversary of the arrangement. These payments are subject to the selection of video works released by the Company whose initial commercial date occurs during the arrangement year. The Company paid the first advance on October 22, 2021.

 

8. SUPPLEMENTAL CASH FLOW INFORMATION

 

   Nine Months Ended
December 31,
 
(In thousands)  2021   2020 
Cash interest paid  $701   $3,014 
Income taxes paid   79    
 
noncash investing and financing activities:          
Accrued dividends on preferred stock   89    89 
Issuance of Class A common stock for payment of accrued preferred stock dividends   267    267 
Issuance of Class A common stock to Starrise, a related party   
    11,046 
Contributed capital under the Starrise transaction, a related party   
    17,187 
Settlement of second lien loan with Class A common stock   
    3,008 
Conversion of note payable   
    15,000 
Class A common stock to be issued in connection with the asset acquisition   

    1,853 
Issuance of Class A common stock for business combination   4,824    
 
Starrise shares used to pay down vendors   

    897 
Treasury shares acquired for withholding taxes   5    
 
Deferred consideration in purchase of a business   1,980    
 
Earnout consideration in purchase of a business   1,461    

 

 

26

 

 

9. SEGMENT INFORMATION

 

We operate in two reportable segments: Cinema Equipment Business and Content & Entertainment Business. Our segments were determined based on the economic characteristics of our products and services, our internal organizational structure, the manner in which our operations are managed and the criteria used by our CODM to evaluate performance, which is generally the segment’s operating income (loss) before depreciation and amortization.

 

Operations of:   Products and services provided:
Cinema Equipment Business  

Financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).

 

We retain ownership of the Systems and the residual cash flows related to the Systems in Phase I Deployment after the repayment of all non-recourse debt at the expiration of exhibitor master license agreements. For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.

 

The Cinema Equipment Business segment also provides monitoring, collection, verification and management services to this segment, as well as to exhibitors who purchase their own equipment, and also collects and disburses VPFs from motion picture studios, distributors and ACFs from alternative content providers, movie exhibitors and theatrical exhibitors (collectively, “Services”).

     
Content & Entertainment Business   Leading independent streaming company of content and channels. We collaborate with producers and other content owners to market, source, curate and distribute independent content to targeted and under-served audiences in theatres and homes, and via mobile and emerging platforms.

 

The following tables present certain financial information related to our reportable segments and Corporate:

 

   As of December 31, 2021 
(In thousands)  Intangible
Assets, net
   Goodwill   Total
Assets
   Notes
Payable,
Non-
Recourse
   Notes
Payable
   Operating
lease
liabilities
 
Cinema Equipment Business  $
   $
   $22,910   $
   $
   $
 
Content & Entertainment Business   15,672    13,659    54,909    
    
     
Corporate       
    21,735    
    
    16 
Total  $15,672   $13,659   $99,554   $
   $
   $16 

 

   As of March 31, 2021 
(In thousands)  Intangible
Assets, net
   Goodwill   Total
Assets
   Notes
Payable,
Non-
Recourse
   Notes
Payable
   Operating
lease
liabilities
 
Cinema Equipment Business  $
   $
   $13,169   $7,786   $
              —
   $1 
Content & Entertainment Business   9,858    8,701    42,733    
    
    69 
Corporate   2    
    19,544    
    4,108    30 
Total  $9,860   $8,701   $75,446   $7,786   $4,108   $100 

 

   Statements of Operations 
   Three Months Ended December 31, 2021 
   (in thousands) 
   Cinema
Equipment
Business
   Content & Entertainment
Business
   Corporate   Consolidated 
Revenues  $2,060   $12,024   $
   $14,084 
Direct operating (exclusive of depreciation and amortization shown below)   139    6,320    
    6,459 
Selling, general and administrative   496    3,701    3,539    7,736 
Allocation of corporate overhead   143    964    (1,107)   
 
Provision for (recovery of) doubtful accounts   (397)   19    
    (378)
Depreciation and amortization of property and equipment   196    138    2    336 
Amortization  of intangible assets   
    693    2    695 
Total operating expenses   577    11,835    2,436    14,848 
Income (loss) from operations  $1,483   $189   $(2,436)  $(764)

 

27

 

 

The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:

 

(In thousands) 

Cinema

Equipment

Business

   Content & Entertainment
Business
   Corporate   Consolidated 
Direct operating  $
     —
   $
    —
   $
    —
   $
     —
 
Selling, general and administrative   
    552    797    1,349 
Total stock-based compensation  $
   $552   $797   $1,349 

 

   Statements of Operations 
   Three Months Ended December 31, 2020
(in thousands)
 
   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Revenues  $910   $9,044   $
   $9,954 
Direct operating (exclusive of depreciation and amortization shown below)   150    4,235    
    4,385 
Selling, general and administrative   524    2,244    2,593    5,361 
Allocation of corporate overhead   143    964    (1,107)   
 
Provision for doubtful accounts   70    
    
    70 
Depreciation and amortization of property and equipment   706    108    8    822 
Amortization of intangible assets   8    588    1    597 
Total operating expenses   1,601    8,139    1,495    11,235 
Loss from operations  $(691)  $905   $(1,495)  $(1,281)

 

The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:

 

   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Direct operating  $
              —
   $
              —
   $
     —
   $
     —
 
Selling, general and administrative   
    39    921    960 
Total stock-based compensation  $
   $39   $921   $960 

 

   Statements of Operations 
   Nine Months Ended December 31, 2021 
   (in thousands) 
   Cinema
Equipment
Business
   Content & Entertainment
Business
   Corporate   Consolidated 
Revenues  $11,544   $27,658   $
   $39,202 
Direct operating (exclusive of depreciation and amortization shown below)   560    13,863    
    14,423 
Selling, general and administrative   1,356    9,999    9,583    20,938 
Allocation of corporate overhead   412    2,763    (3,175)   
 
(Recovery of) provision for doubtful accounts   (500)   82    
    (418)
Depreciation and amortization of property and equipment   1,001    422    2    1,425 
Amortization of intangible assets   
    2,236    2    2,238 
Total operating expenses   2,829    29,365    6,412    38,606 
Income (loss) from operations  $8,715   $(1,707)  $(6,412)  $596 

 

28

 

 

The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:

 

(In thousands) 

Cinema

Equipment

Business

   Content & Entertainment
Business
   Corporate   Consolidated 
Direct operating  $
     —
   $
      —
   $
      —
   $
      —
 
Selling, general and administrative   
    1,063    2,215    3,278 
Total stock-based compensation  $
   $1,063   $2,215   $3,278 

 

   Statements of Operations 
   Nine Months Ended December 31, 2020
(in thousands)
 
   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Revenues  $2,158   $20,996   $
   $23,154 
Direct operating (exclusive of depreciation and amortization shown below)   504    10,890    
    11,394 
Selling, general and administrative   1,704    6,667    6,998    15,369 
Allocation of corporate overhead   438    2,883    (3,321)   
 
Recovery for doubtful accounts   (123)   
    
    (123)
Depreciation and amortization of property and equipment   3,348    312    31    3,691 
Amortization of intangible assets   23    1,752    3    1,778 
Total operating expenses   5,892    22,504    3,711    32,109 
Income (loss) from operations  $(3,736)  $(1,508)  $(3,711)  $(8,955)

  

The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:

 

   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Direct operating  $
    —
   $
    —
   $
       —
   $
      —
 
Selling, general and administrative   
    91    2,081    2,172 
Total stock-based compensation  $
   $91   $2,081   $2,172 

 

10. INCOME TAXES

 

We calculate income tax expense based upon an annual effective tax rate forecast, including estimates and assumptions. We recorded an income tax benefit of approximately $26 thousand and $576 thousand for the three and nine months ended December 31, 2021, respectively. We recorded an income tax benefit of approximately $0 and $181 thousand for the three and nine months ended December 31, 2020, respectively. We have not recorded tax benefits on our loss before income taxes because we have provided for a full valuation allowance that offsets potential deferred tax assets resulting from net operating loss carry forwards, reflecting our inability to use such loss carry forwards.

 

Our effective tax rate for the nine months ended December 31, 2021 and 2020 was negative 14.0% and 0.3%, respectively.

 

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable. 

 

11. SUBSEQUENT EVENTS

 

Equity purchase announcement  

 

On January 4, 2022, the Company entered into an Equity Purchase Agreement among the Company, and David Chu, Augustine Hong, Helen Hong, Michael Hong, Justin Lee, Steven Park, and Kingsoon Ong (collectively, the “Sellers”) and David Chu as representative of the Sellers (the “DMR Agreement”) to acquire all of the outstanding membership interests of Asian Media Rights, LLC d/b/a Digital Media Rights (“DMR”), a diversified specialty streaming, advertising, and content distribution company with significant expertise in building audiences for global content in North America (the “DMR Transaction”). The DMR Transaction is subject to certain closing conditions, including satisfactory financial and legal diligence, and the parties are working toward closing the transaction.

 

29

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our historical consolidated financial statements and the related notes included elsewhere in this report.

 

This report contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which are indicated by words or phrases such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “will,” “estimates,” and similar words. Forward-looking statements represent, as of the date of this report, our judgment relating to, among other things, future results of operations, growth plans, sales, capital requirements and general industry and business conditions applicable to us. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, assumptions and other factors, some of which are beyond our control that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

 

OVERVIEW

 

Since our inception, we have played a significant role in the digital distribution revolution that continues to transform the media landscape. In addition to our pioneering role in transitioning approximately 12,000 movie screens from traditional analog film prints to digital distribution, we have become a leading distributor of independent content, both through organic growth and acquisitions. We distribute digital and physical products for major brands such as the Hallmark Channel, Televisa, ITV, Nelvana, ZDF, Konami, NFL, NHL and Aniplex. We collaborate with producers, international and domestic content creators of movies, television series and short form content to market, source, curate and distribute quality content to targeted audiences through (i) existing and emerging digital home entertainment platforms, including but not limited to, Apple, Amazon Prime, Netflix, Hulu, Xbox, Tubi, Roku, Pluto TV, and cable video-on-demand (“VOD”), and (ii) physical goods, including DVD and Blu-ray Discs, to Walmart, Target, Amazon and others.

 

We report our financial results in two primary segments as follows: (1) cinema equipment business and (2) content and entertainment business (“Content & Entertainment” or “CEG”). The cinema equipment business segment consists of the non-recourse, financing vehicles and administrators for our digital cinema equipment (the “Systems”) installed in movie theatres throughout North America and several international countries. It also provides fee-based support to over 4,609 movie screens as well as directly to exhibitors and other third-party customers in the form of monitoring, billing, collection and verification services. Our Content & Entertainment segment is a market leader in: (1) ancillary market aggregation and distribution of entertainment content and (2) branded and curated over-the-top (“OTT”) digital network business providing entertainment channels and applications.

 

Beginning in December 2015, certain of our cinema equipment began to reach the conclusion of their 10-year deployment payment period with certain distributors and, therefore, Virtual Print Fees (“VPF”) revenues ceased to be recognized on such Systems, related to such distributors. Furthermore, because the Phase I Deployment installation period ended in November 2007, a majority of the VPF revenue associated with the Phase I Deployment Systems has ended. The reduction in VPF revenue on cinema equipment business systems approximately coincided with the conclusion of certain of our non-recourse debt obligations and, therefore, the reduced cash outflows related to such non-recourse debt obligations partially offset the reduced VPF revenue since November 2017.

 

Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Cinedigm recognizes revenue once the customer takes possession of the systems and is predicated on Cinedigm’s receipt of sale proceeds. Such sales were originally contemplated as the conclusion of the digital cinema deployment plan.

 

We are structured so that our cinema equipment business segment operates independently from our Content & Entertainment business. As of December 31, 2021, we had no non-recourse outstanding debt principal that relates to, and is serviced by, our cinema equipment business. We had no outstanding debt principal, as of December 31, 2021 that is attributable to our Content & Entertainment segment and Corporate.

 

30

 

 

Risks and Uncertainties

 

The COVID-19 pandemic and related economic repercussions created significant volatility and uncertainty impacting the Company’s results for the period. As part of our Content & Entertainment business, the Company sells DVDs and Blu-ray discs at brick-and-mortar stores. With the closure of non-essential retail stores beginning in the spring of 2020, the sale of physical discs through our retail partners declined although this was partially offset by digital rentals and purchases.

 

As part of our Cinema Equipment business, the Company earns revenue when movies are exhibited in theatres. As vaccines became readily available and COVID-19 cases decreased, major studios continued to release tentpole films in the theatrical markets as box office results steadily showed improvement in the three months ending December 31, 2021.  However, the number of wide releases remains below pre-pandemic levels in this quarter as studios continue to shuffle release dates and test theatrical windows.  The Canadian government tightened Movie Theatre restrictions amid a Covid surge due to the Omicron variant as well as shuttering all Quebec theatres during this quarter.  Movie theatres in the U.S. remained open and continued to follow NATO CinemaSafe protocols in an effort to help reinforce consumer confidence in the safety of the theatrical moviegoing experience

 

Longer term, there may be a shift in consumer preference towards digital consumption over theatrical viewing. Studios may reduce their theatrical slates to tentpoles and certain genres releasing other content directly on their own streaming services first. If fewer movies are released theatrically, this shift to digital viewing reduces revenue opportunities for virtual print fees and sales of digital cinema equipment. While the Company has been encouraged by the pace of mass vaccinations, spikes or the emergence of new variants could require future closures, which impact the Cinema Equipment business.

 

In connection with the CEG business, if larger branded companies choose to make their content available earlier on their own streaming platforms, this could limit our ability to monetize this content on a transactional digital basis, as consumers can access it via the company’s own streaming platform such as Hallmark Movies Now. However, most content suppliers including filmmakers and producers, do not have their own streaming platforms and rely on us for distribution through our digital home entertainment business and OTT digital networks.  As a result, this risk is limited, and our digital distribution capabilities and digital networks provide us with the opportunity to take advantage of this consumer shift towards digital consumption.

 

Over the first year and a half of the COVD-19 pandemic, film and TV production slowed-down and independent producers and filmmakers had to either suspend or delay their productions due to rising infection rates and the high costs of appropriate COVID-19 production protocols. As a result, there are fewer available films to acquire, so our pipeline for content from completed films and co-productions has been negatively impacted. In addition, with the rise of new variants, productions may be at risk again of shutting down, being delayed or having prohibitive COVID-compliant costs which would further limit available content to acquire.     

 

The COVID-19 pandemic has also resulted in an acceleration of cord-cutting, and, as more consumers move away from cable and satellite, this could lead to a decrease in cable/satellite TV VOD revenues, as well as a decrease in licensing fees as Pay One window budgets shift from licensing and towards originals.  However, given the overall shift towards digital consumption, these risks may be offset by increased revenues from transactional, subscription and ad supported/FAST platforms, including our own owned and operated digital network business.  

  

31

 

 

Liquidity

 

We have incurred net losses historically and have an accumulated deficit of $469.7 million and our working capital is $2.9 million as of December 31, 2021. We may continue to generate net losses for the foreseeable future. In addition, we have had debt-related contractual obligations. Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect Loan (as defined below) non-recourse debt amount by paying an aggregate principal amount of $7.8 million. As of December 31, 2021 there was $0 million principal outstanding and there was no availability under the Credit Facility which expired on September 28, 2021. Net cash provided by operating activities for the nine months ended December 31, 2021 was $4.7 million. Based on these conditions and the Company´s financing strategies, the Company entered into the transactions described below:

 

Capital Raises

 

On February 2, 2021, the Company entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 5,600,000 shares of our Class A common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.25 per share, in a registered direct offering, pursuant to an effective shelf registration statement on Form S-3 which was declared effective by the Securities and Exchange Commission on July 10, 2020 (File No. 333-239710) (the “2020 Shelf Registration Statement”) and an applicable prospectus supplement. The closing of the sale occurred on February 5, 2021. The aggregate gross proceeds for the sale were approximately $7.0 million. The net proceeds to the Company from the sale, after deducting the fees of the placement agent but before paying the Company’s estimated offering expenses, was approximately $6.5 million.

 

In July 2020, we entered into an At-the-Market sales agreement (the “ATM Sales Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”) and B. Riley FBR, Inc. (“B. Riley” and, together with A.G.P., the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agents, shares of Common Stock at the market prices prevailing on Nasdaq at the time of the sale of such shares. The Company is not obligated to sell any shares under the ATM Sales Agreement. Any sales of shares made under the ATM Sales Agreement will be made pursuant to the 2020 Shelf Registration Statement for an aggregate offering price of up to $30 million. During the quarter ended December 31, 2021, we did not sell any shares of Common Stock under the ATM Sales Agreement. The 2020 Shelf Registration Statement is unavailable to us, and accordingly we cannot sell any shares of Common Stock under the ATM Sales Agreement, until September 1, 2022.

 

On July 16, 2020, the Company entered into a securities purchase agreement with certain investors for the purchase and sale of 7,213,334 shares of Class A common stock, par value $0.001 per share, at a purchase price of $1.50 per share, in a registered direct offering, pursuant to the 2020 Shelf Registration Statement and an applicable prospectus supplement. The closing of the sale occurred on July 20, 2020. The aggregate gross proceeds for the sale was approximately $10.8 million. The net proceeds to the Company from the sale, after deducting the fees of the placement agents but before paying the Company’s estimated offering expenses, is approximately $10.1 million.

 

On May 20, 2020, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) for the purchase and sale of 10,666,666 shares of the Class A common stock, at a purchase price of $0.75 per share, in a registered direct offering, pursuant to an effective shelf registration statement on Form S-3 which was declared effective by the Securities and Exchange Commission on May 14, 2020 (File No. 333-238183) and an applicable prospectus supplement. The closing of the sale occurred on May 22, 2020. The aggregate gross proceeds for the sale was $8.0 million. The net proceeds to the Company from the sale, after deducting the fees of the placement agents but before paying the Company’s estimated offering expenses, were approximately $7.1 million.

 

As of December 31, 2021, there is still approximately $38.0 million remaining unsold under the 2020 Shelf Registration Statement.

 

Sale of Cinematic Equipment

 

On March 17, 2021, the Company entered into two separate agreements for the sale of cinematic equipment to American Multi-Cinema, Inc. (“AMC”), The agreements included the sale in tranches of a total of 2,369 cinematic projectors starting in March 2021 and continuing through January 2023 for total cash consideration of $10.8 million. Through December 31, 2021, the Company recognized aggregate revenue for $9.1 million. A portion of the total proceeds were used to paydown the remaining outstanding balance of the Prospect Loan notes payable.

 

Equity Investment in a Related Party

 

On December 27, 2019, the Company entered into, and on February 14, 2020 amended, (see Note 2 – Summary of Significant Accounting Policies), a stock purchase agreement (as so amended, the “Starrise Stock Purchase Agreement”) with BeiTai Investment LP (“BeiTai”), a related party for accounting purposes of Cinedigm and Aim Right Ventures Limited (“Aim Right”), two shareholders of Starrise Media Holdings Limited, a leading Chinese entertainment company (“Starrise”), to buy from them an aggregate of 410,901,000 outstanding Starrise ordinary shares (the “Starrise Share Acquisition”). On February 14, 2020, the Company purchased 162,162,162 of the Starrise ordinary shares from BeiTai and issued BeiTai 21,646,604 shares of Common Stock in consideration therefor. The Starrise shares received were valued at approximately $25 million and the Company issued shares that were valued at approximately $11.2 million. On April 10, 2020, the Company, in accordance with the terms of the Starrise Stock Purchase Agreement, terminated its obligation to purchase Starrise ordinary shares from Aim Right under the Starrise Stock Purchase Agreement.

 

32

 

 

On April 10, 2020, the Company entered into another stock purchase agreement (the “April Starrise Stock Purchase Agreement”) with five (5) shareholders of Starrise – Bison Global Investment SPC – Bison Global No. 1 SP, Huatai Investment LP, Antai Investment LP, Mingtai Investment LP and Shangtai Asset Management LP – all of which are related parties to the Company, to buy an aggregate of 223,380,000 outstanding Starrise ordinary shares from them and for the Company to issue to them an aggregate of 29,855,081 shares of Common Stock as consideration therefor (the “April Starrise Share Acquisition”). On April 15, 2020, the April Starrise Share Acquisition was consummated and this transaction was also recorded as an equity investment in Starrise.

 

Starrise’s ordinary shares (HK 1616) are listed on the main board of the Stock Exchange of Hong Kong Limited. Based on the closing price of HKD 0.159 per share on February 11, 2022, calculated at an exchange rate of 7.8 Hong Kong Dollars to 1 US dollar, the market value of Cinedigm’s ownership in Starrise ordinary shares was approximately $7.4 million. 

 

Borrowings

 

On June 22, 2021, the maturity date of the East West Credit Facility (as defined in Note 5 - Notes Payable) with East West Bank was extended from June 30, 2021 to September 28, 2021 and was not extended.

 

On April 15, 2020, the Company received $2.2 million from East West Bank, the Company’s existing lender, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts are intended to be eligible for forgiveness, subject to the provisions of the CARES Act and could be subject to repayment. On July 7, 2021, the Company received notification from the Lender that the U.S. Small Business Administration had approved the Company’s PPP Loan forgiveness application for the entire PPP Loan amount and accrued interest effective as of June 30, 2021. The forgiveness of the PPP Loan was recognized as a gain of $2.2 million during the Company’s fiscal quarter ending June 30, 2021.

 

Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect Loan (as defined in Note 5 – Notes Payable) outstanding non-recourse debt amount by paying an aggregate principal amount of $7.8 million. Pre-payment of the Prospect Loan was permissible without penalty.

 

Common Stock Purchase Agreement

 

In October 2021, we entered into a Common Stock Purchase Agreement (the “Equity Line Purchase Agreement”) and a Registration Rights Agreement (the “Registration Rights Agreement”) with B. Riley Principal Capital, LLC (“B. Riley Principal Capital”). Pursuant to the Equity Line Purchase Agreement, the Company has the right to sell to B. Riley Principal Capital up to the lesser of (i) $50,000,000 of newly issued shares of Common Stock and (ii) the Exchange Cap (as defined below) (subject to certain conditions and limitations), from time to time during the 24-month period from and after the October 21, 2021. Sales of Common Stock pursuant to the Equity Line Purchase Agreement, and the timing of any sales, are solely at the option of the Company, and the Company is under no obligation to sell any securities to B. Riley Principal Capital under the Equity Line Purchase Agreement. As consideration for B. Riley Principal Capital’s commitment to purchase shares of Common Stock at the Company’s direction upon the terms and subject to the conditions set forth in the Equity Line Purchase Agreement, upon execution of the Equity Line Purchase Agreement, the Company issued 210,084 shares of Common Stock to B. Riley Principal Capital (the “Commitment Shares”). The purchase price of the shares of Common Stock that we elect to sell to B. Riley Principal Capital pursuant to the Equity Line Purchase Agreement will be determined by reference to the volume weighted average price of the Common Stock (“VWAP”) during the applicable purchase date, less a fixed 5% discount to such VWAP. Pursuant to the Registration Rights Agreement, the Company filed a Registration Statement on Form S-1 that was declared effective by the Securities and Exchange Commission on October 21, 2021 (File No. 333-260210) for the resale by B. Riley Principal Capital of up to 25,210,084 shares of Common Stock (including the Commitment Shares) acquired pursuant to the Equity Line Purchase Agreement. During October and November 2021, we sold 5,300,000 shares of Common Stock under the Equity Line Purchase Agreement. Net proceeds from such sales totaled $12.4 million.

 

We believe the combination of: (i) our cash and cash equivalent balances at December 31, 2021 and (ii) expected cash flows from operations, as well as liquidity for our operational and capital needs, for twelve months from the filing of this report. Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. Failure to generate additional revenues, obtain additional capital or manage discretionary spending could have an adverse effect on our financial position, results of operations and liquidity.

 

33

 

 

Critical Accounting Policies and Estimates

 

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In connection with the preparation of our financial statements, we are required to make assumptions and estimates about future events and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated financial statements are prepared. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

 

Our significant accounting policies are discussed in Note 2 - Summary of Significant Accounting Policies, of the Notes to Consolidated Financial Statements, Financial Statements and Supplementary Data, of this Quarterly Report on Form 10-Q. Management believes that the following accounting policies are the most critical to aid in fully understanding and evaluating our reported financial results, and they require management’s most difficult, subjective or complex judgments, resulting from the need to make estimates about the effect of matters that are inherently uncertain. Management has reviewed these critical accounting estimates and related disclosures with the Audit Committee of our board of directors.

 

PROPERTY AND EQUIPMENT

 

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:

 

Computer equipment and software   3-5 years
Internal use software   5 years
Digital cinema projection systems   10 years
Machinery and equipment   3-10 years
Furniture and fixtures   3-6 years

 

Leasehold improvements are being amortized over the shorter of the lease term or the estimated useful life of the improvement. Maintenance and repair costs are charged to expense as incurred. Major renewals, improvements and additions are capitalized.

 

Software developed or purchased for internal use by the Company is capitalized and amortized over its estimated useful life. Changes in these estimates could result in impairment in the value of the asset. 

 

Useful lives are determined based on an estimate of either physical or economic obsolescence, or both. During the three and nine months ended December 31, 2021 and 2020, we have neither made any revisions to estimated useful lives, nor recorded any impairment charges on our property, equipment and internal use software.

 

FAIR VALUE ESTIMATES

 

Goodwill, Finite-Lived Assets and Long-Lived Assets

 

We evaluate our goodwill for impairment in the fourth quarter of each fiscal year (as of March 31), or whenever events or changes in circumstances indicate the fair value of a reporting unit is below its carrying amount. The determination of whether or not goodwill has become impaired involves a significant level of judgment in the assumptions underlying the approach used to determine the value of our reporting units. Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to our operations. To the extent additional information arises, market conditions change or our strategies change, it is possible that the conclusion regarding whether goodwill is impaired could change and result in future goodwill impairment charges that could have a material adverse effect on our consolidated financial position or results of operations.

 

The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test.

 

The quantitative test involves comparing the estimated fair value of a reporting unit with its respective book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however, the fair value of the reporting unit is less than book value, an impairment loss is recognized in an amount equal to the excess.

 

34

 

 

During the three and nine months ended December 31, 2021 and 2020, there were no impairment charges recorded on goodwill. In 2021, we elected to conduct a qualitative goodwill assessment and in 2020 we conducted a quantitative goodwill assessment. In determining fair value, we used various assumptions, including expectations of future cash flows based on projections or forecasts derived from analysis of business prospects, economic or market trends and any regulatory changes that may occur. We estimated the fair value of the reporting unit using a net present value methodology, which is dependent on significant assumptions related to estimated future discounted cash flows, discount rates and tax rates. Certain of the estimates and assumptions that we used in determining the value of our CEG reporting unit are discussed in Note 2 - Summary of Significant Accounting Policies.

 

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. Determining whether impairment has occurred typically requires various estimates and assumptions, including determining which cash flows are directly related to the potentially impaired asset, the useful life over which cash flows will occur, their amount and the asset’s residual value, if any. The assessment for recoverability is based primarily on our ability to recover the carrying value of its long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the assets the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows.

  

REVENUE RECOGNITION

 

We determine revenue recognition by:

 

identifying the contract, or contracts, with the customer;

 

identifying the performance obligations in the contract;

 

determining the transaction price;

 

allocating the transaction price to performance obligations in the contract; and

 

recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.

 

We recognize revenue in the amount that reflects the consideration we expect to receive in exchange for the services provided, sales of physical products (e.g., DVDs and Blu-ray Discs) or when the content is available for subscription on the digital platform or available on the point-of-sale for transactional and video on demand services which is when the control of the promised products and services is transferred to our customers and our performance obligations under the contract have been satisfied. Revenues that might be subject to various taxes are recorded net of transaction taxes assessed by governmental authorities such as sales value-added taxes and other similar taxes.

 

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less. We have in the past entered into arrangements in connection with activation fees due from our System deployments that had extended payment terms. The outstanding balances on these arrangements are insignificant and hence the impact of significant financing would be insignificant.

 

Cinema Equipment Business

 

Our Cinema Equipment Business consists of financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).

 

We retain ownership of our digital cinema equipment (the “Systems”) and the residual cash flows related to the Systems in Phase I Deployment after the end of the 10-year deployment payment period.

 

35

 

 

For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.

 

The Cinema Equipment Business also provides monitoring, data collection, serial data verification and management services to this segment, as well as to exhibitors who purchase their own equipment, in order to collect virtual print fees (“VPFs”) from motion picture studios and distributors and ACFs from alternative content providers, and to distribute those fees to theatrical exhibitors (collectively, “Services”).

 

VPFs are earned, net of administrative fees, pursuant to contracts with movie studios and distributors, whereby amounts are payable by a studio to Phase I Deployment and to Phase II Deployment when movies distributed by the studio are displayed on screens utilizing our Systems installed in movie theatres. VPFs are earned and payable to Phase I Deployment based on a defined fee schedule until the end of the VPF term. One VPF is payable for every digital title initially displayed per System. The amount of VPF revenue is dependent on the number of movie titles released and displayed using the Systems in any given accounting period. VPF revenue is recognized in the period in which the digital title first plays on a System for general audience viewing in a digitally equipped movie theatre, as Phase I Deployment’s and Phase II Deployment’s performance obligations have been substantially met at that time.

 

Phase II Deployment’s agreements with distributors require the payment of VPFs, according to a defined fee schedule, for ten years from the date each system is installed; however, Phase II Deployment may no longer collect VPFs once “cost recoupment,” as defined in the contracts with movie studios and distributors, is achieved. Cost recoupment will occur once the cumulative VPFs and other cash receipts collected by Phase II Deployment have equaled the total of all cash outflows, including the purchase price of all Systems, all financing costs, all “overhead and ongoing costs”, as defined, and including service fees, subject to maximum agreed upon amounts during the three-year rollout period and thereafter. Further, if cost recoupment occurs before the end of the eighth contract year, the studios will pay us a one-time “cost recoupment bonus.” The Company evaluated the constraining estimates related to the variable consideration, i.e., the one-time bonus and determined that it is not probable to conclude at this point in time that a significant reversal in the amount of cumulative revenue recognized will occur when the uncertainty associated with the variable consideration is subsequently resolved.

 

Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Cinedigm recognizes revenue once the customer takes possession of the systems and is predicated on Cinedigm’s receipt of sale proceeds. Such sales were originally contemplated as the conclusion of the digital cinema deployment plan. Total system sales revenue recognized were $1.3 million and $66 thousand, during the three months ended December 31, 2021 and 2020, respectively. Total system sales revenue recognized were $9.1 million and $157 thousand, during the nine months ended December 31, 2021 and 2020, respectively.

 

Revenues earned in connection with up front exhibitor contributions are deferred and recognized over the expected cost recoupment period.

 

Exhibitors who purchased and own Systems using their own financing in Phase II of the Cinema Equipment Business paid us an upfront activation fee of approximately $2.0 thousand per screen (the “Exhibitor-Buyer Structure”). Upfront activation fees were recognized in the period in which these Systems were delivered and ready for content, as we had no further obligations to the customer after that time and collection was reasonably assured. In addition, we recognize activation fee revenue of between $1.0 thousand and $2.0 thousand on Phase II Deployment Systems and for Systems installed by CDF2 Holdings, a related party, (See Note 3 - Other Interests) upon installation and such fees are generally collected upfront upon installation. Our services division manages and collects VPFs on behalf of exhibitors, for which it earns an administrative fee equal to 10% of the VPFs collected.

 

36

 

 

The Cinema Equipment Business earns an administrative fee of approximately 5% of VPFs collected and, in addition, earns an incentive service fee equal to 2.5% of the VPFs earned by Phase 1 DC. This administrative fee is related to the collection and remittance of the VPF’s and the performance obligation is satisfied at that time the related VPF fees are due which is at the time the movies are displayed on screens utilizing our Systems installed in movie theatres. The service fees are recognized as a point in time revenue when the corresponding VPF fees are due from the movie studios and distributors.

 

Content & Entertainment Business

 

CEG earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or “OTT Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Physical Revenue” or “Base Distribution Business”). Fees earned are typically a percentage based on the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/FAST on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the performance obligation is satisfied which is when the content is available for subscription on the digital platform, at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Physical Revenue is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration.

 

Physical goods reserves for sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

CEG also has contracts for the theatrical distribution of third party feature movies and alternative content. CEG’s distribution fee revenue and CEG’s participation in box office receipts is recognized at the time a feature movie and alternative content are viewed. CEG has the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

 

Principal Agent Considerations

 

We determine whether revenue should be reported on a gross or net basis for each revenue stream based on the transfer of control of goods and services. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

 

which party is primarily responsible for fulfilling the promise to provide the specified good or service; and

 

which party has discretion in establishing the price for the specified good or service.

 

Shipping and Handling

 

Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in cost of goods sold because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

 

37

 

 

Credit Losses

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

Our CEG segment recognizes accounts receivable, net of an estimated allowance for product returns and customer chargebacks, at the time that it recognizes revenue from a sale. Reserves for product returns and other allowances is variable consideration as part of the transaction price. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

We record accounts receivable, long-term in connection with activation fees that we earn from Systems deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rates. The outstanding balances on these arrangements are insignificant and hence the impact of significant financing would be insignificant.

 

Contract Liabilities

 

We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable.

 

Deferred revenue pertaining to our Content & Entertainment Business includes amounts related to the sale of DVDs with future release dates.

 

Deferred revenue relating to our Cinema Equipment Business pertains to revenues earned in connection with up front exhibitor contributions that are deferred and recognized over the expected cost recoupment period. It also includes unamortized balances in connection with activation fees due from the Systems deployments that have extended payment terms.

 

The ending deferred revenue balance as of December 31, 2021 was $0.3 million. For the three and nine months ended December 31, 2021 and 2020, respectively, the additions to our deferred revenue balance were primarily due to cash payments received or due in advance of satisfying performance obligations, while the reductions to our deferred revenue balance were primarily due to the recognition of revenue upon fulfillment of our performance obligations, both of which were in the ordinary course of business.

 

During the three months ended December 31, 2021 and 2020, $0.3 million and $1.2 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. During the nine months ended December 31, 2021 and 2020, $0.6 million and $2.5 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. As of December 31, 2021, the aggregate amount of contract revenue allocated to unsatisfied performance obligations was $0.3 million. This amount is to be recognized among January and February of 2022.

 

Participations and royalties payable

 

When we use third parties to distribute company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.

 

38

 

 

BUSINESS COMBINATIONS

 

A business combination is an acquisition of business. Business combinations are accounted by allocating the fair value of the purchase price of the assets acquired and liabilities assumed.

 

Results of Operations for the Three Months Ended December 31, 2021 and 2020

 

Revenues

 

   For the Three Months Ended December 31, 
($ in thousands)  2021   2020   $ Change    % Change 
Cinema Equipment Business  $2,060   $910   $1,150    126%
Content & Entertainment   12,024    9,044    2,980    33%
   $14,084   $9,954   $4,130    41%

 

The revenues in the Content & Entertainment Business segment increased by 33% for the three months ended December 31, 2021 compared to the three months ended December 31, 2020. The increase is attributed to organic growth and the addition of new streaming channels. In addition, the Company deployed new advertising technology from our streaming partner Amagi, which had a material impact on the Company’s advertising fill and click-per-thousand impression (“CPM”) rates.  The revenues in the Cinema Equipment Business segment increased by 126% for the three months ended December 31, 2021 compared to the three months ended December 31, 2020, primarily due to the terms of ongoing digital projector sales to exhibitors in the Cinedigm Equipment Business deployments.

 

Direct Operating Expenses

 

   For the Three Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $139   $150   $(11)   (7)%
Content & Entertainment   6,320    4,235    2,085    49%
   $6,459   $4,385   $2,074    47%

 

The decrease in direct operating expenses in the three months ended December 31, 2021 for the Cinema Equipment Business compared to the prior year period was primarily due to a decrease in property tax liabilities as assets were sold. The increase in direct operating expenses in the three months ended December 31, 2021 for the Content & Entertainment Business compared to the prior year period was primarily due to significant increase in revenue share to the OTT managed channels due to continued growth in revenue and distribution of $1,787 thousand as well as additive owned channel expense for Fandor, Screambox and Bloody Disgusting of $153 thousand.  

 

Selling, General and Administrative Expenses

 

   For the Three Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $496   $524   $(28)   (5)%
Content & Entertainment   3,701    2,244    1,457    65%
Corporate   3,539    2,593    946    36%
   $7,736   $5,361   $2,375    44%

 

Selling, general and administrative expenses for the three months ended December 31, 2021 increased by $2.4 million primarily due to a $2.5 million increase in bonus incentive expense, additional personnel and stock-based compensation to management and employees, partially offset by $0.1 million less legal expense and $0.1 million less computer expense.

 

39

 

 

Bad Debt expense

 

The bad debt benefit recovery was $378 thousand and $70 thousand for the three months ended December 31, 2021 and 2020, respectively. These amounts are related to Cinema Equipment Business and Content & Entertainment accounts that are deemed uncollectable.

 

Depreciation and Amortization Expense on Property and Equipment

 

   For the Three Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $196    706    (510)   (72)%
Content & Entertainment   138    108    30    28%
Corporate   2    8    (6)   (75)%
   $336   $822   $(486)   (59)%

 

Depreciation and amortization expense decreased in our Cinema Equipment Business Segment as the majority of our digital cinema projection systems reached the conclusion of their ten-year useful lives during the year ended March 31, 2021, leading to a lower fixed asset balance to be depreciated in the three months ended December 31, 2021. Content & Entertainment depreciation and amortization expense is higher due to newly developed internal software programs placed in service and an increase in streaming-related content acquisitions.

 

Interest expense, net

 

   For the Three Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $   $629   $(629)   (100)%
Content & Entertainment       9    (9)   (100)%
Corporate   97    310    (213)   (69)%
   $97   $948   $(851)   (90)%

 

Interest expense in the Cinema Equipment Business segment decreased primarily as a result of satisfying debt balances compared to the prior period on the Prospect Loan. Interest expense in our Corporate segment decreased as a result of eliminating the loan balances from our Credit Facility.

 

Income Tax Benefit

 

We recorded income tax benefits of approximately $26 thousand and $0 for the three months ended December 31, 2021 and 2020, respectively.

 

Our effective tax rate for the three months ended December 31, 2021 and 2020 was 3.8% and 0%, respectively.

 

Adjusted EBITDA

 

We define Adjusted EBITDA to be earnings before interest, taxes, depreciation and amortization, other income, net, stock-based compensation and expenses, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment, change in fair value on equity investment in Starrise and certain other items.

 

Consolidated Adjusted EBITDA (including the results of Cinema Equipment Business segment) for the three months ended December 31, 2021 increased by $434 thousand compared to the three months ended December 31, 2020. Adjusted EBITDA from our Cinema Equipment Business segment increased by $1.2 million primarily due to the terms of ongoing digital projector sales to related exhibitors in the Cinedigm deployments. Adjusted EBITDA from the Content & Entertainment business and Corporate segment decreased by $792 thousand for the three months ended December 31, 2021 compared to the three months ended December 31, 2020, due to the bonus incentive expense and additional headcount. 

 

Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including its stockholders, as a valuable financial metric.

 

40

 

 

We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net loss from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful to both management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.

 

We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net loss from continuing operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to income from operations or net loss from continuing operations as an indicator of performance or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

 

Following is the reconciliation of our consolidated net loss to Adjusted EBITDA:

 

   For the Three Months
Ended December 31,
 
($ in thousands)  2021   2020 
Net loss  $(404)  $(9,667)
Add Back:          
Income tax expense (benefit)   (26)    
Depreciation and amortization of property and equipment   336    822 
Amortization of intangible assets   695    597 
Loss on extinguishment of note payable       540 
Interest expense, net   97    948 
Change in fair value on equity investment in Starrise   (453)   6,751 
Acquisition, integration and other expense   107    (66)
Recovery benefit of doubtful accounts   (378)    
Stock-based compensation   1,349    960 
Net income attributable to noncontrolling interest   19    23 
Adjusted EBITDA  $1,342   $908 
           
Adjustments related to the Cinema Equipment Business          
Depreciation and amortization of property and equipment  $(196)  $(706)
Amortization of intangible assets       (8)
Stock-based compensation and expenses        
Acquisition, integration and other expense        
Provision for doubtful accounts        
Other income       (32)
Income from operations   (1,483)   691 
Adjusted EBITDA from non-cinema equipment business  $(337)  $853 

  

Results of Operations for the Nine Months Ended December 31, 2021 and 2020

 

Revenues

 

   For the Nine Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $11,544   $2,158   $9,386    435%
Content & Entertainment   27,658    20,996    6,662    32%
   $39,202   $23,154   $16,048    69%

 

41

 

 

The revenues in the Content & Entertainment Business segment increased by 32% for the nine months ended December 31, 2021 compared to the nine months ended December 31, 2020. The increase is attributed to the addition of several new streaming channels, organic growth in existing channels, and an expansion of the Company’s distribution with new and existing Smart TV platforms. In addition, the Company deployed new advertising technology from our streaming partner Amagi, which had a material impact on the Company’s advertising fill and click-per-thousand impression (“CPM”) rates.  The revenues in the Cinema Equipment Business segment increased by 435% for the nine months ended December 31, 2021 compared to the nine months ended December 31, 2020. Cinema Equipment Business segment increased primarily due to the terms of ongoing digital projector sales to related exhibitors in the Cinedigm deployments.

 

Direct Operating Expenses

 

   For the Nine Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $560   $504   $56    11%
Content & Entertainment   13,863    10,890    2,973    27%
   $14,423   $11,394   $3,029    27%

 

The increase in direct operating expenses in the nine months ended December 31, 2021 for the Cinema Equipment Business compared to the prior year period was primarily due to an increase in property tax obligations in the beginning of the fiscal year for the Cinedigm owned projector assets. The increase in direct operating expenses in the nine months ended December 31, 2021 for the Content & Entertainment Business compared to the prior year period was primarily due to higher streaming and delivery costs driven by increases in revenue and distribution for managed channels, partially offset by a decrease in manufacturing and fulfillment of physical sales.

 

Selling, General and Administrative Expenses

 

   For the Nine Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $1,356   $1,704   $(348)   (20)%
Content & Entertainment   9,999    6,667    3,332    50%
Corporate   9,583    6,998    2,585    37%
   $20,938   $15,369   $5,569    36%

 

Selling, general and administrative expenses for the nine months ended December 31, 2021 increased by $5.6 million primarily due to a $4.9 million increase in bonus incentive expense, additional personnel and stock-based compensation to management and employees, $0.5 million for legal and accounting fees related to securities reporting and consulting, and $0.2 million for remote-working equipment and computer expense.

 

Bad Debt expense

 

The bad debt benefit recovery was $418 thousand and $123 thousand for the nine months ended December 31, 2021 and 2020, respectively. These amounts are related to Cinema Equipment Business and Content & Entertainment accounts that are deemed uncollectable.

 

Depreciation and Amortization Expense on Property and Equipment

 

   For the Nine Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $1,001    3,348    (2,347)   (70)%
Content & Entertainment   422    312    110    35%
Corporate   2    31    (29)   (94)%
   $1,425   $3,691   $(2,266)   (61)%

 

Depreciation and amortization expense decreased in our Cinema Equipment Business Segment as the majority of our digital cinema projection systems reached the conclusion of their ten-year useful lives during the year ended March 31, 2021 leading to a lower fixed asset balance to be depreciated in the nine months ended December 31, 2021. Content & Entertainment depreciation and amortization expense is higher for the newly developed internal software programs placed in service this year and an increase in streaming-related content acquisitions.

 

42

 

 

Interest expense, net

 

   For the Nine Months Ended December 31, 
($ in thousands)  2021   2020   $ Change   % Change 
Cinema Equipment Business  $138   $1,830   $(1,692)   (92)%
Content & Entertainment       9    (9)   (100)%
Corporate   139    1,593    (1,454)   (91)%
   $277   $3,432   $(3,155)   (92)%

 

Interest expense in the Cinema Equipment Business segment decreased primarily as a result of eliminating debt balances compared to the prior period on the Prospect Loan. Interest expense in our Corporate segment decreased as a result of eliminating the loan balance from our Credit Facility, and other loans, in addition to the conversion of certain notes into shares of Class A common stock in the prior year period.

 

Income Tax Benefit

 

We recorded income tax benefits of approximately $576 thousand and $181 thousand for the nine months ended December 31, 2021 and 2020, respectively.

 

Our effective tax rate for the nine months ended December 31, 2021 and 2020 was negative 14.0% and 0.3%, respectively.

 

Adjusted EBITDA

 

We define Adjusted EBITDA to be earnings before interest, taxes, depreciation and amortization, other income, net, stock-based compensation and expenses, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment, change in fair value on equity investment in Starrise and certain other items.

 

Consolidated Adjusted EBITDA (including the results of Cinema Equipment Business segment) for the nine months ended December 31, 2021 increased by $7.9 million compared to the nine months ended December 31, 2020. Adjusted EBITDA from our Cinema Equipment Business segment increased primarily due to the terms of ongoing digital projector sales to related exhibitors in the Cinedigm deployments. Adjusted EBITDA from the Content & Entertainment business and Corporate segment decreased by $1.7 million for the nine months ended December 31, 2021 compared to the nine months ended December 31, 2020, due to additional costs associated with the growth of streaming and digital business based on higher volume for streaming due to the pandemic and adding additional channels and content compared to the prior period.

 

Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including its stockholders, as a valuable financial metric.

 

We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net loss from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.

 

43

 

 

We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net loss from continuing operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to income from operations or net loss from continuing operations as an indicator of performance or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

 

Following is the reconciliation of our consolidated net loss to Adjusted EBITDA:

 

   For the Nine Months
Ended December 31,
 
($ in thousands)  2021   2020 
Net income (loss)  $4,595   $(56,103)
Add Back:          
Income tax benefit   (576)   (181)
Depreciation and amortization of property and equipment   1,425    3,691 
Amortization of intangible assets   2,238    1,778 
(Gain) loss on forgiveness of PPP loan and extinguishment of note payable   (2,178)   852 
Interest expense, net   277    3,432 
Change in fair value on equity investment in Starrise   (1,453)   42,377 
Acquisition, integration and other expense   283    1,539 
Recovery benefit of doubtful accounts   (418)    
Stock-based compensation   3,278    2,172 
Net income attributable to noncontrolling interest   23    60 
Adjusted EBITDA  $7,494   $(383)
           
Adjustments related to the Cinema Equipment Business          
Depreciation and amortization of property and equipment  $(1,001)  $(3,348)
Amortization of intangible assets       (23)
Stock-based compensation and expenses        
Acquisition, integration and other expense   (11)   (32)
Provision for doubtful accounts   500     
Income from operations   (8,715)   3,736 
Adjusted EBITDA from non-cinema equipment business  $(1,733)  $(50)

 

Recent Accounting Pronouncements

 

See Note 2 - Summary of Significant Accounting Policies to our consolidated financial statements included herein.

 

Changes in our cash flows were as follows:

 

   For the Nine Months
Ended December 31,
 
($ in thousands)  2021   2020 
Net cash provided (used in) by operating activities  $4,746   $(16,776)
Net cash (used in) provided by investing activities   (5,031)   (110)
Net cash (used in) provided by financing activities   2,636    28,799 
Net change in cash, cash equivalents, and restricted cash  $2,352   $11,913 

 

As of December 31, 2021, we had cash and cash equivalents of $20.2 million.

 

As of December 31, 2020, we had cash, cash equivalents, and restricted cash balances of $27.2 million.

 

44

 

 

For the nine months ended December 31, 2021, net cash provided by operating activities was primarily driven by income from operations, excluding non-cash expenses such as depreciation, amortization, provision for doubtful accounts and stock-based compensation, including other changes in working capital. Additionally, during the nine months ended December 31, 2021, the Company paid down $32.6 million to vendors at both Content & Entertainment and Corporate. Operating cash flows from Content& Entertainment are typically higher during our fiscal third and fourth quarters, resulting from revenues earned during the holiday season, and lower in the other two quarters as we pay royalties on such revenues. In addition, we make advances on theatrical releases and to certain home entertainment distribution clients for which initial expenditures are generally recovered within six to twenty four months. For the nine months ended December 31, 2021 revenues from the sale of digital projections Systems was $9.1 million.

 

For the nine months ended December 31, 2020, net cash provided by operating activities was primarily driven by loss from operations, excluding non-cash expenses such as depreciation, amortization, recovery for doubtful accounts and stock-based compensation, offset by changes in working capital. Additionally, during the nine months ended December 31, 2020, the Company paid down $22.0 million to vendors at both the CEG and Corporate. Cash received from VPFs declined from the previous year period as Phase I Deployment Systems in our Cinema Equipment Business reached the conclusion of their deployment payment period with certain major studios. Changes in accounts receivable from our studio customers largely impact cash flows from operating activities and vary based on the seasonality of movie release schedules by the major studios. Operating cash flows from CEG are typically higher during our fiscal third and fourth quarters, resulting from revenues earned during the holiday season, and lower in the other two quarters as we pay royalties on such revenues. In addition, we make advances on theatrical releases and to certain home entertainment distribution clients for which initial expenditures are generally recovered within six to twelve months. Cash flows were also impacted as a result of COVID-19, as during the nine months ended December 31, 2020, theatres in many major markets remained closed throughout the third quarter causing the majority of major studios to move wide releases scheduled for the three months ended December 31, 2020 to future dates; however, the theatrical window before the streaming debut was shortened or eliminated to accommodate the lack of theatrical venues. Because our digital cinema business earns a VPF when a movie is first played on a System, the temporary theatre closures resulting from the COVID-19 pandemic resulted in reduced revenues. 

 

For the nine months ended December 31, 2021, cash flows used in investing activities consisted of purchases of property and equipment of $292 thousand and the purchase of two businesses of $4.8 million related to the business combination for FoundationTV and the asset acquisition of Bloody Disgusting (as defined below).

 

For the nine months ended December 31, 2020, cash flows used in investing activities consisted of proceeds from the sale of Starrise shares of $0.8 million, purchases of property and equipment of $0.3 million, the sale of property and equipment of $0.2 million, and the purchase of intangible assets of $0.7 million related to the asset acquisition.

 

For the nine months ended December 31, 2021, net cash flows from financing activities consisted $12.4 million received in connection with the issuance of Class A common Stock, and cash flow used for payments of the remaining outstanding balances of approximately $7.8 million in notes payable and $2.0 million in Credit Facility.

 

For the nine months ended December 31, 2020, cash flows provided by financing activities consisted of payments of approximately $22.4 million in notes payable, offset by $12.8 million from Credit Facility draw, $36.2 million received in connection with the issuance of Class A Common Stock and the exercise of warrants, and $2.2 million received pursuant to the Payment Protection Program of the Coronavirus Aid, Relief and Economic Security Act.

 

We may continue to generate net losses for the foreseeable future primarily due to depreciation and amortization, marketing and promotional activities and content acquisition and marketing costs. Certain of these costs, including costs of content acquisition, marketing and promotional activities, could be reduced if necessary. We feel we are adequately financed for at least the next twelve months; however, we may need to raise additional capital for working capital as deemed necessary. Failure to generate additional revenues, raise additional capital or manage discretionary spending could have an adverse effect on our financial position, results of operations or liquidity.

 

Seasonality

 

Revenues from our Cinema Equipment Business segment derived from the collection of VPFs from motion picture studios are seasonal, coinciding with the timing of releases of movies by the motion picture studios. Generally, motion picture studios release the most marketable movies during the summer and the winter holiday season. The unexpected emergence of a hit movie during other periods can alter the traditional trend. The timing of movie releases can have a significant effect on our results of operations, and the results of one quarter are not necessarily indicative of results for the next quarter or any other quarter. While CEG benefits from the winter holiday season, we believe the seasonality of motion picture exhibition is becoming less pronounced as the motion picture studios are releasing movies somewhat more evenly throughout the year. 

 

45

 

 

Off-balance sheet arrangements

 

We are not a party to any off-balance sheet arrangements, other than CDF2 Holdings, LLC (“CDF2 Holdings”), our wholly-owned unconsolidated subsidiary. As discussed further in Note 3 - Other Interests to the Condensed Consolidated Financial Statements included in Item 1 of this Quarterly Report on Form 10-Q, we hold a 100% equity interest in CDF2 Holdings, which is an unconsolidated variable interest entity (“VIE”), which wholly owns Cinedigm Digital Funding 2, LLC; however, we are not the primary beneficiary of the VIE.

 

Impact of Inflation

 

The impact of inflation on our operations has not been significant to date. However, there can be no assurance that a high rate of inflation in the future would not have an adverse impact on our operating results.

 

Item 4. CONTROLS AND PROCEDURES

 

Definition and Limitations of Disclosure Controls and Procedures

 

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.

 

Evaluation of Disclosure Controls and Procedures

 

The management of the Company, under the supervision and with the participation of our Chief Executive Officer and Chief Operating Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in the Exchange Act), as of December 31, 2021. Based on such evaluation, our principal executive officer and principal financial and accounting officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were not effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported, on a timely basis, and (ii) accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures due to the material weaknesses identified in our internal control over financial reporting as of December 31, 2021.

 

Previously Reported Material Weakness on Internal Control Over Financial Reporting

 

In the 2021 Form 10-K, filed with the SEC on July 30, 2021, management concluded that our internal control over financial reporting was not effective as of March 31, 2021. In the evaluation, management identified material weaknesses in internal controls related to our financial close and reporting process and information and communication controls. Management also concluded that we did not have a sufficient complement of corporate personnel with appropriate levels of accounting and controls knowledge and experience commensurate with our financial reporting requirements to appropriately analyze, record and disclose accounting matters completely and accurately. As a result of this evaluation, management extensively used outside consultants who possessed the appropriate levels of accounting and controls knowledge.

 

46

 

 

Remediation. Following identification of this control deficiency, management is implementing modifications to better ensure that the Company has appropriate and timely reviews on all financial reporting analysis. The material weakness in our internal control over financial reporting will not be considered remediated until these modifications are implemented, in operation for a sufficient period of time, tested, and concluded by management to be designed and operating effectively. In addition, as we continue to evaluate and work to improve our internal control over financial reporting, management may determine to take additional measures to address control deficiencies or determine to modify our remediation plan. Management will test and evaluate the implementation of these modifications to ascertain whether they are designed and operating effectively to provide reasonable assurance that they will prevent or detect a material misstatement in the Company’s financial statements. 

 

The steps we took to address the deficiencies identified included: 

 

we hired a new Chief Financial Officer;

 

we hired a new Executive Vice-President (“EVP”) Accounting;

 

we have engaged in efforts to restructure accounting processes and revise organizational structures to enhance accurate accounting and appropriate financial reporting;

 

we have hired additional experienced accounting personnel in the corporate office to enhance the application of accounting standards and our financial closing and reporting process;

 

we have engaged external advisors to provide financial accounting and reporting assistance;

 

we will enhance information and communication processes through information technology solutions to ensure that information needed for financial reporting is accurate, complete, relevant and reliable, and communicated in a timely manner; and

 

we have engaged external advisors to evaluate and document the design and operating effectiveness of our internal control over financial reporting and assist with the remediation and implementation of our internal control function.

 

As noted above, we believe that, as a result of management’s in-depth review of its accounting processes, and the additional procedures management has implemented, there are no material inaccuracies or omissions of material fact in this Form 10-Q and, to the best of our knowledge, we believe that the consolidated financial statements in this Form 10-Q fairly present in all material respects our financial condition, results of operations and cash flows in conformity with GAAP. 

 

We and our Board treat the controls surrounding, and the integrity of, our financial statements with the utmost priority. Management is committed to the planning and implementation of remediation efforts to address control deficiencies and any other identified areas of risk. These remediation efforts are intended to both address the identified material weakness and to enhance our overall financial control environment. We are committed to maintaining a strong internal control environment, and we believe the measures described above will strengthen our internal control over financial reporting and remediate the material weakness we have identified. Our remediation efforts have begun, and we will continue to devote significant time and attention to these remedial efforts. As we continue to evaluate and work to improve our internal control over financial reporting, management may determine to take additional measures to strengthen controls or to modify the remediation plan described above, which may require additional implementation time. 

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes, other than our remediation efforts discussed above, in the Company’s internal control over financial reporting during the fiscal quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

47

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes to the Risk Factors disclosed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2021.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

48

 

 

ITEM 6. EXHIBITS

 

EXHIBIT INDEX

 

Exhibit
Number
  Description of Document
31.1   Officer’s Certificate Pursuant to 15 U.S.C. Section 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Officer’s Certificate Pursuant to 15 U.S.C. Section 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

49

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CINEDIGM CORP.
     
Date: February 14, 2022 By: /s/ Christopher J. McGurk
    Christopher J. McGurk
Chief Executive Officer and
Chairman of the Board of Directors
(Principal Executive Officer)
     
Date: February 14, 2022 By: /s/ John K. Canning
    John K. Canning
Chief Financial Officer
(Principal Financial Officer)

 

 

50

 

false --03-31 Q3 2022 0001173204 0001173204 2021-04-01 2021-12-31 0001173204 2022-02-11 0001173204 2021-12-31 0001173204 2021-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001173204 us-gaap:SeriesAPreferredStockMember 2021-03-31 0001173204 us-gaap:CommonClassAMember 2021-12-31 0001173204 us-gaap:CommonClassAMember 2021-03-31 0001173204 2021-10-01 2021-12-31 0001173204 2020-10-01 2020-12-31 0001173204 2020-04-01 2020-12-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-03-31 0001173204 us-gaap:TreasuryStockMember 2020-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001173204 us-gaap:RetainedEarningsMember 2020-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001173204 us-gaap:ParentMember 2020-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-03-31 0001173204 2020-03-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-04-01 2020-06-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001173204 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001173204 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001173204 us-gaap:ParentMember 2020-04-01 2020-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001173204 2020-04-01 2020-06-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-06-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-06-30 0001173204 us-gaap:TreasuryStockMember 2020-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001173204 us-gaap:RetainedEarningsMember 2020-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001173204 us-gaap:ParentMember 2020-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-06-30 0001173204 2020-06-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-07-01 2020-09-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001173204 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001173204 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001173204 us-gaap:ParentMember 2020-07-01 2020-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0001173204 2020-07-01 2020-09-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-09-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-09-30 0001173204 us-gaap:TreasuryStockMember 2020-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001173204 us-gaap:RetainedEarningsMember 2020-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001173204 us-gaap:ParentMember 2020-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-09-30 0001173204 2020-09-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:TreasuryStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001173204 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-01 2020-12-31 0001173204 us-gaap:ParentMember 2020-10-01 2020-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-10-01 2020-12-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001173204 us-gaap:TreasuryStockMember 2020-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001173204 us-gaap:RetainedEarningsMember 2020-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001173204 us-gaap:ParentMember 2020-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-12-31 0001173204 2020-12-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001173204 us-gaap:TreasuryStockMember 2021-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001173204 us-gaap:RetainedEarningsMember 2021-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001173204 us-gaap:ParentMember 2021-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2021-03-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001173204 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001173204 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001173204 us-gaap:ParentMember 2021-04-01 2021-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001173204 2021-04-01 2021-06-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-06-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001173204 us-gaap:TreasuryStockMember 2021-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001173204 us-gaap:RetainedEarningsMember 2021-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001173204 us-gaap:ParentMember 2021-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2021-06-30 0001173204 2021-06-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001173204 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001173204 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001173204 us-gaap:ParentMember 2021-07-01 2021-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001173204 2021-07-01 2021-09-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-09-30 0001173204 us-gaap:TreasuryStockMember 2021-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001173204 us-gaap:RetainedEarningsMember 2021-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001173204 us-gaap:ParentMember 2021-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2021-09-30 0001173204 2021-09-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-10-01 2021-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001173204 us-gaap:TreasuryStockMember 2021-10-01 2021-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001173204 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2021-12-31 0001173204 us-gaap:ParentMember 2021-10-01 2021-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2021-10-01 2021-12-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001173204 us-gaap:TreasuryStockMember 2021-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001173204 us-gaap:RetainedEarningsMember 2021-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001173204 us-gaap:ParentMember 2021-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2021-12-31 0001173204 2021-07-09 0001173204 2021-03-17 0001173204 2021-03-01 2021-03-17 0001173204 2019-12-01 2019-12-27 0001173204 2020-02-01 2020-02-14 0001173204 cidm:BeiTaiMember 2020-02-01 2020-02-14 0001173204 2020-02-14 0001173204 cidm:BeiTaiMember 2021-04-01 2021-12-31 0001173204 2020-04-01 2020-04-10 0001173204 2020-04-15 0001173204 us-gaap:BorrowingsMember 2021-07-09 0001173204 cidm:StarriseMember 2020-02-14 0001173204 cidm:StarriseMember 2020-04-10 0001173204 2020-04-10 0001173204 cidm:StarriseMember cidm:StockExchangeOfHongKongLimitedMember 2021-04-01 2021-12-31 0001173204 cidm:StarriseMember cidm:StockExchangeOfHongKongLimitedMember 2020-04-01 2021-03-31 0001173204 cidm:StockExchangeOfHongKongLimitedMember 2021-04-01 2021-12-31 0001173204 cidm:StockExchangeOfHongKongLimitedMember 2020-04-01 2020-12-31 0001173204 2021-04-01 2021-04-01 0001173204 2020-05-01 2020-05-05 0001173204 cidm:StarriseMember 2021-12-31 0001173204 cidm:StarriseMember 2021-03-31 0001173204 cidm:StarriseMember 2021-04-01 2021-12-31 0001173204 cidm:StarriseMember 2020-04-01 2021-03-31 0001173204 us-gaap:UpFrontPaymentArrangementMember 2021-12-31 0001173204 cidm:ServicesMember 2021-12-31 0001173204 srt:MinimumMember us-gaap:ComputerEquipmentMember 2021-04-01 2021-12-31 0001173204 srt:MaximumMember us-gaap:ComputerEquipmentMember 2021-04-01 2021-12-31 0001173204 cidm:InternalUseSoftwareMember 2021-04-01 2021-12-31 0001173204 cidm:DigitalCinemaProjectionSystemsMember 2021-04-01 2021-12-31 0001173204 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-04-01 2021-12-31 0001173204 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-04-01 2021-12-31 0001173204 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2021-04-01 2021-12-31 0001173204 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2021-04-01 2021-12-31 0001173204 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001173204 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001173204 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001173204 us-gaap:FairValueInputsLevel1Member 2021-03-31 0001173204 us-gaap:FairValueInputsLevel2Member 2021-03-31 0001173204 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentEntertainmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentEntertainmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentEntertainmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentEntertainmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentEntertainmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentEntertainmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentEntertainmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentEntertainmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:HoldingsMember 2021-04-01 2021-12-31 0001173204 cidm:HoldingsMember 2021-12-31 0001173204 cidm:HoldingsMember 2021-03-31 0001173204 cidm:HoldingsMember 2021-10-01 2021-12-31 0001173204 cidm:HoldingsMember 2020-10-01 2020-12-31 0001173204 cidm:CONtvMember 2021-12-31 0001173204 2021-05-02 2021-05-12 0001173204 us-gaap:DevelopedTechnologyRightsMember 2021-04-01 2021-12-31 0001173204 2021-09-01 2021-09-17 0001173204 cidm:FoundationTVIncMember 2021-12-31 0001173204 cidm:BloodyDisgustingLLCMember 2021-12-31 0001173204 cidm:AdvertiserRelationshipsMember 2021-12-31 0001173204 us-gaap:TradeNamesMember 2021-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2013-02-01 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoansAgreementMember 2021-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoansAgreementMember 2020-03-31 0001173204 cidm:CDCHMember 2021-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2021-12-31 0001173204 us-gaap:RevolvingCreditFacilityMember 2018-03-30 0001173204 us-gaap:RevolvingCreditFacilityMember cidm:CinedigmCreditFacilityMember us-gaap:PrimeRateMember 2021-04-01 2021-12-31 0001173204 us-gaap:RevolvingCreditFacilityMember cidm:CinedigmCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-04-01 2021-12-31 0001173204 us-gaap:LineOfCreditMember 2019-07-03 0001173204 2021-03-01 2021-03-31 0001173204 cidm:PaycheckProtectionProgramMember 2020-04-01 2020-04-15 0001173204 us-gaap:ConvertibleNotesPayableMember 2020-04-15 0001173204 cidm:CurrentPortionMember 2021-12-31 0001173204 cidm:LongTermPortionMember 2021-12-31 0001173204 cidm:CurrentPortionMember 2021-03-31 0001173204 cidm:LongTermPortionMember 2021-03-31 0001173204 us-gaap:CommonClassAMember 2021-10-11 0001173204 us-gaap:CommonClassAMember 2021-04-01 2021-12-31 0001173204 2020-04-01 2021-03-31 0001173204 2021-05-01 2021-05-31 0001173204 2021-10-01 2021-10-31 0001173204 cidm:CinedigmEquityIncentivePlanMember 2021-04-01 2021-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2021-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2021-04-01 2021-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2021-03-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2020-04-01 2021-03-31 0001173204 us-gaap:CommonClassAMember 2017-08-01 2017-08-01 0001173204 srt:MinimumMember cidm:TwoThousandSeventeenPlanMember us-gaap:CommonClassAMember 2019-12-04 0001173204 srt:MaximumMember cidm:TwoThousandSeventeenPlanMember us-gaap:CommonClassAMember 2019-12-04 0001173204 srt:MinimumMember cidm:TwoThousandSeventeenPlanMember 2020-10-23 0001173204 srt:MaximumMember cidm:TwoThousandSeventeenPlanMember 2020-10-23 0001173204 srt:MinimumMember cidm:TwoThousandSeventeenPlanMember 2021-10-11 0001173204 srt:MaximumMember cidm:TwoThousandSeventeenPlanMember 2021-10-11 0001173204 us-gaap:StockAppreciationRightsSARSMember 2021-04-01 2021-12-31 0001173204 srt:MinimumMember 2021-04-01 2021-12-31 0001173204 srt:MaximumMember 2021-04-01 2021-12-31 0001173204 us-gaap:StockAppreciationRightsSARSMember 2021-10-01 2021-12-31 0001173204 cidm:RestrictedStockAwardsMember 2021-10-01 2021-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2021-10-01 2021-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2020-10-01 2020-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2021-12-31 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember 2013-10-01 2013-10-31 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember us-gaap:EmployeeStockOptionMember 2013-10-01 2013-10-31 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember 2021-12-31 0001173204 cidm:ExercisePriceRangeOneMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisePriceRangeOneMember 2021-12-31 0001173204 cidm:ExercisePriceRangeTwoMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisePriceRangeTwoMember 2021-12-31 0001173204 cidm:OptionsExercisableMember 2021-12-31 0001173204 cidm:OptionsExercisableMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisePriceRangeThreeMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisePriceRangeThreeMember 2021-12-31 0001173204 cidm:ExercisesPriceRangeFourMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisesPriceRangeFourMember 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-07-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-07-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-04-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-04-01 2020-12-31 0001173204 2021-07-01 2021-12-31 0001173204 2020-07-01 2020-12-31 0001173204 cidm:BEMGTermLoanAgreementMember 2021-12-31 0001173204 cidm:BEMGTermLoanAgreementMember 2021-04-01 2021-12-31 0001173204 srt:MinimumMember cidm:BEMGTermLoanAgreementMember 2021-12-31 0001173204 2021-09-01 0001173204 cidm:PhaseIDeploymentMember 2021-04-01 2021-12-31 0001173204 cidm:PhaseIIDeploymentMember 2021-04-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2021-12-31 0001173204 us-gaap:CorporateMember 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2021-03-31 0001173204 cidm:ContentEntertainmentBusinessMember 2021-03-31 0001173204 us-gaap:CorporateMember 2021-03-31 0001173204 cidm:CinemaEquipmentBusinessMember 2021-10-01 2021-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2021-10-01 2021-12-31 0001173204 us-gaap:CorporateMember 2021-10-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2020-10-01 2020-12-31 0001173204 us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2021-04-01 2021-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2021-04-01 2021-12-31 0001173204 us-gaap:CorporateMember 2021-04-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2020-04-01 2020-12-31 0001173204 us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2021-10-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember 2021-10-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2021-10-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-10-01 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-10-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2021-04-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember 2021-04-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2021-04-01 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 2020-03-02 2020-03-27 0001173204 2022-01-01 2022-01-04 xbrli:shares iso4217:USD xbrli:pure iso4217:USD xbrli:shares
EX-31.1 2 f10q1221ex31-1_cinedigm.htm CERTIFICATION

Exhibit 31.1

 

CINEDIGM CORP.

CERTIFICATION

 

I, Christopher J. McGurk, certify that:

 

1. I have reviewed this Form 10-Q of Cinedigm Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 14, 2022 By:  /s/ Christopher J. McGurk
    Christopher J. McGurk
Chief Executive Officer and
Chairman of the Board of Directors
(Principal Executive Officer)

 

EX-31.2 3 f10q1221ex31-2_cinedigm.htm CERTIFICATION

Exhibit 31.2

 

CINEDIGM CORP.

CERTIFICATION

 

I, John K. Canning, certify that:

 

1. I have reviewed this Form 10-Q of Cinedigm Corp.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 14, 2022 By:  /s/ John K. Canning
    John K. Canning
Chief Financial Officer
(Principal Financial Officer)

 

EX-32.1 4 f10q1221ex32-1_cinedigm.htm CERTIFICATION

Exhibit 32.1

 

CINEDIGM CORP.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with Form 10-Q of Cinedigm Corp. (the “Company”) for the period ended December 31, 2021 as filed with the SEC (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: February 14, 2022 By: /s/ Christopher J. McGurk
    Christopher J. McGurk
Chief Executive Officer and
Chairman of the Board of Directors
(Principal Executive Officer)

 

EX-32.2 5 f10q1221ex32-2_cinedigm.htm CERTIFICATION

Exhibit 32.2

 

CINEDIGM CORP.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with Form 10-Q of Cinedigm Corp. (the “Company”) for the period ended December 31, 2021 as filed with the SEC (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: February 14, 2022 By: /s/ John K. Canning
    John K. Canning
Chief Financial Officer
(Principal Financial Officer)

 

EX-101.SCH 6 cidm-20211231.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consdensed Consolidated Statements of Changes in Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consdensed Consolidated Statements of Changes in Equity (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Nature of Operations and Liquidity link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Other Interests link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Business Combination link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Business Combination (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Supplemental Cash Flow Information (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Nature of Operations and Liquidity (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of cash, cash equivalents and restricted cash link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of financial assets link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of goodwill and accumulated impairment charges link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of revenue categories link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Other Interests (Details) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Business Combination (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Business Combination (Details) - Schedule of business combination link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Business Combination (Details) - Schedule of amortization expense per year for the developed technology acquired in the business combination link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Business Combination (Details) - Schedule of amortization expense per year for the intangible assets acquired in the business combination link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Notes Payable (Details) - Schedule of notes payable link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Notes Payable (Details) - Schedule of debt outstanding link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Stockholders' Equity (Details) - Schedule of analysis of option activity link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Stockholders' Equity (Details) - Schedule of stock-based compensation expense link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Stockholders' Equity (Details) - Schedule of SARs outstanding link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease costs link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flows link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - Segment Information (Details) - Schedule of segment reporting, assets and debt link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - Segment Information (Details) - Schedule of segment reporting, statement of operations link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - Segment Information (Details) - Schedule of segment reporting, employee stock-based compensation expense link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 cidm-20211231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cidm-20211231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cidm-20211231_lab.xml XBRL LABEL FILE EX-101.PRE 10 cidm-20211231_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Document And Entity Information - shares
9 Months Ended
Dec. 31, 2021
Feb. 11, 2022
Document Information Line Items    
Entity Registrant Name Cinedigm Corp.  
Trading Symbol CIDM  
Document Type 10-Q  
Current Fiscal Year End Date --03-31  
Entity Common Stock, Shares Outstanding   174,871,216
Amendment Flag false  
Entity Central Index Key 0001173204  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Dec. 31, 2021  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-31810  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 22-3720962  
Entity Address, Address Line One 237 West 35th Street  
Entity Address, Address Line Two Suite 605  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10001  
City Area Code (212)  
Local Phone Number 206-8600  
Title of 12(b) Security CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Current assets    
Cash and cash equivalents $ 20,201 $ 16,849
Accounts receivable, net 29,785 21,093
Inventory 92 166
Unbilled revenue 2,826 1,377
Prepaid and other current assets 5,787 3,657
Total current assets 58,691 43,142
Restricted cash 1,000
Equity investment in Starrise, a related party, at fair value 7,896 6,443
Property and equipment, net 2,438 3,500
Right-of-use assets 16 100
Intangible assets, net 15,672 9,860
Goodwill 13,659 8,701
Other long-term assets 1,182 2,700
Total assets 99,554 75,446
Current liabilities    
Accounts payable and accrued expenses 54,706 46,627
Current portion of notes payable (see Note 5) 1,956
Current portion of notes payable, non-recourse (see Note 5) 7,786
Current portion of deferred consideration on purchase of a business 472
Current portion of earnout consideration on purchase of a business 292
Operating lease liabilities, current portion 16 87
Current portion of deferred revenue 285 924
Total current liabilities 55,771 57,380
PPP Loan 2,152
Deferred consideration on purchase of a business, net of current portion 1,538
Earnout consideration on purchase of a business, net of current portion 1,236
Operating lease liabilities, net of current portion   13
Other long-term liabilities 19
Total liabilities 58,545 59,564
Commitments and contingencies (see Note 7)
Stockholders’ equity    
Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; and 7 shares issued and outstanding at December 31, 2021 and March 31, 2021. Liquidation preference of $3,648 3,559 3,559
Common stock, $0.001 par value; Class A stock 275,000,000 and 200,000,000 shares authorized at December 31, 2021 and March 31, 2021, respectively; 176,187,067 and 167,542,404 shares issued and 174,871,216 and 166,228,568 shares outstanding at December 31, 2021 and March 31, 2021, respectively 174 164
Additional paid-in capital 520,099 499,272
Treasury stock, at cost; 1,315,851 and 1,313,836 Class A common shares at December 31, 2021 and March 31, 2021, respectively (11,608) (11,603)
Accumulated deficit (469,729) (474,080)
Accumulated other comprehensive loss (101) (68)
Total stockholders’ equity of Cinedigm Corp. 42,394 17,244
Deficit attributable to noncontrolling interest (1,385) (1,362)
Total equity 41,009 15,882
Total liabilities and equity $ 99,554 $ 75,446
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Preferred stock, shares authorized 15,000,000 15,000,000
Series A preferred stock    
Preferred stock, shares authorized 20 20
Preferred stock, dividend rate 10.00% 10.00%
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares issued 7 7
Preferred stock, shares outstanding 7 7
Preferred stock, Liquidation preference Value (in Dollars) $ 3,648 $ 3,648
Class A Common Stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 275,000,000 200,000,000
Common stock, shares issued 176,187,067 167,542,404
Common stock, shares outstanding 174,871,216 166,228,568
Treasury stock 1,315,851 1,313,836
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]        
Revenues $ 14,084 $ 9,954 $ 39,202 $ 23,154
Costs and expenses:        
Direct operating (excludes depreciation and amortization shown below) 6,459 4,385 14,423 11,394
Selling, general and administrative 7,736 5,361 20,938 15,369
Bad debt (recovery) (378) 70 (418) (123)
Depreciation and amortization of property and equipment 336 822 1,425 3,691
Amortization of intangible assets 695 597 2,238 1,778
Total operating expenses 14,848 11,235 38,606 32,109
Income (loss) from operations (764) (1,281) 596 (8,955)
Interest expense, net (97) (948) (277) (3,432)
Gain (loss) on forgiveness of PPP loan and extinguishment of note payable (540) 2,178 (852)
Change in fair value of equity investment in Starrise, a related party 453 (6,751) 1,453 (42,377)
Other expense, net (22) (147) 69 (668)
Income (loss) before income taxes (430) (9,667) 4,019 (56,284)
Income tax benefit 26 576 181
Net income (loss) (404) (9,667) 4,595 (56,103)
Net income attributable to noncontrolling interest 19 23 23 60
Net income (loss) attributable to controlling interests (385) (9,644) 4,618 (56,043)
Preferred stock dividends (89) (89) (267) (267)
Net income (loss) attributable to common stockholders $ (474) $ (9,733) $ 4,351 $ (56,310)
Net income (loss) per Class A common stock attributable to common stockholders - basic: (in Dollars per share) $ 0 $ (0.07) $ 0.03 $ (0.49)
Weighted average number of Class A common stock outstanding: basic (in Shares) 173,167,450 136,866,072 169,413,873 115,347,494
Net income (loss) per Class A common stock attributable to common stockholders - diluted: (in Dollars per share) $ 0 $ (0.07) $ 0.03 $ (0.49)
Weighted average number of Class A common stock outstanding: diluted (in Shares) 173,167,450 136,866,072 173,017,364 115,347,494
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ (404) $ (9,667) $ 4,595 $ (56,103)
Other comprehensive (loss) income: foreign exchange translation (14) (76) (33) (186)
Comprehensive income (loss) (418) (9,743) 4,562 (56,289)
Less: comprehensive income attributable to noncontrolling interest 19 23 23 60
Comprehensive income (loss) attributable to controlling interests $ (399) $ (9,720) $ 4,585 $ (56,229)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consdensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Series A
Preferred Stock
Class A
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total Stockholders’ Deficit
Non-Controlling Interest
Total
Balance at Mar. 31, 2020 $ 3,559 $ 62 $ (11,603) $ 400,784 $ (410,904) $ 92 $ (18,010) $ (1,277) $ (19,287)
Balance (in Shares) at Mar. 31, 2020 7 61,937,593 1,313,836            
Foreign exchange translation (80) (80) (80)
Stock issued in connection with the SPA with certain investors, net $ 11 7,139 7,150 7,150
Stock issued in connection with the SPA with certain investors, net (in Shares)   10,666,666              
Issuance of Class A common stock in connection with the Starrise transaction, a related party $ 30 11,016 11,046 11,046
Issuance of Class A common stock in connection with the Starrise transaction, a related party (in Shares)   29,855,081              
Contributed capital under the Starrise transaction, a related party 17,187 17,187 17,187
Issuance of stock in connection with settlement of second lien loan 757 757 757
Issuance of stock in connection with settlement of second lien loan (in Shares)   329,501              
Exercise of warrants for Class A common stock 301 301 301
Exercise of warrants for Class A common stock (in Shares)   236,899              
Stock-based compensation 177 177 177
Preferred stock dividends paid with common stock 89 (89)
Preferred stock dividends paid with common stock (in Shares)   267,079              
Net loss (19,856) (19,856) (14) (19,870)
Balance at Jun. 30, 2020 $ 3,559 $ 103 $ (11,603) 437,450 (430,849) 12 (1,328) (1,291) (2,619)
Balance (in Shares) at Jun. 30, 2020 7 103,292,819 1,313,836            
Foreign exchange translation (30) (30) (30)
July 2020 issuance of Class A common stock, net of $695 in issuance costs $ 7 10,118   10,125 10,125
July 2020 issuance of Class A common stock, net of $695 in issuance costs (in Shares)   7,213,334              
Common stock issued in connection with conversion of Convertible Notes $ 10 14,990 15,000 15,000
Common stock issued in connection with conversion of Convertible Notes (in Shares)   10,000,000              
Issuance of common stock for third party professional service 71 71 71
Issuance of common stock for third party professional service (in Shares) 80,000            
Issuance of Class A common stock to management and employees $ 1 785 786 786
Issuance of Class A common stock to management and employees (in Shares)   689,364              
Issuance of common stock in connection with performance stock units (in Shares)   373,647              
Common stock issued to settle second lien loan   61 61 61
Common stock issued to settle second lien loan (in Shares)   33,465              
Stock-based compensation 178 178 178
Preferred stock dividends paid with common stock 89 (89)
Preferred stock dividends paid with common stock (in Shares)   44,913              
Net loss (26,543) (26,543) (23) (26,566)
Balance at Sep. 30, 2020 $ 3,559 $ 121 $ (11,603) 463,742 (457,481) (18) (1,680) $ (1,314) (2,994)
Balance (in Shares) at Sep. 30, 2020 7 121,727,542 1,313,836            
Foreign exchange translation $ (76) $ (76)   $ (76)
Issuance of common stock in connection with performance stock units (in Shares)   320,000
Issuance of common stock in connection with ATM raises, net $ 27 $ 18,589 $ 18,616 $ 18,616
Issuance of common stock in connection with ATM raises, net (in Shares)   28,405,840              
Class A common stock to be issued in connection with asset acquisition 1,853 1,853 1,853
Common stock issued to settle second lien loan $ 5 2,185 2,190 2,190
Common stock issued to settle second lien loan (in Shares)   3,228,783            
Preferred stock dividends paid with common stock 89 (89)
Preferred stock dividends paid with common stock (in Shares)   171,933              
Stock compensation and expenses 794 794 794
Issuance of Class A common stock to management 166 166 166
Issuance of Class A common stock to management (in Shares)   320,000              
Net loss (9,644) (9,644) (23) (9,667)
Balance at Dec. 31, 2020 $ 3,559 $ 153 $ (11,603) 487,418 (467,214) (94) 12,219 (1,337) 10,882
Balance (in Shares) at Dec. 31, 2020 7 154,174,098 1,313,836            
Balance at Mar. 31, 2021 $ 3,559 $ 164 $ (11,603) 499,272 (474,080) (68) 17,244 (1,362) 15,882
Balance (in Shares) at Mar. 31, 2021 7 166,228,568 1,313,836            
Foreign exchange translation (54) (54) (54)
Stock-based compensation 983 983 983
Stock-based compensation (in Shares)   35,714              
Issuance of common stock in connection with a business combination $ 2 2,504 2,506 2,506
Issuance of common stock in connection with a business combination (in Shares)   1,483,129              
Preferred stock dividends paid with common stock 89 (89)
Preferred stock dividends paid with common stock (in Shares)   53,278              
Net loss 5,187 5,187 7 5,194
Balance at Jun. 30, 2021 $ 3,559 $ 166 $ (11,603) 502,848 (468,982) (122) 25,866 (1,355) 24,511
Balance (in Shares) at Jun. 30, 2021 7 167,800,689 1,313,836            
Foreign exchange translation 35 35 35
Stock-based compensation 946 946 946
Stock-based compensation (in Shares)   132,630              
Issuance of common stock in connection with a business combination $ 1 2,317 2,318 2,318
Issuance of common stock in connection with a business combination (in Shares)   1,179,156              
Treasury stock in connection with taxes withheld from employees $ (5) (5) (5)
Treasury stock in connection with taxes withheld from employees (in Shares)   (2,015) 2,015            
Preferred stock dividends         (89) (89) (89)
Net loss (184) (184) (11) (195)
Balance at Sep. 30, 2021 $ 3,559 $ 167 $ (11,608) 506,111 (469,255) (87) 28,887 (1,366) 27,521
Balance (in Shares) at Sep. 30, 2021 7 169,110,460 1,315,851            
Foreign exchange translation (14) $ (14) $ (14)
Issuance of common stock in connection with performance stock units (in Shares)   263        
Issuance of common stock in connection with ATM raises, net $ 7 $ 12,371 $ 12,378 $ 12,378
Issuance of common stock in connection with ATM raises, net (in Shares)   5,300,000            
Preferred stock dividends accrued       89 (89)    
Stock-based compensation 1,349 1,349 1,349
Stock-based compensation (in Shares)   147,712              
Issuance of common stock in connection with equity line purchase commitment
Issuance of common stock in connection with equity line purchase commitment (in Shares)   210,084              
Preferred stock dividends       178     178   178
Preferred stock dividends (in Shares)   102,697              
Net loss (385) (385) (19) (404)
Balance at Dec. 31, 2021 $ 3,559 $ 174 $ (11,608) $ 520,099 $ (469,729) $ (101) $ 42,394 $ (1,385) $ 41,009
Balance (in Shares) at Dec. 31, 2021 7 174,871,216 1,315,851            
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consdensed Consolidated Statements of Changes in Equity (Unaudited) (Parentheticals)
$ in Thousands
3 Months Ended
Sep. 30, 2020
USD ($)
Statement of Stockholders' Equity [Abstract]  
Issuance costs of class A common stock, net $ 695
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net income (loss) $ 4,595 $ (56,103)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization of property and equipment and amortization of intangible assets 3,663 5,469
Changes in fair value of equity investment in Starrise (1,464) 42,377
(Gain) loss from forgiveness of PPP loan and extinguishment of note payable (2,178) 852
Impairment of advances 782 280
Loss from sale of property and equipment 62
Amortization of debt issuance costs included in interest expense 140
Provision for doubtful accounts (397) (123)
Stock-based compensation 3,278 2,172
Accretion and PIK interest expense added to note payable 294
Interest expense for deferred consideration 30
Interest expense for earnout consideration 67
Other 59
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (8,164) 9,820
Inventory 74 359
Unbilled revenue (1,449) (1,085)
Prepaids and other current assets, and other long-term assets (1,394) 1,765
Accounts payable, accrued expenses, and other liabilities 7,883 (21,831)
Deferred revenue (639) (1,224)
Net cash provided by (used in) operating activities 4,746 (16,776)
Cash flows from investing activities:    
Purchases of property and equipment (292) (339)
Purchase of businesses (4,750)
Proceeds from the sale of property and equipment 156
Sale of equity investment in Starrise 11 815
Purchases of intangible assets (742)
Net cash used in investing activities (5,031) (110)
Cash flows from financing activities:    
Payments of notes payable (7,786) (22,365)
(Payments) proceeds under revolving credit agreement, net (1,956) 12,823
Proceeds from PPP Loan 2,152
Proceeds from issuance of Class A common stock, net 12,378 36,189
Net cash provided by financing activities 2,636 28,799
Net change in cash, cash equivalents, and restricted cash 2,352 11,913
Cash, cash equivalents, and restricted cash at beginning of period 17,849 15,294
Cash, cash equivalents, and restricted cash at end of period $ 20,201 $ 27,207
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
Nature of Operations and Liquidity
9 Months Ended
Dec. 31, 2021
Disclosure of Nature of Operations and Liquidity [Abstract]  
NATURE OF OPERATIONS AND LIQUIDITY

1. NATURE OF OPERATIONS AND LIQUIDITY

 

Cinedigm Corp. (“Cinedigm,” the “Company,” “we,” “us,” or similar pronouns) was incorporated in Delaware on March 31, 2000. We are (i) a distributor and aggregator of independent movie, television and other short form content managing a library of distribution rights to thousands of titles and episodes released across digital, physical, theatrical, home and mobile entertainment platforms (“Streaming”) and (ii) a servicer of digital cinema assets (“Systems”) for over 4,609 movie screens in both North America and several international countries.

 

We report our financial results in two primary segments as follows: (1) cinema equipment business and (2) content and entertainment business (“Content & Entertainment” or “CEG”). The cinema equipment business segment consists of the non-recourse, financing vehicles and administrators for our digital cinema equipment (the “Systems”) installed in movie theatres throughout North America and Australia. It also provides fee-based support to over 4,609 movie screens as well as directly to exhibitors and other third-party customers in the form of monitoring, billing, collection and verification services. Our Content & Entertainment segment operates in: (1) ancillary market aggregation and distribution of entertainment content and (2) branded and curated over-the-top (“OTT”) digital network business providing entertainment channels and applications.

 

Risks and Uncertainties

 

The COVID-19 pandemic and related economic repercussions created significant volatility and uncertainty impacting the Company’s results for the period. As part of our Content & Entertainment business, the Company sells DVDs and Blu-ray discs at brick-and-mortar stores. Due to the lingering effects of the COVID-19 pandemic in the nine-month period ended December 31, 2021, the sale of physical discs through our retail partners declined although this was partially offset by digital purchases of physical product and increases in streaming views. As part of our Cinema Equipment business, the Company earns revenue when movies are exhibited in theatres. Major studios continued to release tentpole films in the theatrical markets as box office results steadily showed improvement in the three months ended December 31, 2021.  However, the number of wide releases remained below pre-pandemic levels during that quarter as studios continue to shuffle release dates and test theatrical windows.  The Canadian government tightened Movie Theatre restrictions amid a Covid surge due to the Omicron variant as well as shuttering all Quebec theatres during that quarter.  Movie theatres in the U.S. remained open and continued to follow NATO CinemaSafe protocols in an effort to help reinforce consumer confidence in the safety of the theatrical moviegoing experience. 

 

Liquidity

 

We have incurred net losses historically and have an accumulated deficit of $469.7 million and our working capital is $2.9 million as of December 31, 2021. We may continue to generate net losses for the foreseeable future. In addition, we have had debt-related contractual obligations. Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect Loan (as defined below) non-recourse debt amount by paying an aggregate principal amount of $7.8 million. As of December 31, 2021 there was $0 million principal outstanding and there was no availability under the Credit Facility which expired on September 28, 2021. Net cash provided by operating activities for the nine months ended December 31, 2021 was $4.7 million. Based on these conditions and the Company´s financing strategies, the Company entered into the transactions described below:

 

Sale of Cinematic Equipment

 

On March 17, 2021, the Company entered into two separate agreements for the sale of cinematic equipment to American Multi-Cinema, Inc. (“AMC”). The agreements included the sale in tranches of a total of 2,369 cinematic projectors starting in March 2021 and continuing through January 2023 for total cash consideration of $10.8 million. Through December 31, 2021, the Company recognized aggregate revenue for $9.1 million. A portion of the total proceeds were used to paydown the remaining outstanding balance of the Prospect Loan notes payable.

  

Equity Investment in a Related Party

 

On December 27, 2019, the Company entered into, and on February 14, 2020 amended, (see Note 2 - Summary of Significant Accounting Policies), a stock purchase agreement (as so amended, the “Starrise Stock Purchase Agreement”) with BeiTai Investment LP (“BeiTai”), a related party for accounting purposes of Cinedigm and Aim Right Ventures Limited (“Aim Right”), two shareholders of Starrise Media Holdings Limited, a leading Chinese entertainment company (“Starrise”), to buy from them an aggregate of 410,901,000 outstanding Starrise ordinary shares (the “Starrise Share Acquisition”). On February 14, 2020, the Company purchased 162,162,162 of the Starrise ordinary shares from BeiTai and issued BeiTai 21,646,604 shares of its Class A common stock, par value $.001 per share (the “Common Stock”) in consideration therefor. The Starrise shares received were valued at approximately $25 million and the Company issued shares that were valued at approximately $11.2 million. On April 10, 2020, the Company, in accordance with the terms of the Stock Purchase Agreement, terminated its obligation to purchase Starrise ordinary shares from Aim Right under the Starrise Stock Purchase Agreement.

 

On April 10, 2020, the Company entered into another stock purchase agreement (the “April Starrise Stock Purchase Agreement”) with five (5) shareholders of Starrise - Bison Global Investment SPC - Bison Global No. 1 SP, Huatai Investment LP, Antai Investment LP, Mingtai Investment LP and Shangtai Asset Management LP - all of which are related parties to the Company to buy an aggregate of 223,380,000 outstanding Starrise ordinary shares from them and for the Company to issue to them an aggregate of 29,855,081 shares of its Common Stock as consideration therefor (the “April Starrise Share Acquisition”). On April 15, 2020, the April Starrise Share Acquisition was consummated and this transaction was also recorded as an equity investment in Starrise.

 

Starrise’s ordinary shares (HK 1616) are listed on the main board of the Stock Exchange of Hong Kong Limited. Based on the closing price of HKD 0.159 per share on February 11, 2022, calculated at an exchange rate of 7.8 Hong Kong Dollars to 1 US dollar, the market value of Cinedigm’s ownership in Starrise ordinary shares was approximately $7.4 million. 

 

Borrowings

 

On June 22, 2021, the maturity date of the East West Credit Facility (as defined in Note 5 - Notes Payable) with East West Bank was extended from June 30, 2021 to September 28, 2021 and was not extended.

 

On April 15, 2020, the Company received $2.2 million from East West Bank, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts were intended to be eligible for forgiveness, subject to the provisions of the CARES Act, and could be subject to repayment. On July 7, 2021, the Company received notification from the lender that the U.S. Small Business Administration had approved the Company’s PPP Loan forgiveness application for the entire PPP Loan amount and accrued interest effective as of June 30, 2021. The forgiveness of the PPP Loan was recognized as a gain of $2.2 million during the Company’s fiscal quarter ended June 30, 2021.

 

Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect loan non-recourse outstanding debt amount by paying an aggregate principal amount of $7.8 million. Pre-payment of the Prospect Loan was permissible without penalty.

 

Common Stock Purchase Agreement

 

In October 2021, we entered into a Common Stock Purchase Agreement (the “Equity Line Purchase Agreement”) and a Registration Rights Agreement (the “Registration Rights Agreement”) with B. Riley Principal Capital, LLC (“B. Riley Principal Capital”). Pursuant to the Equity Line Purchase Agreement, the Company has the right to sell to B. Riley Principal Capital up to the lesser of (i) $50,000,000 of newly issued shares of Common Stock and (ii) the Exchange Cap (as defined below) (subject to certain conditions and limitations), from time to time during the 24-month period from and after the October 21, 2021. Sales of Common Stock pursuant to the Equity Line Purchase Agreement, and the timing of any sales, are solely at the option of the Company, and the Company is under no obligation to sell any securities to B. Riley Principal Capital under the Equity Line Purchase Agreement. As consideration for B. Riley Principal Capital’s commitment to purchase shares of Common Stock at the Company’s direction upon the terms and subject to the conditions set forth in the Equity Line Purchase Agreement, upon execution of the Equity Line Purchase Agreement, the Company issued 210,084 shares of Common Stock to B. Riley Principal Capital (the “Commitment Shares”). The purchase price of the shares of Common Stock that we elect to sell to B. Riley Principal Capital pursuant to the Equity Line Purchase Agreement will be determined by reference to the volume weighted average price of the Common Stock (“VWAP”) during the applicable purchase date, less a fixed 5% discount to such VWAP. Pursuant to the Registration Rights Agreement, the Company filed a Registration Statement on Form S-1 that was declared effective by the Securities and Exchange Commission on October 21, 2021 (File No. 333-260210) for the resale by B. Riley Principal Capital of up to 25,210,084 shares of Common Stock (including the Commitment Shares) acquired pursuant to the Equity Line Purchase Agreement. During October and November 2021, we sold 5,300,000 shares of Common Stock under the Equity Line Purchase Agreement. Net proceeds from such sales totaled $12.4 million.

 

We believe the combination of: (i) our cash and cash equivalent balances at December 31, 2021 and (ii) expected cash flows from operations, as well as liquidity for our operational and capital needs, for twelve months from the filing of this report will be sufficient to satisfy our contractual obligations, as well as liquidity for our operational and capital needs, for twelve months from the filing of this report. Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. Failure to generate additional revenues, obtain additional capital or manage discretionary spending could have an adverse effect on our financial position, results of operations and liquidity.

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies
9 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

BASIS OF PRESENTATION AND CONSOLIDATION

 

Our consolidated financial statements include the accounts of Cinedigm and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

Investments in which we do not have a controlling interest or are not the primary beneficiary, but have the ability to exert significant influence, are accounted for under the equity method of accounting. Noncontrolling interests for which we have been determined to be the primary beneficiary are consolidated and recorded as net loss attributable to noncontrolling interest. See Note 3 - Other Interests to the Consolidated Financial Statements for a discussion of our noncontrolling interests.

 

USE OF ESTIMATES

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates include the adequacy of accounts receivable reserves, return reserves, inventory reserves, recovery of advances, assessment of goodwill impairment, long-lived and finite-lived assets impairment and estimated amortization lives, fair value for asset acquisitions and business combinations, valuation allowances for income taxes and stock awards. Actual results could differ from these estimates.

 

CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

 

We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal. Our Prospect Loan required that we maintain specified cash balances that are restricted to repayment of interest thereunder. See Note 5 - Notes Payable for information about our restricted cash balances.

 

Cash, cash equivalents, and restricted cash consisted of the following:

 

   As of 
(in thousands)  December 31,
2021
   March 31,
2021
 
Cash and Cash Equivalents  $20,201   $26,207 
Restricted Cash   
    1,000 
   $20,201   $27,207 

 

EQUITY INVESTMENT IN STARRISE, A RELATED PARTY

 

On February 14, 2020, the Company acquired an approximately 11.5% interest in Starrise, a leading publicly traded Chinese entertainment company whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Starrise that is related to our major shareholders. When we acquired the Starrise stock, our then-majority affiliated stockholders also maintained a significant beneficial interest in Starrise. Upon consummation of the transaction on February 14, 2020, the Company recorded an initial investment of approximately $25 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.2 million, valued as of the date of the issuance of the Common Stock. The difference in value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital.

 

On April 10, 2020, the Company purchased an additional 15% interest in Starrise in a private transaction from shareholders of Starrise that are affiliated with the then-major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Common Stock of $11.0 million, valued at the date of the issuance of the Common Stock. The difference in the value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Starrise.

 

The Company has made an irrevocable election to apply the fair value accounting option under ASC 825-10, Financial Instruments, as it relates to its equity investment in Starrise. The Company’s investment in Starrise is marked to market and recorded at fair value.  The stock is traded on the Hong Kong Stock exchange with readily available pricing that is classified as Level 1 in the fair value hierarchy. The Company has established a policy that consistently uses either the closing price of last active trades or the latest bid price when there is no active trades, unadjusted at the last day of each reporting period, as the most relevant and representative input to the Level 1 fair value measures of its investment holdings.

 

As of December 31, 2021 and March 31, 2021, the value of our equity investment in Starrise, using the readily determinable fair value inputs from the market pricing of the Stock Exchange of Hong Kong, was approximately $7.9 million and $6.4 million, respectively, resulting in a change in fair value of approximately $1.5 million and ($42.4) million for the nine months ended December 31, 2021 and 2020 respectively, on our consolidated statement of operations. On April 1 and May 5, 2021, the Company sold 80,000 and 600,000 Starrise ordinary shares, respectively for a total amount of $11 thousand. At December 31, 2021 and March 31, 2021, the Company owned 362,307,397 and 362,987,397 ordinary shares or 17% and 26% of Starrise, respectively.

 

NON-MONETARY TRANSACTIONS

 

During the three and nine months ended December 31, 2020, the Company entered into agreements with certain vendors to transfer 5,139,762 and 14,184,765 Starrise ordinary shares to satisfy outstanding liabilities with these vendors. Upon the sale of the Starrise shares by the vendors, with certain restrictions on sales unless the Company gave consent to sell, if the proceeds did not satisfy the amount due to the vendor, the Company was liable for the balance owed. Pursuant to such agreements, the Company reduced the amount payable to its vendors by $0.8 million as of December 31, 2020. There were no such transactions during the nine months ended December 31, 2021.

 

There was no gain or loss resulting from these transactions for the three and nine months ended December 31, 2021 and 2020.

 

ACCOUNTS RECEIVABLE

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

We record accounts receivable, long-term in connection with activation fees that we earn from our digital cinema equipment (the “Systems”) deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rate.

 

ADVANCES

 

Advances, which are recorded within prepaid and other current assets on the consolidated balance sheets, represent amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record impairment charges for amounts that we expect may not be recoverable as of the consolidated balance sheet date. Impairments and accelerated amortization related to advances were $0.4 million and $0.3 million, respectively, for the three months ended December 31, 2021 and 2020. Impairments and accelerated amortization related to advances were $0.8 million and $0.3 million, respectively, for the nine months ended December 31, 2021 and 2020.

 

PROPERTY AND EQUIPMENT

 

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:

 

Computer equipment and software   3 - 5 years 
Internal use software   5 years 
Digital cinema projection systems   10 years 
Machinery and equipment   3 - 10 years 
Furniture and fixtures   3 - 6 years 

 

We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software. Post-configuration training and maintenance costs are expensed as incurred.

 

Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the leasehold improvements. Repair and maintenance costs are charged to expense as incurred. Major renewals, improvements and additions are capitalized. Upon the sale or other disposition of any property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and the gain or loss on disposal is included in the consolidated statements of operations.

 

FAIR VALUE MEASUREMENTS

 

The fair value measurement disclosures are grouped into three levels based on valuation factors:

 

  Level 1 – quoted prices in active markets for identical investments

 

  Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)

 

  Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)

 

Assets and liabilities measured at fair value on a recurring basis use the market approach, where prices and other relevant information are generated by market transactions involving identical or comparable assets or liabilities.

 

The equity investment in Starrise is in Hong Kong dollars and was translated into US dollars as of December 31, 2021 and March 31, 2021 at an exchange rate of 7.8 and 7.8 Hong Kong Dollars to 1 US Dollar, respectively. The fair value of this equity investment is measured by the unadjusted market pricing of Starrise on the Stock Exchange of Hong Kong.

 

The earnout consideration on purchase of Bloody Disgusting business (Note 4) is determined according to the probability-based method to the estimated the value of the earnout based on the premise that there are different probabilities to achieve different forecasts and therefore the defined earnout metric targets. Under this method, weighted-average earnout payments for each earnout period were estimated based on the probability of each forecast scenario. The resultant weighted-average earnout payments are discounted to a present value.

 

The following tables summarize the levels of fair value measurements of our financial assets and liabilities as of December 31, 2021 and March 31, 2021:

 

As of December 31, 2021                
                 
(in thousands)  Level 1   Level 2   Level 3   Total 
Assets:                
Equity investment in Starrise, at fair value  $7,896   $
   $
   $7,896 
   $7,896   $
   $
   $7,896 
                     
Liabilities:                    
Current portion of earnout consideration on purchase of a business  $
   $
    292    292 
Earnout consideration on purchase of a business, net of current portion  $
   $
    1,236    1,236 
   $
   $
   $1,528   $1,528 

  

As of March 31, 2021                
                 
(in thousands)  Level 1   Level 2   Level 3   Total 
Restricted cash  $1,000   $
   $
   $1,000 
Equity investment in Starrise, at fair value   6,443    
    
    6,443 
   $7,443   $
   $
   $7,443 

 

Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.

 

IMPAIRMENT OF LONG-LIVED AND FINITE-LIVED ASSETS

 

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. During the three and nine months ended December 31, 2021 and 2020, no impairment charge was recorded from operations for long-lived assets or finite-lived assets.

 

GOODWILL

 

Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.

 

Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.

 

The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test.

 

No goodwill impairment charge was recorded in the nine months ended December 31, 2021 and 2020.

 

Gross amounts of goodwill and accumulated impairment charges that we have recorded are as follows:

 

(In thousands)    
Goodwill at March 31, 2021  $8,701 
Goodwill from business combinations – see Note 4   4,958 
Goodwill at December 31, 2021  $13,659 

 

REVENUE RECOGNITION

 

We determine revenue recognition by:

 

  identifying the contract, or contracts, with the customer;

 

  identifying the performance obligations in the contract;

 

  determining the transaction price;

 

  allocating the transaction price to performance obligations in the contract; and

 

  recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.

 

We recognize revenue in the amount that reflects the consideration we expect to receive in exchange for the services provided, sales of physical products (e.g., DVDs and Blu-ray Discs) or when the content is available for subscription on the digital platform or available on the point-of-sale for transactional and video on demand services which is when the control of the promised products and services is transferred to our customers and our performance obligations under the contract have been satisfied. Revenues that might be subject to various taxes are recorded net of transaction taxes assessed by governmental authorities such as sales value-added taxes and other similar taxes.

 

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less.

 

Cinema Equipment Business

 

Our Cinema Equipment Business consists of financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).

 

We retain ownership of our digital cinema equipment (the “Systems”) and the residual cash flows related to the Systems in Phase I Deployment after the end of the 10-year deployment payment period.

 

For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.

 

The Cinema Equipment Business also provides monitoring, data collection, serial data verification and management services to this segment, as well as to exhibitors who purchase their own equipment, in order to collect virtual print fees (“VPFs”) from motion picture studios and distributors and Alternative Content Fees (“ACFs”) from alternative content providers, and to distribute those fees to theatrical exhibitors (collectively, “Services”).

 

VPFs are earned, net of administrative fees, pursuant to contracts with movie studios and distributors, whereby amounts are payable by a studio to Phase I Deployment and to Phase II Deployment when movies distributed by the studio are displayed on screens utilizing our Systems installed in movie theatres. VPFs are earned and payable to Phase I Deployment based on a defined fee schedule until the end of the VPF term. One VPF is payable for every digital title initially displayed per System. The amount of VPF revenue is dependent on the number of movie titles released and displayed using the Systems in any given accounting period. VPF revenue is recognized in the period the title first plays for general audience viewing in a digital projector equipped movie theatre. The Phase 1 Deployment’s and Phase 2 Deployments performance obligations for revenue recognition are met at this time. 

  

Phase II Deployment’s agreements with distributors require the payment of VPFs, according to a defined fee schedule, for ten years from the date each system is installed; however, Phase II Deployment may no longer collect VPFs once “cost recoupment,” as defined in the contracts with movie studios and distributors, is achieved. Cost recoupment will occur once the cumulative VPFs and other cash receipts collected by Phase II Deployment have equaled the total of all cash outflows, including the purchase price of all Systems, all financing costs, all “overhead and ongoing costs”, as defined, and including service fees, subject to maximum agreed upon amounts during the three-year rollout period and thereafter. Further, if cost recoupment occurs before the end of the eighth contract year, the studios will pay us a one-time “cost recoupment bonus.” The Company evaluated the constraining estimates related to the variable consideration, i.e., the one-time bonus and determined that it is not probable to conclude at this point in time that a significant reversal in the amount of cumulative revenue recognized will occur when the uncertainty associated with the variable consideration is subsequently resolved.

 

Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Cinedigm recognizes revenue once the customer takes possession of the Systems and Cinedigm received the sale proceeds. Such sales were originally contemplated as the conclusion of the digital cinema deployment plan.  Total system sales revenue recognized was $1.3 million and $66 thousand, during the three months ended December 31, 2021 and 2020, respectively. Total system sales revenue recognized was $9.1 million and $157 thousand, during the nine months ended December 31, 2021 and 2020, respectively. Revenues earned in connection with up front exhibitor contributions are deferred and recognized over the expected cost recoupment period.

Exhibitors who purchased and own Systems using their own financing in Phase II of the Cinema Equipment Business paid us an upfront activation fee of approximately $2.0 thousand per screen (the “Exhibitor-Buyer Structure”). Upfront activation fees were recognized in the period in which these Systems were delivered and ready for content, as we had no further obligations to the customer after that time and collection was reasonably assured. In addition, we recognize activation fee revenue of between $1.0 thousand and $2.0 thousand on Phase II Deployment Systems and for Systems installed by CDF2 Holdings, a related party, (See Note 3 - Other Interests) upon installation and such fees are generally collected upfront upon installation. Our services division manages and collects VPFs on behalf of exhibitors, for which it earns an administrative fee equal to 10% of the VPFs collected.

 

The Cinema Equipment Business earns an administrative fee of approximately 5% of VPFs collected and, in addition, earns an incentive service fee equal to 2.5% of the VPFs earned by Phase 1 DC. This administrative fee is related to the collection and remittance of the VPF’s and the performance obligation is satisfied at that time the related VPF fees are due which is at the time the movies are displayed on screens utilizing our Systems installed in movie theatres. The service fees are recognized as a point in time revenue when the corresponding VPF fees are due from the movie studios and distributors.

 

Content & Entertainment Business

 

CEG earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or “OTT Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Physical Revenue” or “Base Distribution Business”). Fees earned are typically a percentage based on the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”)   on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the performance obligation is satisfied, which is when the content is available for subscription on the digital platform, at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Physical revenue is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration.

  

Physical goods reserved for sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

CEG also has contracts for the theatrical distribution of third party feature movies and alternative content. CEG’s distribution fee revenue and CEG’s participation in box office receipts are recognized at the time a feature movie and alternative content are viewed. CEG has the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

 

Principal Agent Considerations

 

We determine whether revenue should be reported on a gross or net basis for each revenue stream based on the transfer of control of goods and services. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

 

  which party is primarily responsible for fulfilling the promise to provide the specified good or service; and

 

  which party has discretion in establishing the price for the specified good or service.

 

Shipping and Handling

 

Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in cost of goods sold because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

 

Credit Losses

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

Our CEG segment recognizes accounts receivable, net of an estimated allowance for product returns and customer chargebacks, at the time that it recognizes revenue from a sale. Reserves for product returns and other allowances is variable consideration as part of the transaction price. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

We record accounts receivable, long-term in connection with activation fees that we earn from Systems deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rates.

 

Contract Liabilities

 

We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable.

 

Deferred revenue pertaining to our Content & Entertainment Business includes amounts related to the sale of DVDs with future release dates.

 

Deferred revenue relating to our Cinema Equipment Business pertains to revenues earned in connection with up front exhibitor contributions that are deferred and recognized over the expected cost recoupment period. It also includes unamortized balances in connection with activation fees due from the Systems deployments that have extended payment terms.

 

The ending deferred revenue balance as of December 31, 2021 was $0.3 million. For the three and nine months ended December 31, 2021 and 2020, respectively, the additions to our deferred revenue balance were primarily due to cash payments received or due in advance of satisfying performance obligations, while the reductions to our deferred revenue balance were primarily due to the recognition of revenue upon fulfillment of our performance obligations, both of which were in the ordinary course of business.

 

During the three months ended December 31, 2021 and 2020, $0.3 million and $1.2 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. During the nine months ended December 31, 2021 and 2020, $0.6 million and $2.5 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. As of December 31, 2021, the aggregate amount of contract revenue allocated to unsatisfied performance obligations was $0.3 million. This amount is to be recognized during January and February of 2022.

 

Participations and royalties payable

 

When we use third parties to distribute company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.

 

Disaggregation of Revenue

 

The Company disaggregates revenue into different revenue categories for the Cinema Equipment and CEG Businesses. The Cinema Equipment Business revenue categories are: Phase I Deployment revenue, Phase II Deployment revenue, Services, and Digital System Sales, and the Content & Entertainment Business revenue categories are: Base Distribution Business and OTT Streaming and Digital.

 

The following tables present the Company’s revenue categories for the three and nine months ended December 31, 2021 and 2020 (in thousands):

 

   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2021   2020   2021   2020 
Cinema Equipment Business:                    
Phase I Deployment  $133   $281   $372   $424 
Phase II Deployment   87    367    891    1,067 
Services   506    196    1,171    481 
Digital System Sales   1,334    66    9,110    186 
Total Cinema Equipment Business revenue  $2,060   $910   $11,544   $2,158 
                     
Content & Entertainment Business:                    
Base Distribution Business  $3,668   $4,152   $6,368   $9,218 
OTT Streaming and Digital   8,356    4,892    21,290    11,778 
Total Content & Entertainment Business revenue  $12,024   $9,044   $27,658   $20,996 

DIRECT OPERATING COSTS

 

Direct operating costs consist of operating costs such as cost of goods sold, fulfillment expenses, shipping costs, property taxes and insurance on Systems, royalty expenses, impairments of advances, and marketing and direct personnel costs.

 

STOCK-BASED COMPENSATION

 

The Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The Company measures the compensation expense of employee and nonemployee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and nonemployee is required to provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.

 

INCOME TAXES

 

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax bases.

 

Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States.

 

The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10, Income Taxes (Accounting for Uncertainty in Income Taxes), which clarified the accounting for uncertainty in tax positions. This amendment provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.

 

NET INCOME/LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS

 

Basic and diluted net loss per common share has been calculated as follows:

 

Basic and diluted net loss per common share attributable to common stockholders =   Net loss attributable to common stockholders
  Weighted average number of common stock outstanding during the period

 

Stock issued and treasury stock repurchased during the period are weighted for the portion of the period that they are outstanding. Shares issued and any shares that are reacquired during the period are weighted for the portion of the period that they are outstanding.

 

We had net income for the nine months ended December 31, 2021, and therefore the impact of potentially dilutive common shares from outstanding stock options, stock appreciation rights, and warrants, totaling 3,603,491 shares for the nine months ended December 31, 2021, respectively, was included in the computations of diluted earnings per share. For the three months ended December 31, 2021, 12,088,473 potentially dilutive shares have been excluded from the diluted loss per share as their impact would have been antidilutive. We had a net loss for the three months ended December 31, 2021 and therefore no dilution as basic and diluted loss per share are the same for the period. The calculation of diluted net income per share for the nine months ended December 31, 2021 does not include the impact of 8,484,982 potentially dilutive shares relating to stock options, stock appreciation rights, and warrants as their impact would have been anti-dilutive as their exercise prices are above the Company’s average Common Stock price during the period.

 

We incurred net losses for the three and nine months ended December 31, 2020, and therefore the impact of potentially dilutive common shares from outstanding stock options and warrants, totaling 9,040,138 shares as of December 31, 2020, were excluded from the computations of loss per share as their impact would have been anti-dilutive.

 

COMPREHENSIVE INCOME (LOSS)

 

As of the three and nine months ended December 31, 2021 and 2020, comprehensive income (loss) consisted of net loss and foreign currency translation adjustments.

 

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

 

Adopted

 

On December 18, 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The update also simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance to improve consistent application. The amendment in this update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company adopted this guidance on April 1, 2021 and the adoption of this ASU did not have a material impact on our consolidated financial statements.

 

Not yet adopted

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which provides new guidance regarding the measurement and recognition of credit impairment for certain financial assets. Such guidance will impact how the Company determines its allowance for estimated uncollectible receivables and evaluates its available-for-sale investments for impairment. ASU 2016-13 is effective for the Company in the first quarter of fiscal 2023. The Company is currently evaluating the effect that ASU 2016-13 will have on its consolidated financial statements and related disclosures.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
Other Interests
9 Months Ended
Dec. 31, 2021
Disclosure of Other Interests [Abstract]  
OTHER INTERESTS

3. OTHER INTERESTS

 

Investment in CDF2 Holdings

 

We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.

 

CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification Topic 810 (“ASC 810”), “Consolidation.” ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.

 

As of December 31, 2021 and March 31, 2021, our maximum exposure to loss, as it relates to the non-consolidated CDF2 Holdings entity, represents accounts receivable for service fees under a master service agreement with CDF2 Holdings. Such accounts receivable was $0.7 million and $0.3 million as of December 31, 2021 and March 31, 2021, respectively, which are included in accounts receivable, net on the accompanying consolidated balance sheets.

 

The accompanying Consolidated Statements of Operations include $0.5 million and $83 thousand of digital cinema servicing revenue from CDF2 Holdings for the nine months ended December 31, 2021 and 2020, respectively. The accompanying Consolidated Statements of Operations include $0.2 million and $47 thousand of digital cinema servicing revenue from CDF2 Holdings for the three months ended December 31, 2021 and 2020, respectively.

 

Total Stockholders’ Deficit of CDF2 Holdings at December 31, 2021 and March 31, 2021 was $52.9 million and $46.3 million, respectively. We have no obligation to fund the operating loss or the stockholders’ deficit beyond our initial investment of $2.0 million and, accordingly, our investment in CDF2 Holdings as of December 31, 2021 and March 31, 2021 is carried at $0.

 

Majority Interest in CONtv

 

We own an 85% interest in CON TV, LLC, a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the Internet and other consumer digital distribution platforms, such as gaming consoles, set-top boxes, handsets, and tablets.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Combination
9 Months Ended
Dec. 31, 2021
Disclosure of Asset Acquistion [Abstract]  
BUSINESS COMBINATION

4. BUSINESS COMBINATION

 

FoundationTV, Inc.

 

On May 12, 2021, the Company entered into a stock purchase agreement (the “Foundation Stock Purchase Agreement”) with FoundationTV, Inc. (“FoundationTV”), to buy all of FoundationTV´s issued and outstanding stock in consideration of an aggregate of $5.2 million, of which $0.7 million was paid in cash and 1,483,129 shares of Common Stock, which were valued at $2.5 million, were issued at closing stock price of $1.69 on the closing date of June 9, 2021, and an additional $2.0 million will be paid in eight equal installments of one installment on each six month anniversary of closing over forty-eight months, and a final lump sum payment of $225 thousand on the four year anniversary of the closing, reduced by $0.2 million settlement of a prior relationship. The Foundation Stock Purchase Agreement contained certain conditions to closing, including that the Company obtain approval of its stockholders, applicable lenders, and regulatory authorities, as applicable, and representations and warranties and covenants as are customary for transactions of this type. On June 9, 2021, the FoundationTV acquisition was consummated. The Company incurred transaction costs of $36 thousand during the nine months ended December 31, 2021. As of December 31, 2021, the deferred consideration initially measured by bringing to present value the agreed-upon cash payments discounted by a 3% rate, includes a $0.5 million short-term payable and a long-term payable for $1.5 million.

 

Purchase Price    
Purchase Price  $5,237 
Total purchase price  $5,237 
      
Allocation of purchase price     
Developed technology   3,200 
Goodwill   2,037 
Total allocation of purchase price  $5,237 

 

The developed technology acquired in this transaction has a useful life of 10 years. During the three and nine months ended December 31, 2021, the Company recorded $80 thousand and $160 thousand in amortization expense related to the developed technology acquired in the acquisition.

 

Below is the amortization expense per year for the developed technology acquired in the business combination:

 

2022 (remaining)  $80 
2023   320 
2024   320 
2025   320 
2026   320 
2027   320 
2028   320 
2029   320 
2030   320 
2031   320 
2032   80 
Total  $3,040 

 

Bloody Disgusting, LLC

 

On September 17, 2021, the Company entered into an asset purchase agreement (the “Bloody Disgusting Asset Purchase Agreement”) with Bloody Disgusting, LLC (“Bloody Disgusting”), to buy substantially all of the assets of Bloody Disgusting, in consideration of an aggregate of $7.8 million, of which $4.0 million was paid in cash and 1,039,501 shares of Common Stock, which were valued at $2.3 million, were issued at closing stock price of $2.23 on the closing date of September 17, 2021, and $1.5 million as of the fair value of the earnout liability, related to earnout targets, as defined, to be met as of March 2022, March 2023 and March 2024. The fair value of the earnout liability was estimated considering the weighted probability of scenarios on the earnout metrics possible outcomes during the earnout period. The Bloody Disgusting Asset Purchase Agreement contained certain conditions to closing and representations and warranties and covenants as are customary for transactions of this type. On September 17, 2021, the Bloody Disgusting acquisition was consummated. The Company incurred transaction costs of $40 thousand during the nine months ended December 31, 2021. During the three months ended December 31, 2021, the Company finalized the measurement of the assets acquired.

 

Purchase Price    
Purchase Price  $7,780 
Total purchase price  $7,780 
      
Allocation of purchase price     
Current assets   9 
Advertiser relationships   3,750 
Trade name   1,100 
Goodwill   2,921 
Total allocation of purchase price  $7,780 

 

The advertiser relationships acquired in this transaction has a useful life of 12 years and the trade name acquired has a useful life of 10 years. During the three and nine months ended December 31, 2021, the Company recorded $105 thousand in amortization expense related to the intangible assets acquired.

 

Below is the amortization expense per year for the intangible assets acquired in the business combination:

 

   Advertiser relationships   Trade name   Total 
2022 (remaining)  $78   $28   $106 
2023   313    110    423 
2024   313    110    423 
2025   313    110    423 
2026   313    110    423 
2027   313    110    423 
2028   313    110    423 
2029   313    110    423 
2030   313    110    423 
2031   313    110    423 
2032   313    55    368 
2033   313    
    313 
2034   151    
    151 
Total   3,672    1,073   $4,745 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
Notes Payable
9 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
NOTES PAYABLE

5. NOTES PAYABLE

 

Notes payable consisted of the following:

 

   December 31,
2021
   March 31,
2021
 
(In thousands)  Current
Portion
   Long Term
Portion
   Current
Portion
   Long Term
Portion
 
Prospect Loan  $
   $
   $7,786   $
 
Total non-recourse notes payable   
    
    7,786    
 
Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts  $
   $
   $7,786   $
 
Credit Facility  $
   $
   $1,956   $
 
PPP Loan   
    
    
    2,152 
Total recourse notes payable   
    
    1,956    2,152 
Total recourse notes payable, net of unamortized debt issuance costs and debt discounts  $
   $
   $1,956   $2,152 
Total notes payable, net of unamortized debt issuance costs  $
    —
   $
   $9,742   $2,152 

 

Non-recourse debt is generally defined as debt whereby the lenders’ sole recourse with respect to defaults is limited to the value of the asset, which is collateral for the debt. Certain of our subsidiaries are liable with respect to, and their assets serve as collateral for, certain indebtedness for which our assets and the assets of our other subsidiaries that are not parties to the transaction are generally not liable. We have referred to this indebtedness as “non-recourse debt” because the recourse of the lenders is limited to the assets of specific subsidiaries. Such indebtedness includes the Prospect Loan.

 

Prospect Loan

 

In February 2013, our Cinedigm DC Holdings, LLC (“CDCH”), Access Digital Media, Inc (“AccessDM”) and Access Digital Cinema Phase 2, Corp. (“Phase 2 DC”) subsidiaries entered into a term loan agreement (the “Prospect Loan” or the “Term Loan Agreement”) with Prospect Capital Corporation (“Prospect”), pursuant to which CDCH borrowed $70.0 million. The Prospect Loan included interest at LIBOR plus 9.0% (with a 2.0% LIBOR floor), which was payable in cash, and at an additional 2.50% accrued as an increase to the aggregate principal amount of the Prospect Loan until the Prospect Loan was paid off, at which time all accrued interest became payable in cash.

 

Collections of CDCH accounts receivable were deposited into accounts designated to pay certain operating expenses, principal, interest, fees, costs and expenses relating to the Prospect Loan. On a quarterly basis, if there was excess cash flow, it was used for prepayment of the Prospect Loan. We also maintained a debt service fund under the Prospect Loan for future principal and interest payments. As of December 31, 2021, and March 31, 2021, the debt service fund had a balance of $0 and $1.0 million, respectively, which was classified as part of restricted cash on our Consolidated Balance Sheets.

 

On March 4, 2021, CDCH, AccessDM, Phase 2 DC, Christie/AIX, Inc., Cinedigm Digital Funding I, LLC, certain Lenders, and Prospect Capital Corporation, as administrative agent and collateral agent, entered into Amendment No. 3 (the “Prospect Amendment”) to the Term Loan Agreement. Under the Prospect Amendment, the maturity date of the loan under the Term Loan Agreement was extended to March 31, 2022. As a condition to the effectiveness of the Amendment, CDCH paid $3,500,000 to Prospect to reduce the outstanding principal amount of the Loan.

 

The Prospect Loan was secured by, among other things, a first priority pledge of the stock of CDF2 Holdings, our wholly-owned unconsolidated subsidiary, the stock of AccessDM, owned by DC Holdings, and the stock of our Phase 2 DC subsidiary, and was also guaranteed by AccessDM and Phase 2 DC. We provided limited financial support to the Prospect Loan not to exceed $1.5 million per year in the event financial performance did not meet certain defined benchmarks.

 

The Prospect Loan contained customary representations, warranties, affirmative covenants, negative covenants and events of default.

 

Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect Loan outstanding non-recourse debt amount by paying an aggregate principal amount of $7.8 million. Pre-payment of the Prospect Loan was permissible without penalty.

 

The following table summarizes the activity related to the Prospect Loan:

 

   As of 
(In thousands)  December 31,
2021
   March 31,
2021
 
Prospect Loan, at issuance  $70,000   $70,000 
PIK Interest   8,016    6,397 
Payments to date   (78,016)   (68,611)
Prospect Loan, gross  $
   $7,786 
Less unamortized debt issuance costs and debt discounts   
    
 
Prospect Loan, net   
    7,786 
Less current portion   
    (7,786)
Total long term portion  $
   $
 

 

Credit Facility and Cinedigm Revolving Loans

 

On March 30, 2018, the Company entered into the Loan, Guaranty and Security Agreement, dated as of March 30, 2018, by and between the Company, East West Bank and the Guarantors named therein (the “Credit Facility”) for a maximum of $19.0 million in revolving loans outstanding at any one time with a maturity date of March 31, 2020, which may be extended for two successive one-year periods at the sole discretion of the lender, subject to certain conditions.

 

Interest under the Credit Facility is due monthly at a rate elected by the Company of either 0.5% plus Prime Rate or 3.25% above LIBOR Rate established by the lender.

 

On July 3, 2019, the Company entered into an amendment to the Credit Facility (the “EWB Amendment”). The EWB Amendment reduced the size of the facility to $18.0 million, required certain prepayments and daily cash sweeps from collections of receivables to be made, changed in certain respects how the borrowing base is calculated, and extended the maturity date to June 30, 2020. In connection with the EWB Amendment, three of our subsidiaries became Guarantors under the Credit Facility. On June 25, 2020, the Company and East West Bank amended the Credit Facility to extend the maturity of the Credit Facility to June 30, 2021 and waive events of default provisions. On June 22, 2021, the maturity date of the Credit Facility was extended to September 28, 2021. During this extension period, unless an amendment had been entered into, we were not able to access any additional borrowings under the Credit Facility. The September 28, 2021 expiration date has passed and the agreement was not extended.

 

As of December 31, 2021 and March 31, 2021, there was $0 and $2.0 million outstanding, respectively, and there was no availability under the Credit Facility based on the Company’s borrowing base as of December 31, 2021.

 

PPP Loan

 

On April 15, 2020, the Company received $2.2 million from East West Bank, the Company’s existing lender, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts were intended to be eligible for forgiveness, subject to the provisions of the CARES Act, and could be subject to repayment. On July 7, 2021, the Company received notification from the lender that the U.S. Small Business Administration had approved the Company’s PPP Loan forgiveness application for the entire PPP Loan amount and accrued interest effective June 30, 2021.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity
9 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS’ EQUITY

6. STOCKHOLDERS’ EQUITY

 

COMMON STOCK

 

Authorized Class A Common Stock 

 

On October 11, 2021, the Company filed a Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation, pursuant to which the number of shares of Class A common stock authorized for issuance was increased to 275,000,000 shares.

 

During the nine months ended December 31, 2021, we issued 8,642,648 shares of Common Stock which consist of the sale of shares of our Class A common stock, issuance of Common Stock for business combination, the issuances of Common Stock in payment of preferred stock dividends and in payment of board retainer fees.

 

PREFERRED STOCK

 

Cumulative dividends in arrears on preferred stock were $0.1 million and $0.1 million as of December 31, 2021 and March 31, 2021, respectively. In May 2021 and October 2021, we paid preferred stock dividends in arrears in the form of 53,278 and 102,697 shares of Class A common stock, respectively.

 

TREASURY STOCK

 

We have treasury stock, at cost, consisting of 1,315,851 and 1,313,836 shares of Class A common stock at December 31, 2021 and March 31, 2021, respectively.

 

CINEDIGM’S EQUITY INCENTIVE PLANS

 

Stock Based Compensation Awards

 

Awards issued under our 2000 Equity Incentive Plan (the “2000 Plan”) may be in any of the following forms (or a combination thereof) (i) stock option awards; (ii) stock appreciation rights; (iii) stock or restricted stock or restricted stock units; or (iv) performance awards. The 2000 Plan provides for the granting of incentive stock options (“ISOs”) with exercise prices not less than the fair market value of our Common Stock on the date of grant. ISOs granted to shareholders having more than 10% of the total combined voting power of the Company must have exercise prices of at least 110% of the fair market value of our Common Stock on the date of grant. ISOs and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is subject to the continuous service of the participant. The exercise prices and vesting periods (if any) for non-statutory options are set at the discretion of our compensation committee. On November 1, 2017, upon the consummation of the initial equity investment in Cinedigm by Bison, as a result of which there was a change of control of the Company, all stock options (incentive and non-statutory) and shares of restricted stock were vested immediately and the options became fully exercisable.

 

In connection with the grants of stock options and shares of restricted stock under the 2000 Plan, we and the participants have executed stock option agreements and notices of restricted stock awards setting forth the terms of the grants. The 2000 Plan provided for the issuance of up to 2,380,000 shares of Common Stock to employees, outside directors and consultants.

 

As of December 31, 2021, there were 217,837 stock options outstanding in the 2000 Plan with weighted average exercise price of $14.49 and a weighted average contract life of 1.42 years. As of March 31, 2021, there were 261,587 shares pursuant to stock options outstanding in the Plan with weighted average exercise price of $14.99 and a weighted average contract life of 2.11 years. A total of 43,500 options expired and 250 options forfeited during the three and nine months ended December 31, 2021.

 

Options outstanding under the 2000 Plan as of December 31, 2021 is as follows:

 

As of December 31, 2021 
Range of Prices   Options Outstanding   Weighted Average Remaining Life in Years   Weighted Average Exercise Price   Aggregate Intrinsic Value
(In thousands)
 
 $7.40 - $13.69    5,000    3.50   $7.40   $
 
 $14.00 - $24.40    212,837    1.37    14.65    
 
      217,837             $
 

 

An analysis of all options exercisable under the 2000 Plan as of December 31, 2021 is presented below:

 

Options Exercisable   Weighted Average
Remaining Life in Years
   Weighted Average
Exercise Price
   Aggregate Intrinsic Value
(In thousands)
 
 217,837    1.42   $14.49    
 

 

In August 2017, the Company adopted the 2017 Equity Incentive Plan (the “2017 Plan). The 2017 Plan replaced the 2000 Plan, and applies to employees and directors of, and consultants to, the Company. The 2017 Plan provided for the issuance of up to 2,108,270 shares of Class A common stock, in the form of various awards, including stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance awards and cash awards. The Compensation Committee of the Company’s Board of Directors (the “Board”) is authorized to administer the 2017 Plan and make grants thereunder. The approval of the 2017 Plan did not affect awards already granted under the 2000 Plan. On December 4, 2019, upon shareholder approval, the 2017 Plan was amended to increase the maximum number of shares of Class A common stock authorized for issuance thereunder from 2,108,270 shares to 4,098,270.

 

On October 23, 2020, the Company amended its 2017 Plan to increase the number of shares authorized for issuance thereunder from 4,098,270 to 14,098,270.

 

On October 11, 2021, the Company amended its 2017 Plan to increase the number of shares authorized for issuance thereunder from 14,098,270 to 18,098,270.

 

During the nine months ended December 31, 2021, the Company granted 1,807,625 stock appreciation rights (“SARs”). The SARs were granted under the Company’s 2017 Equity Incentive Plan (the “2017 Plan), except for 600,000 SARs granted to an officer of the Company as an inducement grant. All SARs issued have an exercise price equal to the fair value of the Company’s Class A common stock on the date of grant and a maturity date of 10 years. The SARs were valued on the grant date utilizing an option pricing model, as follows:

 

Grant Date: May 23, 2021 – November 30, 2021

 

Maturity Date: May 23, 2031 – November 30, 2031

 

Exercise price: $1.29 - $2.56

 

Volatility: 110.32% - 114.42%

 

Discount rate: 0.96% - 1.50%

 

Expected term: 6 – 6.5 years

 

Stock appreciation rights outstanding under the 2017 Plan as of December 31, 2021 is as follows:

 

As of December 31, 2021 
Range of Prices   SAR´s Outstanding   Weighted Average Remaining Life in Years   Weighted Average Exercise Price   Aggregate Intrinsic Value
(In thousands)
 
 $0.54 - $0.74    5,550,000    8.99   $0.64   $3,131 
 $1.16 - $1.47    2,050,860    8.15    1.37    
 
 $1.71 - $2.10    2,680,738    9.16    1.97    
 
 $2.23 - $2.56    394,375    9.85    2.33    
 
      10,675,973             $3,131 

 

An analysis of all stock appreciation rights exercisable under the 2017 Plan as of December 31, 2021 is presented below:

 

Options Exercisable   Weighted Average
Remaining Life in Years
   Weighted Average
Exercise Price
   Aggregate Intrinsic Value
(In thousands)
 
 2,712,610    7.26   $1.16    775 

 

Employee and director stock-based compensation expense related to our stock-based awards was as follows:

 

   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
(In thousands)  2021   2020   2021   2020 
Selling, general and administrative  $1,349   $960   $3,278   $2,172 
   $1,349   $960   $3,278   $2,172 

 

Total SARs outstanding are as follows:

 

   Nine Months
Ended
December 31,
2021
 
SARs Outstanding March 31, 2021   9,154,933 
Issued   1,807,625 
Forfeited   (286,585)
Total SARs Outstanding December 31, 2021   10,675,923 

 

There was $1 thousand and $1thousand of stock-based compensation recorded for the nine months ended December 31, 2021 and 2020, respectively, related to employees’ restricted stock awards. There was $0 thousand and $1thousand of stock-based compensation recorded for the three months ended December 31, 2021 and 2020, respectively, related to employees’ restricted stock awards.

 

There was $290 thousand and $131 thousand of stock-based compensation for the nine months ended December 31, 2021 and 2020, respectively, related to board of directors. There was $107 thousand and $65 thousand of stock-based compensation for the three months ended December 31, 2021 and 2020, respectively, related to board of directors. During the nine months ended December 31, 2021, the Company issued 245,887 shares to the board of directors.

 

OPTIONS GRANTED OUTSIDE CINEDIGM’S EQUITY INCENTIVE PLAN

 

In October 2013, we issued options outside of the 2000 Plan to 10 individuals who became employees as a result of a business combination. The employees received options to purchase an aggregate of 62,000 shares of our Class A Common Stock at an exercise price of $17.50 per share. The options were fully vested as of October 2017 and expire 10 years from the date of grant, if unexercised. As of December 31, 2021, 12,500 of such options remained outstanding.

  

WARRANTS

 

The following table presents information about outstanding warrants to purchase shares of our Class A common stock as of December 31, 2021. All of the outstanding warrants are fully vested and exercisable.

 

Recipient  Amount
outstanding
   Expiration   Exercise price
per share
 
5-year Warrant issued to BEMG in connection with a term loan agreement   1,400,000    December 2022   $1.80 

 

Warrants for the purchase of 298,519 shares of Common Stock expired unexercised during the nine months ended December 31, 2021.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies
9 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

7. COMMITMENTS AND CONTINGENCIES

 

From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities. Although the results of litigation and claims cannot be predicted with certainty, the Company does not believe it is party to any claim or litigation the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business. Regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources and other factors. 

 

We operate from leased properties under non-cancelable operating lease agreements, certain of which contain escalating lease clauses.

 

The Company leases office space under operating leases. The Company’s portfolio of leases is primarily related to real estate and since most of our leases do not provide a readily determinable implicit rate, the Company estimated its incremental borrowing rate to discount the lease payments based on information available at either the implementation date of Topic 842 or at lease commencement for leases entered into thereafter.

 

The table below presents the lease-related assets and liabilities recorded on the balance sheet as of December 31, 2021 and March 31, 2021:

 

(In thousands)  Classification on the Balance Sheet  December 31,
2021
   March 31,
2021
 
Assets           
Noncurrent  Operating lease right-of-use asset  $       16   $     100 
Liabilities             
Current  Operating leases – current portion   16    87 
Noncurrent  Operating leases – long-term portion   
    13 
Total operating lease liabilities     $16   $100 

 

Lease Costs

 

The table below presents certain information related to lease costs for leases:

 

   Nine months Ended   Nine months Ended 
(In thousands)  December 31,
2021
   December 31,
2020
 
Operating lease cost  $             90   $          160 
Total lease cost  $90   $160 

 

Other Information

 

The table below presents supplemental cash flow information related to leases:

 

   Nine months Ended   Nine months Ended 
(In thousands)  December 31,
2021
   December 31,
2020
 
Cash paid for amounts included in the measurement of lease liabilities                13                162 
Operating cash flows used for operating leases  $13   $162 

 

Distribution arrangement minimum guaranty

 

On September 1, 2021 the Company extended a video works distribution arrangement providing a non-refundable and fully-recoupable advance minimum participation guaranty for a total amount of $3.5 million, where $1.5 million is payable no later than November 1, 2021, $1.0 million at the first year anniversary of the arrangement and $0.9 million on the second-year anniversary of the arrangement. These payments are subject to the selection of video works released by the Company whose initial commercial date occurs during the arrangement year. The Company paid the first advance on October 22, 2021.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplemental Cash Flow Information
9 Months Ended
Dec. 31, 2021
Supplemental Cash Flow Elements [Abstract]  
SUPPLEMENTAL CASH FLOW INFORMATION

8. SUPPLEMENTAL CASH FLOW INFORMATION

 

   Nine Months Ended
December 31,
 
(In thousands)  2021   2020 
Cash interest paid  $701   $3,014 
Income taxes paid   79    
 
noncash investing and financing activities:          
Accrued dividends on preferred stock   89    89 
Issuance of Class A common stock for payment of accrued preferred stock dividends   267    267 
Issuance of Class A common stock to Starrise, a related party   
    11,046 
Contributed capital under the Starrise transaction, a related party   
    17,187 
Settlement of second lien loan with Class A common stock   
    3,008 
Conversion of note payable   
    15,000 
Class A common stock to be issued in connection with the asset acquisition   

    1,853 
Issuance of Class A common stock for business combination   4,824    
 
Starrise shares used to pay down vendors   

    897 
Treasury shares acquired for withholding taxes   5    
 
Deferred consideration in purchase of a business   1,980    
 
Earnout consideration in purchase of a business   1,461    

 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information
9 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
SEGMENT INFORMATION

9. SEGMENT INFORMATION

 

We operate in two reportable segments: Cinema Equipment Business and Content & Entertainment Business. Our segments were determined based on the economic characteristics of our products and services, our internal organizational structure, the manner in which our operations are managed and the criteria used by our CODM to evaluate performance, which is generally the segment’s operating income (loss) before depreciation and amortization.

 

Operations of:   Products and services provided:
Cinema Equipment Business  

Financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).

 

We retain ownership of the Systems and the residual cash flows related to the Systems in Phase I Deployment after the repayment of all non-recourse debt at the expiration of exhibitor master license agreements. For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.

 

The Cinema Equipment Business segment also provides monitoring, collection, verification and management services to this segment, as well as to exhibitors who purchase their own equipment, and also collects and disburses VPFs from motion picture studios, distributors and ACFs from alternative content providers, movie exhibitors and theatrical exhibitors (collectively, “Services”).

     
Content & Entertainment Business   Leading independent streaming company of content and channels. We collaborate with producers and other content owners to market, source, curate and distribute independent content to targeted and under-served audiences in theatres and homes, and via mobile and emerging platforms.

 

The following tables present certain financial information related to our reportable segments and Corporate:

 

   As of December 31, 2021 
(In thousands)  Intangible
Assets, net
   Goodwill   Total
Assets
   Notes
Payable,
Non-
Recourse
   Notes
Payable
   Operating
lease
liabilities
 
Cinema Equipment Business  $
   $
   $22,910   $
   $
   $
 
Content & Entertainment Business   15,672    13,659    54,909    
    
     
Corporate       
    21,735    
    
    16 
Total  $15,672   $13,659   $99,554   $
   $
   $16 

 

   As of March 31, 2021 
(In thousands)  Intangible
Assets, net
   Goodwill   Total
Assets
   Notes
Payable,
Non-
Recourse
   Notes
Payable
   Operating
lease
liabilities
 
Cinema Equipment Business  $
   $
   $13,169   $7,786   $
              —
   $1 
Content & Entertainment Business   9,858    8,701    42,733    
    
    69 
Corporate   2    
    19,544    
    4,108    30 
Total  $9,860   $8,701   $75,446   $7,786   $4,108   $100 

 

   Statements of Operations 
   Three Months Ended December 31, 2021 
   (in thousands) 
   Cinema
Equipment
Business
   Content & Entertainment
Business
   Corporate   Consolidated 
Revenues  $2,060   $12,024   $
   $14,084 
Direct operating (exclusive of depreciation and amortization shown below)   139    6,320    
    6,459 
Selling, general and administrative   496    3,701    3,539    7,736 
Allocation of corporate overhead   143    964    (1,107)   
 
Provision for (recovery of) doubtful accounts   (397)   19    
    (378)
Depreciation and amortization of property and equipment   196    138    2    336 
Amortization  of intangible assets   
    693    2    695 
Total operating expenses   577    11,835    2,436    14,848 
Income (loss) from operations  $1,483   $189   $(2,436)  $(764)

 

The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:

 

(In thousands) 

Cinema

Equipment

Business

   Content & Entertainment
Business
   Corporate   Consolidated 
Direct operating  $
     —
   $
    —
   $
    —
   $
     —
 
Selling, general and administrative   
    552    797    1,349 
Total stock-based compensation  $
   $552   $797   $1,349 

 

   Statements of Operations 
   Three Months Ended December 31, 2020
(in thousands)
 
   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Revenues  $910   $9,044   $
   $9,954 
Direct operating (exclusive of depreciation and amortization shown below)   150    4,235    
    4,385 
Selling, general and administrative   524    2,244    2,593    5,361 
Allocation of corporate overhead   143    964    (1,107)   
 
Provision for doubtful accounts   70    
    
    70 
Depreciation and amortization of property and equipment   706    108    8    822 
Amortization of intangible assets   8    588    1    597 
Total operating expenses   1,601    8,139    1,495    11,235 
Loss from operations  $(691)  $905   $(1,495)  $(1,281)

 

The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:

 

   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Direct operating  $
              —
   $
              —
   $
     —
   $
     —
 
Selling, general and administrative   
    39    921    960 
Total stock-based compensation  $
   $39   $921   $960 

 

   Statements of Operations 
   Nine Months Ended December 31, 2021 
   (in thousands) 
   Cinema
Equipment
Business
   Content & Entertainment
Business
   Corporate   Consolidated 
Revenues  $11,544   $27,658   $
   $39,202 
Direct operating (exclusive of depreciation and amortization shown below)   560    13,863    
    14,423 
Selling, general and administrative   1,356    9,999    9,583    20,938 
Allocation of corporate overhead   412    2,763    (3,175)   
 
(Recovery of) provision for doubtful accounts   (500)   82    
    (418)
Depreciation and amortization of property and equipment   1,001    422    2    1,425 
Amortization of intangible assets   
    2,236    2    2,238 
Total operating expenses   2,829    29,365    6,412    38,606 
Income (loss) from operations  $8,715   $(1,707)  $(6,412)  $596 

 

The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:

 

(In thousands) 

Cinema

Equipment

Business

   Content & Entertainment
Business
   Corporate   Consolidated 
Direct operating  $
     —
   $
      —
   $
      —
   $
      —
 
Selling, general and administrative   
    1,063    2,215    3,278 
Total stock-based compensation  $
   $1,063   $2,215   $3,278 

 

   Statements of Operations 
   Nine Months Ended December 31, 2020
(in thousands)
 
   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Revenues  $2,158   $20,996   $
   $23,154 
Direct operating (exclusive of depreciation and amortization shown below)   504    10,890    
    11,394 
Selling, general and administrative   1,704    6,667    6,998    15,369 
Allocation of corporate overhead   438    2,883    (3,321)   
 
Recovery for doubtful accounts   (123)   
    
    (123)
Depreciation and amortization of property and equipment   3,348    312    31    3,691 
Amortization of intangible assets   23    1,752    3    1,778 
Total operating expenses   5,892    22,504    3,711    32,109 
Income (loss) from operations  $(3,736)  $(1,508)  $(3,711)  $(8,955)

  

The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:

 

   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Direct operating  $
    —
   $
    —
   $
       —
   $
      —
 
Selling, general and administrative   
    91    2,081    2,172 
Total stock-based compensation  $
   $91   $2,081   $2,172 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes
9 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
INCOME TAXES

10. INCOME TAXES

 

We calculate income tax expense based upon an annual effective tax rate forecast, including estimates and assumptions. We recorded an income tax benefit of approximately $26 thousand and $576 thousand for the three and nine months ended December 31, 2021, respectively. We recorded an income tax benefit of approximately $0 and $181 thousand for the three and nine months ended December 31, 2020, respectively. We have not recorded tax benefits on our loss before income taxes because we have provided for a full valuation allowance that offsets potential deferred tax assets resulting from net operating loss carry forwards, reflecting our inability to use such loss carry forwards.

 

Our effective tax rate for the nine months ended December 31, 2021 and 2020 was negative 14.0% and 0.3%, respectively.

 

On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable. 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
Subsequent Events
9 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

11. SUBSEQUENT EVENTS

 

Equity purchase announcement  

 

On January 4, 2022, the Company entered into an Equity Purchase Agreement among the Company, and David Chu, Augustine Hong, Helen Hong, Michael Hong, Justin Lee, Steven Park, and Kingsoon Ong (collectively, the “Sellers”) and David Chu as representative of the Sellers (the “DMR Agreement”) to acquire all of the outstanding membership interests of Asian Media Rights, LLC d/b/a Digital Media Rights (“DMR”), a diversified specialty streaming, advertising, and content distribution company with significant expertise in building audiences for global content in North America (the “DMR Transaction”). The DMR Transaction is subject to certain closing conditions, including satisfactory financial and legal diligence, and the parties are working toward closing the transaction.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accounting Policies, by Policy (Policies)
9 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND CONSOLIDATION

BASIS OF PRESENTATION AND CONSOLIDATION

 

Our consolidated financial statements include the accounts of Cinedigm and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

Investments in which we do not have a controlling interest or are not the primary beneficiary, but have the ability to exert significant influence, are accounted for under the equity method of accounting. Noncontrolling interests for which we have been determined to be the primary beneficiary are consolidated and recorded as net loss attributable to noncontrolling interest. See Note 3 - Other Interests to the Consolidated Financial Statements for a discussion of our noncontrolling interests.

 

USE OF ESTIMATES

USE OF ESTIMATES

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates include the adequacy of accounts receivable reserves, return reserves, inventory reserves, recovery of advances, assessment of goodwill impairment, long-lived and finite-lived assets impairment and estimated amortization lives, fair value for asset acquisitions and business combinations, valuation allowances for income taxes and stock awards. Actual results could differ from these estimates.

 

CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

 

We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal. Our Prospect Loan required that we maintain specified cash balances that are restricted to repayment of interest thereunder. See Note 5 - Notes Payable for information about our restricted cash balances.

 

Cash, cash equivalents, and restricted cash consisted of the following:

 

   As of 
(in thousands)  December 31,
2021
   March 31,
2021
 
Cash and Cash Equivalents  $20,201   $26,207 
Restricted Cash   
    1,000 
   $20,201   $27,207 

 

EQUITY INVESTMENT IN STARRISE, A RELATED PARTY

EQUITY INVESTMENT IN STARRISE, A RELATED PARTY

 

On February 14, 2020, the Company acquired an approximately 11.5% interest in Starrise, a leading publicly traded Chinese entertainment company whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Starrise that is related to our major shareholders. When we acquired the Starrise stock, our then-majority affiliated stockholders also maintained a significant beneficial interest in Starrise. Upon consummation of the transaction on February 14, 2020, the Company recorded an initial investment of approximately $25 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.2 million, valued as of the date of the issuance of the Common Stock. The difference in value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital.

 

On April 10, 2020, the Company purchased an additional 15% interest in Starrise in a private transaction from shareholders of Starrise that are affiliated with the then-major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Common Stock of $11.0 million, valued at the date of the issuance of the Common Stock. The difference in the value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Starrise.

 

The Company has made an irrevocable election to apply the fair value accounting option under ASC 825-10, Financial Instruments, as it relates to its equity investment in Starrise. The Company’s investment in Starrise is marked to market and recorded at fair value.  The stock is traded on the Hong Kong Stock exchange with readily available pricing that is classified as Level 1 in the fair value hierarchy. The Company has established a policy that consistently uses either the closing price of last active trades or the latest bid price when there is no active trades, unadjusted at the last day of each reporting period, as the most relevant and representative input to the Level 1 fair value measures of its investment holdings.

 

As of December 31, 2021 and March 31, 2021, the value of our equity investment in Starrise, using the readily determinable fair value inputs from the market pricing of the Stock Exchange of Hong Kong, was approximately $7.9 million and $6.4 million, respectively, resulting in a change in fair value of approximately $1.5 million and ($42.4) million for the nine months ended December 31, 2021 and 2020 respectively, on our consolidated statement of operations. On April 1 and May 5, 2021, the Company sold 80,000 and 600,000 Starrise ordinary shares, respectively for a total amount of $11 thousand. At December 31, 2021 and March 31, 2021, the Company owned 362,307,397 and 362,987,397 ordinary shares or 17% and 26% of Starrise, respectively.

 

NON-MONETARY TRANSACTIONS

NON-MONETARY TRANSACTIONS

 

During the three and nine months ended December 31, 2020, the Company entered into agreements with certain vendors to transfer 5,139,762 and 14,184,765 Starrise ordinary shares to satisfy outstanding liabilities with these vendors. Upon the sale of the Starrise shares by the vendors, with certain restrictions on sales unless the Company gave consent to sell, if the proceeds did not satisfy the amount due to the vendor, the Company was liable for the balance owed. Pursuant to such agreements, the Company reduced the amount payable to its vendors by $0.8 million as of December 31, 2020. There were no such transactions during the nine months ended December 31, 2021.

 

There was no gain or loss resulting from these transactions for the three and nine months ended December 31, 2021 and 2020.

 

ACCOUNTS RECEIVABLE

ACCOUNTS RECEIVABLE

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

We record accounts receivable, long-term in connection with activation fees that we earn from our digital cinema equipment (the “Systems”) deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rate.

 

ADVANCES

ADVANCES

 

Advances, which are recorded within prepaid and other current assets on the consolidated balance sheets, represent amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record impairment charges for amounts that we expect may not be recoverable as of the consolidated balance sheet date. Impairments and accelerated amortization related to advances were $0.4 million and $0.3 million, respectively, for the three months ended December 31, 2021 and 2020. Impairments and accelerated amortization related to advances were $0.8 million and $0.3 million, respectively, for the nine months ended December 31, 2021 and 2020.

 

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT

 

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:

 

Computer equipment and software   3 - 5 years 
Internal use software   5 years 
Digital cinema projection systems   10 years 
Machinery and equipment   3 - 10 years 
Furniture and fixtures   3 - 6 years 

 

We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software. Post-configuration training and maintenance costs are expensed as incurred.

 

Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the leasehold improvements. Repair and maintenance costs are charged to expense as incurred. Major renewals, improvements and additions are capitalized. Upon the sale or other disposition of any property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and the gain or loss on disposal is included in the consolidated statements of operations.

 

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

 

The fair value measurement disclosures are grouped into three levels based on valuation factors:

 

  Level 1 – quoted prices in active markets for identical investments

 

  Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)

 

  Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)

 

Assets and liabilities measured at fair value on a recurring basis use the market approach, where prices and other relevant information are generated by market transactions involving identical or comparable assets or liabilities.

 

The equity investment in Starrise is in Hong Kong dollars and was translated into US dollars as of December 31, 2021 and March 31, 2021 at an exchange rate of 7.8 and 7.8 Hong Kong Dollars to 1 US Dollar, respectively. The fair value of this equity investment is measured by the unadjusted market pricing of Starrise on the Stock Exchange of Hong Kong.

 

The earnout consideration on purchase of Bloody Disgusting business (Note 4) is determined according to the probability-based method to the estimated the value of the earnout based on the premise that there are different probabilities to achieve different forecasts and therefore the defined earnout metric targets. Under this method, weighted-average earnout payments for each earnout period were estimated based on the probability of each forecast scenario. The resultant weighted-average earnout payments are discounted to a present value.

 

The following tables summarize the levels of fair value measurements of our financial assets and liabilities as of December 31, 2021 and March 31, 2021:

 

As of December 31, 2021                
                 
(in thousands)  Level 1   Level 2   Level 3   Total 
Assets:                
Equity investment in Starrise, at fair value  $7,896   $
   $
   $7,896 
   $7,896   $
   $
   $7,896 
                     
Liabilities:                    
Current portion of earnout consideration on purchase of a business  $
   $
    292    292 
Earnout consideration on purchase of a business, net of current portion  $
   $
    1,236    1,236 
   $
   $
   $1,528   $1,528 

  

As of March 31, 2021                
                 
(in thousands)  Level 1   Level 2   Level 3   Total 
Restricted cash  $1,000   $
   $
   $1,000 
Equity investment in Starrise, at fair value   6,443    
    
    6,443 
   $7,443   $
   $
   $7,443 

 

Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.

 

IMPAIRMENT OF LONG-LIVED AND FINITE-LIVED ASSETS

IMPAIRMENT OF LONG-LIVED AND FINITE-LIVED ASSETS

 

We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. During the three and nine months ended December 31, 2021 and 2020, no impairment charge was recorded from operations for long-lived assets or finite-lived assets.

 

GOODWILL

GOODWILL

 

Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.

 

Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.

 

The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test.

 

No goodwill impairment charge was recorded in the nine months ended December 31, 2021 and 2020.

 

Gross amounts of goodwill and accumulated impairment charges that we have recorded are as follows:

 

(In thousands)    
Goodwill at March 31, 2021  $8,701 
Goodwill from business combinations – see Note 4   4,958 
Goodwill at December 31, 2021  $13,659 

 

REVENUE RECOGNITION

REVENUE RECOGNITION

 

We determine revenue recognition by:

 

  identifying the contract, or contracts, with the customer;

 

  identifying the performance obligations in the contract;

 

  determining the transaction price;

 

  allocating the transaction price to performance obligations in the contract; and

 

  recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.

 

We recognize revenue in the amount that reflects the consideration we expect to receive in exchange for the services provided, sales of physical products (e.g., DVDs and Blu-ray Discs) or when the content is available for subscription on the digital platform or available on the point-of-sale for transactional and video on demand services which is when the control of the promised products and services is transferred to our customers and our performance obligations under the contract have been satisfied. Revenues that might be subject to various taxes are recorded net of transaction taxes assessed by governmental authorities such as sales value-added taxes and other similar taxes.

 

Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less.

 

Cinema Equipment Business

 

Our Cinema Equipment Business consists of financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).

 

We retain ownership of our digital cinema equipment (the “Systems”) and the residual cash flows related to the Systems in Phase I Deployment after the end of the 10-year deployment payment period.

 

For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.

 

The Cinema Equipment Business also provides monitoring, data collection, serial data verification and management services to this segment, as well as to exhibitors who purchase their own equipment, in order to collect virtual print fees (“VPFs”) from motion picture studios and distributors and Alternative Content Fees (“ACFs”) from alternative content providers, and to distribute those fees to theatrical exhibitors (collectively, “Services”).

 

VPFs are earned, net of administrative fees, pursuant to contracts with movie studios and distributors, whereby amounts are payable by a studio to Phase I Deployment and to Phase II Deployment when movies distributed by the studio are displayed on screens utilizing our Systems installed in movie theatres. VPFs are earned and payable to Phase I Deployment based on a defined fee schedule until the end of the VPF term. One VPF is payable for every digital title initially displayed per System. The amount of VPF revenue is dependent on the number of movie titles released and displayed using the Systems in any given accounting period. VPF revenue is recognized in the period the title first plays for general audience viewing in a digital projector equipped movie theatre. The Phase 1 Deployment’s and Phase 2 Deployments performance obligations for revenue recognition are met at this time. 

  

Phase II Deployment’s agreements with distributors require the payment of VPFs, according to a defined fee schedule, for ten years from the date each system is installed; however, Phase II Deployment may no longer collect VPFs once “cost recoupment,” as defined in the contracts with movie studios and distributors, is achieved. Cost recoupment will occur once the cumulative VPFs and other cash receipts collected by Phase II Deployment have equaled the total of all cash outflows, including the purchase price of all Systems, all financing costs, all “overhead and ongoing costs”, as defined, and including service fees, subject to maximum agreed upon amounts during the three-year rollout period and thereafter. Further, if cost recoupment occurs before the end of the eighth contract year, the studios will pay us a one-time “cost recoupment bonus.” The Company evaluated the constraining estimates related to the variable consideration, i.e., the one-time bonus and determined that it is not probable to conclude at this point in time that a significant reversal in the amount of cumulative revenue recognized will occur when the uncertainty associated with the variable consideration is subsequently resolved.

 

Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Cinedigm recognizes revenue once the customer takes possession of the Systems and Cinedigm received the sale proceeds. Such sales were originally contemplated as the conclusion of the digital cinema deployment plan.  Total system sales revenue recognized was $1.3 million and $66 thousand, during the three months ended December 31, 2021 and 2020, respectively. Total system sales revenue recognized was $9.1 million and $157 thousand, during the nine months ended December 31, 2021 and 2020, respectively. Revenues earned in connection with up front exhibitor contributions are deferred and recognized over the expected cost recoupment period.

Exhibitors who purchased and own Systems using their own financing in Phase II of the Cinema Equipment Business paid us an upfront activation fee of approximately $2.0 thousand per screen (the “Exhibitor-Buyer Structure”). Upfront activation fees were recognized in the period in which these Systems were delivered and ready for content, as we had no further obligations to the customer after that time and collection was reasonably assured. In addition, we recognize activation fee revenue of between $1.0 thousand and $2.0 thousand on Phase II Deployment Systems and for Systems installed by CDF2 Holdings, a related party, (See Note 3 - Other Interests) upon installation and such fees are generally collected upfront upon installation. Our services division manages and collects VPFs on behalf of exhibitors, for which it earns an administrative fee equal to 10% of the VPFs collected.

 

The Cinema Equipment Business earns an administrative fee of approximately 5% of VPFs collected and, in addition, earns an incentive service fee equal to 2.5% of the VPFs earned by Phase 1 DC. This administrative fee is related to the collection and remittance of the VPF’s and the performance obligation is satisfied at that time the related VPF fees are due which is at the time the movies are displayed on screens utilizing our Systems installed in movie theatres. The service fees are recognized as a point in time revenue when the corresponding VPF fees are due from the movie studios and distributors.

 

Content & Entertainment Business

 

CEG earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or “OTT Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Physical Revenue” or “Base Distribution Business”). Fees earned are typically a percentage based on the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”)   on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the performance obligation is satisfied, which is when the content is available for subscription on the digital platform, at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Physical revenue is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration.

  

Physical goods reserved for sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

CEG also has contracts for the theatrical distribution of third party feature movies and alternative content. CEG’s distribution fee revenue and CEG’s participation in box office receipts are recognized at the time a feature movie and alternative content are viewed. CEG has the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.

 

Principal Agent Considerations

 

We determine whether revenue should be reported on a gross or net basis for each revenue stream based on the transfer of control of goods and services. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:

 

  which party is primarily responsible for fulfilling the promise to provide the specified good or service; and

 

  which party has discretion in establishing the price for the specified good or service.

 

Shipping and Handling

 

Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in cost of goods sold because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.

 

Credit Losses

 

We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.

 

Our CEG segment recognizes accounts receivable, net of an estimated allowance for product returns and customer chargebacks, at the time that it recognizes revenue from a sale. Reserves for product returns and other allowances is variable consideration as part of the transaction price. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.

 

We record accounts receivable, long-term in connection with activation fees that we earn from Systems deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rates.

 

Contract Liabilities

 

We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable.

 

Deferred revenue pertaining to our Content & Entertainment Business includes amounts related to the sale of DVDs with future release dates.

 

Deferred revenue relating to our Cinema Equipment Business pertains to revenues earned in connection with up front exhibitor contributions that are deferred and recognized over the expected cost recoupment period. It also includes unamortized balances in connection with activation fees due from the Systems deployments that have extended payment terms.

 

The ending deferred revenue balance as of December 31, 2021 was $0.3 million. For the three and nine months ended December 31, 2021 and 2020, respectively, the additions to our deferred revenue balance were primarily due to cash payments received or due in advance of satisfying performance obligations, while the reductions to our deferred revenue balance were primarily due to the recognition of revenue upon fulfillment of our performance obligations, both of which were in the ordinary course of business.

 

During the three months ended December 31, 2021 and 2020, $0.3 million and $1.2 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. During the nine months ended December 31, 2021 and 2020, $0.6 million and $2.5 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. As of December 31, 2021, the aggregate amount of contract revenue allocated to unsatisfied performance obligations was $0.3 million. This amount is to be recognized during January and February of 2022.

 

Participations and royalties payable

 

When we use third parties to distribute company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.

 

Disaggregation of Revenue

 

The Company disaggregates revenue into different revenue categories for the Cinema Equipment and CEG Businesses. The Cinema Equipment Business revenue categories are: Phase I Deployment revenue, Phase II Deployment revenue, Services, and Digital System Sales, and the Content & Entertainment Business revenue categories are: Base Distribution Business and OTT Streaming and Digital.

 

The following tables present the Company’s revenue categories for the three and nine months ended December 31, 2021 and 2020 (in thousands):

 

   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2021   2020   2021   2020 
Cinema Equipment Business:                    
Phase I Deployment  $133   $281   $372   $424 
Phase II Deployment   87    367    891    1,067 
Services   506    196    1,171    481 
Digital System Sales   1,334    66    9,110    186 
Total Cinema Equipment Business revenue  $2,060   $910   $11,544   $2,158 
                     
Content & Entertainment Business:                    
Base Distribution Business  $3,668   $4,152   $6,368   $9,218 
OTT Streaming and Digital   8,356    4,892    21,290    11,778 
Total Content & Entertainment Business revenue  $12,024   $9,044   $27,658   $20,996 

DIRECT OPERATING COSTS

DIRECT OPERATING COSTS

 

Direct operating costs consist of operating costs such as cost of goods sold, fulfillment expenses, shipping costs, property taxes and insurance on Systems, royalty expenses, impairments of advances, and marketing and direct personnel costs.

 

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION

 

The Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The Company measures the compensation expense of employee and nonemployee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and nonemployee is required to provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.

 

INCOME TAXES

INCOME TAXES

 

The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax bases.

 

Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States.

 

The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10, Income Taxes (Accounting for Uncertainty in Income Taxes), which clarified the accounting for uncertainty in tax positions. This amendment provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.

 

NET INCOME/LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS

NET INCOME/LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS

 

Basic and diluted net loss per common share has been calculated as follows:

 

Basic and diluted net loss per common share attributable to common stockholders =   Net loss attributable to common stockholders
  Weighted average number of common stock outstanding during the period

 

Stock issued and treasury stock repurchased during the period are weighted for the portion of the period that they are outstanding. Shares issued and any shares that are reacquired during the period are weighted for the portion of the period that they are outstanding.

 

We had net income for the nine months ended December 31, 2021, and therefore the impact of potentially dilutive common shares from outstanding stock options, stock appreciation rights, and warrants, totaling 3,603,491 shares for the nine months ended December 31, 2021, respectively, was included in the computations of diluted earnings per share. For the three months ended December 31, 2021, 12,088,473 potentially dilutive shares have been excluded from the diluted loss per share as their impact would have been antidilutive. We had a net loss for the three months ended December 31, 2021 and therefore no dilution as basic and diluted loss per share are the same for the period. The calculation of diluted net income per share for the nine months ended December 31, 2021 does not include the impact of 8,484,982 potentially dilutive shares relating to stock options, stock appreciation rights, and warrants as their impact would have been anti-dilutive as their exercise prices are above the Company’s average Common Stock price during the period.

 

We incurred net losses for the three and nine months ended December 31, 2020, and therefore the impact of potentially dilutive common shares from outstanding stock options and warrants, totaling 9,040,138 shares as of December 31, 2020, were excluded from the computations of loss per share as their impact would have been anti-dilutive.

 

COMPREHENSIVE INCOME (LOSS)

COMPREHENSIVE INCOME (LOSS)

 

As of the three and nine months ended December 31, 2021 and 2020, comprehensive income (loss) consisted of net loss and foreign currency translation adjustments.

 

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

 

Adopted

 

On December 18, 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The update also simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance to improve consistent application. The amendment in this update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company adopted this guidance on April 1, 2021 and the adoption of this ASU did not have a material impact on our consolidated financial statements.

 

Not yet adopted

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which provides new guidance regarding the measurement and recognition of credit impairment for certain financial assets. Such guidance will impact how the Company determines its allowance for estimated uncollectible receivables and evaluates its available-for-sale investments for impairment. ASU 2016-13 is effective for the Company in the first quarter of fiscal 2023. The Company is currently evaluating the effect that ASU 2016-13 will have on its consolidated financial statements and related disclosures.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of cash, cash equivalents and restricted cash
   As of 
(in thousands)  December 31,
2021
   March 31,
2021
 
Cash and Cash Equivalents  $20,201   $26,207 
Restricted Cash   
    1,000 
   $20,201   $27,207 

 

Schedule of estimated useful lives of property and equipment
Computer equipment and software   3 - 5 years 
Internal use software   5 years 
Digital cinema projection systems   10 years 
Machinery and equipment   3 - 10 years 
Furniture and fixtures   3 - 6 years 

 

Schedule of fair value measurements of financial assets
As of December 31, 2021                
                 
(in thousands)  Level 1   Level 2   Level 3   Total 
Assets:                
Equity investment in Starrise, at fair value  $7,896   $
   $
   $7,896 
   $7,896   $
   $
   $7,896 
                     
Liabilities:                    
Current portion of earnout consideration on purchase of a business  $
   $
    292    292 
Earnout consideration on purchase of a business, net of current portion  $
   $
    1,236    1,236 
   $
   $
   $1,528   $1,528 

  

As of March 31, 2021                
                 
(in thousands)  Level 1   Level 2   Level 3   Total 
Restricted cash  $1,000   $
   $
   $1,000 
Equity investment in Starrise, at fair value   6,443    
    
    6,443 
   $7,443   $
   $
   $7,443 

 

Schedule of goodwill and accumulated impairment charges
(In thousands)    
Goodwill at March 31, 2021  $8,701 
Goodwill from business combinations – see Note 4   4,958 
Goodwill at December 31, 2021  $13,659 

 

Schedule of revenue categories
   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2021   2020   2021   2020 
Cinema Equipment Business:                    
Phase I Deployment  $133   $281   $372   $424 
Phase II Deployment   87    367    891    1,067 
Services   506    196    1,171    481 
Digital System Sales   1,334    66    9,110    186 
Total Cinema Equipment Business revenue  $2,060   $910   $11,544   $2,158 
                     
Content & Entertainment Business:                    
Base Distribution Business  $3,668   $4,152   $6,368   $9,218 
OTT Streaming and Digital   8,356    4,892    21,290    11,778 
Total Content & Entertainment Business revenue  $12,024   $9,044   $27,658   $20,996 

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Combination (Tables)
9 Months Ended
Dec. 31, 2021
Business Combinations [Abstract]  
Schedule of business combination
Purchase Price    
Purchase Price  $5,237 
Total purchase price  $5,237 
      
Allocation of purchase price     
Developed technology   3,200 
Goodwill   2,037 
Total allocation of purchase price  $5,237 

 

Purchase Price    
Purchase Price  $7,780 
Total purchase price  $7,780 
      
Allocation of purchase price     
Current assets   9 
Advertiser relationships   3,750 
Trade name   1,100 
Goodwill   2,921 
Total allocation of purchase price  $7,780 

 

Schedule of amortization expense per year for the developed technology acquired in the business combination
2022 (remaining)  $80 
2023   320 
2024   320 
2025   320 
2026   320 
2027   320 
2028   320 
2029   320 
2030   320 
2031   320 
2032   80 
Total  $3,040 

 

Schedule of amortization expense per year for the intangible assets acquired in the business combination
   Advertiser relationships   Trade name   Total 
2022 (remaining)  $78   $28   $106 
2023   313    110    423 
2024   313    110    423 
2025   313    110    423 
2026   313    110    423 
2027   313    110    423 
2028   313    110    423 
2029   313    110    423 
2030   313    110    423 
2031   313    110    423 
2032   313    55    368 
2033   313    
    313 
2034   151    
    151 
Total   3,672    1,073   $4,745 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
Notes Payable (Tables)
9 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Schedule of notes payable
   December 31,
2021
   March 31,
2021
 
(In thousands)  Current
Portion
   Long Term
Portion
   Current
Portion
   Long Term
Portion
 
Prospect Loan  $
   $
   $7,786   $
 
Total non-recourse notes payable   
    
    7,786    
 
Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts  $
   $
   $7,786   $
 
Credit Facility  $
   $
   $1,956   $
 
PPP Loan   
    
    
    2,152 
Total recourse notes payable   
    
    1,956    2,152 
Total recourse notes payable, net of unamortized debt issuance costs and debt discounts  $
   $
   $1,956   $2,152 
Total notes payable, net of unamortized debt issuance costs  $
    —
   $
   $9,742   $2,152 

 

Schedule of debt outstanding
   As of 
(In thousands)  December 31,
2021
   March 31,
2021
 
Prospect Loan, at issuance  $70,000   $70,000 
PIK Interest   8,016    6,397 
Payments to date   (78,016)   (68,611)
Prospect Loan, gross  $
   $7,786 
Less unamortized debt issuance costs and debt discounts   
    
 
Prospect Loan, net   
    7,786 
Less current portion   
    (7,786)
Total long term portion  $
   $
 

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Tables)
9 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of analysis of option activity
As of December 31, 2021 
Range of Prices   Options Outstanding   Weighted Average Remaining Life in Years   Weighted Average Exercise Price   Aggregate Intrinsic Value
(In thousands)
 
 $7.40 - $13.69    5,000    3.50   $7.40   $
 
 $14.00 - $24.40    212,837    1.37    14.65    
 
      217,837             $
 

 

Options Exercisable   Weighted Average
Remaining Life in Years
   Weighted Average
Exercise Price
   Aggregate Intrinsic Value
(In thousands)
 
 217,837    1.42   $14.49    
 

 

Schedule of stock appreciation rights outstanding
As of December 31, 2021 
Range of Prices   SAR´s Outstanding   Weighted Average Remaining Life in Years   Weighted Average Exercise Price   Aggregate Intrinsic Value
(In thousands)
 
 $0.54 - $0.74    5,550,000    8.99   $0.64   $3,131 
 $1.16 - $1.47    2,050,860    8.15    1.37    
 
 $1.71 - $2.10    2,680,738    9.16    1.97    
 
 $2.23 - $2.56    394,375    9.85    2.33    
 
      10,675,973             $3,131 

 

Options Exercisable   Weighted Average
Remaining Life in Years
   Weighted Average
Exercise Price
   Aggregate Intrinsic Value
(In thousands)
 
 2,712,610    7.26   $1.16    775 

 

Schedule of stock-based compensation expense
   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
(In thousands)  2021   2020   2021   2020 
Selling, general and administrative  $1,349   $960   $3,278   $2,172 
   $1,349   $960   $3,278   $2,172 

 

Schedule of SARs outstanding
   Nine Months
Ended
December 31,
2021
 
SARs Outstanding March 31, 2021   9,154,933 
Issued   1,807,625 
Forfeited   (286,585)
Total SARs Outstanding December 31, 2021   10,675,923 

 

Schedule of warrants
Recipient  Amount
outstanding
   Expiration   Exercise price
per share
 
5-year Warrant issued to BEMG in connection with a term loan agreement   1,400,000    December 2022   $1.80 

 

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies (Tables)
9 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease-related assets and liabilities
(In thousands)  Classification on the Balance Sheet  December 31,
2021
   March 31,
2021
 
Assets           
Noncurrent  Operating lease right-of-use asset  $       16   $     100 
Liabilities             
Current  Operating leases – current portion   16    87 
Noncurrent  Operating leases – long-term portion   
    13 
Total operating lease liabilities     $16   $100 

 

Schedule of lease costs
   Nine months Ended   Nine months Ended 
(In thousands)  December 31,
2021
   December 31,
2020
 
Operating lease cost  $             90   $          160 
Total lease cost  $90   $160 

 

   Nine months Ended   Nine months Ended 
(In thousands)  December 31,
2021
   December 31,
2020
 
Cash paid for amounts included in the measurement of lease liabilities                13                162 
Operating cash flows used for operating leases  $13   $162 

 

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplemental Cash Flow Information (Tables)
9 Months Ended
Dec. 31, 2021
Supplemental Cash Flow Elements [Abstract]  
Schedule of supplemental cash flows
   Nine Months Ended
December 31,
 
(In thousands)  2021   2020 
Cash interest paid  $701   $3,014 
Income taxes paid   79    
 
noncash investing and financing activities:          
Accrued dividends on preferred stock   89    89 
Issuance of Class A common stock for payment of accrued preferred stock dividends   267    267 
Issuance of Class A common stock to Starrise, a related party   
    11,046 
Contributed capital under the Starrise transaction, a related party   
    17,187 
Settlement of second lien loan with Class A common stock   
    3,008 
Conversion of note payable   
    15,000 
Class A common stock to be issued in connection with the asset acquisition   

    1,853 
Issuance of Class A common stock for business combination   4,824    
 
Starrise shares used to pay down vendors   

    897 
Treasury shares acquired for withholding taxes   5    
 
Deferred consideration in purchase of a business   1,980    
 
Earnout consideration in purchase of a business   1,461    

 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Tables)
9 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of segment reporting, assets and debt
   As of December 31, 2021 
(In thousands)  Intangible
Assets, net
   Goodwill   Total
Assets
   Notes
Payable,
Non-
Recourse
   Notes
Payable
   Operating
lease
liabilities
 
Cinema Equipment Business  $
   $
   $22,910   $
   $
   $
 
Content & Entertainment Business   15,672    13,659    54,909    
    
     
Corporate       
    21,735    
    
    16 
Total  $15,672   $13,659   $99,554   $
   $
   $16 

 

   As of March 31, 2021 
(In thousands)  Intangible
Assets, net
   Goodwill   Total
Assets
   Notes
Payable,
Non-
Recourse
   Notes
Payable
   Operating
lease
liabilities
 
Cinema Equipment Business  $
   $
   $13,169   $7,786   $
              —
   $1 
Content & Entertainment Business   9,858    8,701    42,733    
    
    69 
Corporate   2    
    19,544    
    4,108    30 
Total  $9,860   $8,701   $75,446   $7,786   $4,108   $100 

 

Schedule of segment reporting, statement of operations
   Statements of Operations 
   Three Months Ended December 31, 2021 
   (in thousands) 
   Cinema
Equipment
Business
   Content & Entertainment
Business
   Corporate   Consolidated 
Revenues  $2,060   $12,024   $
   $14,084 
Direct operating (exclusive of depreciation and amortization shown below)   139    6,320    
    6,459 
Selling, general and administrative   496    3,701    3,539    7,736 
Allocation of corporate overhead   143    964    (1,107)   
 
Provision for (recovery of) doubtful accounts   (397)   19    
    (378)
Depreciation and amortization of property and equipment   196    138    2    336 
Amortization  of intangible assets   
    693    2    695 
Total operating expenses   577    11,835    2,436    14,848 
Income (loss) from operations  $1,483   $189   $(2,436)  $(764)

 

   Statements of Operations 
   Three Months Ended December 31, 2020
(in thousands)
 
   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Revenues  $910   $9,044   $
   $9,954 
Direct operating (exclusive of depreciation and amortization shown below)   150    4,235    
    4,385 
Selling, general and administrative   524    2,244    2,593    5,361 
Allocation of corporate overhead   143    964    (1,107)   
 
Provision for doubtful accounts   70    
    
    70 
Depreciation and amortization of property and equipment   706    108    8    822 
Amortization of intangible assets   8    588    1    597 
Total operating expenses   1,601    8,139    1,495    11,235 
Loss from operations  $(691)  $905   $(1,495)  $(1,281)

 

   Statements of Operations 
   Nine Months Ended December 31, 2021 
   (in thousands) 
   Cinema
Equipment
Business
   Content & Entertainment
Business
   Corporate   Consolidated 
Revenues  $11,544   $27,658   $
   $39,202 
Direct operating (exclusive of depreciation and amortization shown below)   560    13,863    
    14,423 
Selling, general and administrative   1,356    9,999    9,583    20,938 
Allocation of corporate overhead   412    2,763    (3,175)   
 
(Recovery of) provision for doubtful accounts   (500)   82    
    (418)
Depreciation and amortization of property and equipment   1,001    422    2    1,425 
Amortization of intangible assets   
    2,236    2    2,238 
Total operating expenses   2,829    29,365    6,412    38,606 
Income (loss) from operations  $8,715   $(1,707)  $(6,412)  $596 

 

   Statements of Operations 
   Nine Months Ended December 31, 2020
(in thousands)
 
   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Revenues  $2,158   $20,996   $
   $23,154 
Direct operating (exclusive of depreciation and amortization shown below)   504    10,890    
    11,394 
Selling, general and administrative   1,704    6,667    6,998    15,369 
Allocation of corporate overhead   438    2,883    (3,321)   
 
Recovery for doubtful accounts   (123)   
    
    (123)
Depreciation and amortization of property and equipment   3,348    312    31    3,691 
Amortization of intangible assets   23    1,752    3    1,778 
Total operating expenses   5,892    22,504    3,711    32,109 
Income (loss) from operations  $(3,736)  $(1,508)  $(3,711)  $(8,955)

  

Schedule of segment reporting, employee stock-based compensation expense
(In thousands) 

Cinema

Equipment

Business

   Content & Entertainment
Business
   Corporate   Consolidated 
Direct operating  $
     —
   $
    —
   $
    —
   $
     —
 
Selling, general and administrative   
    552    797    1,349 
Total stock-based compensation  $
   $552   $797   $1,349 

 

   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Direct operating  $
              —
   $
              —
   $
     —
   $
     —
 
Selling, general and administrative   
    39    921    960 
Total stock-based compensation  $
   $39   $921   $960 

 

(In thousands) 

Cinema

Equipment

Business

   Content & Entertainment
Business
   Corporate   Consolidated 
Direct operating  $
     —
   $
      —
   $
      —
   $
      —
 
Selling, general and administrative   
    1,063    2,215    3,278 
Total stock-based compensation  $
   $1,063   $2,215   $3,278 

 

   Cinema
Equipment
Business
   Content & Entertainment   Corporate   Consolidated 
Direct operating  $
    —
   $
    —
   $
       —
   $
      —
 
Selling, general and administrative   
    91    2,081    2,172 
Total stock-based compensation  $
   $91   $2,081   $2,172 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Nature of Operations and Liquidity (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 10, 2020
Mar. 17, 2021
Feb. 14, 2020
Dec. 27, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Jul. 09, 2021
Jun. 30, 2021
Apr. 15, 2020
Nature of Operations and Liquidity [Abstract]                      
Accumulated deficit         $ 469.7   $ 469.7        
Working capital         2.9   2.9        
Aggregate principal amount                 $ 7.8    
Outstanding amount         0.0   0.0        
Net cash provided by operating activities             4.7        
Agreements included the sale in tranches (in Shares)   2,369                  
Cash consideration   $ 10.8                  
Recognized aggregate revenue         $ 0.3 $ 1.2 9.1 $ 2.5      
Maturity description       On December 27, 2019, the Company entered into, and on February 14, 2020 amended, (see Note 2 - Summary of Significant Accounting Policies), a stock purchase agreement (as so amended, the “Starrise Stock Purchase Agreement”) with BeiTai Investment LP (“BeiTai”), a related party for accounting purposes of Cinedigm and Aim Right Ventures Limited (“Aim Right”), two shareholders of Starrise Media Holdings Limited, a leading Chinese entertainment company (“Starrise”), to buy from them an aggregate of 410,901,000 outstanding Starrise ordinary shares (the “Starrise Share Acquisition”).              
Number of shares acquired (in Shares)     162,162,162                
Comon per share (in Dollars per share)     $ 1                
Starrise shares issued amount             $ 11.2        
Converted aggregate description On April 10, 2020, the Company entered into another stock purchase agreement (the “April Starrise Stock Purchase Agreement”) with five (5) shareholders of Starrise - Bison Global Investment SPC - Bison Global No. 1 SP, Huatai Investment LP, Antai Investment LP, Mingtai Investment LP and Shangtai Asset Management LP - all of which are related parties to the Company to buy an aggregate of 223,380,000 outstanding Starrise ordinary shares from them and for the Company to issue to them an aggregate of 29,855,081 shares of its Common Stock as consideration therefor (the “April Starrise Share Acquisition”).                    
Stock purchase agreement, description             Starrise’s ordinary shares (HK 1616) are listed on the main board of the Stock Exchange of Hong Kong Limited. Based on the closing price of HKD 0.159 per share on February 11, 2022, calculated at an exchange rate of 7.8 Hong Kong Dollars to 1 US dollar, the market value of Cinedigm’s ownership in Starrise ordinary shares was approximately $7.4 million.        
Received amount from east west bank                     $ 2.2
Interest rate                     1.00%
PPP Loan recognized gain                   $ 2.2  
Equity line purchase agreement, description             (i) $50,000,000 of newly issued shares of Common Stock and (ii) the Exchange Cap (as defined below) (subject to certain conditions and limitations), from time to time during the 24-month period from and after the October 21, 2021. Sales of Common Stock pursuant to the Equity Line Purchase Agreement, and the timing of any sales, are solely at the option of the Company, and the Company is under no obligation to sell any securities to B. Riley Principal Capital under the Equity Line Purchase Agreement. As consideration for B. Riley Principal Capital’s commitment to purchase shares of Common Stock at the Company’s direction upon the terms and subject to the conditions set forth in the Equity Line Purchase Agreement, upon execution of the Equity Line Purchase Agreement, the Company issued 210,084 shares of Common Stock to B. Riley Principal Capital (the “Commitment Shares”). The purchase price of the shares of Common Stock that we elect to sell to B. Riley Principal Capital pursuant to the Equity Line Purchase Agreement will be determined by reference to the volume weighted average price of the Common Stock (“VWAP”) during the applicable purchase date, less a fixed 5% discount to such VWAP. Pursuant to the Registration Rights Agreement, the Company filed a Registration Statement on Form S-1 that was declared effective by the Securities and Exchange Commission on October 21, 2021 (File No. 333-260210) for the resale by B. Riley Principal Capital of up to 25,210,084 shares of Common Stock (including the Commitment Shares) acquired pursuant to the Equity Line Purchase Agreement. During October and November 2021, we sold 5,300,000 shares of Common Stock under the Equity Line Purchase Agreement. Net proceeds from such sales totaled $12.4 million.        
Borrowings [Member]                      
Nature of Operations and Liquidity [Abstract]                      
Aggregate principal amount                 $ 7.8    
BeiTai [Member]                      
Nature of Operations and Liquidity [Abstract]                      
Number of shares issued for acquisition (in Shares)     21,646,604                
Starrise shares issued amount             $ 25.0        
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 01, 2021
shares
May 05, 2020
USD ($)
shares
Apr. 10, 2020
USD ($)
Feb. 14, 2020
USD ($)
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Mar. 31, 2021
USD ($)
shares
Summary of Significant Accounting Policies (Details) [Line Items]                  
Initial investment     $ 28,200,000 $ 25,000,000          
Issuance of common stock value     $ 11,000,000 $ 11,200,000          
Sale of starrise's ordinary shares (in Shares) | shares 80,000 600,000              
Sale of starrises ordinary value   $ 11,000              
Transfer of Starrise shares (in Shares) | shares           5,139,762   14,184,765  
Amount payable to vendors               $ 800,000  
Impairment accelerated amortization         $ 400,000 $ 300,000      
Impairments and accelerated amortization advances             $ 800,000 300,000  
Foreign currency exchange rate, translation         7.8   7.8   7.8
Sales revenue         $ 1,300,000 66,000 $ 9,100,000 157,000  
Activation fee revenue, per screen             2,000    
Activation fee revenue range, minimum         1,000   1,000    
Activation fee revenue range, maximum         2,000   2,000    
Deferred revenue balance         300,000   300,000    
Deferred revenue         300,000 $ 1,200,000 9,100,000 $ 2,500,000  
Deferred revenue             600,000    
Unsatisfied performance obligations         $ 300,000   $ 300,000    
Tax benefit percentage             50.00%    
Warrants of right shares (in Shares) | shares         3,603,491   3,603,491    
Potentially dilutive shares (in Shares) | shares         12,088,473   8,484,982 9,040,138  
Starisse [Member]                  
Summary of Significant Accounting Policies (Details) [Line Items]                  
Ownership percentage     15.00% 11.50%          
Shares owned (in Shares) | shares         362,307,397   362,307,397   362,987,397
Shares percentage             17.00%   26.00%
Services [Member]                  
Summary of Significant Accounting Policies (Details) [Line Items]                  
Administrative fee VPFs         5.00%   5.00%    
Incentive fees, percentage of VPF Phase I         2.50%   2.50%    
Stock Exchange of Hong Kong Limited [Member]                  
Summary of Significant Accounting Policies (Details) [Line Items]                  
Change in fair value             $ 1,500,000 $ (42,400,000)  
Stock Exchange of Hong Kong Limited [Member] | Starisse [Member]                  
Summary of Significant Accounting Policies (Details) [Line Items]                  
Market pricing             $ 7,900,000   $ 6,400,000
Up-front Payment Arrangement [Member]                  
Summary of Significant Accounting Policies (Details) [Line Items]                  
Administrative fee VPFs         10.00%   10.00%    
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details) - Schedule of cash, cash equivalents and restricted cash - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Schedule of cash, cash equivalents and restricted cash [Abstract]    
Cash and Cash Equivalents $ 20,201 $ 26,207
Restricted Cash 1,000
Total $ 20,201 $ 27,207
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment
9 Months Ended
Dec. 31, 2021
Internal use software [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 5 years
Digital cinema projection systems [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 10 years
Minimum [Member] | Computer equipment and software [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 3 years
Minimum [Member] | Machinery and equipment [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 3 years
Minimum [Member] | Furniture and fixtures [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 3 years
Maximum [Member] | Computer equipment and software [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 5 years
Maximum [Member] | Machinery and equipment [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 10 years
Maximum [Member] | Furniture and fixtures [Member]  
Public Utility, Property, Plant and Equipment [Line Items]  
Property and equipment estimated useful lives 6 years
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of financial assets - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Assets:    
Equity investment in Starrise, at fair value $ 7,896 $ 6,443
Total fair value 7,896 7,443
Liabilities:    
Current portion of earnout consideration on purchase of a business 292  
Earnout consideration on purchase of a business, net of current portion 1,236  
Total fair value 1,528  
Restricted cash   1,000
Level 1 [Member]    
Assets:    
Equity investment in Starrise, at fair value 7,896 6,443
Total fair value 7,896 7,443
Liabilities:    
Current portion of earnout consideration on purchase of a business  
Earnout consideration on purchase of a business, net of current portion  
Total fair value  
Restricted cash   1,000
Level 2 [Member]    
Assets:    
Equity investment in Starrise, at fair value
Total fair value
Liabilities:    
Current portion of earnout consideration on purchase of a business  
Earnout consideration on purchase of a business, net of current portion  
Total fair value  
Restricted cash  
Level 3 [Member]    
Assets:    
Equity investment in Starrise, at fair value
Total fair value
Liabilities:    
Current portion of earnout consideration on purchase of a business 292  
Earnout consideration on purchase of a business, net of current portion 1,236  
Total fair value $ 1,528  
Restricted cash  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details) - Schedule of goodwill and accumulated impairment charges
$ in Thousands
9 Months Ended
Dec. 31, 2021
USD ($)
Schedule of goodwill and accumulated impairment charges [Abstract]  
Goodwill gross beginning $ 8,701
Goodwill from business combinations – see Note 4 4,958
Goodwill gross ending $ 13,659
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Details) - Schedule of revenue categories - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Cinema Equipment Business [Member]        
Cinema Equipment Business:        
Total Cinema Equipment Business revenue $ 2,060 $ 910 $ 11,544 $ 2,158
Content & Entertainment Business [Member]        
Content & Entertainment Business:        
Total Content & Entertainment Business revenue 12,024 9,044 27,658 20,996
Phase I Deployment [Member] | Cinema Equipment Business [Member]        
Cinema Equipment Business:        
Total Cinema Equipment Business revenue 133 281 372 424
Phase II Deployment [Member] | Cinema Equipment Business [Member]        
Cinema Equipment Business:        
Total Cinema Equipment Business revenue 87 367 891 1,067
Services [Member] | Cinema Equipment Business [Member]        
Cinema Equipment Business:        
Total Cinema Equipment Business revenue 506 196 1,171 481
Digital System Sales [Member] | Cinema Equipment Business [Member]        
Cinema Equipment Business:        
Total Cinema Equipment Business revenue 1,334 66 9,110 186
Base Distribution Business [Member] | Content & Entertainment Business [Member]        
Content & Entertainment Business:        
Total Content & Entertainment Business revenue 3,668 4,152 6,368 9,218
OTT Streaming and Digital [Member] | Content & Entertainment Business [Member]        
Content & Entertainment Business:        
Total Content & Entertainment Business revenue $ 8,356 $ 4,892 $ 21,290 $ 11,778
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Other Interests (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Mar. 31, 2021
Other Interests [Abstract]          
Servicing revenue     $ 500 $ 83  
CDF2 Holdings [Member]          
Other Interests [Abstract]          
Digital cinema servicing revenue $ 200 $ 47      
CDF2 Holdings [Member]          
Other Interests [Abstract]          
Ownership percentage     100.00%    
Accounts receivable 700   $ 700   $ 300
Total Stockholders’ Deficit 52,900   52,900   46,300
Initial investment amount $ 2,000   $ 2,000   $ 0
CON TV, LLC [Member]          
Other Interests [Abstract]          
Majority interest, percentage 85.00%   85.00%    
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Combination (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
May 12, 2021
Sep. 17, 2021
Dec. 31, 2021
Dec. 31, 2021
Business Combination (Details) [Line Items]        
Description of stock purchase agreement On May 12, 2021, the Company entered into a stock purchase agreement (the “Foundation Stock Purchase Agreement”) with FoundationTV, Inc. (“FoundationTV”), to buy all of FoundationTV´s issued and outstanding stock in consideration of an aggregate of $5.2 million, of which $0.7 million was paid in cash and 1,483,129 shares of Common Stock, which were valued at $2.5 million, were issued at closing stock price of $1.69 on the closing date of June 9, 2021, and an additional $2.0 million will be paid in eight equal installments of one installment on each six month anniversary of closing over forty-eight months, and a final lump sum payment of $225 thousand on the four year anniversary of the closing, reduced by $0.2 million settlement of a prior relationship.      
Incurred transaction cost       $ 36,000
Cash payments discounted       3.00%
Short-term payable     $ 500 $ 500
Long-term payable     1,500 1,500
Amortization expense     $ 80,000 $ 160,000
Description of business combination   the Company entered into an asset purchase agreement (the “Bloody Disgusting Asset Purchase Agreement”) with Bloody Disgusting, LLC (“Bloody Disgusting”), to buy substantially all of the assets of Bloody Disgusting, in consideration of an aggregate of $7.8 million, of which $4.0 million was paid in cash and 1,039,501 shares of Common Stock, which were valued at $2.3 million, were issued at closing stock price of $2.23 on the closing date of September 17, 2021, and $1.5 million as of the fair value of the earnout liability, related to earnout targets, as defined, to be met as of March 2022, March 2023 and March 2024. The fair value of the earnout liability was estimated considering the weighted probability of scenarios on the earnout metrics possible outcomes during the earnout period. The Bloody Disgusting Asset Purchase Agreement contained certain conditions to closing and representations and warranties and covenants as are customary for transactions of this type. On September 17, 2021, the Bloody Disgusting acquisition was consummated. The Company incurred transaction costs of $40 thousand during the nine months ended December 31, 2021.    
Transaction useful life       12 years
Trade name acquired usefull life       10 years
Amortization intangible assets       $ 105,000
Developed Technology Rights [Member]        
Business Combination (Details) [Line Items]        
Useful life       10 years
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Combination (Details) - Schedule of business combination
$ in Thousands
Dec. 31, 2021
USD ($)
FoundationTV, Inc. [Member]  
Purchase Price  
Purchase Price $ 5,237
Total purchase price 5,237
Allocation of purchase price  
Developed technology 3,200
Goodwill 2,037
Total allocation of purchase price 5,237
Bloody Disgusting, LLC. [Member]  
Purchase Price  
Purchase Price 7,780
Total purchase price 7,780
Allocation of purchase price  
Current assets 9
Advertiser relationships 3,750
Trade name 1,100
Goodwill 2,921
Total allocation of purchase price $ 7,780
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Combination (Details) - Schedule of amortization expense per year for the developed technology acquired in the business combination
$ in Thousands
Dec. 31, 2021
USD ($)
Schedule of amortization expense per year for the developed technology acquired in the business combination [Abstract]  
2022 (remaining) $ 80
2023 320
2024 320
2025 320
2026 320
2027 320
2028 320
2029 320
2030 320
2031 320
2032 80
Total $ 3,040
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Combination (Details) - Schedule of amortization expense per year for the intangible assets acquired in the business combination
$ in Thousands
Dec. 31, 2021
USD ($)
Finite-Lived Intangible Assets [Line Items]  
2022 (remaining) $ 106
2023 423
2024 423
2025 423
2026 423
2027 423
2028 423
2029 423
2030 423
2031 423
2032 368
2033 313
2034 151
Total 4,745
Advertiser relationships [Member]  
Finite-Lived Intangible Assets [Line Items]  
2022 (remaining) 78
2023 313
2024 313
2025 313
2026 313
2027 313
2028 313
2029 313
2030 313
2031 313
2032 313
2033 313
2034 151
Total 3,672
Trade Name [Member]  
Finite-Lived Intangible Assets [Line Items]  
2022 (remaining) 28
2023 110
2024 110
2025 110
2026 110
2027 110
2028 110
2029 110
2030 110
2031 110
2032 55
2033
2034
Total $ 1,073
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Notes Payable (Details) - USD ($)
1 Months Ended 9 Months Ended
Mar. 31, 2021
Apr. 15, 2020
Feb. 28, 2013
Dec. 31, 2021
Jul. 09, 2021
Mar. 31, 2020
Jul. 03, 2019
Mar. 30, 2018
Notes Payable (Details) [Line Items]                
Restricted cash $ 1,000,000              
Principal amount loan         $ 7,800,000      
Credit facility outstanding $ 2,000,000     $ 0        
PPP Loan [Member]                
Notes Payable (Details) [Line Items]                
Credit facility outstanding   $ 2,200,000            
CDCH [Member]                
Notes Payable (Details) [Line Items]                
Principal amount loan       3,500,000        
Line of Credit [Member]                
Notes Payable (Details) [Line Items]                
Maximum borrowing capacity             $ 18,000,000  
Prospect Loan [Member]                
Notes Payable (Details) [Line Items]                
Restricted cash       0   $ 1,000,000    
Prospect Loan [Member]                
Notes Payable (Details) [Line Items]                
Debt loan agreement     $ 70,000,000          
Basis spread on variable rate     9.00%          
Debt interest rate     2.50%          
Debt instrument maximum amount of support       $ 1,500,000        
Prospect Loan [Member] | London Interbank Offered Rate (LIBOR) [Member]                
Notes Payable (Details) [Line Items]                
Debt variable rate basis floor     2.00%          
Revolving Credit Facility [Member]                
Notes Payable (Details) [Line Items]                
Maximum borrowing capacity               $ 19,000,000
Convertible Notes Payable [Member]                
Notes Payable (Details) [Line Items]                
Debt interest rate   1.00%            
Prime Rate [Member] | Cinedigm Credit Facility [Member] | Revolving Credit Facility [Member]                
Notes Payable (Details) [Line Items]                
Basis spread on variable rate       0.50%        
London Interbank Offered Rate (LIBOR) [Member] | Cinedigm Credit Facility [Member] | Revolving Credit Facility [Member]                
Notes Payable (Details) [Line Items]                
Basis spread on variable rate       3.25%        
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Notes Payable (Details) - Schedule of notes payable - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Long Term Portion [Member]    
Debt Instrument [Line Items]    
Prospect Loan
Total non-recourse notes payable
Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts
Credit Facility
PPP Loan 2,152
Total recourse notes payable 2,152
Total recourse notes payable, net of unamortized debt issuance costs and debt discounts 2,152
Total notes payable, net of unamortized debt issuance costs 2,152
Current Portion [Member]    
Debt Instrument [Line Items]    
Prospect Loan 7,786
Total non-recourse notes payable 7,786
Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts 7,786
Credit Facility 1,956
PPP Loan
Total recourse notes payable 1,956
Total recourse notes payable, net of unamortized debt issuance costs and debt discounts 1,956
Total notes payable, net of unamortized debt issuance costs $ 9,742
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.0.1
Notes Payable (Details) - Schedule of debt outstanding - USD ($)
$ in Thousands
Sep. 30, 2021
Mar. 31, 2021
Schedule of debt outstanding [Abstract]    
Prospect Loan, at issuance $ 70,000 $ 70,000
PIK Interest 8,016 6,397
Payments to date (78,016) (68,611)
Prospect Loan, gross 7,786
Less unamortized debt issuance costs and debt discounts
Prospect Loan, net 7,786
Less current portion (7,786)
Total long term portion
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 01, 2017
shares
Oct. 31, 2021
shares
May 31, 2021
shares
Oct. 31, 2013
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
Mar. 31, 2021
USD ($)
$ / shares
shares
Oct. 11, 2021
shares
Oct. 23, 2020
shares
Dec. 04, 2019
shares
Stockholders' Equity (Details) [Line Items]                        
Dividends preferred stock (in Dollars) | $             $ 100   $ 100      
Stock Dividends   102,697 53,278                  
Treasury stock shares         1,315,851   1,315,851   1,313,836      
Share-based Payment arrangement, option, exercise price range, shares outstanding         217,837   217,837          
Options expired         43,500              
Options forfeited             250          
Granted shares             1,807,625          
Maturity date             10 years          
Stock-based compensation (in Dollars) | $             $ 290 $ 131        
Common stock expired unexercised             298,519          
Gaiam Americas, Inc. and Gaiam, Inc. GVE [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Number of employees joining company following acquisition       10                
Shares under option, granted       62,000                
Weighted average exercise price per share, granted (in Dollars per share) | $ / shares       $ 17.5                
Options, outstanding shares         12,500   12,500          
Board of Directors [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Shares issued         245,887   245,887          
SARs [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Stock based compensation (in Dollars) | $         $ 1              
SARs [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Granted shares             600,000          
Board of Directors [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Stock based compensation (in Dollars) | $         107 $ 65            
Restricted Stock Awards [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Stock based compensation (in Dollars) | $         $ 0              
Class A Common Stock [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Common stock, shares authorized         275,000,000   275,000,000   200,000,000 275,000,000    
Shares of common stock             8,642,648          
Common stock shares 2,108,270                      
Minimum [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Fair value common stock per share (in Dollars per share) | $ / shares             $ 1.29          
Volatility percentage             110.32%          
Discount rate percentage             0.96%          
Expected term             6          
Maximum [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Fair value common stock per share (in Dollars per share) | $ / shares             $ 2.56          
Volatility percentage             114.42%          
Discount rate percentage             1.50%          
Expected term             6.5 years          
Cinedigm Equity Incentive Plan [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Percent voting power threshold             10.00%          
Exercise price if voting threshold is met, percent             110.00%          
Cinedigm Equity Incentive Plan [Member] | Class A Common Stock [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Number of shares authorized         2,380,000   2,380,000          
Share-based Payment arrangement, option, exercise price range, shares outstanding         217,837   217,837   261,587      
Share-based payment arrangement, option, exercise price range, outstanding, weighted average exercise price (in Dollars per share) | $ / shares         $ 14.49   $ 14.49   $ 14.99      
Options outstanding, weighted average remaining contractual term             1 year 5 months 1 day   2 years 1 month 9 days      
Two Thousand seventeen Plan [Member] | Minimum [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Common stock, shares authorized                   14,098,270 4,098,270  
Two Thousand seventeen Plan [Member] | Minimum [Member] | Class A Common Stock [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Number of shares authorized                       2,108,270
Two Thousand seventeen Plan [Member] | Maximum [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Common stock, shares authorized                   18,098,270 14,098,270  
Two Thousand seventeen Plan [Member] | Maximum [Member] | Class A Common Stock [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Number of shares authorized                       4,098,270
Stock option [Member] | Gaiam Americas, Inc. and Gaiam, Inc. GVE [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Aware expiration period       10 years                
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Details) - Schedule of analysis of option activity
9 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options Outstanding (in Shares) | shares 217,837
Aggregate Intrinsic Value (in Dollars) | $
$7.40 - $13.69 [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Prices, Minimum $ 7.4
Range of Prices, Maximum $ 13.69
Options Outstanding (in Shares) | shares 5,000
Weighted Average Remaining Life in Years 3 years 6 months
Weighted Average Exercise Price $ 7.4
Aggregate Intrinsic Value (in Dollars) | $
$14.00 - $24.40 [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Range of Prices, Minimum $ 14
Range of Prices, Maximum $ 24.4
Options Outstanding (in Shares) | shares 212,837
Weighted Average Remaining Life in Years 1 year 4 months 13 days
Weighted Average Exercise Price $ 14.65
Aggregate Intrinsic Value (in Dollars) | $
Options Exercisable [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Weighted Average Remaining Life in Years 1 year 5 months 1 day
Weighted Average Exercise Price $ 14.49
Aggregate Intrinsic Value (in Dollars) | $
Options Exercisable (in Shares) | shares 217,837
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding
$ / shares in Units, $ in Thousands
9 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding [Line Items]  
Options Outstanding (in Shares) | shares 10,675,973
Aggregate Intrinsic Value (in Dollars) | $ $ 3,131
$0.54 - $0.74 [Member]  
Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding [Line Items]  
Range of Prices, Minimum $ 0.54
Range of Prices, Maximum $ 0.74
Options Outstanding (in Shares) | shares 5,550,000
Weighted Average Remaining Life in Years 8 years 11 months 26 days
Weighted Average Exercise Price $ 0.64
Aggregate Intrinsic Value (in Dollars) | $ $ 3,131
$1.16 - $1.47 [Member]  
Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding [Line Items]  
Range of Prices, Minimum $ 1.16
Range of Prices, Maximum $ 1.47
Options Outstanding (in Shares) | shares 2,050,860
Weighted Average Remaining Life in Years 8 years 1 month 24 days
Weighted Average Exercise Price $ 1.37
Aggregate Intrinsic Value (in Dollars) | $
$1.71 - $2.10 [Member]  
Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding [Line Items]  
Range of Prices, Minimum $ 1.71
Range of Prices, Maximum $ 2.1
Options Outstanding (in Shares) | shares 2,680,738
Weighted Average Remaining Life in Years 9 years 1 month 28 days
Weighted Average Exercise Price $ 1.97
Aggregate Intrinsic Value (in Dollars) | $
$2.23 - $2.56 [Member]  
Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding [Line Items]  
Range of Prices, Minimum $ 2.23
Range of Prices, Maximum $ 2.56
Options Outstanding (in Shares) | shares 394,375
Weighted Average Remaining Life in Years 9 years 10 months 6 days
Weighted Average Exercise Price $ 2.33
Aggregate Intrinsic Value (in Dollars) | $
Options Exercisable [Member]  
Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding [Line Items]  
Weighted Average Remaining Life in Years 7 years 3 months 3 days
Weighted Average Exercise Price $ 1.16
Aggregate Intrinsic Value (in Dollars) | $ $ 775
Options Exercisable (in Shares) | shares 2,712,610
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Details) - Schedule of stock-based compensation expense - USD ($)
$ in Thousands
6 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Stockholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]        
Selling, general and administrative $ 1,349 $ 960 $ 3,278 $ 2,172
Selling, general and administrative [Member]        
Stockholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]        
Selling, general and administrative $ 1,349 $ 960 $ 3,278 $ 2,172
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Details) - Schedule of SARs outstanding
9 Months Ended
Dec. 31, 2021
shares
Schedule of SARs outstanding [Abstract]  
SARs Outstanding March 31, 2021 9,154,933
Issued 1,807,625
Forfeited (286,585)
Total SARs Outstanding December 31, 2021 10,675,923
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity (Details) - Schedule of warrants - BEMG in connection with a term loan agreement [Member]
9 Months Ended
Dec. 31, 2021
$ / shares
shares
Class of Warrant or Right [Line Items]  
Amount outstanding | shares 1,400,000
Expiration 2022-12
Minimum [Member]  
Class of Warrant or Right [Line Items]  
Exercise price per share | $ / shares $ 1.8
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies (Details)
$ in Millions
Sep. 01, 2021
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Minimum participation guaranty $ 3.5
Arrangement payable 1.5
First year anniversary arrangement 1.0
Second year anniversary arrangement $ 0.9
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Assets    
Noncurrent $ 16 $ 100
Liabilities    
Current 16 87
Noncurrent 13
Total operating lease liabilities $ 16 $ 100
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies (Details) - Schedule of lease costs - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Schedule of lease costs [Abstract]    
Operating lease cost $ 90 $ 160
Total lease cost 90 160
Cash paid for amounts included in the measurement of lease liabilities 13 162
Operating cash flows used for operating leases $ 13 $ 162
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flows - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Schedule of supplemental cash flows [Abstract]    
Cash interest paid $ 701 $ 3,014
Income taxes paid 79
noncash investing and financing activities:    
Accrued dividends on preferred stock 89 89
Issuance of Class A common stock for payment of accrued preferred stock dividends 267 267
Issuance of Class A common stock to Starrise, a related party 11,046
Contributed capital under the Starrise transaction, a related party 17,187
Settlement of second lien loan with Class A common stock 3,008
Conversion of note payable 15,000
Class A common stock to be issued in connection with the asset acquisition 1,853
Issuance of Class A common stock for business combination 4,824
Starrise shares used to pay down vendors 897
Treasury shares acquired for withholding taxes 5
Deferred consideration in purchase of a business 1,980
Earnout consideration in purchase of a business $ 1,461
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Details)
9 Months Ended
Dec. 31, 2021
Segment Information (Details) [Line Items]  
Number of reportable segments 2
Phase I Deployment [Member]  
Segment Information (Details) [Line Items]  
Number of systems installed 1,631
Phase II Deployment [Member]  
Segment Information (Details) [Line Items]  
Number of systems installed 2,978
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Details) - Schedule of segment reporting, assets and debt - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Segment Information (Details) - Schedule of segment reporting, assets and debt [Line Items]    
Intangible Assets, net $ 15,672 $ 9,860
Goodwill 13,659 8,701
Total Assets 99,554 75,446
Notes Payable, Non-Recourse 7,786
Notes Payable 4,108
Operating lease liabilities 16 100
Cinema Equipment Business [Member]    
Segment Information (Details) - Schedule of segment reporting, assets and debt [Line Items]    
Intangible Assets, net
Goodwill
Total Assets 22,910 13,169
Notes Payable, Non-Recourse 7,786
Notes Payable
Operating lease liabilities 1
Content & Entertainment Business [Member]    
Segment Information (Details) - Schedule of segment reporting, assets and debt [Line Items]    
Intangible Assets, net 15,672 9,858
Goodwill 13,659 8,701
Total Assets 54,909 42,733
Notes Payable, Non-Recourse
Notes Payable
Operating lease liabilities   69
Corporate [Member]    
Segment Information (Details) - Schedule of segment reporting, assets and debt [Line Items]    
Intangible Assets, net   2
Goodwill
Total Assets 21,735 19,544
Notes Payable, Non-Recourse
Notes Payable 4,108
Operating lease liabilities $ 16 $ 30
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Details) - Schedule of segment reporting, statement of operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]        
Revenues $ 14,084 $ 9,954 $ 39,202 $ 23,154
Direct operating (exclusive of depreciation and amortization shown below) 6,459 4,385 14,423 11,394
Selling, general and administrative 7,736 5,361 20,938 15,369
Allocation of corporate overhead
Provision for (recovery of) doubtful accounts (378) 70 (418) (123)
Depreciation and amortization of property and equipment 336 822 1,425 3,691
Amortization of intangible assets 695 597 2,238 1,778
Total operating expenses 14,848 11,235 38,606 32,109
Income (loss) from operations (764) (1,281) 596 (8,955)
Cinema Equipment Business [Member]        
Segment Reporting Information [Line Items]        
Revenues 2,060 910 11,544 2,158
Direct operating (exclusive of depreciation and amortization shown below) 139 150 560 504
Selling, general and administrative 496 524 1,356 1,704
Allocation of corporate overhead 143 143 412 438
Provision for (recovery of) doubtful accounts (397) 70 (500) (123)
Depreciation and amortization of property and equipment 196 706 1,001 3,348
Amortization of intangible assets 8 23
Total operating expenses 577 1,601 2,829 5,892
Income (loss) from operations 1,483 (691) 8,715 (3,736)
Content & Entertainment Business [Member]        
Segment Reporting Information [Line Items]        
Revenues 12,024 9,044 27,658 20,996
Direct operating (exclusive of depreciation and amortization shown below) 6,320 4,235 13,863 10,890
Selling, general and administrative 3,701 2,244 9,999 6,667
Allocation of corporate overhead 964 964 2,763 2,883
Provision for (recovery of) doubtful accounts 19 82
Depreciation and amortization of property and equipment 138 108 422 312
Amortization of intangible assets 693 588 2,236 1,752
Total operating expenses 11,835 8,139 29,365 22,504
Income (loss) from operations 189 905 (1,707) (1,508)
Corporate [Member]        
Segment Reporting Information [Line Items]        
Revenues
Direct operating (exclusive of depreciation and amortization shown below)
Selling, general and administrative 3,539 2,593 9,583 6,998
Allocation of corporate overhead (1,107) (1,107) (3,175) (3,321)
Provision for (recovery of) doubtful accounts
Depreciation and amortization of property and equipment 2 8 2 31
Amortization of intangible assets 2 1 2 3
Total operating expenses 2,436 1,495 6,412 3,711
Income (loss) from operations $ (2,436) $ (1,495) $ (6,412) $ (3,711)
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
Segment Information (Details) - Schedule of segment reporting, employee stock-based compensation expense - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation $ 1,349 $ 960 $ 3,278 $ 2,172
Cinema Equipment Business [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation
Content & Entertainment Business [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation 552 39 1,063 91
Corporate [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation 797 921 2,215 2,081
Direct operating [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation
Direct operating [Member] | Cinema Equipment Business [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation
Direct operating [Member] | Content & Entertainment Business [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation
Direct operating [Member] | Corporate [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation
Selling, general and administrative [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation 1,349 960 3,278 2,172
Selling, general and administrative [Member] | Cinema Equipment Business [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation
Selling, general and administrative [Member] | Content & Entertainment Business [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation 552 39 1,063 91
Selling, general and administrative [Member] | Corporate [Member]        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Total stock-based compensation $ 797 $ 921 $ 2,215 $ 2,081
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 27, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]          
Income tax expense benefit   $ 26 $ 0 $ 576 $ 181
Effective tax rate percentage       14.00% 0.30%
Income tax description Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable.        
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.22.0.1
Subsequent Events (Details)
Jan. 04, 2022
Subsequent Events [Abstract]  
Description of purchase agreement the Company entered into an Equity Purchase Agreement among the Company, and David Chu, Augustine Hong, Helen Hong, Michael Hong, Justin Lee, Steven Park, and Kingsoon Ong (collectively, the “Sellers”) and David Chu as representative of the Sellers (the “DMR Agreement”) to acquire all of the outstanding membership interests of Asian Media Rights, LLC d/b/a Digital Media Rights (“DMR”), a diversified specialty streaming, advertising, and content distribution company with significant expertise in building audiences for global content in North America (the “DMR Transaction”). The DMR Transaction is subject to certain closing conditions, including satisfactory financial and legal diligence, and the parties are working toward closing the transaction.
XML 69 f10q1221_cinedigmcorp_htm.xml IDEA: XBRL DOCUMENT 0001173204 2021-04-01 2021-12-31 0001173204 2022-02-11 0001173204 2021-12-31 0001173204 2021-03-31 0001173204 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001173204 us-gaap:SeriesAPreferredStockMember 2021-03-31 0001173204 us-gaap:CommonClassAMember 2021-12-31 0001173204 us-gaap:CommonClassAMember 2021-03-31 0001173204 2021-10-01 2021-12-31 0001173204 2020-10-01 2020-12-31 0001173204 2020-04-01 2020-12-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-03-31 0001173204 us-gaap:TreasuryStockMember 2020-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001173204 us-gaap:RetainedEarningsMember 2020-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001173204 us-gaap:ParentMember 2020-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-03-31 0001173204 2020-03-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-04-01 2020-06-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001173204 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001173204 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001173204 us-gaap:ParentMember 2020-04-01 2020-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001173204 2020-04-01 2020-06-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-06-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-06-30 0001173204 us-gaap:TreasuryStockMember 2020-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001173204 us-gaap:RetainedEarningsMember 2020-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001173204 us-gaap:ParentMember 2020-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-06-30 0001173204 2020-06-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-07-01 2020-09-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001173204 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001173204 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001173204 us-gaap:ParentMember 2020-07-01 2020-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-07-01 2020-09-30 0001173204 2020-07-01 2020-09-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-09-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-09-30 0001173204 us-gaap:TreasuryStockMember 2020-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001173204 us-gaap:RetainedEarningsMember 2020-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001173204 us-gaap:ParentMember 2020-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2020-09-30 0001173204 2020-09-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:TreasuryStockMember 2020-10-01 2020-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001173204 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-01 2020-12-31 0001173204 us-gaap:ParentMember 2020-10-01 2020-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-10-01 2020-12-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001173204 us-gaap:TreasuryStockMember 2020-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001173204 us-gaap:RetainedEarningsMember 2020-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001173204 us-gaap:ParentMember 2020-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2020-12-31 0001173204 2020-12-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-03-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001173204 us-gaap:TreasuryStockMember 2021-03-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001173204 us-gaap:RetainedEarningsMember 2021-03-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001173204 us-gaap:ParentMember 2021-03-31 0001173204 us-gaap:NoncontrollingInterestMember 2021-03-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001173204 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001173204 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001173204 us-gaap:ParentMember 2021-04-01 2021-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001173204 2021-04-01 2021-06-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-06-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001173204 us-gaap:TreasuryStockMember 2021-06-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001173204 us-gaap:RetainedEarningsMember 2021-06-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001173204 us-gaap:ParentMember 2021-06-30 0001173204 us-gaap:NoncontrollingInterestMember 2021-06-30 0001173204 2021-06-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001173204 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001173204 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001173204 us-gaap:ParentMember 2021-07-01 2021-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001173204 2021-07-01 2021-09-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-09-30 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-09-30 0001173204 us-gaap:TreasuryStockMember 2021-09-30 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001173204 us-gaap:RetainedEarningsMember 2021-09-30 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001173204 us-gaap:ParentMember 2021-09-30 0001173204 us-gaap:NoncontrollingInterestMember 2021-09-30 0001173204 2021-09-30 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-10-01 2021-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001173204 us-gaap:TreasuryStockMember 2021-10-01 2021-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001173204 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2021-12-31 0001173204 us-gaap:ParentMember 2021-10-01 2021-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2021-10-01 2021-12-31 0001173204 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001173204 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001173204 us-gaap:TreasuryStockMember 2021-12-31 0001173204 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001173204 us-gaap:RetainedEarningsMember 2021-12-31 0001173204 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001173204 us-gaap:ParentMember 2021-12-31 0001173204 us-gaap:NoncontrollingInterestMember 2021-12-31 0001173204 2021-07-09 0001173204 2021-03-17 0001173204 2021-03-01 2021-03-17 0001173204 2019-12-01 2019-12-27 0001173204 2020-02-01 2020-02-14 0001173204 cidm:BeiTaiMember 2020-02-01 2020-02-14 0001173204 2020-02-14 0001173204 cidm:BeiTaiMember 2021-04-01 2021-12-31 0001173204 2020-04-01 2020-04-10 0001173204 2020-04-15 0001173204 us-gaap:BorrowingsMember 2021-07-09 0001173204 cidm:StarriseMember 2020-02-14 0001173204 cidm:StarriseMember 2020-04-10 0001173204 2020-04-10 0001173204 cidm:StarriseMember cidm:StockExchangeOfHongKongLimitedMember 2021-04-01 2021-12-31 0001173204 cidm:StarriseMember cidm:StockExchangeOfHongKongLimitedMember 2020-04-01 2021-03-31 0001173204 cidm:StockExchangeOfHongKongLimitedMember 2021-04-01 2021-12-31 0001173204 cidm:StockExchangeOfHongKongLimitedMember 2020-04-01 2020-12-31 0001173204 2021-04-01 2021-04-01 0001173204 2020-05-01 2020-05-05 0001173204 cidm:StarriseMember 2021-12-31 0001173204 cidm:StarriseMember 2021-03-31 0001173204 cidm:StarriseMember 2021-04-01 2021-12-31 0001173204 cidm:StarriseMember 2020-04-01 2021-03-31 0001173204 us-gaap:UpFrontPaymentArrangementMember 2021-12-31 0001173204 cidm:ServicesMember 2021-12-31 0001173204 srt:MinimumMember us-gaap:ComputerEquipmentMember 2021-04-01 2021-12-31 0001173204 srt:MaximumMember us-gaap:ComputerEquipmentMember 2021-04-01 2021-12-31 0001173204 cidm:InternalUseSoftwareMember 2021-04-01 2021-12-31 0001173204 cidm:DigitalCinemaProjectionSystemsMember 2021-04-01 2021-12-31 0001173204 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2021-04-01 2021-12-31 0001173204 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2021-04-01 2021-12-31 0001173204 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2021-04-01 2021-12-31 0001173204 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2021-04-01 2021-12-31 0001173204 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001173204 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001173204 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001173204 us-gaap:FairValueInputsLevel1Member 2021-03-31 0001173204 us-gaap:FairValueInputsLevel2Member 2021-03-31 0001173204 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:PhaseIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:PhaseIIDeploymentMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 us-gaap:ServiceMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:DigitalSystemSalesMember cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentEntertainmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentEntertainmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentEntertainmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:BaseDistributionBusinessMember cidm:ContentEntertainmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentEntertainmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentEntertainmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentEntertainmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:OTTStreamingandDigitalMember cidm:ContentEntertainmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessOneMember 2021-10-01 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessOneMember 2020-10-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessOneMember 2021-04-01 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessOneMember 2020-04-01 2020-12-31 0001173204 cidm:HoldingsMember 2021-04-01 2021-12-31 0001173204 cidm:HoldingsMember 2021-12-31 0001173204 cidm:HoldingsMember 2021-03-31 0001173204 cidm:HoldingsMember 2021-10-01 2021-12-31 0001173204 cidm:HoldingsMember 2020-10-01 2020-12-31 0001173204 cidm:CONtvMember 2021-12-31 0001173204 2021-05-02 2021-05-12 0001173204 us-gaap:DevelopedTechnologyRightsMember 2021-04-01 2021-12-31 0001173204 2021-09-01 2021-09-17 0001173204 cidm:FoundationTVIncMember 2021-12-31 0001173204 cidm:BloodyDisgustingLLCMember 2021-12-31 0001173204 cidm:AdvertiserRelationshipsMember 2021-12-31 0001173204 us-gaap:TradeNamesMember 2021-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2013-02-01 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2013-02-28 0001173204 cidm:TwoThousandThirteenProspectTermLoansAgreementMember 2021-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoansAgreementMember 2020-03-31 0001173204 cidm:CDCHMember 2021-12-31 0001173204 cidm:TwoThousandThirteenProspectTermLoanAgreementMember 2021-12-31 0001173204 us-gaap:RevolvingCreditFacilityMember 2018-03-30 0001173204 us-gaap:RevolvingCreditFacilityMember cidm:CinedigmCreditFacilityMember us-gaap:PrimeRateMember 2021-04-01 2021-12-31 0001173204 us-gaap:RevolvingCreditFacilityMember cidm:CinedigmCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-04-01 2021-12-31 0001173204 us-gaap:LineOfCreditMember 2019-07-03 0001173204 2021-03-01 2021-03-31 0001173204 cidm:PaycheckProtectionProgramMember 2020-04-01 2020-04-15 0001173204 us-gaap:ConvertibleNotesPayableMember 2020-04-15 0001173204 cidm:CurrentPortionMember 2021-12-31 0001173204 cidm:LongTermPortionMember 2021-12-31 0001173204 cidm:CurrentPortionMember 2021-03-31 0001173204 cidm:LongTermPortionMember 2021-03-31 0001173204 us-gaap:CommonClassAMember 2021-10-11 0001173204 us-gaap:CommonClassAMember 2021-04-01 2021-12-31 0001173204 2020-04-01 2021-03-31 0001173204 2021-05-01 2021-05-31 0001173204 2021-10-01 2021-10-31 0001173204 cidm:CinedigmEquityIncentivePlanMember 2021-04-01 2021-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2021-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2021-04-01 2021-12-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2021-03-31 0001173204 cidm:CinedigmEquityIncentivePlanMember us-gaap:CommonClassAMember 2020-04-01 2021-03-31 0001173204 us-gaap:CommonClassAMember 2017-08-01 2017-08-01 0001173204 srt:MinimumMember cidm:TwoThousandSeventeenPlanMember us-gaap:CommonClassAMember 2019-12-04 0001173204 srt:MaximumMember cidm:TwoThousandSeventeenPlanMember us-gaap:CommonClassAMember 2019-12-04 0001173204 srt:MinimumMember cidm:TwoThousandSeventeenPlanMember 2020-10-23 0001173204 srt:MaximumMember cidm:TwoThousandSeventeenPlanMember 2020-10-23 0001173204 srt:MinimumMember cidm:TwoThousandSeventeenPlanMember 2021-10-11 0001173204 srt:MaximumMember cidm:TwoThousandSeventeenPlanMember 2021-10-11 0001173204 us-gaap:StockAppreciationRightsSARSMember 2021-04-01 2021-12-31 0001173204 srt:MinimumMember 2021-04-01 2021-12-31 0001173204 srt:MaximumMember 2021-04-01 2021-12-31 0001173204 us-gaap:StockAppreciationRightsSARSMember 2021-10-01 2021-12-31 0001173204 cidm:RestrictedStockAwardsMember 2021-10-01 2021-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2021-10-01 2021-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2020-10-01 2020-12-31 0001173204 srt:BoardOfDirectorsChairmanMember 2021-12-31 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember 2013-10-01 2013-10-31 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember us-gaap:EmployeeStockOptionMember 2013-10-01 2013-10-31 0001173204 cidm:GaiamAmericasIncAndGaiamIncGVEMember 2021-12-31 0001173204 cidm:ExercisePriceRangeOneMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisePriceRangeOneMember 2021-12-31 0001173204 cidm:ExercisePriceRangeTwoMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisePriceRangeTwoMember 2021-12-31 0001173204 cidm:OptionsExercisableMember 2021-12-31 0001173204 cidm:OptionsExercisableMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisePriceRangeThreeMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisePriceRangeThreeMember 2021-12-31 0001173204 cidm:ExercisesPriceRangeFourMember 2021-04-01 2021-12-31 0001173204 cidm:ExercisesPriceRangeFourMember 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-07-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-07-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-04-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-04-01 2020-12-31 0001173204 2021-07-01 2021-12-31 0001173204 2020-07-01 2020-12-31 0001173204 cidm:BEMGTermLoanAgreementMember 2021-12-31 0001173204 cidm:BEMGTermLoanAgreementMember 2021-04-01 2021-12-31 0001173204 srt:MinimumMember cidm:BEMGTermLoanAgreementMember 2021-12-31 0001173204 2021-09-01 0001173204 cidm:PhaseIDeploymentMember 2021-04-01 2021-12-31 0001173204 cidm:PhaseIIDeploymentMember 2021-04-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2021-12-31 0001173204 us-gaap:CorporateMember 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2021-03-31 0001173204 cidm:ContentEntertainmentBusinessMember 2021-03-31 0001173204 us-gaap:CorporateMember 2021-03-31 0001173204 cidm:CinemaEquipmentBusinessMember 2021-10-01 2021-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2021-10-01 2021-12-31 0001173204 us-gaap:CorporateMember 2021-10-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2020-10-01 2020-12-31 0001173204 us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2021-04-01 2021-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2021-04-01 2021-12-31 0001173204 us-gaap:CorporateMember 2021-04-01 2021-12-31 0001173204 cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 cidm:ContentAndEntertainmentSegmentMember 2020-04-01 2020-12-31 0001173204 us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2021-10-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember 2021-10-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2021-10-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-10-01 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2021-10-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2020-10-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-10-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2020-10-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2021-04-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember 2021-04-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2021-04-01 2021-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2021-04-01 2021-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 us-gaap:OperatingExpenseMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:CinemaEquipmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CorporateMember 2020-04-01 2020-12-31 0001173204 cidm:ContentEntertainmentBusinessMember 2020-04-01 2020-12-31 0001173204 2020-03-02 2020-03-27 0001173204 2022-01-01 2022-01-04 shares iso4217:USD pure iso4217:USD shares 10-Q true 2021-12-31 false 001-31810 Cinedigm Corp. DE 22-3720962 237 West 35th Street Suite 605 New York NY 10001 (212) 206-8600 CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE CIDM NASDAQ Yes Yes Non-accelerated Filer true false false 174871216 20201000 16849000 29785000 21093000 92000 166000 2826000 1377000 5787000 3657000 58691000 43142000 1000000 7896000 6443000 2438000 3500000 16000 100000 15672000 9860000 13659000 8701000 1182000 2700000 99554000 75446000 54706000 46627000 1956000 7786000 472000 292000 16000 87000 285000 924000 55771000 57380000 2152000 1538000 1236000 13000 19000 58545000 59564000 15000000 15000000 0.10 0.10 0.001 0.001 20 20 7 7 7 7 3648000 3648000 3559000 3559000 0.001 0.001 275000000 200000000 176187067 167542404 174871216 166228568 174000 164000 520099000 499272000 1315851 1313836 11608000 11603000 -469729000 -474080000 -101000 -68000 42394000 17244000 -1385000 -1362000 41009000 15882000 99554000 75446000 14084000 9954000 39202000 23154000 6459000 4385000 14423000 11394000 7736000 5361000 20938000 15369000 -378000 70000 -418000 -123000 336000 822000 1425000 3691000 695000 597000 2238000 1778000 14848000 11235000 38606000 32109000 -764000 -1281000 596000 -8955000 97000 948000 277000 3432000 -540000 2178000 -852000 453000 -6751000 1453000 -42377000 -22000 -147000 69000 -668000 -430000 -9667000 4019000 -56284000 -26000 -576000 -181000 -404000 -9667000 4595000 -56103000 -19000 -23000 -23000 -60000 -385000 -9644000 4618000 -56043000 89000 89000 267000 267000 -474000 -9733000 4351000 -56310000 0 -0.07 0.03 -0.49 173167450 136866072 169413873 115347494 0 -0.07 0.03 -0.49 173167450 136866072 173017364 115347494 -404000 -9667000 4595000 -56103000 -14000 -76000 -33000 -186000 -418000 -9743000 4562000 -56289000 -19000 -23000 -23000 -60000 -399000 -9720000 4585000 -56229000 7 3559000 61937593 62000 1313836 -11603000 400784000 -410904000 92000 -18010000 -1277000 -19287000 -80000 -80000 -80000 10666666 11000 7139000 7150000 7150000 29855081 30000 11016000 11046000 11046000 17187000 17187000 17187000 329501 757000 757000 757000 236899 301000 301000 301000 177000 177000 177000 267079 89000 -89000 -19856000 -19856000 -14000 -19870000 7 3559000 103292819 103000 1313836 -11603000 437450000 -430849000 12000 -1328000 -1291000 -2619000 -30000 -30000 -30000 695000 7213334 7000 10118000 10125000 10125000 10000000 10000 14990000 15000000 15000000 80000 71000 71000 71000 689364 1000 785000 786000 786000 373647 33465 61000 61000 61000 178000 178000 178000 44913 89000 -89000 -26543000 -26543000 -23000 -26566000 7 3559000 121727542 121000 1313836 -11603000 463742000 -457481000 -18000 -1680000 -1314000 -2994000 -76000 -76000 -76000 3228783 5000 2185000 2190000 2190000 171933 89000 -89000 794000 794000 794000 320000 166000 166000 166000 320000 28405840 27000 18589000 18616000 18616000 1853000 1853000 1853000 -9644000 -9644000 -23000 -9667000 7 3559000 154174098 153000 1313836 -11603000 487418000 -467214000 -94000 12219000 -1337000 10882000 7 3559000 166228568 164000 1313836 -11603000 499272000 -474080000 -68000 17244000 -1362000 15882000 -54000 -54000 -54000 35714 983000 983000 983000 1483129 2000 2504000 2506000 2506000 53278 89000 -89000 5187000 5187000 7000 5194000 7 3559000 167800689 166000 1313836 -11603000 502848000 -468982000 -122000 25866000 -1355000 24511000 35000 35000 35000 132630 946000 946000 946000 1179156 1000 2317000 2318000 2318000 -2015 2015 -5000 -5000 -5000 -89000 -89000 -89000 -184000 -184000 -11000 -195000 7 3559000 169110460 167000 1315851 -11608000 506111000 -469255000 -87000 28887000 -1366000 27521000 -14000 -14000 -14000 147712 1349000 1349000 1349000 210084 102697 178000 178000 178000 263 5300000 7000 12371000 12378000 12378000 89000 -89000 -385000 -385000 -19000 -404000 7 3559000 174871216 174000 1315851 -11608000 520099000 -469729000 -101000 42394000 -1385000 41009000 4595000 -56103000 3663000 5469000 1464000 -42377000 -2178000 852000 -782000 -280000 -62000 140000 -397000 -123000 3278000 2172000 -294000 30000 67000 59000 8164000 -9820000 -74000 -359000 1449000 1085000 1394000 -1765000 7883000 -21831000 -639000 -1224000 4746000 -16776000 292000 339000 4750000 156000 -11000 -815000 742000 -5031000 -110000 7786000 22365000 -1956000 12823000 2152000 12378000 36189000 2636000 28799000 2352000 11913000 17849000 15294000 20201000 27207000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>1. NATURE OF OPERATIONS AND LIQUIDITY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cinedigm Corp. (“Cinedigm,” the “Company,” “we,” “us,” or similar pronouns) was incorporated in Delaware on March 31, 2000. We are (i) a distributor and aggregator of independent movie, television and other short form content managing a library of distribution rights to thousands of titles and episodes released across digital, physical, theatrical, home and mobile entertainment platforms (“Streaming”) and (ii) a servicer of digital cinema assets (“Systems”) for over 4,609 movie screens in both North America and several international countries.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We report our financial results in two primary segments as follows: (1) cinema equipment business and (2) content and entertainment business (“Content &amp; Entertainment” or “CEG”). The cinema equipment business segment consists of the non-recourse, financing vehicles and administrators for our digital cinema equipment (the “Systems”) installed in movie theatres throughout North America and Australia. It also provides fee-based support to over 4,609 movie screens as well as directly to exhibitors and other third-party customers in the form of monitoring, billing, collection and verification services. Our Content &amp; Entertainment segment operates in: (1) ancillary market aggregation and distribution of entertainment content and (2) branded and curated over-the-top (“OTT”) digital network business providing entertainment channels and applications.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Risks and Uncertainties</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The COVID-19 pandemic and related economic repercussions created significant volatility and uncertainty impacting the Company’s results for the period. As part of our Content &amp; Entertainment business, the Company sells DVDs and Blu-ray discs at brick-and-mortar stores. Due to the lingering effects of the COVID-19 pandemic in the nine-month period ended December 31, 2021, the sale of physical discs through our retail partners declined although this was partially offset by digital purchases of physical product and increases in streaming views. As part of our Cinema Equipment business, the Company earns revenue when movies are exhibited in theatres. Major studios continued to release tentpole films in the theatrical markets as box office results steadily showed improvement in the three months ended December 31, 2021.  However, the number of wide releases remained below pre-pandemic levels during that quarter as studios continue to shuffle release dates and test theatrical windows.  The Canadian government tightened Movie Theatre restrictions amid a Covid surge due to the Omicron variant as well as shuttering all Quebec theatres during that quarter.  Movie theatres in the U.S. remained open and continued to follow NATO CinemaSafe protocols in an effort to help reinforce consumer confidence in the safety of the theatrical moviegoing experience. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Liquidity</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have incurred net losses historically and have an accumulated deficit of $469.7 million and our working capital is $2.9 million as of December 31, 2021. We may continue to generate net losses for the foreseeable future. In addition, we have had debt-related contractual obligations. Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect Loan (as defined below) non-recourse debt amount by paying an aggregate principal amount of $7.8 million. As of December 31, 2021 there was $0 million principal outstanding and there was no availability under the Credit Facility which expired on September 28, 2021. Net cash provided by operating activities for the nine months ended December 31, 2021 was $4.7 million. Based on these conditions and the Company´s financing strategies, the Company entered into the transactions described below:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sale of Cinematic Equipment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 17, 2021, the Company entered into two separate agreements for the sale of cinematic equipment to American Multi-Cinema, Inc. (“AMC”). The agreements included the sale in tranches of a total of 2,369 cinematic projectors starting in March 2021 and continuing through January 2023 for total cash consideration of $10.8 million. Through December 31, 2021, the Company recognized aggregate revenue for $9.1 million. A portion of the total proceeds were used to paydown the remaining outstanding balance of the Prospect Loan notes payable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity Investment in a Related Party</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 27, 2019, the Company entered into, and on February 14, 2020 amended, (see Note 2 - <i>Summary of Significant Accounting Policies</i>), a stock purchase agreement (as so amended, the “Starrise Stock Purchase Agreement”) with BeiTai Investment LP (“BeiTai”), a related party for accounting purposes of Cinedigm and Aim Right Ventures Limited (“Aim Right”), two shareholders of Starrise Media Holdings Limited, a leading Chinese entertainment company (“Starrise”), to buy from them an aggregate of 410,901,000 outstanding Starrise ordinary shares (the “Starrise Share Acquisition”). On February 14, 2020, the Company purchased 162,162,162 of the Starrise ordinary shares from BeiTai and issued BeiTai 21,646,604 shares of its Class A common stock, par value $.001 per share (the “Common Stock”) in consideration therefor. The Starrise shares received were valued at approximately $25 million and the Company issued shares that were valued at approximately $11.2 million. On April 10, 2020, the Company, in accordance with the terms of the Stock Purchase Agreement, terminated its obligation to purchase Starrise ordinary shares from Aim Right under the Starrise Stock Purchase Agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 10, 2020, the Company entered into another stock purchase agreement (the “April Starrise Stock Purchase Agreement”) with five (5) shareholders of Starrise - Bison Global Investment SPC - Bison Global No. 1 SP, Huatai Investment LP, Antai Investment LP, Mingtai Investment LP and Shangtai Asset Management LP - all of which are related parties to the Company to buy an aggregate of 223,380,000 outstanding Starrise ordinary shares from them and for the Company to issue to them an aggregate of 29,855,081 shares of its Common Stock as consideration therefor (the “April Starrise Share Acquisition”). On April 15, 2020, the April Starrise Share Acquisition was consummated and this transaction was also recorded as an equity investment in Starrise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Starrise’s ordinary shares (HK 1616) are listed on the main board of the Stock Exchange of Hong Kong Limited. Based on the closing price of HKD 0.159 per share on February 11, 2022, calculated at an exchange rate of 7.8 Hong Kong Dollars to 1 US dollar, the market value of Cinedigm’s ownership in Starrise ordinary shares was approximately $7.4 million. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Borrowings</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 22, 2021, the maturity date of the East West Credit Facility (as defined in Note 5 - <i>Notes Payable) </i>with East West Bank was extended from June 30, 2021 to September 28, 2021 and was not extended.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 15, 2020, the Company received $2.2 million from East West Bank, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts were intended to be eligible for forgiveness, subject to the provisions of the CARES Act, and could be subject to repayment. On July 7, 2021, the Company received notification from the lender that the U.S. Small Business Administration had approved the Company’s PPP Loan forgiveness application for the entire PPP Loan amount and accrued interest effective as of June 30, 2021. The forgiveness of the PPP Loan was recognized as a gain of $2.2 million during the Company’s fiscal quarter ended June 30, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon a series of payments between April 30 and July 9, 2021, the Company paid in full the Prospect loan non-recourse outstanding debt amount by paying an aggregate principal amount of $7.8 million. Pre-payment of the Prospect Loan was permissible without penalty.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Common Stock Purchase Agreement</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, we entered into a Common Stock Purchase Agreement (the “Equity Line Purchase Agreement”) and a Registration Rights Agreement (the “Registration Rights Agreement”) with B. Riley Principal Capital, LLC (“B. Riley Principal Capital”). Pursuant to the Equity Line Purchase Agreement, the Company has the right to sell to B. Riley Principal Capital up to the lesser of (i) $50,000,000 of newly issued shares of Common Stock and (ii) the Exchange Cap (as defined below) (subject to certain conditions and limitations), from time to time during the 24-month period from and after the October 21, 2021. Sales of Common Stock pursuant to the Equity Line Purchase Agreement, and the timing of any sales, are solely at the option of the Company, and the Company is under no obligation to sell any securities to B. Riley Principal Capital under the Equity Line Purchase Agreement. As consideration for B. Riley Principal Capital’s commitment to purchase shares of Common Stock at the Company’s direction upon the terms and subject to the conditions set forth in the Equity Line Purchase Agreement, upon execution of the Equity Line Purchase Agreement, the Company issued 210,084 shares of Common Stock to B. Riley Principal Capital (the “Commitment Shares”). The purchase price of the shares of Common Stock that we elect to sell to B. Riley Principal Capital pursuant to the Equity Line Purchase Agreement will be determined by reference to the volume weighted average price of the Common Stock (“VWAP”) during the applicable purchase date, less a fixed 5% discount to such VWAP. Pursuant to the Registration Rights Agreement, the Company filed a Registration Statement on Form S-1 that was declared effective by the Securities and Exchange Commission on October 21, 2021 (File No. 333-260210) for the resale by B. Riley Principal Capital of up to 25,210,084 shares of Common Stock (including the Commitment Shares) acquired pursuant to the Equity Line Purchase Agreement. During October and November 2021<span>, we sold 5,300,000 shares of Common Stock under the Equity Line Purchase Agreement. Net proceeds from such sales totaled $12.4 million.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe the combination of: (i) our cash and cash equivalent balances at December 31, 2021 and (ii) expected cash flows from operations, as well as liquidity for our operational and capital needs, for twelve months from the filing of this report will be sufficient to satisfy our contractual obligations, as well as liquidity for our operational and capital needs, for twelve months from the filing of this report. Our capital requirements will depend on many factors, and we may need to use capital resources and obtain additional capital. Failure to generate additional revenues, obtain additional capital or manage discretionary spending could have an adverse effect on our financial position, results of operations and liquidity.</p> 469700000 2900000 7800000 0 4700000 2369 10800000 9100000 On December 27, 2019, the Company entered into, and on February 14, 2020 amended, (see Note 2 - Summary of Significant Accounting Policies), a stock purchase agreement (as so amended, the “Starrise Stock Purchase Agreement”) with BeiTai Investment LP (“BeiTai”), a related party for accounting purposes of Cinedigm and Aim Right Ventures Limited (“Aim Right”), two shareholders of Starrise Media Holdings Limited, a leading Chinese entertainment company (“Starrise”), to buy from them an aggregate of 410,901,000 outstanding Starrise ordinary shares (the “Starrise Share Acquisition”). 162162162 21646604 1 25000000 11200000 On April 10, 2020, the Company entered into another stock purchase agreement (the “April Starrise Stock Purchase Agreement”) with five (5) shareholders of Starrise - Bison Global Investment SPC - Bison Global No. 1 SP, Huatai Investment LP, Antai Investment LP, Mingtai Investment LP and Shangtai Asset Management LP - all of which are related parties to the Company to buy an aggregate of 223,380,000 outstanding Starrise ordinary shares from them and for the Company to issue to them an aggregate of 29,855,081 shares of its Common Stock as consideration therefor (the “April Starrise Share Acquisition”). Starrise’s ordinary shares (HK 1616) are listed on the main board of the Stock Exchange of Hong Kong Limited. Based on the closing price of HKD 0.159 per share on February 11, 2022, calculated at an exchange rate of 7.8 Hong Kong Dollars to 1 US dollar, the market value of Cinedigm’s ownership in Starrise ordinary shares was approximately $7.4 million. 2200000 0.01 2200000 7800000 (i) $50,000,000 of newly issued shares of Common Stock and (ii) the Exchange Cap (as defined below) (subject to certain conditions and limitations), from time to time during the 24-month period from and after the October 21, 2021. Sales of Common Stock pursuant to the Equity Line Purchase Agreement, and the timing of any sales, are solely at the option of the Company, and the Company is under no obligation to sell any securities to B. Riley Principal Capital under the Equity Line Purchase Agreement. As consideration for B. Riley Principal Capital’s commitment to purchase shares of Common Stock at the Company’s direction upon the terms and subject to the conditions set forth in the Equity Line Purchase Agreement, upon execution of the Equity Line Purchase Agreement, the Company issued 210,084 shares of Common Stock to B. Riley Principal Capital (the “Commitment Shares”). The purchase price of the shares of Common Stock that we elect to sell to B. Riley Principal Capital pursuant to the Equity Line Purchase Agreement will be determined by reference to the volume weighted average price of the Common Stock (“VWAP”) during the applicable purchase date, less a fixed 5% discount to such VWAP. Pursuant to the Registration Rights Agreement, the Company filed a Registration Statement on Form S-1 that was declared effective by the Securities and Exchange Commission on October 21, 2021 (File No. 333-260210) for the resale by B. Riley Principal Capital of up to 25,210,084 shares of Common Stock (including the Commitment Shares) acquired pursuant to the Equity Line Purchase Agreement. During October and November 2021, we sold 5,300,000 shares of Common Stock under the Equity Line Purchase Agreement. Net proceeds from such sales totaled $12.4 million. <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>BASIS OF PRESENTATION AND CONSOLIDATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our consolidated financial statements include the accounts of Cinedigm and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in which we do not have a controlling interest or are not the primary beneficiary, but have the ability to exert significant influence, are accounted for under the equity method of accounting. Noncontrolling interests for which we have been determined to be the primary beneficiary are consolidated and recorded as net loss attributable to noncontrolling interest. See Note 3 <i>- Other Interests</i> to the Consolidated Financial Statements for a discussion of our noncontrolling interests.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>USE OF ESTIMATES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates include the adequacy of accounts receivable reserves, return reserves, inventory reserves, recovery of advances, assessment of goodwill impairment, long-lived and finite-lived assets impairment and estimated amortization lives, fair value for asset acquisitions and business combinations, valuation allowances for income taxes and stock awards. Actual results could differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>CASH, CASH EQUIVALENTS, AND RESTRICTED CASH</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal. Our Prospect Loan required that we maintain specified cash balances that are restricted to repayment of interest thereunder. See Note 5 - <i>Notes Payable </i>for information about our restricted cash balances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash, cash equivalents, and restricted cash consisted of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(in thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31,<br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Cash and Cash Equivalents</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">20,201</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">26,207</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Restricted Cash</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">20,201</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">27,207</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>EQUITY INVESTMENT IN STARRISE, A RELATED PARTY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14, 2020, the Company acquired an approximately 11.5% interest in Starrise, a leading publicly traded Chinese entertainment company whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Starrise that is related to our major shareholders. When we acquired the Starrise stock, our then-majority affiliated stockholders also maintained a significant beneficial interest in Starrise. Upon consummation of the transaction on February 14, 2020, the Company recorded an initial investment of approximately $25 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.2 million, valued as of the date of the issuance of the Common Stock. The difference in value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 10, 2020, the Company purchased an additional 15% interest in Starrise in a private transaction from shareholders of Starrise that are affiliated with the then-major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Common Stock of $11.0 million, valued at the date of the issuance of the Common Stock. The difference in the value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Starrise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has made an irrevocable election to apply the fair value accounting option under ASC 825-10, <i>Financial Instruments</i>, as it relates to its equity investment in Starrise. The Company’s investment in Starrise is marked to market and recorded at fair value.  The stock is traded on the Hong Kong Stock exchange with readily available pricing that is classified as Level 1 in the fair value hierarchy. The Company has established a policy that consistently uses either the closing price of last active trades or the latest bid price when there is no active trades, unadjusted at the last day of each reporting period, as the most relevant and representative input to the Level 1 fair value measures of its investment holdings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and March 31, 2021, the value of our equity investment in Starrise, using the readily determinable fair value inputs from the market pricing of the Stock Exchange of Hong Kong, was approximately $7.9 million and $6.4 million, respectively, resulting in a change in fair value of approximately $1.5 million and ($42.4) million for the nine months ended December 31, 2021 and 2020 respectively, on our consolidated statement of operations. On April 1 and May 5, 2021, the Company sold 80,000 and 600,000 Starrise ordinary shares, respectively for a total amount of $11 thousand. At December 31, 2021 and March 31, 2021, the Company owned 362,307,397 and 362,987,397 ordinary shares or 17% and 26% of Starrise, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NON-MONETARY TRANSACTIONS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three and nine months ended December 31, 2020, the Company entered into agreements with certain vendors to transfer 5,139,762 and 14,184,765 Starrise ordinary shares to satisfy outstanding liabilities with these vendors. Upon the sale of the Starrise shares by the vendors, with certain restrictions on sales unless the Company gave consent to sell, if the proceeds did not satisfy the amount due to the vendor, the Company was liable for the balance owed. Pursuant to such agreements, the Company reduced the amount payable to its vendors by $0.8 million as of December 31, 2020. There were no such transactions during the nine months ended December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was no gain or loss resulting from these transactions for the three and nine months ended December 31, 2021 and 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ACCOUNTS RECEIVABLE</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We record accounts receivable, long-term in connection with activation fees that we earn from our digital cinema equipment (the “Systems”) deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ADVANCES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advances, which are recorded within prepaid and other current assets on the consolidated balance sheets, represent amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record impairment charges for amounts that we expect may not be recoverable as of the consolidated balance sheet date. Impairments and accelerated amortization related to advances were $0.4 million and $0.3 million, respectively, for the three months ended December 31, 2021 and 2020. Impairments and accelerated amortization related to advances were $0.8 million and $0.3 million, respectively, for the nine months ended December 31, 2021 and 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PROPERTY AND EQUIPMENT</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Computer equipment and software</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: center"><span style="font-size: 10pt">3 - 5 years</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Internal use software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">5 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Digital cinema projection systems</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">10 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">3 - 10 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">3 - 6 years</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software. Post-configuration training and maintenance costs are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the leasehold improvements. Repair and maintenance costs are charged to expense as incurred. Major renewals, improvements and additions are capitalized. Upon the sale or other disposition of any property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and the gain or loss on disposal is included in the consolidated statements of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>FAIR VALUE MEASUREMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value measurement disclosures are grouped into three levels based on valuation factors:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Level 1 – quoted prices in active markets for identical investments</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities measured at fair value on a recurring basis use the market approach, where prices and other relevant information are generated by market transactions involving identical or comparable assets or liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The equity investment in Starrise is in Hong Kong dollars and was translated into US dollars as of December 31, 2021 and March 31, 2021 at an exchange rate of 7.8 and 7.8 Hong Kong Dollars to 1 US Dollar, respectively. The fair value of this equity investment is measured by the unadjusted market pricing of Starrise on the Stock Exchange of Hong Kong.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The earnout consideration on purchase of Bloody Disgusting business (Note 4) is determined according to the probability-based method to the estimated the value of the earnout based on the premise that there are different probabilities to achieve different forecasts and therefore the defined earnout metric targets. Under this method, weighted-average earnout payments for each earnout period were estimated based on the probability of each forecast scenario. The resultant weighted-average earnout payments are discounted to a present value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables summarize the levels of fair value measurements of our financial assets and liabilities as of December 31, 2021 and March 31, 2021:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of December 31, 2021</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left; padding-bottom: 1.5pt">Equity investment in Starrise, at fair value</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7,896</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7,896</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,896</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,896</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Current portion of earnout consideration on purchase of a business</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">292</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">292</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Earnout consideration on purchase of a business, net of current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,236</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,236</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,528</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,528</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold">As of March 31, 2021</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(in thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 1</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left">Restricted cash</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Equity investment in Starrise, at fair value</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,443</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,443</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,443</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,443</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>IMPAIRMENT OF LONG-LIVED AND FINITE-LIVED ASSETS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. During the three and nine months ended December 31, 2021 and 2020, no impairment charge was recorded from operations for long-lived assets or finite-lived assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>GOODWILL</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No goodwill impairment charge was recorded in the nine months ended December 31, 2021 and 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross amounts of goodwill and accumulated impairment charges that we have recorded are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(In thousands)</td><td style="border-bottom: Black 1.5pt solid; font-size: 12pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 12pt; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 84%">Goodwill at March 31, 2021</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,701</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Goodwill from business combinations – see Note 4</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,958</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Goodwill at December 31, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,659</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>REVENUE RECOGNITION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We determine revenue recognition by:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identifying the contract, or contracts, with the customer;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identifying the performance obligations in the contract;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">determining the transaction price;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">allocating the transaction price to performance obligations in the contract; and</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize revenue in the amount that reflects the consideration we expect to receive in exchange for the services provided, sales of physical products (e.g., DVDs and Blu-ray Discs) or when the content is available for subscription on the digital platform or available on the point-of-sale for transactional and video on demand services which is when the control of the promised products and services is transferred to our customers and our performance obligations under the contract have been satisfied. Revenues that might be subject to various taxes are recorded net of transaction taxes assessed by governmental authorities such as sales value-added taxes and other similar taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cinema Equipment Business</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Cinema Equipment Business consists of financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We retain ownership of our digital cinema equipment (the “Systems”) and the residual cash flows related to the Systems in Phase I Deployment after the end of the 10-year deployment payment period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Cinema Equipment Business also provides monitoring, data collection, serial data verification and management services to this segment, as well as to exhibitors who purchase their own equipment, in order to collect virtual print fees (“VPFs”) from motion picture studios and distributors and Alternative Content Fees (“ACFs”) from alternative content providers, and to distribute those fees to theatrical exhibitors (collectively, “Services”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VPFs are earned, net of administrative fees, pursuant to contracts with movie studios and distributors, whereby amounts are payable by a studio to Phase I Deployment and to Phase II Deployment when movies distributed by the studio are displayed on screens utilizing our Systems installed in movie theatres. VPFs are earned and payable to Phase I Deployment based on a defined fee schedule until the end of the VPF term. One VPF is payable for every digital title initially displayed per System. The amount of VPF revenue is dependent on the number of movie titles released and displayed using the Systems in any given accounting period. VPF revenue is recognized in the period the title first plays for general audience viewing in a digital projector equipped movie theatre. The Phase 1 Deployment’s and Phase 2 Deployments performance obligations for revenue recognition are met at this time. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phase II Deployment’s agreements with distributors require the payment of VPFs, according to a defined fee schedule, for ten years from the date each system is installed; however, Phase II Deployment may no longer collect VPFs once “cost recoupment,” as defined in the contracts with movie studios and distributors, is achieved. Cost recoupment will occur once the cumulative VPFs and other cash receipts collected by Phase II Deployment have equaled the total of all cash outflows, including the purchase price of all Systems, all financing costs, all “overhead and ongoing costs”, as defined, and including service fees, subject to maximum agreed upon amounts during the three-year rollout period and thereafter. Further, if cost recoupment occurs before the end of the eighth contract year, the studios will pay us a one-time “cost recoupment bonus.” The Company evaluated the constraining estimates related to the variable consideration, i.e., the one-time bonus and determined that it is not probable to conclude at this point in time that a significant reversal in the amount of cumulative revenue recognized will occur when the uncertainty associated with the variable consideration is subsequently resolved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Cinedigm recognizes revenue once the customer takes possession of the Systems and Cinedigm received the sale proceeds. Such sales were originally contemplated as the conclusion of the digital cinema deployment plan.  Total system sales revenue recognized was $1.3 million and $66 thousand, during the three months ended December 31, 2021 and 2020, respectively. Total system sales revenue recognized was $9.1 million and $157 thousand, during the nine months ended December 31, 2021 and 2020, respectively. Revenues earned in connection with up front exhibitor contributions are deferred and recognized over the expected cost recoupment period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibitors who purchased and own Systems using their own financing in Phase II of the Cinema Equipment Business paid us an upfront activation fee of approximately $2.0 thousand per screen (the “Exhibitor-Buyer Structure”). Upfront activation fees were recognized in the period in which these Systems were delivered and ready for content, as we had no further obligations to the customer after that time and collection was reasonably assured. In addition, we recognize activation fee revenue of between $1.0 thousand and $2.0 thousand on Phase II Deployment Systems and for Systems installed by CDF2 Holdings, a related party, (See Note 3 - <i>Other Interests</i>) upon installation and such fees are generally collected upfront upon installation. Our services division manages and collects VPFs on behalf of exhibitors, for which it earns an administrative fee equal to 10% of the VPFs collected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Cinema Equipment Business earns an administrative fee of approximately 5% of VPFs collected and, in addition, earns an incentive service fee equal to 2.5% of the VPFs earned by Phase 1 DC. This administrative fee is related to the collection and remittance of the VPF’s and the performance obligation is satisfied at that time the related VPF fees are due which is at the time the movies are displayed on screens utilizing our Systems installed in movie theatres. The service fees are recognized as a point in time revenue when the corresponding VPF fees are due from the movie studios and distributors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Content &amp; Entertainment Business</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CEG earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or “OTT Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Physical Revenue” or “Base Distribution Business”). Fees earned are typically a percentage based on the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”)   on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the performance obligation is satisfied, which is when the content is available for subscription on the digital platform, at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Physical revenue is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Physical goods reserved for sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CEG also has contracts for the theatrical distribution of third party feature movies and alternative content. CEG’s distribution fee revenue and CEG’s participation in box office receipts are recognized at the time a feature movie and alternative content are viewed. CEG has the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Principal Agent Considerations</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We determine whether revenue should be reported on a gross or net basis for each revenue stream based on the transfer of control of goods and services. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">which party is primarily responsible for fulfilling the promise to provide the specified good or service; and</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">which party has discretion in establishing the price for the specified good or service.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Shipping and Handling</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in cost of goods sold because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Credit Losses</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our CEG segment recognizes accounts receivable, net of an estimated allowance for product returns and customer chargebacks, at the time that it recognizes revenue from a sale. Reserves for product returns and other allowances is variable consideration as part of the transaction price. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We record accounts receivable, long-term in connection with activation fees that we earn from Systems deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Contract Liabilities</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue pertaining to our Content &amp; Entertainment Business includes amounts related to the sale of DVDs with future release dates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue relating to our Cinema Equipment Business pertains to revenues earned in connection with up front exhibitor contributions that are deferred and recognized over the expected cost recoupment period. It also includes unamortized balances in connection with activation fees due from the Systems deployments that have extended payment terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ending deferred revenue balance as of December 31, 2021 was $0.3 million. For the three and nine months ended December 31, 2021 and 2020, respectively, the additions to our deferred revenue balance were primarily due to cash payments received or due in advance of satisfying performance obligations, while the reductions to our deferred revenue balance were primarily due to the recognition of revenue upon fulfillment of our performance obligations, both of which were in the ordinary course of business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended December 31, 2021 and 2020, $0.3 million and $1.2 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. During the nine months ended December 31, 2021 and 2020, $0.6 million and $2.5 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. As of December 31, 2021, the aggregate amount of contract revenue allocated to unsatisfied performance obligations was $0.3 million. This amount is to be recognized during January and February of 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Participations and royalties payable</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When we use third parties to distribute company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Disaggregation of Revenue</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company disaggregates revenue into different revenue categories for the Cinema Equipment and CEG Businesses. The Cinema Equipment Business revenue categories are: Phase I Deployment revenue, Phase II Deployment revenue, Services, and Digital System Sales, and the Content &amp; Entertainment Business revenue categories are: Base Distribution Business and OTT Streaming and Digital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables present the Company’s revenue categories for the three and nine months ended December 31, 2021 and 2020 (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Cinema Equipment Business:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; padding-left: 1pt">Phase I Deployment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">133</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">281</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">372</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">424</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 1pt">Phase II Deployment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 1pt">Services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">506</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">196</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,171</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">481</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1pt">Digital System Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,334</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">66</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,110</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">186</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total Cinema Equipment Business revenue</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,060</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">910</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11,544</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,158</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 1pt">Content &amp; Entertainment Business:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 1pt">Base Distribution Business</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,668</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,152</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,218</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1pt">OTT Streaming and Digital</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,356</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,892</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,290</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,778</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total Content &amp; Entertainment Business revenue</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">12,024</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,044</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">27,658</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">20,996</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>DIRECT OPERATING COSTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Direct operating costs consist of operating costs such as cost of goods sold, fulfillment expenses, shipping costs, property taxes and insurance on Systems, royalty expenses, impairments of advances, and marketing and direct personnel costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>STOCK-BASED COMPENSATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, <i>Compensation—Stock Compensation </i>(“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The Company measures the compensation expense of employee and nonemployee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and nonemployee is required to provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>INCOME TAXES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax bases.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10,<i> Income Taxes</i> <i>(Accounting for Uncertainty in Income Taxes)</i>, which clarified the accounting for uncertainty in tax positions. This amendment provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NET INCOME/LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic and diluted net loss per common share has been calculated as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td rowspan="2" style="text-align: left; width: 49%; font-size: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per common share attributable to common stockholders</span></td> <td rowspan="2" style="width: 2%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</span></td> <td style="vertical-align: top; width: 49%; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Net loss attributable to common stockholders</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Weighted average number of common stock outstanding during the period</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock issued and treasury stock repurchased during the period are weighted for the portion of the period that they are outstanding. Shares issued and any shares that are reacquired during the period are weighted for the portion of the period that they are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We had net income for the nine months ended December 31, 2021, and therefore the impact of potentially dilutive common shares from outstanding stock options, stock appreciation rights, and warrants, totaling 3,603,491 shares for the nine months ended December 31, 2021, respectively, was included in the computations of diluted earnings per share. For the three months ended December 31, 2021, 12,088,473 potentially dilutive shares have been excluded from the diluted loss per share as their impact would have been antidilutive. We had a net loss for the three months ended December 31, 2021 and therefore no dilution as basic and diluted loss per share are the same for the period. The calculation of diluted net income per share for the nine months ended December 31, 2021 does not include the impact of 8,484,982 potentially dilutive shares relating to stock options, stock appreciation rights, and warrants as their impact would have been anti-dilutive as their exercise prices are above the Company’s average Common Stock price during the period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incurred net losses for the three and nine months ended December 31, 2020, and therefore the impact of potentially dilutive common shares from outstanding stock options and warrants, totaling 9,040,138 shares as of December 31, 2020, were excluded from the computations of loss per share as their impact would have been anti-dilutive.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COMPREHENSIVE INCOME (LOSS)</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the three and nine months ended December 31, 2021 and 2020, comprehensive income (loss) consisted of net loss and foreign currency translation adjustments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Adopted</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 18, 2019, the FASB issued ASU 2019-12, “<i>Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,</i>” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The update also simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance to improve consistent application. The amendment in this update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company adopted this guidance on April 1, 2021 and the adoption of this ASU did not have a material impact on our consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Not yet adopted</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </i>(“ASU 2016-13”), which provides new guidance regarding the measurement and recognition of credit impairment for certain financial assets. Such guidance will impact how the Company determines its allowance for estimated uncollectible receivables and evaluates its available-for-sale investments for impairment. ASU 2016-13 is effective for the Company in the first quarter of fiscal 2023. The Company is currently evaluating the effect that ASU 2016-13 will have on its consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>BASIS OF PRESENTATION AND CONSOLIDATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our consolidated financial statements include the accounts of Cinedigm and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in which we do not have a controlling interest or are not the primary beneficiary, but have the ability to exert significant influence, are accounted for under the equity method of accounting. Noncontrolling interests for which we have been determined to be the primary beneficiary are consolidated and recorded as net loss attributable to noncontrolling interest. See Note 3 <i>- Other Interests</i> to the Consolidated Financial Statements for a discussion of our noncontrolling interests.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>USE OF ESTIMATES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires us to make estimates and assumptions that affect the assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates include the adequacy of accounts receivable reserves, return reserves, inventory reserves, recovery of advances, assessment of goodwill impairment, long-lived and finite-lived assets impairment and estimated amortization lives, fair value for asset acquisitions and business combinations, valuation allowances for income taxes and stock awards. Actual results could differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>CASH, CASH EQUIVALENTS, AND RESTRICTED CASH</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” We maintain bank accounts with major banks, which from time to time may exceed the Federal Deposit Insurance Corporation’s insured limits. We periodically assess the financial condition of the institutions and believe that the risk of any loss is minimal. Our Prospect Loan required that we maintain specified cash balances that are restricted to repayment of interest thereunder. See Note 5 - <i>Notes Payable </i>for information about our restricted cash balances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash, cash equivalents, and restricted cash consisted of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(in thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31,<br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Cash and Cash Equivalents</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">20,201</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">26,207</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Restricted Cash</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">20,201</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">27,207</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(in thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31,<br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Cash and Cash Equivalents</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">20,201</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">26,207</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Restricted Cash</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">20,201</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">27,207</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 20201000 26207000 1000000 20201000 27207000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>EQUITY INVESTMENT IN STARRISE, A RELATED PARTY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 14, 2020, the Company acquired an approximately 11.5% interest in Starrise, a leading publicly traded Chinese entertainment company whose ordinary shares are listed on the Stock Exchange of Hong Kong. The Company acquired such interest as a strategic investment and in a private transaction from a shareholder of Starrise that is related to our major shareholders. When we acquired the Starrise stock, our then-majority affiliated stockholders also maintained a significant beneficial interest in Starrise. Upon consummation of the transaction on February 14, 2020, the Company recorded an initial investment of approximately $25 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Company’s common stock of $11.2 million, valued as of the date of the issuance of the Common Stock. The difference in value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 10, 2020, the Company purchased an additional 15% interest in Starrise in a private transaction from shareholders of Starrise that are affiliated with the then-major shareholder of the Company. The Company recorded an additional equity investment of approximately $28.2 million, which is the fair market value of the Starrise shares on the transaction date on the Stock Exchange of Hong Kong, in exchange for the Common Stock of $11.0 million, valued at the date of the issuance of the Common Stock. The difference in the value of shares received in Starrise and shares issued by the Company was deemed as contributed capital and recorded in additional paid-in capital. This transaction was also recorded as an equity investment in Starrise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has made an irrevocable election to apply the fair value accounting option under ASC 825-10, <i>Financial Instruments</i>, as it relates to its equity investment in Starrise. The Company’s investment in Starrise is marked to market and recorded at fair value.  The stock is traded on the Hong Kong Stock exchange with readily available pricing that is classified as Level 1 in the fair value hierarchy. The Company has established a policy that consistently uses either the closing price of last active trades or the latest bid price when there is no active trades, unadjusted at the last day of each reporting period, as the most relevant and representative input to the Level 1 fair value measures of its investment holdings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and March 31, 2021, the value of our equity investment in Starrise, using the readily determinable fair value inputs from the market pricing of the Stock Exchange of Hong Kong, was approximately $7.9 million and $6.4 million, respectively, resulting in a change in fair value of approximately $1.5 million and ($42.4) million for the nine months ended December 31, 2021 and 2020 respectively, on our consolidated statement of operations. On April 1 and May 5, 2021, the Company sold 80,000 and 600,000 Starrise ordinary shares, respectively for a total amount of $11 thousand. At December 31, 2021 and March 31, 2021, the Company owned 362,307,397 and 362,987,397 ordinary shares or 17% and 26% of Starrise, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.115 25000000 11200000 0.15 28200000 11000000 7900000 6400000 1500000 -42400000 80000 600000 11000 362307397 362987397 0.17 0.26 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NON-MONETARY TRANSACTIONS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three and nine months ended December 31, 2020, the Company entered into agreements with certain vendors to transfer 5,139,762 and 14,184,765 Starrise ordinary shares to satisfy outstanding liabilities with these vendors. Upon the sale of the Starrise shares by the vendors, with certain restrictions on sales unless the Company gave consent to sell, if the proceeds did not satisfy the amount due to the vendor, the Company was liable for the balance owed. Pursuant to such agreements, the Company reduced the amount payable to its vendors by $0.8 million as of December 31, 2020. There were no such transactions during the nine months ended December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was no gain or loss resulting from these transactions for the three and nine months ended December 31, 2021 and 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 5139762 14184765 800000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ACCOUNTS RECEIVABLE</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We record accounts receivable, long-term in connection with activation fees that we earn from our digital cinema equipment (the “Systems”) deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ADVANCES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advances, which are recorded within prepaid and other current assets on the consolidated balance sheets, represent amounts prepaid to studios or content producers for which we provide content distribution services. We evaluate advances regularly for recoverability and record impairment charges for amounts that we expect may not be recoverable as of the consolidated balance sheet date. Impairments and accelerated amortization related to advances were $0.4 million and $0.3 million, respectively, for the three months ended December 31, 2021 and 2020. Impairments and accelerated amortization related to advances were $0.8 million and $0.3 million, respectively, for the nine months ended December 31, 2021 and 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 400000 300000 800000 300000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PROPERTY AND EQUIPMENT</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation expense is recorded using the straight-line method over the estimated useful lives of the respective assets as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Computer equipment and software</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: center"><span style="font-size: 10pt">3 - 5 years</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Internal use software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">5 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Digital cinema projection systems</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">10 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">3 - 10 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">3 - 6 years</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We capitalize costs associated with software developed or obtained for internal use when the preliminary project stage is completed, and it is determined that the software will provide significantly enhanced capabilities and modifications. These capitalized costs are included in property and equipment and include external direct cost of services procured in developing or obtaining internal-use software and personnel and related expenses for employees who are directly associated with, and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. Once the software is ready for its intended use, the costs are amortized over the useful life of the software. Post-configuration training and maintenance costs are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the leasehold improvements. Repair and maintenance costs are charged to expense as incurred. Major renewals, improvements and additions are capitalized. Upon the sale or other disposition of any property and equipment, the cost and related accumulated depreciation and amortization are removed from the accounts and the gain or loss on disposal is included in the consolidated statements of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Computer equipment and software</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: center"><span style="font-size: 10pt">3 - 5 years</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Internal use software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">5 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Digital cinema projection systems</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">10 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">3 - 10 years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-size: 10pt">3 - 6 years</span></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> P3Y P5Y P5Y P10Y P3Y P10Y P3Y P6Y <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>FAIR VALUE MEASUREMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value measurement disclosures are grouped into three levels based on valuation factors:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Level 1 – quoted prices in active markets for identical investments</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities measured at fair value on a recurring basis use the market approach, where prices and other relevant information are generated by market transactions involving identical or comparable assets or liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The equity investment in Starrise is in Hong Kong dollars and was translated into US dollars as of December 31, 2021 and March 31, 2021 at an exchange rate of 7.8 and 7.8 Hong Kong Dollars to 1 US Dollar, respectively. The fair value of this equity investment is measured by the unadjusted market pricing of Starrise on the Stock Exchange of Hong Kong.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The earnout consideration on purchase of Bloody Disgusting business (Note 4) is determined according to the probability-based method to the estimated the value of the earnout based on the premise that there are different probabilities to achieve different forecasts and therefore the defined earnout metric targets. Under this method, weighted-average earnout payments for each earnout period were estimated based on the probability of each forecast scenario. The resultant weighted-average earnout payments are discounted to a present value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables summarize the levels of fair value measurements of our financial assets and liabilities as of December 31, 2021 and March 31, 2021:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of December 31, 2021</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left; padding-bottom: 1.5pt">Equity investment in Starrise, at fair value</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7,896</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7,896</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,896</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,896</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Current portion of earnout consideration on purchase of a business</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">292</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">292</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Earnout consideration on purchase of a business, net of current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,236</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,236</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,528</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,528</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold">As of March 31, 2021</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(in thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 1</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left">Restricted cash</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Equity investment in Starrise, at fair value</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,443</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,443</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,443</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,443</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cash and cash equivalents, accounts receivable, unbilled revenue and accounts payable and accrued expenses are financial instruments and are recorded at cost in the consolidated balance sheets. The estimated fair values of these financial instruments approximate their carrying amounts because of their short-term nature.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 7.8 7.8 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of December 31, 2021</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in">Assets:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left; padding-bottom: 1.5pt">Equity investment in Starrise, at fair value</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7,896</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">7,896</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,896</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">7,896</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Current portion of earnout consideration on purchase of a business</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">292</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">292</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Earnout consideration on purchase of a business, net of current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,236</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,236</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,528</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,528</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold">As of March 31, 2021</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(in thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 1</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left">Restricted cash</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Equity investment in Starrise, at fair value</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,443</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,443</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,443</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,443</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 7896000 7896000 7896000 7896000 292000 292000 1236000 1236000 1528000 1528000 1000000 1000000 6443000 6443000 7443000 7443000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>IMPAIRMENT OF LONG-LIVED AND FINITE-LIVED ASSETS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We review the recoverability of our long-lived assets and finite-lived intangible assets, when events or conditions occur that indicate a possible impairment exists. The assessment for recoverability is based primarily on our ability to recover the carrying value of our long-lived and finite-lived assets from expected future undiscounted net cash flows. If the total of expected future undiscounted net cash flows is less than the total carrying value of the asset, the asset is deemed not to be recoverable and possibly impaired. We then estimate the fair value of the asset to determine whether an impairment loss should be recognized. An impairment loss will be recognized if the asset’s fair value is determined to be less than its carrying value. Fair value is determined by computing the expected future discounted cash flows. During the three and nine months ended December 31, 2021 and 2020, no impairment charge was recorded from operations for long-lived assets or finite-lived assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>GOODWILL</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is the excess of the purchase price paid over the fair value of the net assets of an acquired business. Goodwill is tested for impairment on an annual basis or more often if warranted by events or changes in circumstances indicating that the carrying value may exceed fair value, also known as impairment indicators.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inherent in the fair value determination for each reporting unit are certain judgments and estimates relating to future cash flows, including management’s interpretation of current economic indicators and market conditions, and assumptions about our strategic plans with regard to its operations. To the extent additional information arises, market conditions change, or our strategies change, it is possible that the conclusion regarding whether our remaining goodwill is impaired could change and result in future goodwill impairment charges that will have a material effect on our consolidated financial position or results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has the option to assess goodwill for possible impairment by performing a qualitative analysis to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount or to perform the quantitative impairment test.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No goodwill impairment charge was recorded in the nine months ended December 31, 2021 and 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross amounts of goodwill and accumulated impairment charges that we have recorded are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(In thousands)</td><td style="border-bottom: Black 1.5pt solid; font-size: 12pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 12pt; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 84%">Goodwill at March 31, 2021</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,701</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Goodwill from business combinations – see Note 4</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,958</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Goodwill at December 31, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,659</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(In thousands)</td><td style="border-bottom: Black 1.5pt solid; font-size: 12pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 12pt; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 12pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 84%">Goodwill at March 31, 2021</td><td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,701</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Goodwill from business combinations – see Note 4</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,958</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Goodwill at December 31, 2021</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,659</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 8701000 4958000 13659000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>REVENUE RECOGNITION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We determine revenue recognition by:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identifying the contract, or contracts, with the customer;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identifying the performance obligations in the contract;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">determining the transaction price;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">allocating the transaction price to performance obligations in the contract; and</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">recognizing revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize revenue in the amount that reflects the consideration we expect to receive in exchange for the services provided, sales of physical products (e.g., DVDs and Blu-ray Discs) or when the content is available for subscription on the digital platform or available on the point-of-sale for transactional and video on demand services which is when the control of the promised products and services is transferred to our customers and our performance obligations under the contract have been satisfied. Revenues that might be subject to various taxes are recorded net of transaction taxes assessed by governmental authorities such as sales value-added taxes and other similar taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment terms and conditions vary by customer and typically provide net 30 to 90 day terms. We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to our customer and payment for that product or service will be one year or less.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cinema Equipment Business</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Cinema Equipment Business consists of financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We retain ownership of our digital cinema equipment (the “Systems”) and the residual cash flows related to the Systems in Phase I Deployment after the end of the 10-year deployment payment period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Cinema Equipment Business also provides monitoring, data collection, serial data verification and management services to this segment, as well as to exhibitors who purchase their own equipment, in order to collect virtual print fees (“VPFs”) from motion picture studios and distributors and Alternative Content Fees (“ACFs”) from alternative content providers, and to distribute those fees to theatrical exhibitors (collectively, “Services”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VPFs are earned, net of administrative fees, pursuant to contracts with movie studios and distributors, whereby amounts are payable by a studio to Phase I Deployment and to Phase II Deployment when movies distributed by the studio are displayed on screens utilizing our Systems installed in movie theatres. VPFs are earned and payable to Phase I Deployment based on a defined fee schedule until the end of the VPF term. One VPF is payable for every digital title initially displayed per System. The amount of VPF revenue is dependent on the number of movie titles released and displayed using the Systems in any given accounting period. VPF revenue is recognized in the period the title first plays for general audience viewing in a digital projector equipped movie theatre. The Phase 1 Deployment’s and Phase 2 Deployments performance obligations for revenue recognition are met at this time. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phase II Deployment’s agreements with distributors require the payment of VPFs, according to a defined fee schedule, for ten years from the date each system is installed; however, Phase II Deployment may no longer collect VPFs once “cost recoupment,” as defined in the contracts with movie studios and distributors, is achieved. Cost recoupment will occur once the cumulative VPFs and other cash receipts collected by Phase II Deployment have equaled the total of all cash outflows, including the purchase price of all Systems, all financing costs, all “overhead and ongoing costs”, as defined, and including service fees, subject to maximum agreed upon amounts during the three-year rollout period and thereafter. Further, if cost recoupment occurs before the end of the eighth contract year, the studios will pay us a one-time “cost recoupment bonus.” The Company evaluated the constraining estimates related to the variable consideration, i.e., the one-time bonus and determined that it is not probable to conclude at this point in time that a significant reversal in the amount of cumulative revenue recognized will occur when the uncertainty associated with the variable consideration is subsequently resolved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of our standard cinema equipment licensing agreements, exhibitors will continue to have the right to use our Systems through the end of the term of the licensing agreement, after which time, they have the option to: (1) return the Systems to us; (2) renew their license agreement for successive one-year terms; or (3) purchase the Systems from us at fair market value. As permitted by these agreements, we typically pursue the sale of the Systems to such exhibitors. Cinedigm recognizes revenue once the customer takes possession of the Systems and Cinedigm received the sale proceeds. Such sales were originally contemplated as the conclusion of the digital cinema deployment plan.  Total system sales revenue recognized was $1.3 million and $66 thousand, during the three months ended December 31, 2021 and 2020, respectively. Total system sales revenue recognized was $9.1 million and $157 thousand, during the nine months ended December 31, 2021 and 2020, respectively. Revenues earned in connection with up front exhibitor contributions are deferred and recognized over the expected cost recoupment period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibitors who purchased and own Systems using their own financing in Phase II of the Cinema Equipment Business paid us an upfront activation fee of approximately $2.0 thousand per screen (the “Exhibitor-Buyer Structure”). Upfront activation fees were recognized in the period in which these Systems were delivered and ready for content, as we had no further obligations to the customer after that time and collection was reasonably assured. In addition, we recognize activation fee revenue of between $1.0 thousand and $2.0 thousand on Phase II Deployment Systems and for Systems installed by CDF2 Holdings, a related party, (See Note 3 - <i>Other Interests</i>) upon installation and such fees are generally collected upfront upon installation. Our services division manages and collects VPFs on behalf of exhibitors, for which it earns an administrative fee equal to 10% of the VPFs collected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Cinema Equipment Business earns an administrative fee of approximately 5% of VPFs collected and, in addition, earns an incentive service fee equal to 2.5% of the VPFs earned by Phase 1 DC. This administrative fee is related to the collection and remittance of the VPF’s and the performance obligation is satisfied at that time the related VPF fees are due which is at the time the movies are displayed on screens utilizing our Systems installed in movie theatres. The service fees are recognized as a point in time revenue when the corresponding VPF fees are due from the movie studios and distributors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Content &amp; Entertainment Business</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CEG earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video on demand (“VOD” or “OTT Streaming and Digital”), and physical goods (e.g., DVDs and Blu-ray Discs) (“Physical Revenue” or “Base Distribution Business”). Fees earned are typically a percentage based on the net amounts received from our customers. Depending upon the nature of the agreements with the platform and content providers, the fee rate that we earn varies. The Company’s performance obligations include the delivery of content for transactional, subscription and ad supported/free ad-supported streaming TV (“FAST”)   on the digital platforms, and shipment of DVDs and Blu-ray Discs. Revenue is recognized at the point in time when the performance obligation is satisfied, which is when the content is available for subscription on the digital platform, at the time of shipment for physical goods, or point-of-sale for transactional and VOD services as the control over the content or the physical title is transferred to the customer. The Company considers the delivery of content through various distribution channels to be a single performance obligation. Physical revenue is recognized after deducting the reserves for sales returns and other allowances, which are accounted for as variable consideration.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Physical goods reserved for sales returns and other allowances are recorded based upon historical experience. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CEG also has contracts for the theatrical distribution of third party feature movies and alternative content. CEG’s distribution fee revenue and CEG’s participation in box office receipts are recognized at the time a feature movie and alternative content are viewed. CEG has the right to receive or bill a portion of the theatrical distribution fee in advance of the exhibition date, and therefore such amount is recorded as a receivable at the time of execution, and all related distribution revenue is deferred until the third party feature movies’ or alternative content’s theatrical release date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Principal Agent Considerations</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We determine whether revenue should be reported on a gross or net basis for each revenue stream based on the transfer of control of goods and services. Key indicators that we use in evaluating gross versus net treatment include, but are not limited to, the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">which party is primarily responsible for fulfilling the promise to provide the specified good or service; and</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">which party has discretion in establishing the price for the specified good or service.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Shipping and Handling</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shipping and handling costs are incurred to move physical goods (e.g., DVDs and Blu-ray Discs) to customers. We recognize all shipping and handling costs as an expense in cost of goods sold because we are responsible for delivery of the product to our customers prior to transfer of control to the customer.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Credit Losses</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain reserves for potential credit losses on accounts receivable. We review the composition of accounts receivable and analyze historical bad debts, customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate the adequacy of these reserves. Reserves are recorded primarily on a specific identification basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our CEG segment recognizes accounts receivable, net of an estimated allowance for product returns and customer chargebacks, at the time that it recognizes revenue from a sale. Reserves for product returns and other allowances is variable consideration as part of the transaction price. If actual future returns and allowances differ from past experience, adjustments to our allowances may be required.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We record accounts receivable, long-term in connection with activation fees that we earn from Systems deployments that have extended payment terms. Such accounts receivable are discounted to their present value at prevailing market rates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Contract Liabilities</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generally record a receivable related to revenue when we have an unconditional right to invoice and receive payment, and we record deferred revenue (contract liability) when cash payments are received or due in advance of our performance, even if amounts are refundable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue pertaining to our Content &amp; Entertainment Business includes amounts related to the sale of DVDs with future release dates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue relating to our Cinema Equipment Business pertains to revenues earned in connection with up front exhibitor contributions that are deferred and recognized over the expected cost recoupment period. It also includes unamortized balances in connection with activation fees due from the Systems deployments that have extended payment terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ending deferred revenue balance as of December 31, 2021 was $0.3 million. For the three and nine months ended December 31, 2021 and 2020, respectively, the additions to our deferred revenue balance were primarily due to cash payments received or due in advance of satisfying performance obligations, while the reductions to our deferred revenue balance were primarily due to the recognition of revenue upon fulfillment of our performance obligations, both of which were in the ordinary course of business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended December 31, 2021 and 2020, $0.3 million and $1.2 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. During the nine months ended December 31, 2021 and 2020, $0.6 million and $2.5 million, respectively, of revenue was recognized that was included in the deferred revenue balance at the beginning of the period. As of December 31, 2021, the aggregate amount of contract revenue allocated to unsatisfied performance obligations was $0.3 million. This amount is to be recognized during January and February of 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Participations and royalties payable</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When we use third parties to distribute company owned content, we record participations payable, which represent amounts owed to the distributor under revenue-sharing arrangements. When we provide content distribution services, we record accounts payable and accrued expenses to studios or content producers for royalties owed under licensing arrangements. We identify and record as a reduction to the liability any expenses that are to be reimbursed to us by such studios or content producers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Disaggregation of Revenue</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company disaggregates revenue into different revenue categories for the Cinema Equipment and CEG Businesses. The Cinema Equipment Business revenue categories are: Phase I Deployment revenue, Phase II Deployment revenue, Services, and Digital System Sales, and the Content &amp; Entertainment Business revenue categories are: Base Distribution Business and OTT Streaming and Digital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables present the Company’s revenue categories for the three and nine months ended December 31, 2021 and 2020 (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Cinema Equipment Business:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; padding-left: 1pt">Phase I Deployment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">133</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">281</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">372</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">424</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 1pt">Phase II Deployment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 1pt">Services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">506</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">196</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,171</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">481</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1pt">Digital System Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,334</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">66</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,110</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">186</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total Cinema Equipment Business revenue</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,060</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">910</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11,544</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,158</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 1pt">Content &amp; Entertainment Business:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 1pt">Base Distribution Business</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,668</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,152</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,218</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1pt">OTT Streaming and Digital</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,356</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,892</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,290</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,778</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total Content &amp; Entertainment Business revenue</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">12,024</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,044</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">27,658</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">20,996</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 1300000 66000 9100000 157000 2000 1000 2000 0.10 0.05 0.025 300000 300000 1200000 600000 2500000 300000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left">Cinema Equipment Business:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; padding-left: 1pt">Phase I Deployment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">133</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">281</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">372</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">424</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 1pt">Phase II Deployment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 1pt">Services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">506</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">196</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,171</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">481</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1pt">Digital System Sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,334</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">66</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,110</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">186</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total Cinema Equipment Business revenue</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,060</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">910</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11,544</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,158</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-left: 1pt">Content &amp; Entertainment Business:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 1pt">Base Distribution Business</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,668</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,152</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,218</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 1pt">OTT Streaming and Digital</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,356</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,892</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,290</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,778</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total Content &amp; Entertainment Business revenue</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">12,024</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,044</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">27,658</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">20,996</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 133000 281000 372000 424000 87000 367000 891000 1067000 506000 196000 1171000 481000 1334000 66000 9110000 186000 2060000 910000 11544000 2158000 3668000 4152000 6368000 9218000 8356000 4892000 21290000 11778000 12024000 9044000 27658000 20996000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>DIRECT OPERATING COSTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Direct operating costs consist of operating costs such as cost of goods sold, fulfillment expenses, shipping costs, property taxes and insurance on Systems, royalty expenses, impairments of advances, and marketing and direct personnel costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>STOCK-BASED COMPENSATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company issues stock-based awards to employees and non-employees, generally in the form of restricted stock, restricted stock units, stock appreciation rights and performance stock units. The Company accounts for its stock-based compensation awards in accordance with FASB ASC Topic 718, <i>Compensation—Stock Compensation </i>(“ASC 718”). ASC 718 requires all stock-based payments, including grants of stock options and restricted stock units and modifications to existing stock options, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values. The Company measures the compensation expense of employee and nonemployee services received in exchange for an award of equity instruments based on the fair value of the award on the grant date. That cost is recognized on a straight-line basis over the period during which the employee and nonemployee is required to provide service in exchange for the award. The fair values of options and stock appreciation rights are calculated as of the date of grant using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company’s estimates of these assumptions are primarily based on the trading price of the Company’s stock, historical data, peer company data and judgment regarding future trends and factors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>INCOME TAXES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to operating loss and tax credit carryforwards and for differences between the carrying amounts of existing assets and liabilities and their respective tax bases.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Valuation allowances are established when management is unable to conclude that it is more likely than not that some portion, or all, of the deferred tax asset will ultimately be realized. The Company is primarily subject to income taxes in the United States.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company accounts for uncertain tax positions in accordance with an amendment to ASC Topic 740-10,<i> Income Taxes</i> <i>(Accounting for Uncertainty in Income Taxes)</i>, which clarified the accounting for uncertainty in tax positions. This amendment provides that the tax effects from an uncertain tax position can be recognized in the financial statements only if the position is “more-likely-than-not” to be sustained were it to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. If an uncertain tax position meets the “more-likely-than-not” threshold, the largest amount of tax benefit that is more than 50% likely to be recognized upon ultimate settlement with the taxing authority is recorded. The Company has no uncertain tax positions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.50 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NET INCOME/LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic and diluted net loss per common share has been calculated as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td rowspan="2" style="text-align: left; width: 49%; font-size: 10pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per common share attributable to common stockholders</span></td> <td rowspan="2" style="width: 2%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</span></td> <td style="vertical-align: top; width: 49%; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Net loss attributable to common stockholders</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Weighted average number of common stock outstanding during the period</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock issued and treasury stock repurchased during the period are weighted for the portion of the period that they are outstanding. Shares issued and any shares that are reacquired during the period are weighted for the portion of the period that they are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We had net income for the nine months ended December 31, 2021, and therefore the impact of potentially dilutive common shares from outstanding stock options, stock appreciation rights, and warrants, totaling 3,603,491 shares for the nine months ended December 31, 2021, respectively, was included in the computations of diluted earnings per share. For the three months ended December 31, 2021, 12,088,473 potentially dilutive shares have been excluded from the diluted loss per share as their impact would have been antidilutive. We had a net loss for the three months ended December 31, 2021 and therefore no dilution as basic and diluted loss per share are the same for the period. The calculation of diluted net income per share for the nine months ended December 31, 2021 does not include the impact of 8,484,982 potentially dilutive shares relating to stock options, stock appreciation rights, and warrants as their impact would have been anti-dilutive as their exercise prices are above the Company’s average Common Stock price during the period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incurred net losses for the three and nine months ended December 31, 2020, and therefore the impact of potentially dilutive common shares from outstanding stock options and warrants, totaling 9,040,138 shares as of December 31, 2020, were excluded from the computations of loss per share as their impact would have been anti-dilutive.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 3603491 12088473 8484982 9040138 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COMPREHENSIVE INCOME (LOSS)</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the three and nine months ended December 31, 2021 and 2020, comprehensive income (loss) consisted of net loss and foreign currency translation adjustments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Adopted</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 18, 2019, the FASB issued ASU 2019-12, “<i>Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,</i>” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The update also simplifies GAAP for other areas of Topic 740 by clarifying and amending existing guidance to improve consistent application. The amendment in this update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. Early adoption is permitted. The Company adopted this guidance on April 1, 2021 and the adoption of this ASU did not have a material impact on our consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Not yet adopted</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </i>(“ASU 2016-13”), which provides new guidance regarding the measurement and recognition of credit impairment for certain financial assets. Such guidance will impact how the Company determines its allowance for estimated uncollectible receivables and evaluates its available-for-sale investments for impairment. ASU 2016-13 is effective for the Company in the first quarter of fiscal 2023. The Company is currently evaluating the effect that ASU 2016-13 will have on its consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>3. OTHER INTERESTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investment in CDF2 Holdings</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We indirectly own 100% of the common equity of CDF2 Holdings, LLC (“CDF2 Holdings”), which was created for the purpose of capitalizing on the conversion of the exhibition industry from film to digital technology. CDF2 Holdings assists its customers in procuring the equipment necessary to convert their systems to digital technology by providing financing, equipment, installation and related ongoing services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CDF2 Holdings is a Variable Interest Entity (“VIE”), as defined in Accounting Standards Codification Topic 810 (“ASC 810”), “Consolidation.” ASC 810 requires the consolidation of VIEs by an entity that has a controlling financial interest in the VIE which entity is thereby defined as the primary beneficiary of the VIE. To be a primary beneficiary, an entity must have the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, among other factors. Although we indirectly, wholly own CDF2 Holdings, we, a third party that also has a variable interest in CDF2 Holdings, and an independent third party manager must mutually approve all business activities and transactions that significantly impact CDF2 Holdings’ economic performance. We have therefore assessed our variable interests in CDF2 Holdings and determined that we are not the primary beneficiary of CDF2 Holdings. As a result, CDF2 Holdings’ financial position and results of operations are not consolidated in our financial position and results of operations. In completing our assessment, we identified the activities that we consider most significant to the economic performance of CDF2 Holdings and determined that we do not have the power to direct those activities, and therefore we account for our investment in CDF2 Holdings under the equity method of accounting.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and March 31, 2021, our maximum exposure to loss, as it relates to the non-consolidated CDF2 Holdings entity, represents accounts receivable for service fees under a master service agreement with CDF2 Holdings. Such accounts receivable was $0.7 million and $0.3 million as of December 31, 2021 and March 31, 2021, respectively, which are included in accounts receivable, net on the accompanying consolidated balance sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Consolidated Statements of Operations include $0.5 million and $83 thousand of digital cinema servicing revenue from CDF2 Holdings for the nine months ended December 31, 2021 and 2020, respectively. The accompanying Consolidated Statements of Operations include $0.2 million and $47 thousand of digital cinema servicing revenue from CDF2 Holdings for the three months ended December 31, 2021 and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total Stockholders’ Deficit of CDF2 Holdings at December 31, 2021 and March 31, 2021 was $52.9 million and $46.3 million, respectively. We have no obligation to fund the operating loss or the stockholders’ deficit beyond our initial investment of $2.0 million and, accordingly, our investment in CDF2 Holdings as of December 31, 2021 and March 31, 2021 is carried at $0.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Majority Interest in CONtv</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own an 85% interest in CON TV, LLC, a worldwide digital network that creates original content, and sells and distributes on-demand digital content on the Internet and other consumer digital distribution platforms, such as gaming consoles, set-top boxes, handsets, and tablets.</p> 1 700000 300000 500000 83000 200000 47000 52900000 46300000 2000000 0 0.85 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4. BUSINESS COMBINATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>FoundationTV, Inc.</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 12, 2021, the Company entered into a stock purchase agreement (the “Foundation Stock Purchase Agreement”) with FoundationTV, Inc. (“FoundationTV”), to buy all of FoundationTV´s issued and outstanding stock in consideration of an aggregate of $5.2 million, of which $0.7 million was paid in cash and 1,483,129 shares of Common Stock, which were valued at $2.5 million, were issued at closing stock price of $1.69 on the closing date of June 9, 2021, and an additional $2.0 million will be paid in eight equal installments of one installment on each six month anniversary of closing over forty-eight months, and a final lump sum payment of $225 thousand on the four year anniversary of the closing, reduced by $0.2 million settlement of a prior relationship. The Foundation Stock Purchase Agreement contained certain conditions to closing, including that the Company obtain approval of its stockholders, applicable lenders, and regulatory authorities, as applicable, and representations and warranties and covenants as are customary for transactions of this type. On June 9, 2021, the FoundationTV acquisition was consummated. The Company incurred transaction costs of $36 thousand during the nine months ended December 31, 2021. As of December 31, 2021, the deferred consideration initially measured by bringing to present value the agreed-upon cash payments discounted by a 3% rate, includes a $0.5 million short-term payable and a long-term payable for $1.5 million.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Purchase Price</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; font-size: 10pt; text-align: justify">Purchase Price</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">5,237</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total purchase price</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">5,237</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Allocation of purchase price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify">Developed technology</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,200</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: justify">Goodwill</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,037</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total allocation of purchase price</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">5,237</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The developed technology acquired in this transaction has a useful life of 10 years. During the three and nine months ended December 31, 2021, the Company recorded $80 thousand and $160 thousand in amortization expense related to the developed technology acquired in the acquisition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Below is the amortization expense per year for the developed technology acquired in the business combination:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 88%; font-size: 10pt">2022 (remaining)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">80</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2024</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2027</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2030</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2031</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2032</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">80</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; font-size: 10pt">Total</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,040</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bloody Disgusting, LLC</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 17, 2021, the Company entered into an asset purchase agreement (the “Bloody Disgusting Asset Purchase Agreement”) with Bloody Disgusting, LLC (“Bloody Disgusting”), to buy substantially all of the assets of Bloody Disgusting, in consideration of an aggregate of $7.8 million, of which $4.0 million was paid in cash and 1,039,501 shares of Common Stock, which were valued at $2.3 million, were issued at closing stock price of $2.23 on the closing date of September 17, 2021, and $1.5 million as of the fair value of the earnout liability, related to earnout targets, as defined, to be met as of March 2022, March 2023 and March 2024. The fair value of the earnout liability was estimated considering the weighted probability of scenarios on the earnout metrics possible outcomes during the earnout period. The Bloody Disgusting Asset Purchase Agreement contained certain conditions to closing and representations and warranties and covenants as are customary for transactions of this type. On September 17, 2021, the Bloody Disgusting acquisition was consummated. The Company incurred transaction costs of $40 thousand during the nine months ended December 31, 2021. During the three months ended December 31, 2021, the Company finalized the measurement of the assets acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Purchase Price</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; font-size: 10pt; text-align: justify">Purchase Price</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">7,780</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total purchase price</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,780</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Allocation of purchase price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify">Current assets</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: justify">Advertiser relationships</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,750</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify">Trade name</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,100</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: justify">Goodwill</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,921</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total allocation of purchase price</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,780</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The advertiser relationships acquired in this transaction has a useful life of 12 years and the trade name acquired has a useful life of 10 years. During the three and nine months ended December 31, 2021, the Company recorded $105 thousand in amortization expense related to the intangible assets acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Below is the amortization expense per year for the intangible assets acquired in the business combination:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Advertiser relationships</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Trade name</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 64%; font-size: 10pt">2022 (remaining)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">78</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">28</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">106</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2024</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2027</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2030</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2031</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2032</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">55</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">368</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2033</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-292">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2034</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">151</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-293">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">151</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; font-size: 10pt">Total</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,672</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,073</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">4,745</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> On May 12, 2021, the Company entered into a stock purchase agreement (the “Foundation Stock Purchase Agreement”) with FoundationTV, Inc. (“FoundationTV”), to buy all of FoundationTV´s issued and outstanding stock in consideration of an aggregate of $5.2 million, of which $0.7 million was paid in cash and 1,483,129 shares of Common Stock, which were valued at $2.5 million, were issued at closing stock price of $1.69 on the closing date of June 9, 2021, and an additional $2.0 million will be paid in eight equal installments of one installment on each six month anniversary of closing over forty-eight months, and a final lump sum payment of $225 thousand on the four year anniversary of the closing, reduced by $0.2 million settlement of a prior relationship. 36000 0.03 500 1500 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Purchase Price</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; font-size: 10pt; text-align: justify">Purchase Price</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">5,237</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total purchase price</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">5,237</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Allocation of purchase price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify">Developed technology</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,200</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: justify">Goodwill</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,037</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total allocation of purchase price</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">5,237</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Purchase Price</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; font-size: 10pt; text-align: justify">Purchase Price</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">7,780</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total purchase price</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,780</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Allocation of purchase price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify">Current assets</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: justify">Advertiser relationships</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,750</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify">Trade name</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,100</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: justify">Goodwill</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,921</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: justify">Total allocation of purchase price</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,780</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> 5237000 5237000 3200000 2037000 5237000 P10Y 80000 160000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 88%; font-size: 10pt">2022 (remaining)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">80</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2024</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2027</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2030</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2031</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">320</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2032</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">80</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; font-size: 10pt">Total</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,040</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 80000 320000 320000 320000 320000 320000 320000 320000 320000 320000 80000 3040000 the Company entered into an asset purchase agreement (the “Bloody Disgusting Asset Purchase Agreement”) with Bloody Disgusting, LLC (“Bloody Disgusting”), to buy substantially all of the assets of Bloody Disgusting, in consideration of an aggregate of $7.8 million, of which $4.0 million was paid in cash and 1,039,501 shares of Common Stock, which were valued at $2.3 million, were issued at closing stock price of $2.23 on the closing date of September 17, 2021, and $1.5 million as of the fair value of the earnout liability, related to earnout targets, as defined, to be met as of March 2022, March 2023 and March 2024. The fair value of the earnout liability was estimated considering the weighted probability of scenarios on the earnout metrics possible outcomes during the earnout period. The Bloody Disgusting Asset Purchase Agreement contained certain conditions to closing and representations and warranties and covenants as are customary for transactions of this type. On September 17, 2021, the Bloody Disgusting acquisition was consummated. The Company incurred transaction costs of $40 thousand during the nine months ended December 31, 2021. 7780000 7780000 9000 3750000 1100000 2921000 7780000 P12Y P10Y 105000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Advertiser relationships</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Trade name</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 64%; font-size: 10pt">2022 (remaining)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">78</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">28</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">106</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2024</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2025</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2026</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2027</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2028</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2029</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2030</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2031</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">110</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2032</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">55</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">368</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">2033</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-292">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">313</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">2034</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">151</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-293">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">151</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; font-size: 10pt">Total</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,672</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,073</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">4,745</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> 78000 28000 106000 313000 110000 423000 313000 110000 423000 313000 110000 423000 313000 110000 423000 313000 110000 423000 313000 110000 423000 313000 110000 423000 313000 110000 423000 313000 110000 423000 313000 55000 368000 313000 313000 151000 151000 3672000 1073000 4745000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>5. NOTES PAYABLE</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notes payable consisted of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Current<br/> Portion</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Long Term<br/> Portion</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Current<br/> Portion</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Long Term<br/> Portion</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; font-size: 10pt; text-align: left">Prospect Loan</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-294">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-295">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">7,786</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-296">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total non-recourse notes payable</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-297">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-298">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">7,786</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-299">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-300">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-301">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">7,786</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-302">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Credit Facility</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,956</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">PPP Loan</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,152</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total recourse notes payable</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,956</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,152</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total recourse notes payable, net of unamortized debt issuance costs and debt discounts</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,956</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,152</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total notes payable, net of unamortized debt issuance costs</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">9,742</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,152</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-recourse debt is generally defined as debt whereby the lenders’ sole recourse with respect to defaults is limited to the value of the asset, which is collateral for the debt. Certain of our subsidiaries are liable with respect to, and their assets serve as collateral for, certain indebtedness for which our assets and the assets of our other subsidiaries that are not parties to the transaction are generally not liable. We have referred to this indebtedness as “non-recourse debt” because the recourse of the lenders is limited to the assets of specific subsidiaries. Such indebtedness includes the Prospect Loan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Prospect Loan</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2013, our Cinedigm DC Holdings, LLC (“CDCH”), Access Digital Media, Inc (“AccessDM”) and Access Digital Cinema Phase 2, Corp. (“Phase 2 DC”) subsidiaries entered into a term loan agreement (the “Prospect Loan” or the “Term Loan Agreement”) with Prospect Capital Corporation (“Prospect”), pursuant to which CDCH borrowed $70.0 million. The Prospect Loan included interest at LIBOR plus 9.0% (with a 2.0% LIBOR floor), which was payable in cash, and at an additional 2.50% accrued as an increase to the aggregate principal amount of the Prospect Loan until the Prospect Loan was paid off, at which time all accrued interest became payable in cash.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Collections of CDCH accounts receivable were deposited into accounts designated to pay certain operating expenses, principal, interest, fees, costs and expenses relating to the Prospect Loan. On a quarterly basis, if there was excess cash flow, it was used for prepayment of the Prospect Loan. We also maintained a debt service fund under the Prospect Loan for future principal and interest payments. As of December 31, 2021, and March 31, 2021, the debt service fund had a balance of $0 and $1.0 million, respectively, which was classified as part of restricted cash on our Consolidated Balance Sheets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 4, 2021, CDCH, AccessDM, Phase 2 DC, Christie/AIX, Inc., Cinedigm Digital Funding I, LLC, certain Lenders, and Prospect Capital Corporation, as administrative agent and collateral agent, entered into Amendment No. 3 (the “Prospect Amendment”) to the Term Loan Agreement. Under the Prospect Amendment, the maturity date of the loan under the Term Loan Agreement was extended to March 31, 2022. As a condition to the effectiveness of the Amendment, CDCH paid $3,500,000 to Prospect to reduce the outstanding principal amount of the Loan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Prospect Loan was secured by, among other things, a first priority pledge of the stock of CDF2 Holdings, our wholly-owned unconsolidated subsidiary, the stock of AccessDM, owned by DC Holdings, and the stock of our Phase 2 DC subsidiary, and was also guaranteed by AccessDM and Phase 2 DC. We provided limited financial support to the Prospect Loan not to exceed $1.5 million per year in the event financial performance did not meet certain defined benchmarks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Prospect Loan contained customary representations, warranties, affirmative covenants, negative covenants and events of default.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Upon a series of payments between April 30 and July 9, 2021</span>, <span>the Company paid in full the Prospect Loan outstanding non-recourse debt amount by paying an aggregate principal amount of $7.8 million. Pre-payment of the Prospect Loan was permissible without penalty.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes the activity related to the Prospect Loan:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Prospect Loan, at issuance</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">70,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">70,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">PIK Interest</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">8,016</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,397</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Payments to date</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(78,016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(68,611</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Prospect Loan, gross</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,786</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Less unamortized debt issuance costs and debt discounts</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Prospect Loan, net</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">7,786</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(7,786</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt">Total long term portion</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">—</div></td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">—</div></td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Credit Facility and Cinedigm Revolving Loans</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 30, 2018, the Company entered into the Loan, Guaranty and Security Agreement, dated as of March 30, 2018, by and between the Company, East West Bank and the Guarantors named therein (the “Credit Facility”) for a maximum of $19.0 million in revolving loans outstanding at any one time with a maturity date of March 31, 2020, which may be extended for two successive one-year periods at the sole discretion of the lender, subject to certain conditions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interest under the Credit Facility is due monthly at a rate elected by the Company of either 0.5% plus Prime Rate or 3.25% above LIBOR Rate established by the lender.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 3, 2019, the Company entered into an amendment to the Credit Facility (the “EWB Amendment”). The EWB Amendment reduced the size of the facility to $18.0 million, required certain prepayments and daily cash sweeps from collections of receivables to be made, changed in certain respects how the borrowing base is calculated, and extended the maturity date to June 30, 2020. In connection with the EWB Amendment, three of our subsidiaries became Guarantors under the Credit Facility. On June 25, 2020, the Company and East West Bank amended the Credit Facility to extend the maturity of the Credit Facility to June 30, 2021 and waive events of default provisions. On June 22, 2021, the maturity date of the Credit Facility was extended to September 28, 2021. During this extension period, unless an amendment had been entered into, we were not able to access any additional borrowings under the Credit Facility. The September 28, 2021 expiration date has passed and the agreement was not extended.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and March 31, 2021, there was $0 and $2.0 million outstanding, respectively, and there was no availability under the Credit Facility based on the Company’s borrowing base as of December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>PPP Loan</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 15, 2020, the Company received $2.2 million from East West Bank, the Company’s existing lender, pursuant to the Paycheck Protection Program (the “PPP Loan”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 10, 2022 (the “PPP Maturity Date”), accrues interest at 1% per annum and may be prepaid in whole or in part without penalty. No interest payments are due within the initial six months of the PPP Loan. The interest accrued during the initial six-month period is due and payable, together with the principal, on the PPP Maturity Date. The Company used all proceeds from the PPP Loan to retain employees, maintain payroll and make lease and utility payments to support business continuity throughout the COVID-19 pandemic, which amounts were intended to be eligible for forgiveness, subject to the provisions of the CARES Act, and could be subject to repayment. On July 7, 2021, the Company received notification from the lender that the U.S. Small Business Administration had approved the Company’s PPP Loan forgiveness application for the entire PPP Loan amount and accrued interest effective June 30, 2021.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Current<br/> Portion</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Long Term<br/> Portion</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Current<br/> Portion</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Long Term<br/> Portion</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; font-size: 10pt; text-align: left">Prospect Loan</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-294">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-295">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">7,786</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-296">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total non-recourse notes payable</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-297">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-298">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">7,786</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-299">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-300">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-301">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">7,786</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-302">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Credit Facility</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,956</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">PPP Loan</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,152</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total recourse notes payable</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,956</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,152</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total recourse notes payable, net of unamortized debt issuance costs and debt discounts</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,956</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,152</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Total notes payable, net of unamortized debt issuance costs</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">9,742</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,152</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 7786000 7786000 7786000 1956000 2152000 1956000 2152000 1956000 2152000 9742000 2152000 70000000 0.09 0.02 0.025 0 1000000 3500000 1500000 7800000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Prospect Loan, at issuance</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">70,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">70,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">PIK Interest</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">8,016</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,397</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Payments to date</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(78,016</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(68,611</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Prospect Loan, gross</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">7,786</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Less unamortized debt issuance costs and debt discounts</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Prospect Loan, net</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">7,786</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt">Less current portion</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(7,786</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt">Total long term portion</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">—</div></td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">—</div></td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 70000000 70000000 8016000 6397000 -78016000 -68611000 7786000 7786000 7786000 19000000 0.005 0.0325 18000000 0 2000000 2200000 0.01 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>6. STOCKHOLDERS’ EQUITY </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COMMON STOCK</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Authorized Class A Common Stock </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 11, 2021, the Company filed a Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation, pursuant to which the number of shares of Class A common stock authorized for issuance was increased to 275,000,000 shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended December 31, 2021, we issued 8,642,648 shares of Common Stock which consist of the sale of shares of our Class A common stock, issuance of Common Stock for business combination, the issuances of Common Stock in payment of preferred stock dividends and in payment of board retainer fees.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PREFERRED STOCK</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cumulative dividends in arrears on preferred stock were $0.1 million and $0.1 million as of December 31, 2021 and March 31, 2021, respectively. In May 2021 and October 2021, we paid preferred stock dividends in arrears in the form of 53,278 and 102,697 shares of Class A common stock, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>TREASURY STOCK</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have treasury stock, at cost, consisting of 1,315,851 and 1,313,836 shares of Class A common stock at December 31, 2021 and March 31, 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>CINEDIGM’S EQUITY INCENTIVE PLANS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stock Based Compensation Awards</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awards issued under our 2000 Equity Incentive Plan (the “2000 Plan”) may be in any of the following forms (or a combination thereof) (i) stock option awards; (ii) stock appreciation rights; (iii) stock or restricted stock or restricted stock units; or (iv) performance awards. The 2000 Plan provides for the granting of incentive stock options (“ISOs”) with exercise prices not less than the fair market value of our Common Stock on the date of grant. ISOs granted to shareholders having more than 10% of the total combined voting power of the Company must have exercise prices of at least 110% of the fair market value of our Common Stock on the date of grant. ISOs and non-statutory stock options granted under the 2000 Plan are subject to vesting provisions, and exercise is subject to the continuous service of the participant. The exercise prices and vesting periods (if any) for non-statutory options are set at the discretion of our compensation committee. On November 1, 2017, upon the consummation of the initial equity investment in Cinedigm by Bison, as a result of which there was a change of control of the Company, all stock options (incentive and non-statutory) and shares of restricted stock were vested immediately and the options became fully exercisable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the grants of stock options and shares of restricted stock under the 2000 Plan, we and the participants have executed stock option agreements and notices of restricted stock awards setting forth the terms of the grants. The 2000 Plan provided for the issuance of up to 2,380,000 shares of Common Stock to employees, outside directors and consultants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, there were 217,837 stock options outstanding in the 2000 Plan with weighted average exercise price of $14.49 and a weighted average contract life of 1.42 years. As of March 31, 2021, there were 261,587 shares pursuant to stock options outstanding in the Plan with weighted average exercise price of $14.99 and a weighted average contract life of 2.11 years. A total of 43,500 options expired and 250 options forfeited during the three and nine months ended December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Options outstanding under the 2000 Plan as of December 31, 2021 is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of December 31, 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Range of Prices</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Options Outstanding</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Remaining Life in Years</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Intrinsic Value<br/> (In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 18%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">$7.40 - $13.69</span></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">5,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">3.50</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 17%; font-size: 10pt; text-align: right">7.40</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 17%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">$14.00 - $24.40</span></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">212,837</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1.37</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">14.65</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">217,837</td><td style="font-size: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-324">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An analysis of all options exercisable under the 2000 Plan as of December 31, 2021 is presented below:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Options Exercisable</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average<br/> Remaining Life in Years</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Intrinsic Value <br/> (In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 23%; font-size: 10pt; text-align: right">217,837</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">1.42</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">14.49</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-325">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2017, the Company adopted the 2017 Equity Incentive Plan (the “2017 Plan). The 2017 Plan replaced the 2000 Plan, and applies to employees and directors of, and consultants to, the Company. The 2017 Plan provided for the issuance of up to 2,108,270 shares of Class A common stock, in the form of various awards, including stock options, stock appreciation rights, stock, restricted stock, restricted stock units, performance awards and cash awards. The Compensation Committee of the Company’s Board of Directors (the “Board”) is authorized to administer the 2017 Plan and make grants thereunder. The approval of the 2017 Plan did not affect awards already granted under the 2000 Plan. On December 4, 2019, upon shareholder approval, the 2017 Plan was amended to increase the maximum number of shares of Class A common stock authorized for issuance thereunder from 2,108,270 shares to 4,098,270.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 23, 2020, the Company amended its 2017 Plan to increase the number of shares authorized for issuance thereunder from 4,098,270 to 14,098,270.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 11, 2021, the Company amended its 2017 Plan to increase the number of shares authorized for issuance thereunder from 14,098,270 to 18,098,270.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended December 31, 2021, the Company granted 1,807,625 stock appreciation rights (“SARs”). The SARs were granted under the Company’s 2017 Equity Incentive Plan (the “2017 Plan), except for 600,000 SARs granted to an officer of the Company as an inducement grant. All SARs issued have an exercise price equal to the fair value of the Company’s Class A common stock on the date of grant and a maturity date of 10 years. The SARs were valued on the grant date utilizing an option pricing model, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Grant Date: May 23, 2021 – November 30, 2021</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maturity Date: May 23, 2031 – November 30, 2031</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exercise price: $1.29 - $2.56</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Volatility: 110.32% - 114.42%</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Discount rate: 0.96% - 1.50%</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Expected term: 6 – 6.5 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stock appreciation rights outstanding under the 2017 Plan as of December 31, 2021 is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of December 31, 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Range of Prices</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">SAR´s Outstanding</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Remaining Life in Years</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Intrinsic Value<br/> (In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 18%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">$0.54 - $0.74</span></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">5,550,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">8.99</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 17%; font-size: 10pt; text-align: right">0.64</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 17%; font-size: 10pt; text-align: right">3,131</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">$1.16 - $1.47</span></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,050,860</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">8.15</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1.37</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-326">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">$1.71 - $2.10</span></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,680,738</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9.16</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1.97</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-327">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">$2.23 - $2.56</span></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">394,375</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9.85</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2.33</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">10,675,973</td><td style="font-size: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,131</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An analysis of all stock appreciation rights exercisable under the 2017 Plan as of December 31, 2021 is presented below:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Options Exercisable</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average<br/> Remaining Life in Years</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Intrinsic Value <br/> (In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 23%; font-size: 10pt; text-align: right">2,712,610</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">7.26</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">1.16</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">775</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employee and director stock-based compensation expense related to our stock-based awards was as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended<br/> December 31,</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended<br/> December 31,</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">1,349</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">960</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">3,278</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">2,172</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,349</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">960</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,278</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">2,172</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total SARs outstanding are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine Months<br/> Ended <br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; font-size: 10pt">SARs Outstanding March 31, 2021</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right">9,154,933</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt">Issued</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,807,625</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.5pt">Forfeited</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(286,585</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; padding-bottom: 4pt">Total SARs Outstanding December 31, 2021</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">10,675,923</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was $1 thousand and $1thousand of stock-based compensation recorded for the nine months ended December 31, 2021 and 2020, respectively, related to employees’ restricted stock awards. There was $0 thousand and $1thousand of stock-based compensation recorded for the three months ended December 31, 2021 and 2020, respectively, related to employees’ restricted stock awards.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was $290 thousand and $131 thousand of stock-based compensation for the nine months ended December 31, 2021 and 2020, respectively, related to board of directors. There was $107 thousand and $65 thousand of stock-based compensation for the three months ended December 31, 2021 and 2020, respectively, related to board of directors. During the nine months ended December 31, 2021, the Company issued 245,887 shares to the board of directors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>OPTIONS GRANTED OUTSIDE CINEDIGM’S EQUITY INCENTIVE PLAN</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2013, we issued options outside of the 2000 Plan to 10 individuals who became employees as a result of a business combination. The employees received options to purchase an aggregate of 62,000 shares of our Class A Common Stock at an exercise price of $17.50 per share. The options were fully vested as of October 2017 and expire 10 years from the date of grant, if unexercised. As of December 31, 2021, 12,500 of such options remained outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>WARRANTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents information about outstanding warrants to purchase shares of our Class A common stock as of December 31, 2021. All of the outstanding warrants are fully vested and exercisable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">Recipient</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Amount <br/> outstanding</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Expiration</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Exercise price<br/> per share</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 64%; font-size: 10pt; text-align: left">5-year Warrant issued to BEMG in connection with a term loan agreement</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right">1,400,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">December 2022</span></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1.80</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrants for the purchase of 298,519 shares of Common Stock expired unexercised during the nine months ended December 31, 2021.</p> 275000000 8642648 100000 100000 53278 102697 1315851 1313836 0.10 1.10 2380000 217837 14.49 P1Y5M1D 261587 14.99 P2Y1M9D 43500 250 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of December 31, 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Range of Prices</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Options Outstanding</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Remaining Life in Years</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Intrinsic Value<br/> (In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 18%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">$7.40 - $13.69</span></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">5,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">3.50</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 17%; font-size: 10pt; text-align: right">7.40</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 17%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">$14.00 - $24.40</span></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">212,837</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1.37</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">14.65</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">217,837</td><td style="font-size: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-324">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Options Exercisable</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average<br/> Remaining Life in Years</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Intrinsic Value <br/> (In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 23%; font-size: 10pt; text-align: right">217,837</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">1.42</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">14.49</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-325">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 7.4 13.69 5000 P3Y6M 7.4 14 24.4 212837 P1Y4M13D 14.65 217837 217837 P1Y5M1D 14.49 2108270 2108270 4098270 4098270 14098270 14098270 18098270 1807625 600000 P10Y 1.29 2.56 1.1032 1.1442 0.0096 0.015 6 6.5 years <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="18" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">As of December 31, 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Range of Prices</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">SAR´s Outstanding</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Remaining Life in Years</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average Exercise Price</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Intrinsic Value<br/> (In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 18%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">$0.54 - $0.74</span></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">5,550,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 17%; font-size: 10pt; text-align: right">8.99</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 17%; font-size: 10pt; text-align: right">0.64</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 17%; font-size: 10pt; text-align: right">3,131</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">$1.16 - $1.47</span></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,050,860</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">8.15</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1.37</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-326">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">$1.71 - $2.10</span></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,680,738</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9.16</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1.97</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-327">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">$2.23 - $2.56</span></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">394,375</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9.85</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2.33</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">10,675,973</td><td style="font-size: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,131</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Options Exercisable</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average<br/> Remaining Life in Years</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate Intrinsic Value <br/> (In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 23%; font-size: 10pt; text-align: right">2,712,610</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">7.26</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">1.16</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; width: 22%; font-size: 10pt; text-align: right">775</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.54 0.74 5550000 P8Y11M26D 0.64 3131000 1.16 1.47 2050860 P8Y1M24D 1.37 1.71 2.1 2680738 P9Y1M28D 1.97 2.23 2.56 394375 P9Y10M6D 2.33 10675973 3131000 2712610 P7Y3M3D 1.16 775000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended<br/> December 31,</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended<br/> December 31,</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">1,349</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">960</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">3,278</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">2,172</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,349</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">960</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,278</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">2,172</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1349000 960000 3278000 2172000 1349000 960000 3278000 2172000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine Months<br/> Ended <br/> December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; font-size: 10pt">SARs Outstanding March 31, 2021</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right">9,154,933</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt">Issued</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,807,625</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.5pt">Forfeited</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">(286,585</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; padding-bottom: 4pt">Total SARs Outstanding December 31, 2021</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">10,675,923</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 9154933 1807625 286585 10675923 1000 0 290000 131000 107000 65000 245887 10 62000 17.5 P10Y 12500 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">Recipient</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Amount <br/> outstanding</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Expiration</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Exercise price<br/> per share</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 64%; font-size: 10pt; text-align: left">5-year Warrant issued to BEMG in connection with a term loan agreement</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right">1,400,000</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: center"><span style="font-size: 10pt">December 2022</span></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1.80</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1400000 2022-12 1.8 298519 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>7. COMMITMENTS AND CONTINGENCIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities. Although the results of litigation and claims cannot be predicted with certainty, the Company does not believe it is party to any claim or litigation the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business. Regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources and other factors. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate from leased properties under non-cancelable operating lease agreements, certain of which contain escalating lease clauses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases office space under operating leases. The Company’s portfolio of leases is primarily related to real estate and since most of our leases do not provide a readily determinable implicit rate, the Company estimated its incremental borrowing rate to discount the lease payments based on information available at either the implementation date of Topic 842 or at lease commencement for leases entered into thereafter.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below presents the lease-related assets and liabilities recorded on the balance sheet as of December 31, 2021 and March 31, 2021:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Classification on the Balance Sheet</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold">Assets</td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; width: 37%">Noncurrent</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 37%; font-size: 10pt; text-align: left">Operating lease right-of-use asset</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right">       16</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">     100</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold">Liabilities</td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Current</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">Operating leases – current portion</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">16</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">87</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt">Noncurrent</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">Operating leases – long-term portion</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">13</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total operating lease liabilities</td><td> </td> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">16</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">100</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Lease Costs</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below presents certain information related to lease costs for leases:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Nine months Ended</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold">Nine months Ended</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-size: 10pt; font-weight: bold">December 31, <br/> 2020</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Operating lease cost</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">             90</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">          160</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Total lease cost</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">90</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">160</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Other Information</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below presents supplemental cash flow information related to leases:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Nine months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Nine months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(In thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Cash paid for amounts included in the measurement of lease liabilities</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">             13</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 9%; padding-bottom: 1.5pt; text-align: right">            162</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Operating cash flows used for operating leases</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">162</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Distribution arrangement minimum guaranty</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 1, 2021 the Company extended a video works distribution arrangement providing a non-refundable and fully-recoupable advance minimum participation guaranty for a total amount of $3.5 million, where $1.5 million is payable no later than November 1, 2021, $1.0 million at the first year anniversary of the arrangement and $0.9 million on the second-year anniversary of the arrangement. These payments are subject to the selection of video works released by the Company whose initial commercial date occurs during the arrangement year. The Company paid the first advance on October 22, 2021.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Classification on the Balance Sheet</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold">Assets</td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; width: 37%">Noncurrent</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 37%; font-size: 10pt; text-align: left">Operating lease right-of-use asset</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right">       16</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">     100</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; font-weight: bold">Liabilities</td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt">Current</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">Operating leases – current portion</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">16</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">87</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt">Noncurrent</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">Operating leases – long-term portion</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">13</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total operating lease liabilities</td><td> </td> <td> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">16</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">100</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 16000 100000 16000 87000 13000 16000 100000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Nine months Ended</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-size: 10pt; font-weight: bold">Nine months Ended</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-size: 10pt; font-weight: bold">December 31, <br/> 2020</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-size: 10pt; text-align: left">Operating lease cost</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">             90</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">          160</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left">Total lease cost</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">90</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">160</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 12pt; text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Nine months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Nine months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(In thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Cash paid for amounts included in the measurement of lease liabilities</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">             13</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 9%; padding-bottom: 1.5pt; text-align: right">            162</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Operating cash flows used for operating leases</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">162</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 90000 160000 90000 160000 13000 162000 13000 162000 3500000 1500000 1000000 900000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>8. SUPPLEMENTAL CASH FLOW INFORMATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended <br/> December 31,</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; font-size: 10pt; text-align: left">Cash interest paid</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">701</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">3,014</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Income taxes paid</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">79</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">noncash investing and financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Accrued dividends on preferred stock</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">89</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">89</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Issuance of Class A common stock for payment of accrued preferred stock dividends</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">267</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">267</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Issuance of Class A common stock to Starrise, a related party</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">11,046</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Contributed capital under the Starrise transaction, a related party</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">17,187</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Settlement of second lien loan with Class A common stock</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-333">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,008</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Conversion of note payable</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-334">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">15,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Class A common stock to be issued in connection with the asset acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="-sec-ix-hidden: hidden-fact-335; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">—</p></td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,853</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Issuance of Class A common stock for business combination</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">4,824</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-336">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Starrise shares used to pay down vendors</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="-sec-ix-hidden: hidden-fact-337; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">—</p></td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">897</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Treasury shares acquired for withholding taxes</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">5</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-338">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Deferred consideration in purchase of a business</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,980</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-339">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Earnout consideration in purchase of a business</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,461</td><td style="font-size: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="-sec-ix-hidden: hidden-fact-340; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">—</p></td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended <br/> December 31,</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; font-size: 10pt; text-align: left">Cash interest paid</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">701</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">3,014</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">Income taxes paid</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">79</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; font-size: 10pt; text-align: left">noncash investing and financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Accrued dividends on preferred stock</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">89</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">89</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Issuance of Class A common stock for payment of accrued preferred stock dividends</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">267</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">267</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Issuance of Class A common stock to Starrise, a related party</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">11,046</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Contributed capital under the Starrise transaction, a related party</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">17,187</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Settlement of second lien loan with Class A common stock</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-333">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,008</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Conversion of note payable</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-334">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">15,000</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Class A common stock to be issued in connection with the asset acquisition</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="-sec-ix-hidden: hidden-fact-335; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">—</p></td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,853</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Issuance of Class A common stock for business combination</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">4,824</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-336">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Starrise shares used to pay down vendors</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="-sec-ix-hidden: hidden-fact-337; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">—</p></td><td style="text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">897</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Treasury shares acquired for withholding taxes</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">5</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-338">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Deferred consideration in purchase of a business</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,980</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-339">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; font-size: 10pt; text-align: left">Earnout consideration in purchase of a business</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,461</td><td style="font-size: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="-sec-ix-hidden: hidden-fact-340; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">—</p></td><td style="text-align: left"> </td></tr> </table> 701000 3014000 79000 89000 89000 267000 267000 11046000 17187000 3008000 15000000 1853000 4824000 897000 5000 1980000 1461000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>9. SEGMENT INFORMATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate in two reportable segments: Cinema Equipment Business and Content &amp; Entertainment Business. Our segments were determined based on the economic characteristics of our products and services, our internal organizational structure, the manner in which our operations are managed and the criteria used by our CODM to evaluate performance, which is generally the segment’s operating income (loss) before depreciation and amortization.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 30%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Operations of:</b></span></td> <td style="width: 1%"> </td> <td style="width: 69%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Products and services provided:</b></span></td></tr> <tr style="vertical-align: top"> <td><span style="font-size: 10pt">Cinema Equipment Business</span></td> <td style="text-align: justify"> </td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financing vehicles and administrators for 1,631 Systems installed nationwide in our first deployment phase (“Phase I Deployment”) to theatrical exhibitors and for 2,978 Systems installed domestically and internationally in our second deployment phase (“Phase II Deployment”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We retain ownership of the Systems and the residual cash flows related to the Systems in Phase I Deployment after the repayment of all non-recourse debt at the expiration of exhibitor master license agreements. For certain Phase II Deployment Systems, we do not retain ownership of the residual cash flows and digital cinema equipment in Phase II Deployment after the completion of cost recoupment and at the expiration of the exhibitor master license agreements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Cinema Equipment Business segment also provides monitoring, collection, verification and management services to this segment, as well as to exhibitors who purchase their own equipment, and also collects and disburses VPFs from motion picture studios, distributors and ACFs from alternative content providers, movie exhibitors and theatrical exhibitors (collectively, “Services”).</p></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span style="font-size: 10pt">Content &amp; Entertainment Business</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-size: 10pt">Leading independent streaming company of content and channels. We collaborate with producers and other content owners to market, source, curate and distribute independent content to targeted and under-served audiences in theatres and homes, and via mobile and emerging platforms.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables present certain financial information related to our reportable segments and Corporate:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(In thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intangible <br/> Assets, net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Goodwill</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes <br/> Payable, <br/> Non-<br/> Recourse</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes <br/> Payable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating <br/> lease<br/> liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt">Cinema Equipment Business</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">22,910</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-343">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-344">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">—</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Content &amp; Entertainment Business</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,659</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Corporate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,735</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">16</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">15,672</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,659</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">99,554</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">16</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="margin: 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.5pt solid">(In thousands)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intangible <br/> Assets, net</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Goodwill</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Assets</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes <br/> Payable, <br/> Non-<br/> Recourse</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes <br/> Payable</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating <br/> lease<br/> liabilities</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Cinema Equipment Business</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-353">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-354">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">13,169</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">7,786</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-355">              —</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Content &amp; Entertainment Business</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9,858</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">8,701</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">42,733</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-357">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">69</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Corporate</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-358">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">19,544</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-359">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">4,108</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">30</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">9,860</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">8,701</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">75,446</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,786</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">4,108</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">100</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Statements of Operations</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended December 31, 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cinema <br/> Equipment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Content &amp; Entertainment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corporate</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,060</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">12,024</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-360">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">14,084</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Direct operating (exclusive of depreciation and amortization shown below)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">139</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,320</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-361">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,459</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">496</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,701</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,539</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">7,736</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Allocation of corporate overhead</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">143</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">964</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(1,107</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Provision for (recovery of) doubtful accounts</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(397</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">19</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(378</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Depreciation and amortization of property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">196</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">138</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">336</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Amortization  of intangible assets</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">693</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">695</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">577</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,835</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,436</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">14,848</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Income (loss) from operations</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,483</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">189</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(2,436</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(764</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Cinema</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Business</b></p></td><td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Content &amp; Entertainment<br/> Business</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Consolidated</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Direct operating</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">     —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">     —</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">552</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">797</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">1,349</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total stock-based compensation</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">552</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">797</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,349</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Statements of Operations</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended December 31, 2020<br/> (in thousands)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cinema <br/> Equipment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Content &amp; Entertainment</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corporate</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">910</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">9,044</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">9,954</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Direct operating (exclusive of depreciation and amortization shown below)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">150</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">4,235</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">4,385</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">524</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,244</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,593</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">5,361</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Allocation of corporate overhead</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">143</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">964</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(1,107</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Provision for doubtful accounts</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">70</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">70</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Depreciation and amortization of property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">706</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">108</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">8</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">822</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Amortization of intangible assets</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">8</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">588</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">597</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,601</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">8,139</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,495</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,235</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Loss from operations</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(691</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">905</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(1,495</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(1,281</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Cinema <br/> Equipment<br/> Business</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Content &amp; Entertainment</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Consolidated</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Direct operating</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">              —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">              —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">     —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">     —</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">39</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">921</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">960</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total stock-based compensation</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">39</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">921</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">960</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Statements of Operations</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended December 31, 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cinema <br/> Equipment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Content &amp; Entertainment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corporate</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,544</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">27,658</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">39,202</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Direct operating (exclusive of depreciation and amortization shown below)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">560</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">13,863</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">14,423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,356</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9,999</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9,583</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">20,938</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Allocation of corporate overhead</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">412</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,763</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(3,175</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">(Recovery of) provision for doubtful accounts</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(500</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">82</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(418</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Depreciation and amortization of property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,001</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">422</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,425</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Amortization of intangible assets</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,236</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,238</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,829</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">29,365</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,412</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">38,606</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Income (loss) from operations</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">8,715</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(1,707</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(6,412</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">596</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Cinema</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Business</b></p></td><td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Content &amp; Entertainment<br/> Business</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Consolidated</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Direct operating</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">     —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-393">      —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">      —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">      —</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">1,063</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">2,215</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">3,278</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total stock-based compensation</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,063</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">2,215</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,278</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Statements of Operations</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended December 31, 2020 <br/> (in thousands)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cinema <br/> Equipment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Content &amp; Entertainment</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corporate</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,158</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">20,996</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">23,154</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Direct operating (exclusive of depreciation and amortization shown below)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">504</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">10,890</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">11,394</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,704</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,998</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">15,369</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Allocation of corporate overhead</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">438</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,883</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(3,321</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Recovery for doubtful accounts</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(123</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(123</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Depreciation and amortization of property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,348</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">312</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">31</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,691</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Amortization of intangible assets</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">23</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,752</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">3</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,778</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">5,892</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">22,504</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">3,711</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">32,109</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Income (loss) from operations</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(3,736</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(1,508</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(3,711</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(8,955</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following employee and director stock-based compensation expense related to our stock-based awards is included in the above amounts as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Cinema <br/> Equipment<br/> Business</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Content &amp; Entertainment</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Consolidated</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Direct operating</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">       —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">      —</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">91</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">2,081</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">2,172</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total stock-based compensation</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">91</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">2,081</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">2,172</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> 2 1631 2978 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(In thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intangible <br/> Assets, net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Goodwill</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes <br/> Payable, <br/> Non-<br/> Recourse</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes <br/> Payable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating <br/> lease<br/> liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt">Cinema Equipment Business</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">22,910</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-343">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-344">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">—</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Content &amp; Entertainment Business</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,672</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,659</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">—</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Corporate</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">—</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,735</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">16</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">15,672</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,659</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">99,554</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">16</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="margin: 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="22" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2021</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1.5pt solid">(In thousands)</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intangible <br/> Assets, net</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Goodwill</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> Assets</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes <br/> Payable, <br/> Non-<br/> Recourse</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes <br/> Payable</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating <br/> lease<br/> liabilities</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Cinema Equipment Business</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-353">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-354">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">13,169</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">7,786</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-355">              —</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Content &amp; Entertainment Business</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9,858</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">8,701</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">42,733</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-357">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">69</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Corporate</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-358">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">19,544</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-359">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">4,108</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">30</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">9,860</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">8,701</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">75,446</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">7,786</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">4,108</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">100</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 22910000 15672000 13659000 54909000 21735000 16000 15672000 13659000 99554000 16000 13169000 7786000 1000 9858000 8701000 42733000 69000 2000 19544000 4108000 30000 9860000 8701000 75446000 7786000 4108000 100000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Statements of Operations</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended December 31, 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cinema <br/> Equipment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Content &amp; Entertainment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corporate</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,060</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">12,024</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-360">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">14,084</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Direct operating (exclusive of depreciation and amortization shown below)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">139</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,320</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-361">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,459</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">496</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,701</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,539</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">7,736</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Allocation of corporate overhead</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">143</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">964</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(1,107</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Provision for (recovery of) doubtful accounts</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(397</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">19</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(378</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Depreciation and amortization of property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">196</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">138</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">336</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Amortization  of intangible assets</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">693</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">695</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">577</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,835</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,436</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">14,848</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Income (loss) from operations</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,483</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">189</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(2,436</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(764</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Statements of Operations</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended December 31, 2020<br/> (in thousands)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cinema <br/> Equipment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Content &amp; Entertainment</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corporate</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">910</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">9,044</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">9,954</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Direct operating (exclusive of depreciation and amortization shown below)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">150</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">4,235</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">4,385</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">524</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,244</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,593</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">5,361</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Allocation of corporate overhead</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">143</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">964</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(1,107</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Provision for doubtful accounts</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">70</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">70</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Depreciation and amortization of property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">706</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">108</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">8</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">822</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Amortization of intangible assets</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">8</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">588</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">597</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,601</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">8,139</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,495</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,235</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Loss from operations</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(691</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">905</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(1,495</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(1,281</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Statements of Operations</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended December 31, 2021</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cinema <br/> Equipment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Content &amp; Entertainment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corporate</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">11,544</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">27,658</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">39,202</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Direct operating (exclusive of depreciation and amortization shown below)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">560</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">13,863</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">14,423</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,356</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9,999</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">9,583</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">20,938</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Allocation of corporate overhead</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">412</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,763</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(3,175</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">(Recovery of) provision for doubtful accounts</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(500</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">82</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(418</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Depreciation and amortization of property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,001</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">422</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,425</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Amortization of intangible assets</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">—</div></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,236</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,238</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,829</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">29,365</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">6,412</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">38,606</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Income (loss) from operations</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">8,715</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(1,707</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(6,412</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">596</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">Statements of Operations</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nine Months Ended December 31, 2020 <br/> (in thousands)</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cinema <br/> Equipment<br/> Business</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Content &amp; Entertainment</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corporate</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">2,158</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">20,996</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">—</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">23,154</td><td style="width: 1%; padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Direct operating (exclusive of depreciation and amortization shown below)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">504</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">10,890</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">11,394</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Selling, general and administrative</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">1,704</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,667</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">6,998</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">15,369</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Allocation of corporate overhead</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">438</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">2,883</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(3,321</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">—</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Recovery for doubtful accounts</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(123</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">(123</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; text-indent: -9pt; padding-left: 9pt">Depreciation and amortization of property and equipment</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,348</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">312</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">31</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right">3,691</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Amortization of intangible assets</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">23</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,752</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">3</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">1,778</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total operating expenses</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">5,892</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">22,504</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right">3,711</td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">32,109</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Income (loss) from operations</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(3,736</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(1,508</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(3,711</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">(8,955</td><td style="padding-bottom: 4pt; font-size: 10pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> 2060000 12024000 14084000 139000 6320000 6459000 496000 3701000 3539000 7736000 143000 964000 -1107000 -397000 19000 -378000 196000 138000 2000 336000 693000 2000 695000 577000 11835000 2436000 14848000 1483000 189000 -2436000 -764000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Cinema</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Business</b></p></td><td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Content &amp; Entertainment<br/> Business</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Consolidated</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Direct operating</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">     —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">     —</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">552</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">797</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">1,349</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total stock-based compensation</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">552</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">797</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,349</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Cinema <br/> Equipment<br/> Business</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Content &amp; Entertainment</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Consolidated</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Direct operating</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">              —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">              —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">     —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">     —</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">39</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">921</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">960</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total stock-based compensation</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">39</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">921</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">960</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold">(In thousands)</td><td style="font-size: 10pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Cinema</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Business</b></p></td><td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Content &amp; Entertainment<br/> Business</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Consolidated</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Direct operating</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">     —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-393">      —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">      —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">      —</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">1,063</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">2,215</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">3,278</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total stock-based compensation</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">1,063</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">2,215</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">3,278</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Cinema <br/> Equipment<br/> Business</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Content &amp; Entertainment</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate</td><td style="font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: center">Consolidated</td><td style="font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Direct operating</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">    —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">       —</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">      —</div></td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; font-size: 10pt; text-align: left">Selling, general and administrative</td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">—</div></td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">91</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">2,081</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-size: 10pt; text-align: right">2,172</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Total stock-based compensation</td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">—</div></td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">91</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">2,081</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-size: 10pt; text-align: right">2,172</td><td style="font-size: 10pt; text-align: left"> </td></tr> </table> 552000 797000 1349000 552000 797000 1349000 910000 9044000 9954000 150000 4235000 4385000 524000 2244000 2593000 5361000 143000 964000 -1107000 70000 70000 706000 108000 8000 822000 8000 588000 1000 597000 1601000 8139000 1495000 11235000 -691000 905000 -1495000 -1281000 39000 921000 960000 39000 921000 960000 11544000 27658000 39202000 560000 13863000 14423000 1356000 9999000 9583000 20938000 412000 2763000 -3175000 -500000 82000 -418000 1001000 422000 2000 1425000 2236000 2000 2238000 2829000 29365000 6412000 38606000 8715000 -1707000 -6412000 596000 1063000 2215000 3278000 1063000 2215000 3278000 2158000 20996000 23154000 504000 10890000 11394000 1704000 6667000 6998000 15369000 438000 2883000 -3321000 -123000 -123000 3348000 312000 31000 3691000 23000 1752000 3000 1778000 5892000 22504000 3711000 32109000 -3736000 -1508000 -3711000 -8955000 91000 2081000 2172000 91000 2081000 2172000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>10. INCOME TAXES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>We calculate income tax expense based upon an annual effective tax rate forecast, including estimates and assumptions. We recorded an income tax benefit of approximately $26 thousand and $576 thousand for the three and nine months ended December 31, 2021, respectively. We recorded an income tax benefit of approximately $0 and $181 thousand for the three and nine months ended December 31, 2020, respectively. We have not recorded tax benefits on our loss before income taxes because we have provided for a full valuation allowance that offsets potential deferred tax assets resulting from net operating loss carry forwards, reflecting our inability to use such loss carry forwards.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Our effective tax rate for the nine months ended December 31, 2021 and 2020 was negative 14.0% and 0.3%, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable. </span></p> 26000 576000 0 181000 0.14 0.003 Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law. The Act contains several new or changed income tax provisions, including but not limited to the following: increased limitation threshold for determining deductible interest expense; class life changes to qualified improvements (in general, from 39 years to 15 years); and the ability to carry back net operating losses incurred from tax years 2018 through 2020 up to the five preceding tax years. The Company has evaluated the new tax provisions of the CARES Act and determined the impact to be either immaterial or not applicable. <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>11. SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity purchase announcement  </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 4, 2022, the Company entered into an Equity Purchase Agreement among the Company, and David Chu, Augustine Hong, Helen Hong, Michael Hong, Justin Lee, Steven Park, and Kingsoon Ong (collectively, the “Sellers”) and David Chu as representative of the Sellers (the “DMR Agreement”) to acquire all of the outstanding membership interests of Asian Media Rights, LLC d/b/a Digital Media Rights (“DMR”), a diversified specialty streaming, advertising, and content distribution company with significant expertise in building audiences for global content in North America (the “DMR Transaction”). The DMR Transaction is subject to certain closing conditions, including satisfactory financial and legal diligence, and the parties are working toward closing the transaction.</p> the Company entered into an Equity Purchase Agreement among the Company, and David Chu, Augustine Hong, Helen Hong, Michael Hong, Justin Lee, Steven Park, and Kingsoon Ong (collectively, the “Sellers”) and David Chu as representative of the Sellers (the “DMR Agreement”) to acquire all of the outstanding membership interests of Asian Media Rights, LLC d/b/a Digital Media Rights (“DMR”), a diversified specialty streaming, advertising, and content distribution company with significant expertise in building audiences for global content in North America (the “DMR Transaction”). The DMR Transaction is subject to certain closing conditions, including satisfactory financial and legal diligence, and the parties are working toward closing the transaction. false --03-31 Q3 2022 0001173204 EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ⅅ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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 73 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 340 539 1 false 77 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.cinedigm.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.cinedigm.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.cinedigm.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consdensed Consolidated Statements of Changes in Equity (Unaudited) Sheet http://www.cinedigm.com/role/ShareholdersEquityType2or3 Consdensed Consolidated Statements of Changes in Equity (Unaudited) Statements 6 false false R7.htm 006 - Statement - Consdensed Consolidated Statements of Changes in Equity (Unaudited) (Parentheticals) Sheet http://www.cinedigm.com/role/ShareholdersEquityType2or3_Parentheticals Consdensed Consolidated Statements of Changes in Equity (Unaudited) (Parentheticals) Statements 7 false false R8.htm 007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.cinedigm.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 8 false false R9.htm 008 - Disclosure - Nature of Operations and Liquidity Sheet http://www.cinedigm.com/role/NatureofOperationsandLiquidity Nature of Operations and Liquidity Notes 9 false false R10.htm 009 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.cinedigm.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 010 - Disclosure - Other Interests Sheet http://www.cinedigm.com/role/OtherInterests Other Interests Notes 11 false false R12.htm 011 - Disclosure - Business Combination Sheet http://www.cinedigm.com/role/BusinessCombination Business Combination Notes 12 false false R13.htm 012 - Disclosure - Notes Payable Notes http://www.cinedigm.com/role/NotesPayable Notes Payable Notes 13 false false R14.htm 013 - Disclosure - Stockholders' Equity Sheet http://www.cinedigm.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 014 - Disclosure - Commitments and Contingencies Sheet http://www.cinedigm.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 15 false false R16.htm 015 - Disclosure - Supplemental Cash Flow Information Sheet http://www.cinedigm.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information Notes 16 false false R17.htm 016 - Disclosure - Segment Information Sheet http://www.cinedigm.com/role/SegmentInformation Segment Information Notes 17 false false R18.htm 017 - Disclosure - Income Taxes Sheet http://www.cinedigm.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 018 - Disclosure - Subsequent Events Sheet http://www.cinedigm.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 019 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.cinedigm.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.cinedigm.com/role/SummaryofSignificantAccountingPolicies 20 false false R21.htm 020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.cinedigm.com/role/SummaryofSignificantAccountingPolicies 21 false false R22.htm 021 - Disclosure - Business Combination (Tables) Sheet http://www.cinedigm.com/role/BusinessCombinationTables Business Combination (Tables) Tables http://www.cinedigm.com/role/BusinessCombination 22 false false R23.htm 022 - Disclosure - Notes Payable (Tables) Notes http://www.cinedigm.com/role/NotesPayableTables Notes Payable (Tables) Tables http://www.cinedigm.com/role/NotesPayable 23 false false R24.htm 023 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.cinedigm.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.cinedigm.com/role/StockholdersEquity 24 false false R25.htm 024 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.cinedigm.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://www.cinedigm.com/role/CommitmentsandContingencies 25 false false R26.htm 025 - Disclosure - Supplemental Cash Flow Information (Tables) Sheet http://www.cinedigm.com/role/SupplementalCashFlowInformationTables Supplemental Cash Flow Information (Tables) Tables http://www.cinedigm.com/role/SupplementalCashFlowInformation 26 false false R27.htm 026 - Disclosure - Segment Information (Tables) Sheet http://www.cinedigm.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.cinedigm.com/role/SegmentInformation 27 false false R28.htm 027 - Disclosure - Nature of Operations and Liquidity (Details) Sheet http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails Nature of Operations and Liquidity (Details) Details http://www.cinedigm.com/role/NatureofOperationsandLiquidity 28 false false R29.htm 028 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables 29 false false R30.htm 029 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of cash, cash equivalents and restricted cash Sheet http://www.cinedigm.com/role/ScheduleofcashcashequivalentsandrestrictedcashTable Summary of Significant Accounting Policies (Details) - Schedule of cash, cash equivalents and restricted cash Details http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables 30 false false R31.htm 030 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment Sheet http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment Details http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables 31 false false R32.htm 031 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of financial assets Sheet http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of financial assets Details http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables 32 false false R33.htm 032 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of goodwill and accumulated impairment charges Sheet http://www.cinedigm.com/role/ScheduleofgoodwillandaccumulatedimpairmentchargesTable Summary of Significant Accounting Policies (Details) - Schedule of goodwill and accumulated impairment charges Details http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables 33 false false R34.htm 033 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of revenue categories Sheet http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable Summary of Significant Accounting Policies (Details) - Schedule of revenue categories Details http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables 34 false false R35.htm 034 - Disclosure - Other Interests (Details) Sheet http://www.cinedigm.com/role/OtherInterestsDetails Other Interests (Details) Details http://www.cinedigm.com/role/OtherInterests 35 false false R36.htm 035 - Disclosure - Business Combination (Details) Sheet http://www.cinedigm.com/role/BusinessCombinationDetails Business Combination (Details) Details http://www.cinedigm.com/role/BusinessCombinationTables 36 false false R37.htm 036 - Disclosure - Business Combination (Details) - Schedule of business combination Sheet http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable Business Combination (Details) - Schedule of business combination Details http://www.cinedigm.com/role/BusinessCombinationTables 37 false false R38.htm 037 - Disclosure - Business Combination (Details) - Schedule of amortization expense per year for the developed technology acquired in the business combination Sheet http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable Business Combination (Details) - Schedule of amortization expense per year for the developed technology acquired in the business combination Details http://www.cinedigm.com/role/BusinessCombinationTables 38 false false R39.htm 038 - Disclosure - Business Combination (Details) - Schedule of amortization expense per year for the intangible assets acquired in the business combination Sheet http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable Business Combination (Details) - Schedule of amortization expense per year for the intangible assets acquired in the business combination Details http://www.cinedigm.com/role/BusinessCombinationTables 39 false false R40.htm 039 - Disclosure - Notes Payable (Details) Notes http://www.cinedigm.com/role/NotesPayableDetails Notes Payable (Details) Details http://www.cinedigm.com/role/NotesPayableTables 40 false false R41.htm 040 - Disclosure - Notes Payable (Details) - Schedule of notes payable Notes http://www.cinedigm.com/role/ScheduleofnotespayableTable Notes Payable (Details) - Schedule of notes payable Details http://www.cinedigm.com/role/NotesPayableTables 41 false false R42.htm 041 - Disclosure - Notes Payable (Details) - Schedule of debt outstanding Notes http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable Notes Payable (Details) - Schedule of debt outstanding Details http://www.cinedigm.com/role/NotesPayableTables 42 false false R43.htm 042 - Disclosure - Stockholders' Equity (Details) Sheet http://www.cinedigm.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.cinedigm.com/role/StockholdersEquityTables 43 false false R44.htm 043 - Disclosure - Stockholders' Equity (Details) - Schedule of analysis of option activity Sheet http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable Stockholders' Equity (Details) - Schedule of analysis of option activity Details http://www.cinedigm.com/role/StockholdersEquityTables 44 false false R45.htm 044 - Disclosure - Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding Sheet http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding Details http://www.cinedigm.com/role/StockholdersEquityTables 45 false false R46.htm 045 - Disclosure - Stockholders' Equity (Details) - Schedule of stock-based compensation expense Sheet http://www.cinedigm.com/role/ScheduleofstockbasedcompensationexpenseTable Stockholders' Equity (Details) - Schedule of stock-based compensation expense Details http://www.cinedigm.com/role/StockholdersEquityTables 46 false false R47.htm 046 - Disclosure - Stockholders' Equity (Details) - Schedule of SARs outstanding Sheet http://www.cinedigm.com/role/ScheduleofSARsoutstandingTable Stockholders' Equity (Details) - Schedule of SARs outstanding Details http://www.cinedigm.com/role/StockholdersEquityTables 47 false false R48.htm 047 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants Sheet http://www.cinedigm.com/role/ScheduleofwarrantsTable Stockholders' Equity (Details) - Schedule of warrants Details http://www.cinedigm.com/role/StockholdersEquityTables 48 false false R49.htm 048 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.cinedigm.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.cinedigm.com/role/CommitmentsandContingenciesTables 49 false false R50.htm 049 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities Sheet http://www.cinedigm.com/role/ScheduleofleaserelatedassetsandliabilitiesTable Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities Details http://www.cinedigm.com/role/CommitmentsandContingenciesTables 50 false false R51.htm 050 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease costs Sheet http://www.cinedigm.com/role/ScheduleofleasecostsTable Commitments and Contingencies (Details) - Schedule of lease costs Details http://www.cinedigm.com/role/CommitmentsandContingenciesTables 51 false false R52.htm 051 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flows Sheet http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flows Details http://www.cinedigm.com/role/SupplementalCashFlowInformationTables 52 false false R53.htm 052 - Disclosure - Segment Information (Details) Sheet http://www.cinedigm.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.cinedigm.com/role/SegmentInformationTables 53 false false R54.htm 053 - Disclosure - Segment Information (Details) - Schedule of segment reporting, assets and debt Sheet http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable Segment Information (Details) - Schedule of segment reporting, assets and debt Details http://www.cinedigm.com/role/SegmentInformationTables 54 false false R55.htm 054 - Disclosure - Segment Information (Details) - Schedule of segment reporting, statement of operations Sheet http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable Segment Information (Details) - Schedule of segment reporting, statement of operations Details http://www.cinedigm.com/role/SegmentInformationTables 55 false false R56.htm 055 - Disclosure - Segment Information (Details) - Schedule of segment reporting, employee stock-based compensation expense Sheet http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable Segment Information (Details) - Schedule of segment reporting, employee stock-based compensation expense Details http://www.cinedigm.com/role/SegmentInformationTables 56 false false R57.htm 056 - Disclosure - Income Taxes (Details) Sheet http://www.cinedigm.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.cinedigm.com/role/IncomeTaxes 57 false false R58.htm 057 - Disclosure - Subsequent Events (Details) Sheet http://www.cinedigm.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.cinedigm.com/role/SubsequentEvents 58 false false All Reports Book All Reports f10q1221_cinedigmcorp.htm cidm-20211231.xsd cidm-20211231_cal.xml cidm-20211231_def.xml cidm-20211231_lab.xml cidm-20211231_pre.xml f10q1221ex31-1_cinedigm.htm f10q1221ex31-2_cinedigm.htm f10q1221ex32-1_cinedigm.htm f10q1221ex32-2_cinedigm.htm http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 75 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q1221_cinedigmcorp.htm": { "axisCustom": 1, "axisStandard": 28, "contextCount": 340, "dts": { "calculationLink": { "local": [ "cidm-20211231_cal.xml" ] }, "definitionLink": { "local": [ "cidm-20211231_def.xml" ] }, "inline": { "local": [ "f10q1221_cinedigmcorp.htm" ] }, "labelLink": { "local": [ "cidm-20211231_lab.xml" ] }, "presentationLink": { "local": [ "cidm-20211231_pre.xml" ] }, "schema": { "local": [ "cidm-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd" ] } }, "elementCount": 683, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 235, "http://www.cinedigm.com/20211231": 169, "http://xbrl.sec.gov/dei/2021": 5, "total": 409 }, "keyCustom": 166, "keyStandard": 373, "memberCustom": 38, "memberStandard": 34, "nsprefix": "cidm", "nsuri": "http://www.cinedigm.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.cinedigm.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.cinedigm.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Other Interests", "role": "http://www.cinedigm.com/role/OtherInterests", "shortName": "Other Interests", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Business Combination", "role": "http://www.cinedigm.com/role/BusinessCombination", "shortName": "Business Combination", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Notes Payable", "role": "http://www.cinedigm.com/role/NotesPayable", "shortName": "Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Stockholders' Equity", "role": "http://www.cinedigm.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Commitments and Contingencies", "role": "http://www.cinedigm.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Supplemental Cash Flow Information", "role": "http://www.cinedigm.com/role/SupplementalCashFlowInformation", "shortName": "Supplemental Cash Flow Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Segment Information", "role": "http://www.cinedigm.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Income Taxes", "role": "http://www.cinedigm.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Subsequent Events", "role": "http://www.cinedigm.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.cinedigm.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://www.cinedigm.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Business Combination (Tables)", "role": "http://www.cinedigm.com/role/BusinessCombinationTables", "shortName": "Business Combination (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Notes Payable (Tables)", "role": "http://www.cinedigm.com/role/NotesPayableTables", "shortName": "Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Stockholders' Equity (Tables)", "role": "http://www.cinedigm.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cidm:ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://www.cinedigm.com/role/CommitmentsandContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cidm:ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Supplemental Cash Flow Information (Tables)", "role": "http://www.cinedigm.com/role/SupplementalCashFlowInformationTables", "shortName": "Supplemental Cash Flow Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cidm:ReconciliationOfAssetsAndDebtFromSegmentToConsolidatedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Segment Information (Tables)", "role": "http://www.cinedigm.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cidm:ReconciliationOfAssetsAndDebtFromSegmentToConsolidatedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAppropriated", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Nature of Operations and Liquidity (Details)", "role": "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails", "shortName": "Nature of Operations and Liquidity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c133", "decimals": "-5", "lang": null, "name": "cidm:DebtInstrumentsFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c146", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentQuotedMarketValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c146", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentQuotedMarketValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of cash, cash equivalents and restricted cash", "role": "http://www.cinedigm.com/role/ScheduleofcashcashequivalentsandrestrictedcashTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of cash, cash equivalents and restricted cash", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c161", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment", "role": "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of estimated useful lives of property and equipment", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c161", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of financial assets", "role": "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of financial assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "cidm:GoodwillGrossbegginng", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of goodwill and accumulated impairment charges", "role": "http://www.cinedigm.com/role/ScheduleofgoodwillandaccumulatedimpairmentchargesTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of goodwill and accumulated impairment charges", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "cidm:GoodwillGrossbegginng", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c189", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of revenue categories", "role": "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of revenue categories", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c189", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "cidm:ServicingRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Other Interests (Details)", "role": "http://www.cinedigm.com/role/OtherInterestsDetails", "shortName": "Other Interests (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "cidm:ServicingRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c211", "decimals": null, "first": true, "lang": "en-US", "name": "cidm:DescriptionOfStockPurchaseAgreement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Business Combination (Details)", "role": "http://www.cinedigm.com/role/BusinessCombinationDetails", "shortName": "Business Combination (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c211", "decimals": null, "first": true, "lang": "en-US", "name": "cidm:DescriptionOfStockPurchaseAgreement", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c214", "decimals": "-3", "first": true, "lang": null, "name": "cidm:PurchasedPrice", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Business Combination (Details) - Schedule of business combination", "role": "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable", "shortName": "Business Combination (Details) - Schedule of business combination", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ImpairedFinancingReceivablesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c214", "decimals": "-3", "first": true, "lang": null, "name": "cidm:PurchasedPrice", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Business Combination (Details) - Schedule of amortization expense per year for the developed technology acquired in the business combination", "role": "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable", "shortName": "Business Combination (Details) - Schedule of amortization expense per year for the developed technology acquired in the business combination", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Business Combination (Details) - Schedule of amortization expense per year for the intangible assets acquired in the business combination", "role": "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable", "shortName": "Business Combination (Details) - Schedule of amortization expense per year for the intangible assets acquired in the business combination", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "role": "http://www.cinedigm.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "lang": null, "name": "us-gaap:OtherCostAndExpenseOperating", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RestrictedCashAndCashEquivalents", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Notes Payable (Details)", "role": "http://www.cinedigm.com/role/NotesPayableDetails", "shortName": "Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c133", "decimals": "-5", "lang": null, "name": "us-gaap:PrincipalAmountOutstandingOfLoansHeldInPortfolio", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c235", "decimals": "-3", "first": true, "lang": null, "name": "cidm:PaycheckProtectionProgramLoan", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Notes Payable (Details) - Schedule of notes payable", "role": "http://www.cinedigm.com/role/ScheduleofnotespayableTable", "shortName": "Notes Payable (Details) - Schedule of notes payable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c235", "decimals": "-3", "first": true, "lang": null, "name": "cidm:PaycheckProtectionProgramLoan", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c116", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Notes Payable (Details) - Schedule of debt outstanding", "role": "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable", "shortName": "Notes Payable (Details) - Schedule of debt outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c116", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PreferredStockAmountOfPreferredDividendsInArrears", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Stockholders' Equity (Details)", "role": "http://www.cinedigm.com/role/StockholdersEquityDetails", "shortName": "Stockholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PreferredStockAmountOfPreferredDividendsInArrears", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Stockholders' Equity (Details) - Schedule of analysis of option activity", "role": "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "shortName": "Stockholders' Equity (Details) - Schedule of analysis of option activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c264", "decimals": "2", "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "INF", "first": true, "lang": null, "name": "cidm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding", "role": "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable", "shortName": "Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "INF", "first": true, "lang": null, "name": "cidm:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c278", "decimals": "-3", "first": true, "lang": null, "name": "cidm:SellingGeneralAndAdministrative", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Stockholders' Equity (Details) - Schedule of stock-based compensation expense", "role": "http://www.cinedigm.com/role/ScheduleofstockbasedcompensationexpenseTable", "shortName": "Stockholders' Equity (Details) - Schedule of stock-based compensation expense", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c278", "decimals": "-3", "first": true, "lang": null, "name": "cidm:SellingGeneralAndAdministrative", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "cidm:ScheduleOfSARsOutstandingTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Stockholders' Equity (Details) - Schedule of SARs outstanding", "role": "http://www.cinedigm.com/role/ScheduleofSARsoutstandingTable", "shortName": "Stockholders' Equity (Details) - Schedule of SARs outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "cidm:ScheduleOfSARsOutstandingTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c280", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Stockholders' Equity (Details) - Schedule of warrants", "role": "http://www.cinedigm.com/role/ScheduleofwarrantsTable", "shortName": "Stockholders' Equity (Details) - Schedule of warrants", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c280", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c283", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.cinedigm.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c283", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "first": true, "lang": null, "name": "cidm:NetIncomeloss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)", "role": "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "first": true, "lang": null, "name": "cidm:NetIncomeloss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "cidm:ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "cidm:OperatingLeaseRightOfUseAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities", "role": "http://www.cinedigm.com/role/ScheduleofleaserelatedassetsandliabilitiesTable", "shortName": "Commitments and Contingencies (Details) - Schedule of lease-related assets and liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "cidm:ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "cidm:OperatingLeaseRightOfUseAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Commitments and Contingencies (Details) - Schedule of lease costs", "role": "http://www.cinedigm.com/role/ScheduleofleasecostsTable", "shortName": "Commitments and Contingencies (Details) - Schedule of lease costs", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flows", "role": "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable", "shortName": "Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flows", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - Segment Information (Details)", "role": "http://www.cinedigm.com/role/SegmentInformationDetails", "shortName": "Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - Segment Information (Details) - Schedule of segment reporting, assets and debt", "role": "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable", "shortName": "Segment Information (Details) - Schedule of segment reporting, assets and debt", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c3", "decimals": "-3", "lang": null, "name": "us-gaap:SecuredDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - Segment Information (Details) - Schedule of segment reporting, statement of operations", "role": "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable", "shortName": "Segment Information (Details) - Schedule of segment reporting, statement of operations", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "lang": null, "name": "us-gaap:DirectOperatingCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "055 - Disclosure - Segment Information (Details) - Schedule of segment reporting, employee stock-based compensation expense", "role": "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable", "shortName": "Segment Information (Details) - Schedule of segment reporting, employee stock-based compensation expense", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "056 - Disclosure - Income Taxes (Details)", "role": "http://www.cinedigm.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c8", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c339", "decimals": null, "first": true, "lang": "en-US", "name": "cidm:PurchaseAgreementDescrption", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "057 - Disclosure - Subsequent Events (Details)", "role": "http://www.cinedigm.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c339", "decimals": null, "first": true, "lang": "en-US", "name": "cidm:PurchaseAgreementDescrption", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c11", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Consdensed Consolidated Statements of Changes in Equity (Unaudited)", "role": "http://www.cinedigm.com/role/ShareholdersEquityType2or3", "shortName": "Consdensed Consolidated Statements of Changes in Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c11", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c46", "decimals": "-3", "first": true, "lang": null, "name": "cidm:IssuanceCostsOfClassACommonStockNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Consdensed Consolidated Statements of Changes in Equity (Unaudited) (Parentheticals)", "role": "http://www.cinedigm.com/role/ShareholdersEquityType2or3_Parentheticals", "shortName": "Consdensed Consolidated Statements of Changes in Equity (Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c46", "decimals": "-3", "first": true, "lang": null, "name": "cidm:IssuanceCostsOfClassACommonStockNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://www.cinedigm.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Nature of Operations and Liquidity", "role": "http://www.cinedigm.com/role/NatureofOperationsandLiquidity", "shortName": "Nature of Operations and Liquidity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q1221_cinedigmcorp.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 77, "tag": { "cidm_AccountsReceivableServiceEquityInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts receivable by the company for services provided to CDF2.", "label": "AccountsReceivableServiceEquityInvestment", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableServiceEquityInvestment", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "monetaryItemType" }, "cidm_AccretionExpenseAddedToDeferredConsideration": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion expense added to deferred consideration.", "label": "AccretionExpenseAddedToDeferredConsideration", "terseLabel": "Interest expense for deferred consideration" } } }, "localname": "AccretionExpenseAddedToDeferredConsideration", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_AccretionExpenseAddedToEarnoutConsideration": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion expense added to earnout consideration.", "label": "AccretionExpenseAddedToEarnoutConsideration", "terseLabel": "Interest expense for earnout consideration" } } }, "localname": "AccretionExpenseAddedToEarnoutConsideration", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_ActivationFeeRevenuePerScreen": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Activation Fee Revenue, Per Screen", "label": "ActivationFeeRevenuePerScreen", "terseLabel": "Activation fee revenue, per screen" } } }, "localname": "ActivationFeeRevenuePerScreen", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_ActivationFeeRevenueRangeMaximum": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Range of revenue on Phase 2 DC systems the company recognizes for activation fees per unit, maximum.", "label": "ActivationFeeRevenueRangeMaximum", "terseLabel": "Activation fee revenue range, maximum" } } }, "localname": "ActivationFeeRevenueRangeMaximum", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_ActivationFeeRevenueRangeMinimum": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Range of revenue on Phase 2 DC systems the company recognizes for activation fees per unit, minimum.", "label": "ActivationFeeRevenueRangeMinimum", "terseLabel": "Activation fee revenue range, minimum" } } }, "localname": "ActivationFeeRevenueRangeMinimum", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_AdministrativeFeesVpf": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Administrative fee percentage (of Virtual Print Fees collected) that the company will deduct from VPFs remitted to exhibitors, in exchange for the management and administration of billing and collections of VPFs. Specific to Phase 2 DC systems and CDF2 systems.", "label": "AdministrativeFeesVpf", "terseLabel": "Administrative fee VPFs" } } }, "localname": "AdministrativeFeesVpf", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "cidm_AdvancesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AdvancesPolicyTextBlock", "terseLabel": "ADVANCES" } } }, "localname": "AdvancesPolicyTextBlock", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "cidm_AdvertiserRelationships": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advertiser relationships.", "label": "AdvertiserRelationships", "terseLabel": "Advertiser relationships" } } }, "localname": "AdvertiserRelationships", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_AdvertiserRelationshipsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AdvertiserRelationshipsMember", "terseLabel": "Advertiser relationships [Member]" } } }, "localname": "AdvertiserRelationshipsMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "domainItemType" }, "cidm_AgreementsIncludedTheSaleInTranches": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AgreementsIncludedTheSaleInTranches", "terseLabel": "Agreements included the sale in tranches (in Shares)" } } }, "localname": "AgreementsIncludedTheSaleInTranches", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "sharesItemType" }, "cidm_AllocationOfPurchasePriceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AllocationOfPurchasePriceAbstract", "terseLabel": "Allocation of purchase price" } } }, "localname": "AllocationOfPurchasePriceAbstract", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "stringItemType" }, "cidm_AmortizationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization expense.", "label": "AmortizationExpense", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationExpense", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "cidm_AmortizationExpenseIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "AmortizationExpenseIntangibleAssets", "terseLabel": "Amortization intangible assets" } } }, "localname": "AmortizationExpenseIntangibleAssets", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "cidm_AmountPayableToVendors": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "AmountPayableToVendors", "terseLabel": "Amount payable to vendors" } } }, "localname": "AmountPayableToVendors", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_BEMGTermLoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BEMGTermLoanAgreementMember", "terseLabel": "BEMG in connection with a term loan agreement [Member]" } } }, "localname": "BEMGTermLoanAgreementMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofwarrantsTable" ], "xbrltype": "domainItemType" }, "cidm_BaseDistributionBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BaseDistributionBusinessMember", "terseLabel": "Base Distribution Business [Member]" } } }, "localname": "BaseDistributionBusinessMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "domainItemType" }, "cidm_BeiTaiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BeiTaiMember", "terseLabel": "BeiTai [Member]" } } }, "localname": "BeiTaiMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "domainItemType" }, "cidm_BloodyDisgustingLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BloodyDisgustingLLCMember", "terseLabel": "Bloody Disgusting, LLC. [Member]" } } }, "localname": "BloodyDisgustingLLCMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "domainItemType" }, "cidm_BusinessCombinationCashPaymentDiscounted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination cash payment discounted.", "label": "BusinessCombinationCashPaymentDiscounted", "terseLabel": "Cash payments discounted" } } }, "localname": "BusinessCombinationCashPaymentDiscounted", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "percentItemType" }, "cidm_BusinessCombinationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Line Items]" } } }, "localname": "BusinessCombinationDetailsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "cidm_BusinessCombinationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Table]" } } }, "localname": "BusinessCombinationDetailsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "cidm_BusinessCombinationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Asset Acquistion [Abstract]" } } }, "localname": "BusinessCombinationLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombination" ], "xbrltype": "stringItemType" }, "cidm_BusinessCombinationNumberOfSharesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Number of Shares Acquired", "label": "BusinessCombinationNumberOfSharesAcquired", "terseLabel": "Number of shares acquired (in Shares)" } } }, "localname": "BusinessCombinationNumberOfSharesAcquired", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "sharesItemType" }, "cidm_BusinessCombinationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination [Table]" } } }, "localname": "BusinessCombinationTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombination" ], "xbrltype": "stringItemType" }, "cidm_CDCHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CDCHMember", "terseLabel": "CDCH [Member]" } } }, "localname": "CDCHMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "cidm_CONtvMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONtvMember", "terseLabel": "CON TV, LLC [Member]" } } }, "localname": "CONtvMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "domainItemType" }, "cidm_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for amounts included in the measurement of lease liabilities.", "label": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofleasecostsTable" ], "xbrltype": "monetaryItemType" }, "cidm_ChangeInFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "ChangeInFairValue", "terseLabel": "Change in fair value" } } }, "localname": "ChangeInFairValue", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_CinedigmCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CinedigmCreditFacilityMember", "terseLabel": "Cinedigm Credit Facility [Member]" } } }, "localname": "CinedigmCreditFacilityMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "cidm_CinedigmEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CinedigmEquityIncentivePlanMember", "terseLabel": "Cinedigm Equity Incentive Plan [Member]" } } }, "localname": "CinedigmEquityIncentivePlanMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cidm_CinemaEquipmentBusinessAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CinemaEquipmentBusinessAbstract", "terseLabel": "Cinema Equipment Business:" } } }, "localname": "CinemaEquipmentBusinessAbstract", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "stringItemType" }, "cidm_CinemaEquipmentBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CinemaEquipmentBusinessMember", "terseLabel": "Cinema Equipment Business [Member]" } } }, "localname": "CinemaEquipmentBusinessMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "domainItemType" }, "cidm_CinemaEquipmentBusinessOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CinemaEquipmentBusinessOneMember", "terseLabel": "Cinema Equipment Business [Member]" } } }, "localname": "CinemaEquipmentBusinessOneMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "domainItemType" }, "cidm_ClassACommonStockToBeIssuedInConnectionWithAssetAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of class A common stock to be issued in connection with asset acquisition.", "label": "ClassACommonStockToBeIssuedInConnectionWithAssetAcquisition", "terseLabel": "Class A common stock to be issued in connection with asset acquisition" } } }, "localname": "ClassACommonStockToBeIssuedInConnectionWithAssetAcquisition", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_ClassACommonStockToBeIssuedInConnectionWithTheAssetAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of Class A common stock to be issued in connection with the asset acquisition.", "label": "ClassACommonStockToBeIssuedInConnectionWithTheAssetAcquisition", "terseLabel": "Class A common stock to be issued in connection with the asset acquisition" } } }, "localname": "ClassACommonStockToBeIssuedInConnectionWithTheAssetAcquisition", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_ClassOfWarrantOrRighstYearandMonthFromWhichWarrantsOrRightsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the warrants or rights are exercisable, in year and month format.", "label": "ClassOfWarrantOrRighstYearandMonthFromWhichWarrantsOrRightsExercisable", "terseLabel": "Expiration" } } }, "localname": "ClassOfWarrantOrRighstYearandMonthFromWhichWarrantsOrRightsExercisable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofwarrantsTable" ], "xbrltype": "gYearMonthItemType" }, "cidm_CommonStockExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares expired.", "label": "CommonStockExpired", "terseLabel": "Common stock expired unexercised" } } }, "localname": "CommonStockExpired", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "cidm_CommonStockIssuedInConnectionWithConversionOfConvertibleNotesAndSecondLienLoans": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued in connection with conversion of Convertible Notes and second lien loans.", "label": "CommonStockIssuedInConnectionWithConversionOfConvertibleNotesAndSecondLienLoans", "terseLabel": "Issuance of stock in connection with settlement of second lien loan" } } }, "localname": "CommonStockIssuedInConnectionWithConversionOfConvertibleNotesAndSecondLienLoans", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_CommonStockIssuedInConnectionWithConversionOfConvertibleNotesAndSecondLienLoansShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock issued in connection with conversion of Convertible Notes and second lien loans.", "label": "CommonStockIssuedInConnectionWithConversionOfConvertibleNotesAndSecondLienLoansShares", "terseLabel": "Issuance of stock in connection with settlement of second lien loan (in Shares)" } } }, "localname": "CommonStockIssuedInConnectionWithConversionOfConvertibleNotesAndSecondLienLoansShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_CommonStockIssuedToSettleSecondLienLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued to settle second lien loan", "label": "CommonStockIssuedToSettleSecondLienLoan", "terseLabel": "Common stock issued to settle second lien loan" } } }, "localname": "CommonStockIssuedToSettleSecondLienLoan", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_CommonStockIssuedToSettleSecondLienLoaninShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CommonStockIssuedToSettleSecondLienLoaninShares", "terseLabel": "Common stock issued to settle second lien loan (in Shares)" } } }, "localname": "CommonStockIssuedToSettleSecondLienLoaninShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_ComonPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ComonPerShare", "terseLabel": "Comon per share (in Dollars per share)" } } }, "localname": "ComonPerShare", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "perShareItemType" }, "cidm_ContentAndEntertainmentSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ContentAndEntertainmentSegmentMember", "terseLabel": "Content & Entertainment Business [Member]" } } }, "localname": "ContentAndEntertainmentSegmentMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "domainItemType" }, "cidm_ContentEntertainmentBusinessAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ContentEntertainmentBusinessAbstract", "terseLabel": "Content & Entertainment Business:" } } }, "localname": "ContentEntertainmentBusinessAbstract", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "stringItemType" }, "cidm_ContentEntertainmentBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ContentEntertainmentBusinessMember", "terseLabel": "Content & Entertainment Business [Member]" } } }, "localname": "ContentEntertainmentBusinessMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable" ], "xbrltype": "domainItemType" }, "cidm_ContentEntertainmentBusinessOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ContentEntertainmentBusinessOneMember", "terseLabel": "Content & Entertainment Business [Member]" } } }, "localname": "ContentEntertainmentBusinessOneMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "domainItemType" }, "cidm_ContributedCapitalUnderTheStarriseTransactionARelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contributed capital under the Starrise transaction, a related party", "label": "ContributedCapitalUnderTheStarriseTransactionARelatedParty", "terseLabel": "Contributed capital under the Starrise transaction, a related party" } } }, "localname": "ContributedCapitalUnderTheStarriseTransactionARelatedParty", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_ConversionOfNotePayable1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ConversionOfNotePayable1", "terseLabel": "Conversion of note payable" } } }, "localname": "ConversionOfNotePayable1", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_ConvertedAggregateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Converted Aggregate Description", "label": "ConvertedAggregateDescription", "terseLabel": "Converted aggregate description" } } }, "localname": "ConvertedAggregateDescription", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "stringItemType" }, "cidm_CreditFacility": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value payment of credit facility.", "label": "CreditFacility", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacility", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "cidm_CurrentPortionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CurrentPortionMember", "terseLabel": "Current Portion [Member]" } } }, "localname": "CurrentPortionMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "domainItemType" }, "cidm_CurrentPortionOfDeferredConsiderationOnPurchaseOfABusiness": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current portion of deferred consideration on purchase of a business.", "label": "CurrentPortionOfDeferredConsiderationOnPurchaseOfABusiness", "terseLabel": "Current portion of deferred consideration on purchase of a business" } } }, "localname": "CurrentPortionOfDeferredConsiderationOnPurchaseOfABusiness", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "cidm_CurrentPortionOfEarnoutConsiderationOnPurchaseOfABusiness": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of current portion of earnout consideration on purchase of a business.", "label": "CurrentPortionOfEarnoutConsiderationOnPurchaseOfABusiness", "terseLabel": "Current portion of earnout consideration on purchase of a business" } } }, "localname": "CurrentPortionOfEarnoutConsiderationOnPurchaseOfABusiness", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "cidm_DebtInstrumentMaximumAmountOfSupport": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Maximum Amount of Support.", "label": "DebtInstrumentMaximumAmountOfSupport", "terseLabel": "Debt instrument maximum amount of support" } } }, "localname": "DebtInstrumentMaximumAmountOfSupport", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "cidm_DebtInstrumentPaymentsToDate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total payments to date made by company for term loan debt instruments.", "label": "DebtInstrumentPaymentsToDate", "terseLabel": "Payments to date" } } }, "localname": "DebtInstrumentPaymentsToDate", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable" ], "xbrltype": "monetaryItemType" }, "cidm_DebtInstrumentsFaceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "DebtInstrumentsFaceAmount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentsFaceAmount", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_DebtLoanAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "DebtLoanAgreement", "terseLabel": "Debt loan agreement" } } }, "localname": "DebtLoanAgreement", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "cidm_DebtVariableRateBasisFloor": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Variable Rate Basis, Floor.", "label": "DebtVariableRateBasisFloor", "terseLabel": "Debt variable rate basis floor" } } }, "localname": "DebtVariableRateBasisFloor", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "percentItemType" }, "cidm_DeferredConsiderationInPurchaseOfABusiness": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred consideration in purchase of a business.", "label": "DeferredConsiderationInPurchaseOfABusiness", "terseLabel": "Deferred consideration in purchase of a business" } } }, "localname": "DeferredConsiderationInPurchaseOfABusiness", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_DeferredRevenueArrangementType_Domain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DeferredRevenueArrangementType_ [Domain]" } } }, "localname": "DeferredRevenueArrangementType_Domain", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cidm_DeferredRevenues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "DeferredRevenues", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenues", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_DescriptionOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DescriptionOfBusinessCombination", "terseLabel": "Description of business combination" } } }, "localname": "DescriptionOfBusinessCombination", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "cidm_DescriptionOfStockPurchaseAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of stock purchase agreement.", "label": "DescriptionOfStockPurchaseAgreement", "terseLabel": "Description of stock purchase agreement" } } }, "localname": "DescriptionOfStockPurchaseAgreement", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "cidm_DevelopedTechnology": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "DevelopedTechnology", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnology", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_DigitalCinemaProjectionSystemsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DigitalCinemaProjectionSystemsMember", "terseLabel": "Digital cinema projection systems [Member]" } } }, "localname": "DigitalCinemaProjectionSystemsMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "cidm_DigitalSystemSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DigitalSystemSalesMember", "terseLabel": "Digital System Sales [Member]" } } }, "localname": "DigitalSystemSalesMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "domainItemType" }, "cidm_DirectOperatingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Direct Operating Costs Policy Text block.", "label": "DirectOperatingCostsPolicyTextBlock", "terseLabel": "DIRECT OPERATING COSTS" } } }, "localname": "DirectOperatingCostsPolicyTextBlock", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "cidm_DiscountRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Discount rate percentage.", "label": "DiscountRatePercentage", "terseLabel": "Discount rate percentage" } } }, "localname": "DiscountRatePercentage", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "cidm_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_EarnoutConsiderationInPurchaseOfABusiness": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of earnout consideration in purchase of a business.", "label": "EarnoutConsiderationInPurchaseOfABusiness", "terseLabel": "Earnout consideration in purchase of a business" } } }, "localname": "EarnoutConsiderationInPurchaseOfABusiness", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_EarnoutConsiderationOnPurchaseOfABusinessNetOfCurrentPortion": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of earnout consideration on purchase of a business, net of current portion.", "label": "EarnoutConsiderationOnPurchaseOfABusinessNetOfCurrentPortion", "terseLabel": "Earnout consideration on purchase of a business, net of current portion" } } }, "localname": "EarnoutConsiderationOnPurchaseOfABusinessNetOfCurrentPortion", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "cidm_EquityLinePurchaseAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity line purchase agreement, description.", "label": "EquityLinePurchaseAgreementDescription", "terseLabel": "Equity line purchase agreement, description" } } }, "localname": "EquityLinePurchaseAgreementDescription", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "stringItemType" }, "cidm_EquityMethodInvestmentsSummarizedFinancialInformationEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity, including noncontrolling interest, reported by an equity method investment of the entity.", "label": "EquityMethodInvestmentsSummarizedFinancialInformationEquity", "terseLabel": "Total Stockholders\u2019 Deficit" } } }, "localname": "EquityMethodInvestmentsSummarizedFinancialInformationEquity", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "monetaryItemType" }, "cidm_ExerciseOfWarrantsForClassACommonStockinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise of warrants for Class A common stock (in Shares).", "label": "ExerciseOfWarrantsForClassACommonStockinShares", "terseLabel": "Exercise of warrants for Class A common stock (in Shares)" } } }, "localname": "ExerciseOfWarrantsForClassACommonStockinShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_ExercisePriceRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePriceRangeOneMember", "terseLabel": "$7.40 - $13.69 [Member]", "verboseLabel": "$0.54 - $0.74 [Member]" } } }, "localname": "ExercisePriceRangeOneMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "domainItemType" }, "cidm_ExercisePriceRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePriceRangeThreeMember", "terseLabel": "$1.71 - $2.10 [Member]" } } }, "localname": "ExercisePriceRangeThreeMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "domainItemType" }, "cidm_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisePriceRangeTwoMember", "terseLabel": "$14.00 - $24.40 [Member]", "verboseLabel": "$1.16 - $1.47 [Member]" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "domainItemType" }, "cidm_ExercisesPriceRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ExercisesPriceRangeFourMember", "terseLabel": "$2.23 - $2.56 [Member]" } } }, "localname": "ExercisesPriceRangeFourMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "domainItemType" }, "cidm_FairValueCommonStockPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value common stock per share.", "label": "FairValueCommonStockPerShare", "terseLabel": "Fair value common stock per share (in Dollars per share)" } } }, "localname": "FairValueCommonStockPerShare", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "cidm_FiniteLivedIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssets", "terseLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssets", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearEleven": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearEleven", "terseLabel": "2032" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearEleven", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearNine": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearNine", "terseLabel": "2030" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearNine", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearSeven": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearSeven", "terseLabel": "2029" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearSeven", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearSix": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense rolling year six.", "label": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearSix", "terseLabel": "2028" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearSix", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTen": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTen", "terseLabel": "2031" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTen", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTherteen": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTherteen", "terseLabel": "2034" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTherteen", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwelve": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwelve", "terseLabel": "2033" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwelve", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseYearEight", "terseLabel": "2030" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearEight", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseYearNine", "terseLabel": "2031" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearNine", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven", "terseLabel": "2029" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseYearSix", "terseLabel": "2028" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearSix", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTen", "terseLabel": "2032" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTen", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_FoundationTVIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FoundationTVIncMember", "terseLabel": "FoundationTV, Inc. [Member]" } } }, "localname": "FoundationTVIncMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "domainItemType" }, "cidm_GaiamAmericasIncAndGaiamIncGVEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GaiamAmericasIncAndGaiamIncGVEMember", "terseLabel": "Gaiam Americas, Inc. and Gaiam, Inc. (GVE) [Member]", "verboseLabel": "Gaiam Americas, Inc. and Gaiam, Inc. GVE [Member]" } } }, "localname": "GaiamAmericasIncAndGaiamIncGVEMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cidm_GainLossFromForgivenesOfPPPLoanAndExtinguishmentOfNotePayable": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "GainLossFromForgivenesOfPPPLoanAndExtinguishmentOfNotePayable", "terseLabel": "(Gain) loss from forgiveness of PPP loan and extinguishment of note payable" } } }, "localname": "GainLossFromForgivenesOfPPPLoanAndExtinguishmentOfNotePayable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_GainsLossOnExtinguishmentOfDebt": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "GainsLossOnExtinguishmentOfDebt", "negatedLabel": "Loss from sale of property and equipment" } } }, "localname": "GainsLossOnExtinguishmentOfDebt", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_GoodwillGrossbegginng": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Goodwill gross.", "label": "GoodwillGrossbegginng", "terseLabel": "Goodwill gross beginning" } } }, "localname": "GoodwillGrossbegginng", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofgoodwillandaccumulatedimpairmentchargesTable" ], "xbrltype": "monetaryItemType" }, "cidm_GoodwillGrossending": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "GoodwillGrossending", "terseLabel": "Goodwill gross ending" } } }, "localname": "GoodwillGrossending", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofgoodwillandaccumulatedimpairmentchargesTable" ], "xbrltype": "monetaryItemType" }, "cidm_HoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "HoldingsMember", "terseLabel": "CDF2 Holdings [Member]" } } }, "localname": "HoldingsMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "domainItemType" }, "cidm_ImpairmentOfPrepaidAdvances": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Impairment of prepaid advances", "label": "ImpairmentOfPrepaidAdvances", "negatedLabel": "Impairment of advances" } } }, "localname": "ImpairmentOfPrepaidAdvances", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_ImpairmentsAndAcceleratedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairments and accelerated amortization.", "label": "ImpairmentsAndAcceleratedAmortization", "terseLabel": "Impairments and accelerated amortization advances" } } }, "localname": "ImpairmentsAndAcceleratedAmortization", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_IncentiveFeesPercentageOfVPFPhaseI": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IIncentive Fees, Percentage of VPF Phase I", "label": "IncentiveFeesPercentageOfVPFPhaseI", "terseLabel": "Incentive fees, percentage of VPF Phase I" } } }, "localname": "IncentiveFeesPercentageOfVPFPhaseI", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "cidm_IncomeTaxDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income tax description.", "label": "IncomeTaxDescription", "terseLabel": "Income tax description" } } }, "localname": "IncomeTaxDescription", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "cidm_IncreaseDecreaseInUnbilledRevenue": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInUnbilledRevenue", "negatedLabel": "Unbilled revenue" } } }, "localname": "IncreaseDecreaseInUnbilledRevenue", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_InternalUseSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "InternalUseSoftwareMember", "terseLabel": "Internal use software [Member]" } } }, "localname": "InternalUseSoftwareMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "cidm_IssuanceCostsOfClassACommonStockNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value for issuance costs of class A common stock, net.", "label": "IssuanceCostsOfClassACommonStockNet", "terseLabel": "Issuance costs of class A common stock, net" } } }, "localname": "IssuanceCostsOfClassACommonStockNet", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3_Parentheticals" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfClassACommonStockForPaymentOfPreferredStockDividends": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of Class A common stock for payment of preferred stock dividends.", "label": "IssuanceOfClassACommonStockForPaymentOfPreferredStockDividends", "terseLabel": "Issuance of Class A common stock for payment of accrued preferred stock dividends" } } }, "localname": "IssuanceOfClassACommonStockForPaymentOfPreferredStockDividends", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfClassACommonStockInConnectionWithTheStarriseTransactionARelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "IssuanceOfClassACommonStockInConnectionWithTheStarriseTransactionARelatedParty.", "label": "IssuanceOfClassACommonStockInConnectionWithTheStarriseTransactionARelatedParty", "terseLabel": "Issuance of Class A common stock in connection with the Starrise transaction, a related party" } } }, "localname": "IssuanceOfClassACommonStockInConnectionWithTheStarriseTransactionARelatedParty", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfClassACommonStockInConnectionWithTheStarriseTransactionARelatedPartyin": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IssuanceOfClassACommonStockInConnectionWithTheStarriseTransactionARelatedPartyin", "label": "IssuanceOfClassACommonStockInConnectionWithTheStarriseTransactionARelatedPartyin", "terseLabel": "Issuance of Class A common stock in connection with the Starrise transaction, a related party (in Shares)" } } }, "localname": "IssuanceOfClassACommonStockInConnectionWithTheStarriseTransactionARelatedPartyin", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_IssuanceOfClassACommonStockToManagement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value for issuance of Class A common stock to management.", "label": "IssuanceOfClassACommonStockToManagement", "terseLabel": "Issuance of Class A common stock to management" } } }, "localname": "IssuanceOfClassACommonStockToManagement", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfClassACommonStockToManagementAndEmployees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of Class A common stock to management and employees", "label": "IssuanceOfClassACommonStockToManagementAndEmployees", "terseLabel": "Issuance of Class A common stock to management and employees" } } }, "localname": "IssuanceOfClassACommonStockToManagementAndEmployees", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfClassACommonStockToManagementinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This share for issuance of Class A common stock to management.", "label": "IssuanceOfClassACommonStockToManagementinShares", "terseLabel": "Issuance of Class A common stock to management (in Shares)" } } }, "localname": "IssuanceOfClassACommonStockToManagementinShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_IssuanceOfClassACommonStockToStarriseARelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Issuance of Class A common stock to Starrise, a related party.", "label": "IssuanceOfClassACommonStockToStarriseARelatedParty", "terseLabel": "Issuance of Class A common stock to Starrise, a related party" } } }, "localname": "IssuanceOfClassACommonStockToStarriseARelatedParty", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfCommonStockInConnectionWithABusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "IssuanceOfCommonStockInConnectionWithABusinessCombination", "terseLabel": "Issuance of common stock in connection with a business combination" } } }, "localname": "IssuanceOfCommonStockInConnectionWithABusinessCombination", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfCommonStockInConnectionWithABusinessCombinationinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IssuanceOfCommonStockInConnectionWithABusinessCombinationinShares", "terseLabel": "Issuance of common stock in connection with a business combination (in Shares)" } } }, "localname": "IssuanceOfCommonStockInConnectionWithABusinessCombinationinShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_IssuanceOfCommonStockInConnectionWithATMRaisesNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value for issuance of common stock in connection with ATM raises, net.", "label": "IssuanceOfCommonStockInConnectionWithATMRaisesNet", "terseLabel": "Issuance of common stock in connection with ATM raises, net" } } }, "localname": "IssuanceOfCommonStockInConnectionWithATMRaisesNet", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfCommonStockInConnectionWithATMRaisesNetinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This share of issuance of common stock in connection with ATM raises, net.", "label": "IssuanceOfCommonStockInConnectionWithATMRaisesNetinShares", "terseLabel": "Issuance of common stock in connection with ATM raises, net (in Shares)" } } }, "localname": "IssuanceOfCommonStockInConnectionWithATMRaisesNetinShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_IssuanceOfCommonStockInConnectionWithEquityLinePurchaseCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value for ssuance of common stock in connection with equity line purchase commitment.", "label": "IssuanceOfCommonStockInConnectionWithEquityLinePurchaseCommitment", "terseLabel": "Issuance of common stock in connection with equity line purchase commitment" } } }, "localname": "IssuanceOfCommonStockInConnectionWithEquityLinePurchaseCommitment", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfCommonStockValueThirdPartyProfessionalServiceFees": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "IssuanceOfCommonStockValueThirdPartyProfessionalServiceFees", "negatedLabel": "Accretion and PIK interest expense added to note payable" } } }, "localname": "IssuanceOfCommonStockValueThirdPartyProfessionalServiceFees", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_IssuanceOfSharesForAssetAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of shares for asset acquisition.", "label": "IssuanceOfSharesForAssetAcquisition", "terseLabel": "Issuance of common stock value" } } }, "localname": "IssuanceOfSharesForAssetAcquisition", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_LongTermPortionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LongTermPortionMember", "terseLabel": "Long Term Portion [Member]" } } }, "localname": "LongTermPortionMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "domainItemType" }, "cidm_LongtermPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Long-term payable.", "label": "LongtermPayable", "terseLabel": "Long-term payable" } } }, "localname": "LongtermPayable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "cidm_LossFromOperation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loss from operations.", "label": "LossFromOperation", "terseLabel": "Income (loss) from operations" } } }, "localname": "LossFromOperation", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "cidm_MaturityDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maturity date.", "label": "MaturityDate", "terseLabel": "Maturity date" } } }, "localname": "MaturityDate", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "cidm_MaturityDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maturity Description", "label": "MaturityDescription", "terseLabel": "Maturity description" } } }, "localname": "MaturityDescription", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "stringItemType" }, "cidm_NatureofOperationsandLiquidityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations and Liquidity [Abstract]" } } }, "localname": "NatureofOperationsandLiquidityDetailsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "stringItemType" }, "cidm_NatureofOperationsandLiquidityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations and Liquidity (Details) [Table]" } } }, "localname": "NatureofOperationsandLiquidityDetailsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "stringItemType" }, "cidm_NatureofOperationsandLiquidityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Nature of Operations and Liquidity [Abstract]" } } }, "localname": "NatureofOperationsandLiquidityLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidity" ], "xbrltype": "stringItemType" }, "cidm_NatureofOperationsandLiquidityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations and Liquidity [Table]" } } }, "localname": "NatureofOperationsandLiquidityTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidity" ], "xbrltype": "stringItemType" }, "cidm_NetCashProvidedsByOperatingActivities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "NetCashProvidedsByOperatingActivities", "terseLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedsByOperatingActivities", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_NetIncomeloss": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "NetIncomeloss", "terseLabel": "Net income (loss)" } } }, "localname": "NetIncomeloss", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "cidm_NetIncomelossAttributableToControllingInterests": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "NetIncomelossAttributableToControllingInterests", "totalLabel": "Net income (loss) attributable to controlling interests" } } }, "localname": "NetIncomelossAttributableToControllingInterests", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "cidm_NetIncomelosses": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "cidm_NetIncomelossAttributableToControllingInterests", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "NetIncomelosses", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomelosses", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "cidm_NonMonetaryTransactionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NonMonetaryTransactionsPolicyTextBlock", "terseLabel": "NON-MONETARY TRANSACTIONS" } } }, "localname": "NonMonetaryTransactionsPolicyTextBlock", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "cidm_NoncashInvestingAndFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NoncashInvestingAndFinancingActivitiesAbstract", "terseLabel": "noncash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingActivitiesAbstract", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "stringItemType" }, "cidm_NonrecourseNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of total non-recourse notes payable.", "label": "NonrecourseNotesPayable", "terseLabel": "Total non-recourse notes payable" } } }, "localname": "NonrecourseNotesPayable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "cidm_NonrecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts.", "label": "NonrecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts", "terseLabel": "Total non-recourse notes payable, net of unamortized debt issuance costs and debt discounts" } } }, "localname": "NonrecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "cidm_NotesPayableDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) [Line Items]" } } }, "localname": "NotesPayableDetailsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "cidm_NotesPayableDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) [Table]" } } }, "localname": "NotesPayableDetailsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "cidm_NotesPayableNetOfUnamortizedDebtIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of total notes payable, net of unamortized debt issuance costs.", "label": "NotesPayableNetOfUnamortizedDebtIssuanceCosts", "terseLabel": "Total notes payable, net of unamortized debt issuance costs" } } }, "localname": "NotesPayableNetOfUnamortizedDebtIssuanceCosts", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "cidm_NumberOfSystemsInstalled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of systems installed.", "label": "NumberOfSystemsInstalled", "terseLabel": "Number of systems installed" } } }, "localname": "NumberOfSystemsInstalled", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SegmentInformationDetails" ], "xbrltype": "integerItemType" }, "cidm_NumberofEmployeesJoiningCompanyFollowingAcquisition": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of employees joining company following acquisition.", "label": "NumberofEmployeesJoiningCompanyFollowingAcquisition", "terseLabel": "Number of employees joining company following acquisition" } } }, "localname": "NumberofEmployeesJoiningCompanyFollowingAcquisition", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "integerItemType" }, "cidm_OTTStreamingandDigitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTTStreamingandDigitalMember", "terseLabel": "OTT Streaming and Digital [Member]" } } }, "localname": "OTTStreamingandDigitalMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "domainItemType" }, "cidm_OperatingExpenses1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "OperatingExpenses1", "terseLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses1", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "cidm_OperatingLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "OperatingLeaseLiabilities", "terseLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilities", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofleaserelatedassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "cidm_OperatingLeaseRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "OperatingLeaseRightOfUseAssets", "terseLabel": "Noncurrent" } } }, "localname": "OperatingLeaseRightOfUseAssets", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofleaserelatedassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "cidm_OperatingLeasesLiabilityCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "OperatingLeasesLiabilityCurrent", "terseLabel": "Current" } } }, "localname": "OperatingLeasesLiabilityCurrent", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofleaserelatedassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "cidm_OperatingLeasesLiabilityNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "OperatingLeasesLiabilityNoncurrent", "terseLabel": "Noncurrent" } } }, "localname": "OperatingLeasesLiabilityNoncurrent", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofleaserelatedassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "cidm_OptionsExercisableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OptionsExercisableMember", "terseLabel": "Options Exercisable [Member]" } } }, "localname": "OptionsExercisableMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "domainItemType" }, "cidm_OtherComprehensiveLossForeignExchangeTranslation": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "OtherComprehensiveLossForeignExchangeTranslation", "terseLabel": "Other comprehensive (loss) income: foreign exchange translation" } } }, "localname": "OtherComprehensiveLossForeignExchangeTranslation", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "cidm_OtherInterestsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Interests [Abstract]" } } }, "localname": "OtherInterestsDetailsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "stringItemType" }, "cidm_OtherInterestsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Interests (Details) [Table]" } } }, "localname": "OtherInterestsDetailsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "stringItemType" }, "cidm_OtherInterestsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Other Interests [Abstract]" } } }, "localname": "OtherInterestsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterests" ], "xbrltype": "stringItemType" }, "cidm_OtherInterestsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Interests [Table]" } } }, "localname": "OtherInterestsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterests" ], "xbrltype": "stringItemType" }, "cidm_OutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "OutstandingAmount", "terseLabel": "Outstanding amount" } } }, "localname": "OutstandingAmount", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_PPPLoanRecognizedGain": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "PPPLoanRecognizedGain", "terseLabel": "PPP Loan recognized gain" } } }, "localname": "PPPLoanRecognizedGain", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_PaycheckProtectionProgramLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of Paycheck Protection Program loan.", "label": "PaycheckProtectionProgramLoan", "terseLabel": "PPP Loan" } } }, "localname": "PaycheckProtectionProgramLoan", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "cidm_PaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PaycheckProtectionProgramMember", "terseLabel": "PPP Loan [Member]" } } }, "localname": "PaycheckProtectionProgramMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "cidm_PhaseIDeploymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Phase I Deployment [Member]", "label": "PhaseIDeploymentMember", "terseLabel": "Phase I Deployment [Member]" } } }, "localname": "PhaseIDeploymentMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable", "http://www.cinedigm.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cidm_PhaseIIDeploymentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Phase II Deployment [Member]", "label": "PhaseIIDeploymentMember", "terseLabel": "Phase II Deployment [Member]" } } }, "localname": "PhaseIIDeploymentMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable", "http://www.cinedigm.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cidm_PikInterestAccrued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued payment-in-kind interest, which will be paid off as a portion of the net capital of the note.", "label": "PikInterestAccrued", "terseLabel": "PIK Interest" } } }, "localname": "PikInterestAccrued", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable" ], "xbrltype": "monetaryItemType" }, "cidm_PreferredStockDividendRatesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "PreferredStockDividendRatesPercentage", "terseLabel": "Preferred stock, dividend rate" } } }, "localname": "PreferredStockDividendRatesPercentage", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "percentItemType" }, "cidm_PreferredStockDividends": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "PreferredStockDividends", "terseLabel": "Preferred stock dividends" } } }, "localname": "PreferredStockDividends", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_PreferredStockDividendsAccrued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value for preferred stock dividends accrued.", "label": "PreferredStockDividendsAccrued", "terseLabel": "Preferred stock dividends accrued" } } }, "localname": "PreferredStockDividendsAccrued", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_PreferredStockDividendsPaidWithCommonStocks": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "PreferredStockDividendsPaidWithCommonStocks", "terseLabel": "Preferred stock dividends paid with common stock" } } }, "localname": "PreferredStockDividendsPaidWithCommonStocks", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_PreferredStockDividendsinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PreferredStockDividendsinShares", "terseLabel": "Preferred stock dividends (in Shares)" } } }, "localname": "PreferredStockDividendsinShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_ProceedsFromPPPLoanCARESAct": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "ProceedsFromPPPLoanCARESAct", "terseLabel": "Proceeds from PPP Loan" } } }, "localname": "ProceedsFromPPPLoanCARESAct", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_ProspectLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ProspectLoan", "terseLabel": "Prospect Loan" } } }, "localname": "ProspectLoan", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "cidm_ProvisionForDoubtfulAccountsTotal": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "ProvisionForDoubtfulAccountsTotal", "terseLabel": "Provision for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccountsTotal", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_ProvisionForrecoveryOfDoubtfulAccounts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "ProvisionForrecoveryOfDoubtfulAccounts", "terseLabel": "Provision for (recovery of) doubtful accounts" } } }, "localname": "ProvisionForrecoveryOfDoubtfulAccounts", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "cidm_PurchaseAgreementDescrption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of purchase agreement.", "label": "PurchaseAgreementDescrption", "terseLabel": "Description of purchase agreement" } } }, "localname": "PurchaseAgreementDescrption", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "cidm_PurchasePriceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PurchasePriceAbstract", "terseLabel": "Purchase Price" } } }, "localname": "PurchasePriceAbstract", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "stringItemType" }, "cidm_PurchasedPrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "PurchasedPrice", "terseLabel": "Purchase Price" } } }, "localname": "PurchasedPrice", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_ReceivedAmountFromEastWestBank": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "ReceivedAmountFromEastWestBank", "terseLabel": "Received amount from east west bank" } } }, "localname": "ReceivedAmountFromEastWestBank", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_ReconciliationOfAssetsAndDebtFromSegmentToConsolidatedTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ReconciliationOfAssetsAndDebtFromSegmentToConsolidatedTableTextBlock", "terseLabel": "Schedule of segment reporting, assets and debt" } } }, "localname": "ReconciliationOfAssetsAndDebtFromSegmentToConsolidatedTableTextBlock", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "cidm_RecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of total recourse notes payable, net of unamortized debt issuance costs and debt discounts", "label": "RecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts", "terseLabel": "Total recourse notes payable, net of unamortized debt issuance costs and debt discounts" } } }, "localname": "RecourseNotesPayableNetOfUnamortizedDebtIssuanceCostsAndDebtDiscounts", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "cidm_RestrictedCashAndCashEquivalentPurposeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RestrictedCashAndCashEquivalentPurposeAxis", "terseLabel": "Restricted Cash and Cash Equivalents Purpose [Axis]" } } }, "localname": "RestrictedCashAndCashEquivalentPurposeAxis", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "cidm_RestrictedCashAndCashEquivalentPurposeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RestrictedCashAndCashEquivalentPurpose [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentPurposeDomain", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "cidm_RestrictedStockAwardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RestrictedStockAwardsMember", "terseLabel": "Restricted Stock Awards [Member]" } } }, "localname": "RestrictedStockAwardsMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cidm_SaleOfInvestmentSecurities": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale of investment securities.", "label": "SaleOfInvestmentSecurities", "negatedLabel": "Sale of equity investment in Starrise" } } }, "localname": "SaleOfInvestmentSecurities", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cidm_SaleOfInvestmentToPayDownVendors": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sale of Investment to Pay Down Vendors.", "label": "SaleOfInvestmentToPayDownVendors", "terseLabel": "Starrise shares used to pay down vendors" } } }, "localname": "SaleOfInvestmentToPayDownVendors", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_SaleOfStarrisesOrdinaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The sale Sale of starrise's ordinary shares", "label": "SaleOfStarrisesOrdinaryShares", "terseLabel": "Sale of starrise's ordinary shares (in Shares)" } } }, "localname": "SaleOfStarrisesOrdinaryShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "cidm_SaleOfStarrisesOrdinaryValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of Sale Starrises ordinary value.", "label": "SaleOfStarrisesOrdinaryValue", "terseLabel": "Sale of starrises ordinary value" } } }, "localname": "SaleOfStarrisesOrdinaryValue", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_SalesRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sales revenue", "label": "SalesRevenue", "terseLabel": "Sales revenue" } } }, "localname": "SalesRevenue", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_ScheduleOfAmortizationExpensePerYearForTheDevelopedTechnologyAcquiredInTheBusinessCombinationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of amortization expense per year for the developed technology acquired in the business combination [Abstract]" } } }, "localname": "ScheduleOfAmortizationExpensePerYearForTheDevelopedTechnologyAcquiredInTheBusinessCombinationAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfAmortizationExpensePerYearForTheIntangibleAssetsAcquiredInTheBusinessCombinationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of amortization expense per year for the intangible assets acquired in the business combination [Abstract]" } } }, "localname": "ScheduleOfAmortizationExpensePerYearForTheIntangibleAssetsAcquiredInTheBusinessCombinationAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfAnalysisOfOptionActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of analysis of option activity [Abstract]" } } }, "localname": "ScheduleOfAnalysisOfOptionActivityAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfBusinessCombinationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of business combination [Abstract]" } } }, "localname": "ScheduleOfBusinessCombinationAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfCashCashEquivalentsAndRestrictedCashAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of cash, cash equivalents and restricted cash [Abstract]" } } }, "localname": "ScheduleOfCashCashEquivalentsAndRestrictedCashAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfDebtOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of debt outstanding [Abstract]" } } }, "localname": "ScheduleOfDebtOutstandingAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of estimated useful lives of property and equipment [Abstract]" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfFairValueMeasurementsOfFinancialAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of fair value measurements of financial assets [Abstract]" } } }, "localname": "ScheduleOfFairValueMeasurementsOfFinancialAssetsAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfGoodwillAndAccumulatedImpairmentChargesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of goodwill and accumulated impairment charges [Abstract]" } } }, "localname": "ScheduleOfGoodwillAndAccumulatedImpairmentChargesAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfLeaseCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of lease costs [Abstract]" } } }, "localname": "ScheduleOfLeaseCostsAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfLeaseRelatedAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of lease-related assets and liabilities [Abstract]" } } }, "localname": "ScheduleOfLeaseRelatedAssetsAndLiabilitiesAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "terseLabel": "Schedule of lease-related assets and liabilities" } } }, "localname": "ScheduleOfLeaserelatedAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "cidm_ScheduleOfNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of notes payable [Abstract]" } } }, "localname": "ScheduleOfNotesPayableAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfRevenueCategoriesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of revenue categories [Abstract]" } } }, "localname": "ScheduleOfRevenueCategoriesAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfSARsOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ScheduleOfSARsOutstandingTableTextBlock", "terseLabel": "Schedule of SARs outstanding" } } }, "localname": "ScheduleOfSARsOutstandingTableTextBlock", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "cidm_ScheduleOfSarsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of SARs outstanding [Abstract]" } } }, "localname": "ScheduleOfSarsOutstandingAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfSegmentReportingAssetsAndDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of segment reporting, assets and debt [Abstract]" } } }, "localname": "ScheduleOfSegmentReportingAssetsAndDebtAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfSegmentReportingEmployeeStockBasedCompensationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of segment reporting, employee stock-based compensation expense [Abstract]" } } }, "localname": "ScheduleOfSegmentReportingEmployeeStockBasedCompensationExpenseAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfSegmentReportingStatementOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of segment reporting, statement of operations [Abstract]" } } }, "localname": "ScheduleOfSegmentReportingStatementOfOperationsAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfStockAppreciationRightsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock appreciation rights outstanding [Abstract]" } } }, "localname": "ScheduleOfStockAppreciationRightsOutstandingAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfStockBasedCompensationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock-based compensation expense [Abstract]" } } }, "localname": "ScheduleOfStockBasedCompensationExpenseAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfSupplementalCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of supplemental cash flows [Abstract]" } } }, "localname": "ScheduleOfSupplementalCashFlowsAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_ScheduleOfWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of warrants [Abstract]" } } }, "localname": "ScheduleOfWarrantsAbstract", "nsuri": "http://www.cinedigm.com/20211231", "xbrltype": "stringItemType" }, "cidm_SegmentInformationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Information (Details) [Line Items]" } } }, "localname": "SegmentInformationDetailsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "cidm_SegmentInformationDetailsScheduleofsegmentreportingassetsanddebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Information (Details) - Schedule of segment reporting, assets and debt [Line Items]" } } }, "localname": "SegmentInformationDetailsScheduleofsegmentreportingassetsanddebtLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable" ], "xbrltype": "stringItemType" }, "cidm_SegmentInformationDetailsScheduleofsegmentreportingassetsanddebtTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Information (Details) - Schedule of segment reporting, assets and debt [Table]" } } }, "localname": "SegmentInformationDetailsScheduleofsegmentreportingassetsanddebtTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable" ], "xbrltype": "stringItemType" }, "cidm_SegmentInformationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Information (Details) [Table]" } } }, "localname": "SegmentInformationDetailsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "cidm_SellingGeneralAndAdministrative": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "SellingGeneralAndAdministrative", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrative", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockbasedcompensationexpenseTable" ], "xbrltype": "monetaryItemType" }, "cidm_ServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ServicesMember", "terseLabel": "Services [Member]" } } }, "localname": "ServicesMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cidm_ServicingRevenue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Servicing revenue.", "label": "ServicingRevenue", "terseLabel": "Servicing revenue" } } }, "localname": "ServicingRevenue", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "monetaryItemType" }, "cidm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingIntrinsicValue", "terseLabel": "Aggregate Intrinsic Value (in Dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingIntrinsicValue", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "monetaryItemType" }, "cidm_ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross", "terseLabel": "Granted shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodGross", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "cidm_ShareBasedCompensationShareAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "ShareBasedCompensationShareAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "terseLabel": "Range of Prices, Maximum" } } }, "localname": "ShareBasedCompensationShareAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "perShareItemType" }, "cidm_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfExercisableOptions", "terseLabel": "Options Exercisable (in Shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "sharesItemType" }, "cidm_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions", "terseLabel": "Options Outstanding (in Shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "sharesItemType" }, "cidm_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisPriceRangeLowerRangeLimit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisPriceRangeLowerRangeLimit", "terseLabel": "Range of Prices, Minimum" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisPriceRangeLowerRangeLimit", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "perShareItemType" }, "cidm_SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanExercisePriceifVotingThresholdisMetPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrange by share-based payment award, equity incentive plan, exercise price if voting threshold is met, percent.", "label": "SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanExercisePriceifVotingThresholdisMetPercent", "terseLabel": "Exercise price if voting threshold is met, percent" } } }, "localname": "SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanExercisePriceifVotingThresholdisMetPercent", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "cidm_SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanPercentVotingPowerThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrange by share-based payment award, equity incentive plan, percent voting power threshold.", "label": "SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanPercentVotingPowerThreshold", "terseLabel": "Percent voting power threshold" } } }, "localname": "SharebasedCompensationArrangebySharebasedPaymentAwardEquityIncentivePlanPercentVotingPowerThreshold", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "cidm_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Life in Years.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "terseLabel": "Weighted Average Remaining Life in Years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "durationItemType" }, "cidm_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price.", "label": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "perShareItemType" }, "cidm_SharesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares percentage.", "label": "SharesPercentage", "terseLabel": "Shares percentage" } } }, "localname": "SharesPercentage", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "cidm_StarriseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Starrise [Member]", "label": "StarriseMember", "terseLabel": "Starisse [Member]", "verboseLabel": "Starrise [Member]" } } }, "localname": "StarriseMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cidm_StarriseSharesIssuedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount starrise shares issued amount.", "label": "StarriseSharesIssuedAmount", "terseLabel": "Starrise shares issued amount" } } }, "localname": "StarriseSharesIssuedAmount", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_StockExchangeOfHongKongLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StockExchangeOfHongKongLimitedMember", "terseLabel": "Stock Exchange of Hong Kong Limited [Member]" } } }, "localname": "StockExchangeOfHongKongLimitedMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cidm_StockIssuedDuringPeriodSharesIssuanceInConnectionWithTheSPA": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Issuance in Connection with the SPA", "label": "StockIssuedDuringPeriodSharesIssuanceInConnectionWithTheSPA", "terseLabel": "Stock issued in connection with the SPA with certain investors, net (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuanceInConnectionWithTheSPA", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "cidm_StockIssuedDuringPeriodStockCompensationAndExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value for stock compensation and expenses.", "label": "StockIssuedDuringPeriodStockCompensationAndExpenses", "terseLabel": "Stock compensation and expenses" } } }, "localname": "StockIssuedDuringPeriodStockCompensationAndExpenses", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_StockIssuedDuringPeriodValueExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Exercise of Warrants", "label": "StockIssuedDuringPeriodValueExerciseOfWarrants", "terseLabel": "Exercise of warrants for Class A common stock" } } }, "localname": "StockIssuedDuringPeriodValueExerciseOfWarrants", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_StockIssuedDuringPeriodValueIssuanceInConnectionWithTheSPA": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Issuance in Connection with the SPA", "label": "StockIssuedDuringPeriodValueIssuanceInConnectionWithTheSPA", "terseLabel": "Stock issued in connection with the SPA with certain investors, net" } } }, "localname": "StockIssuedDuringPeriodValueIssuanceInConnectionWithTheSPA", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "cidm_StockPurchaseAgreementDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock purchase agreement, description.", "label": "StockPurchaseAgreementDescription", "terseLabel": "Stock purchase agreement, description" } } }, "localname": "StockPurchaseAgreementDescription", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "stringItemType" }, "cidm_StockbasedCompensation1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "StockbasedCompensation1", "terseLabel": "Stock-based compensation (in Dollars)" } } }, "localname": "StockbasedCompensation1", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_StockholdersEquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) [Line Items]" } } }, "localname": "StockholdersEquityDetailsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "cidm_StockholdersEquityDetailsScheduleofstockappreciationrightsoutstandingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofstockappreciationrightsoutstandingLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "stringItemType" }, "cidm_StockholdersEquityDetailsScheduleofstockappreciationrightsoutstandingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of stock appreciation rights outstanding [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofstockappreciationrightsoutstandingTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "stringItemType" }, "cidm_StockholdersEquityDetailsScheduleofstockbasedcompensationexpenseLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofstockbasedcompensationexpenseLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockbasedcompensationexpenseTable" ], "xbrltype": "stringItemType" }, "cidm_StockholdersEquityDetailsScheduleofstockbasedcompensationexpenseTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) - Schedule of stock-based compensation expense [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofstockbasedcompensationexpenseTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofstockbasedcompensationexpenseTable" ], "xbrltype": "stringItemType" }, "cidm_StockholdersEquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Details) [Table]" } } }, "localname": "StockholdersEquityDetailsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "cidm_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "cidm_SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluemeasurementsoffinancialassetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of financial assets [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluemeasurementsoffinancialassetsLineItems", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "stringItemType" }, "cidm_SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluemeasurementsoffinancialassetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of fair value measurements of financial assets [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluemeasurementsoffinancialassetsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "stringItemType" }, "cidm_SummaryofSignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "cidm_TotalAllocationOfPurchasePrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of allocation of purchase price.", "label": "TotalAllocationOfPurchasePrice", "terseLabel": "Total allocation of purchase price" } } }, "localname": "TotalAllocationOfPurchasePrice", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_TotalCashConsideration": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "TotalCashConsideration", "terseLabel": "Cash consideration" } } }, "localname": "TotalCashConsideration", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_TotalPurchasePrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "TotalPurchasePrice", "terseLabel": "Total purchase price" } } }, "localname": "TotalPurchasePrice", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_TotalRecourseNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This value of recourse notes payable.", "label": "TotalRecourseNotesPayable", "terseLabel": "Total recourse notes payable" } } }, "localname": "TotalRecourseNotesPayable", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "cidm_TradeNameAcquiredUsefullLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TradeNameAcquiredUsefullLife", "terseLabel": "Trade name acquired usefull life" } } }, "localname": "TradeNameAcquiredUsefullLife", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "durationItemType" }, "cidm_TradingName": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "TradingName", "terseLabel": "Trade name" } } }, "localname": "TradingName", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "cidm_TransferOfStarriseShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfer of Starrise shares.", "label": "TransferOfStarriseShares", "terseLabel": "Transfer of Starrise shares (in Shares)" } } }, "localname": "TransferOfStarriseShares", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "cidm_TreasurySharesAcquiredForWithholdingTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Treasury shares acquired for withholding taxes.", "label": "TreasurySharesAcquiredForWithholdingTaxes", "terseLabel": "Treasury shares acquired for withholding taxes" } } }, "localname": "TreasurySharesAcquiredForWithholdingTaxes", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "cidm_TwoThousandSeventeenPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoThousandSeventeenPlanMember", "terseLabel": "2017 Plan [Member]", "verboseLabel": "Two Thousand seventeen Plan [Member]" } } }, "localname": "TwoThousandSeventeenPlanMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "cidm_TwoThousandThirteenProspectTermLoanAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoThousandThirteenProspectTermLoanAgreementMember", "terseLabel": "Prospect Loan [Member]" } } }, "localname": "TwoThousandThirteenProspectTermLoanAgreementMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "cidm_TwoThousandThirteenProspectTermLoansAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TwoThousandThirteenProspectTermLoansAgreementMember", "terseLabel": "Prospect Loan [Member]" } } }, "localname": "TwoThousandThirteenProspectTermLoansAgreementMember", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "cidm_UnamortizedDebtIssuanceCostsAndDebtDiscounts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Less unamortized debt issuance costs and debt discounts.", "label": "UnamortizedDebtIssuanceCostsAndDebtDiscounts", "negatedLabel": "Less unamortized debt issuance costs and debt discounts" } } }, "localname": "UnamortizedDebtIssuanceCostsAndDebtDiscounts", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable" ], "xbrltype": "monetaryItemType" }, "cidm_UnbilledRevenueCurrent": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "UnbilledRevenueCurrent", "terseLabel": "Unbilled revenue" } } }, "localname": "UnbilledRevenueCurrent", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "cidm_UnsatisfiedPerformanceObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unsatisfied Performance Obligations", "label": "UnsatisfiedPerformanceObligations", "terseLabel": "Unsatisfied performance obligations" } } }, "localname": "UnsatisfiedPerformanceObligations", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cidm_VolatilityPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Volatility percentage.", "label": "VolatilityPercentage", "terseLabel": "Volatility percentage" } } }, "localname": "VolatilityPercentage", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "cidm_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Working Capital", "label": "WorkingCapital", "terseLabel": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "cidm_fairValueMarketPricing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value market pricing.", "label": "fairValueMarketPricing", "terseLabel": "Market pricing" } } }, "localname": "fairValueMarketPricing", "nsuri": "http://www.cinedigm.com/20211231", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r567" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r565" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.cinedigm.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]", "terseLabel": "Board of Directors [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r268", "r308", "r354", "r356", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r541", "r543", "r558", "r559" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r268", "r308", "r354", "r356", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r541", "r543", "r558", "r559" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable", "http://www.cinedigm.com/role/ScheduleofwarrantsTable", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r193", "r334", "r336", "r487", "r540", "r542" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable", "http://www.cinedigm.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r193", "r334", "r336", "r487", "r540", "r542" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable", "http://www.cinedigm.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r268", "r308", "r343", "r354", "r356", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r541", "r543", "r558", "r559" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable", "http://www.cinedigm.com/role/ScheduleofwarrantsTable", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r268", "r308", "r343", "r354", "r356", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r541", "r543", "r558", "r559" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable", "http://www.cinedigm.com/role/ScheduleofwarrantsTable", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r198", "r469" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r7", "r20", "r199", "r200" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r23", "r55", "r56", "r57", "r527", "r548", "r549" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r54", "r57", "r64", "r65", "r66", "r112", "r113", "r114", "r425", "r544", "r545", "r568" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Transaction useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r21", "r380", "r473" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r112", "r113", "r114", "r377", "r378", "r379", "r436" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments to Additional Paid in Capital, Other", "terseLabel": "Contributed capital under the Starrise transaction, a related party" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r358", "r375", "r381" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r76", "r92", "r288", "r457" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs included in interest expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r92", "r227", "r235" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement", "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionConsiderationTransferredTransactionCost": { "auth_ref": [ "r410", "r411", "r412", "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction cost incurred as part of consideration transferred in asset acquisition.", "label": "Asset Acquisition, Consideration Transferred, Transaction Cost", "terseLabel": "Incurred transaction cost" } } }, "localname": "AssetAcquisitionConsiderationTransferredTransactionCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r92", "r239" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment accelerated amortization" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r106", "r175", "r182", "r189", "r216", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r420", "r426", "r444", "r471", "r473", "r505", "r523" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet", "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "netLabel": "Assets", "terseLabel": "ASSETS", "verboseLabel": "Assets:" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet", "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable", "http://www.cinedigm.com/role/ScheduleofleaserelatedassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r8", "r9", "r52", "r106", "r216", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r420", "r426", "r444", "r471", "r473" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r439" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Total fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r360", "r376" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "BASIS OF PRESENTATION AND CONSOLIDATION" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Obligations to pay to another in accordance with an expressed or implied agreement.", "label": "Borrowings [Member]", "terseLabel": "Borrowings [Member]" } } }, "localname": "BorrowingsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r353", "r355" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r353", "r355", "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Number of shares issued for acquisition (in Shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r407", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Current portion of earnout consideration on purchase of a business" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r407", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Earnout consideration on purchase of a business, net of current portion" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "BUSINESS COMBINATION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r30", "r473", "r550", "r551" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Total" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofcashcashequivalentsandrestrictedcashTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r30", "r94" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r11", "r95" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "CASH, CASH EQUIVALENTS, AND RESTRICTED CASH" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r88", "r94", "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r88", "r445" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r30" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofcashcashequivalentsandrestrictedcashTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "terseLabel": "SUPPLEMENTAL CASH FLOW INFORMATION" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SupplementalCashFlowInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r103", "r106", "r128", "r131", "r139", "r142", "r144", "r150", "r151", "r152", "r216", "r254", "r258", "r259", "r260", "r263", "r264", "r306", "r307", "r310", "r314", "r444", "r566" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.cinedigm.com/role/ShareholdersEquityType2or3", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r329", "r357" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofwarrantsTable" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofwarrantsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofwarrantsTable" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Amount outstanding", "verboseLabel": "Warrants of right shares (in Shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofwarrantsTable", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r329", "r357" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofwarrantsTable" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r46", "r251", "r510", "r532" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (see Note 7)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r248", "r249", "r250", "r252", "r555" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "netLabel": "Class A Common Stock [Member]", "terseLabel": "Class A Common Stock", "verboseLabel": "Class A" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.cinedigm.com/role/ShareholdersEquityType2or3", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsShares": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits.", "label": "Common Stock Dividends, Shares", "terseLabel": "Common stock shares" } } }, "localname": "CommonStockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r112", "r113", "r436" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r320" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19", "r473" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; Class A stock 275,000,000 and 200,000,000 shares authorized at December 31, 2021 and March 31, 2021, respectively; 176,187,067 and 167,542,404 shares issued and 174,871,216 and 166,228,568 shares outstanding at December 31, 2021 and March 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r60", "r62", "r72", "r418", "r419", "r431", "r514", "r536" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "cidm_NetIncomelossAttributableToControllingInterests", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Net income attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r60", "r62", "r71", "r417", "r431", "r513", "r535" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and software\t[Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r331", "r332", "r335" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue balance" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r14", "r506", "r521", "r552" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]", "terseLabel": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]", "terseLabel": "Corporate [Member]" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r102", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r282", "r289", "r290", "r292", "r301" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r15", "r16", "r105", "r110", "r265", "r266", "r267", "r268", "r269", "r270", "r272", "r278", "r279", "r280", "r281", "r283", "r284", "r285", "r286", "r287", "r288", "r295", "r296", "r297", "r298", "r458", "r506", "r507", "r521" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r16", "r293", "r507", "r521" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Prospect Loan, gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r265", "r295", "r296", "r456", "r458", "r459" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Prospect Loan, at issuance" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r43", "r266" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r44", "r105", "r110", "r265", "r266", "r267", "r268", "r269", "r270", "r272", "r278", "r279", "r280", "r281", "r283", "r284", "r285", "r286", "r287", "r288", "r295", "r296", "r297", "r298", "r458" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r44", "r105", "r110", "r265", "r266", "r267", "r268", "r269", "r270", "r272", "r278", "r279", "r280", "r281", "r283", "r284", "r285", "r286", "r287", "r288", "r291", "r295", "r296", "r297", "r298", "r321", "r323", "r324", "r325", "r455", "r456", "r458", "r459", "r520" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueArrangementTypeAxis": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred revenue arrangement.", "label": "Deferred Revenue Arrangement Type [Axis]" } } }, "localname": "DeferredRevenueArrangementTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Current portion of deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred consideration on purchase of a business, net of current portion" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue, Revenue Recognized", "terseLabel": "Recognized aggregate revenue", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r92", "r240" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation and amortization of property and equipment" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement", "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r92", "r170" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization of property and equipment and amortization of intangible assets" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed Technology Rights [Member]" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DirectOperatingCosts": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate direct operating costs incurred during the reporting period.", "label": "Direct Operating Costs", "terseLabel": "Direct operating (exclusive of depreciation and amortization shown below)" } } }, "localname": "DirectOperatingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r334", "r336", "r337", "r338", "r339", "r340", "r341", "r342" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of revenue categories" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsPreferredStockCash": { "auth_ref": [ "r326", "r519" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.", "label": "Dividends, Preferred Stock, Cash", "negatedLabel": "Preferred stock dividends" } } }, "localname": "DividendsPreferredStockCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r73", "r117", "r118", "r119", "r120", "r121", "r125", "r128", "r142", "r143", "r144", "r147", "r148", "r437", "r438", "r515", "r537" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net income (loss) per Class A common stock attributable to common stockholders - basic: (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r73", "r117", "r118", "r119", "r120", "r121", "r128", "r142", "r143", "r144", "r147", "r148", "r437", "r438", "r515", "r537" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net income (loss) per Class A common stock attributable to common stockholders - diluted: (in Dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r145", "r146" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "NET INCOME/LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r108", "r386", "r397" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Effective tax rate percentage" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther": { "auth_ref": [ "r386", "r397" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent", "terseLabel": "Tax benefit percentage" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Employee Benefits and Share-based Compensation", "terseLabel": "Stock based compensation (in Dollars)" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r64", "r65", "r66", "r112", "r113", "r114", "r116", "r122", "r124", "r149", "r218", "r320", "r326", "r377", "r378", "r379", "r393", "r394", "r436", "r446", "r447", "r448", "r449", "r450", "r451", "r544", "r545", "r546", "r568" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentAggregateCost": { "auth_ref": [ "r31" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.", "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Initial investment amount" } } }, "localname": "EquityMethodInvestmentAggregateCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership percentage", "verboseLabel": "Majority interest, percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentQuotedMarketValue": { "auth_ref": [ "r215" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available.", "label": "Equity Method Investment, Quoted Market Value", "terseLabel": "Initial investment" } } }, "localname": "EquityMethodInvestmentQuotedMarketValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r31", "r176", "r212" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity investment in Starrise, a related party, at fair value", "verboseLabel": "Equity investment in Starrise, at fair value" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet", "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "OTHER INTERESTS" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/OtherInterests" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r31", "r87", "r214", "r444" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments [Policy Text Block]", "terseLabel": "EQUITY INVESTMENT IN STARRISE, A RELATED PARTY" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesFvNiGainLoss": { "auth_ref": [ "r211" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Gain (Loss)", "negatedLabel": "Changes in fair value of equity investment in Starrise" } } }, "localname": "EquitySecuritiesFvNiGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r439", "r440" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of fair value measurements of financial assets" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r280", "r295", "r296", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r440", "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r442", "r443" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r280", "r344", "r345", "r350", "r352", "r440", "r476" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r280", "r295", "r296", "r344", "r345", "r350", "r352", "r440", "r477" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r280", "r295", "r296", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r440", "r478" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r280", "r295", "r296", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r352", "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableImpairedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Financing Receivable, Impaired [Line Items]" } } }, "localname": "FinancingReceivableImpairedLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months", "terseLabel": "2022 (remaining)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2022 (remaining)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling after Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r236" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearforthedevelopedtechnologyacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r228", "r230", "r234", "r237", "r488", "r489" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails", "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r228", "r233" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails", "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r234", "r488" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r452", "r453" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign Currency Exchange Rate, Translation", "terseLabel": "Foreign currency exchange rate, translation" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "pureItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r92", "r299", "r300" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "terseLabel": "Gain (loss) on forgiveness of PPP loan and extinguishment of note payable" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r220", "r221", "r473", "r504" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet", "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r224", "r231" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "GOODWILL" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillGross": { "auth_ref": [ "r222", "r223" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Gross", "terseLabel": "Goodwill" } } }, "localname": "GoodwillGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r222", "r223" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "terseLabel": "Goodwill from business combinations \u2013 see Note 4" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofgoodwillandaccumulatedimpairmentchargesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairedFinancingReceivablesTableTextBlock": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of impaired financing receivables.", "label": "Impaired Financing Receivables [Table Text Block]", "terseLabel": "Schedule of business combination" } } }, "localname": "ImpairedFinancingReceivablesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r238", "r244" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "IMPAIRMENT OF LONG-LIVED AND FINITE-LIVED ASSETS" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r69", "r175", "r181", "r185", "r188", "r191", "r502", "r511", "r517", "r538" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "cidm_NetIncomelosses", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r242", "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable", "http://www.cinedigm.com/role/ScheduleofstockbasedcompensationexpenseTable" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable", "http://www.cinedigm.com/role/ScheduleofstockbasedcompensationexpenseTable" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r108", "r387", "r388", "r391", "r395", "r398", "r400", "r401", "r402" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r109", "r123", "r124", "r173", "r385", "r396", "r399", "r539" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "cidm_NetIncomelosses", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r63", "r383", "r384", "r388", "r389", "r390", "r392" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r89", "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r91" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable, accrued expenses, and other liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r91" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r91" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r91" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r91" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaids and other current assets, and other long-term assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": { "auth_ref": [ "r129", "r130", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r144" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares", "terseLabel": "Potentially dilutive shares (in Shares)" } } }, "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsCurrent": { "auth_ref": [ "r2" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current portion of nonphysical assets, excluding financial assets, if these assets are classified into the current and noncurrent portions.", "label": "Intangible Assets, Current", "terseLabel": "Current assets" } } }, "localname": "IntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r226", "r232" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net", "verboseLabel": "Intangible Assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet", "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r67", "r169", "r454", "r457", "r516" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "terseLabel": "Cash interest paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r6", "r51", "r473" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r209", "r210" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate", "terseLabel": "Interest rate" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r465", "r466" ], "calculation": { "http://www.cinedigm.com/role/ScheduleofleasecostsTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofleasecostsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of lease costs" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r41", "r106", "r183", "r216", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r421", "r426", "r427", "r444", "r471", "r472" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:", "verboseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable", "http://www.cinedigm.com/role/ScheduleofleaserelatedassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r106", "r216", "r444", "r473", "r509", "r530" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r42", "r106", "r216", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r421", "r426", "r427", "r444", "r471", "r472", "r473" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r439" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "terseLabel": "Total fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumMonthendOutstandingAmount": { "auth_ref": [ "r14", "r16", "r506", "r507", "r521" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum month-end amount borrowed under the credit facility during the period.", "label": "Line of Credit Facility, Maximum Month-end Outstanding Amount", "terseLabel": "Credit facility outstanding" } } }, "localname": "LineOfCreditFacilityMaximumMonthendOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR [Member]", "verboseLabel": "London Interbank Offered Rate (LIBOR) [Member]" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r16", "r279", "r294", "r295", "r296", "r507", "r525" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Total long term portion" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.", "label": "Long-term Debt and Lease Obligation, Including Current Maturities", "terseLabel": "Prospect Loan, net" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r40" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "negatedLabel": "Less current portion" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofdebtoutstandingTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r44" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes Payable, Noncurrent", "terseLabel": "PPP Loan" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails", "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r44", "r253" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails", "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r75" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Marketable Securities, Unrealized Gain (Loss)", "terseLabel": "Change in fair value of equity investment in Starrise, a related party" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r50", "r106", "r216", "r254", "r258", "r259", "r260", "r263", "r264", "r444", "r508", "r529" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Deficit attributable to noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r153", "r161" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "NATURE OF OPERATIONS AND LIQUIDITY" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidity" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r88" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r88" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r88", "r90", "r93" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r4", "r58", "r61", "r66", "r70", "r93", "r106", "r115", "r117", "r118", "r119", "r120", "r123", "r124", "r140", "r175", "r181", "r185", "r188", "r191", "r216", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r438", "r444", "r512", "r534" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r117", "r118", "r119", "r120", "r125", "r126", "r141", "r144", "r175", "r181", "r185", "r188", "r191" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income (loss) attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r112", "r113", "r114", "r326", "r415" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-Controlling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r16", "r507", "r525" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes Payable", "terseLabel": "Notes Payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Current portion of notes payable (see Note 5)" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SegmentInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]", "terseLabel": "Direct operating [Member]" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r175", "r181", "r185", "r188", "r191" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income (loss) from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r463", "r466" ], "calculation": { "http://www.cinedigm.com/role/ScheduleofleasecostsTable": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofleasecostsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r461" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r461" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r461" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r462", "r464" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows used for operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofleasecostsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r460" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeAxis": { "auth_ref": [ "r302", "r433", "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.", "label": "Option Indexed to Issuer's Equity, Type [Axis]" } } }, "localname": "OptionIndexedToIssuersEquityTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.", "label": "Option Indexed to Issuer's Equity, Type [Domain]" } } }, "localname": "OptionIndexedToIssuersEquityTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r35" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Minimum participation guaranty" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year One", "terseLabel": "First year anniversary arrangement" } } }, "localname": "OtherCommitmentDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInSecondAndThirdYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid in second and third fiscal years following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year Two and Three", "terseLabel": "Arrangement payable" } } }, "localname": "OtherCommitmentDueInSecondAndThirdYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentDueInSecondYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Other Commitment, to be Paid, Year Two", "terseLabel": "Second year anniversary arrangement" } } }, "localname": "OtherCommitmentDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": { "auth_ref": [ "r417", "r418", "r424" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent", "totalLabel": "Comprehensive income (loss) attributable to controlling interests" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r59", "r62", "r417", "r418", "r424" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "negatedLabel": "Less: comprehensive income attributable to noncontrolling interest" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCostAndExpenseOperating": { "auth_ref": [ "r78" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other Cost and Expense, Operating", "terseLabel": "Direct operating (excludes depreciation and amortization shown below)" } } }, "localname": "OtherCostAndExpenseOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "Other General and Administrative Expense", "terseLabel": "Allocation of corporate overhead" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r93" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Other Noncash Expense", "terseLabel": "Other" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r80" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other expense, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherTaxExpenseBenefit": { "auth_ref": [ "r107", "r385", "r392" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other income tax expense (benefit).", "label": "Other Tax Expense (Benefit)", "terseLabel": "Income tax expense benefit" } } }, "localname": "OtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Stockholders\u2019 Deficit" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates": { "auth_ref": [ "r82" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).", "label": "Payments to Acquire Businesses and Interest in Affiliates", "negatedLabel": "Purchase of businesses" } } }, "localname": "PaymentsToAcquireBusinessesAndInterestInAffiliates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r83" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchases of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": { "auth_ref": [ "r83" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Payments to Acquire Other Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "terseLabel": "Settlement of second lien loan with Class A common stock" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r360", "r376" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockAmountOfPreferredDividendsInArrears": { "auth_ref": [ "r322" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate amount of cumulative preferred dividends in arrears.", "label": "Preferred Stock, Amount of Preferred Dividends in Arrears", "terseLabel": "Dividends preferred stock (in Dollars)" } } }, "localname": "PreferredStockAmountOfPreferredDividendsInArrears", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendsShares": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.", "label": "Preferred Stock Dividends, Shares", "terseLabel": "Preferred stock dividends paid with common stock (in Shares)" } } }, "localname": "PreferredStockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "auth_ref": [ "r103", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.", "label": "Preferred Stock, Liquidation Preference, Value", "terseLabel": "Preferred stock, Liquidation preference Value (in Dollars)" } } }, "localname": "PreferredStockLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18", "r306" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionTerms": { "auth_ref": [ "r305", "r321" ], "lang": { "en-us": { "role": { "documentation": "The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer.", "label": "Preferred Stock, Redemption Terms", "terseLabel": "Expected term" } } }, "localname": "PreferredStockRedemptionTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18", "r306" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18", "r473" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, 15,000,000 shares authorized; Series A 10% - $0.001 par value per share; 20 shares authorized; and 7 shares issued and outstanding at December 31, 2021 and March 31, 2021. Liquidation preference of $3,648" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r8", "r28", "r29" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate [Member]" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrincipalAmountOutstandingOfLoansHeldInPortfolio": { "auth_ref": [ "r482" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This is the result of the principal amount outstanding of total loans managed or securitized less securitized loans and loans that are in the process of being securitized.", "label": "Principal Amount Outstanding of Loans Held-in-portfolio", "terseLabel": "Principal amount loan" } } }, "localname": "PrincipalAmountOutstandingOfLoansHeldInPortfolio", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r84" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of Class A common stock, net" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Proceeds from (Repayments of) Lines of Credit", "terseLabel": "(Payments) proceeds under revolving credit agreement, net" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r81" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Proceeds from the sale of property and equipment" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r4", "r58", "r61", "r66", "r86", "r106", "r115", "r123", "r124", "r175", "r181", "r185", "r188", "r191", "r216", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r417", "r422", "r423", "r430", "r431", "r438", "r444", "r517" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r34", "r241" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r12", "r13", "r241", "r473", "r518", "r531" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r32", "r241", "r556", "r557" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property and equipment estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r74", "r219" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Bad debt (recovery)" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PublicUtilityPropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Public Utility, Property, Plant and Equipment [Line Items]" } } }, "localname": "PublicUtilityPropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilityPropertyPlantAndEquipmentTable": { "auth_ref": [ "r33", "r560" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, deprecation expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Public Utility, Property, Plant and Equipment [Table]" } } }, "localname": "PublicUtilityPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofestimatedusefullivesofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": { "auth_ref": [ "r181", "r185" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r181", "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "terseLabel": "Schedule of segment reporting, employee stock-based compensation expense" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r351", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails", "http://www.cinedigm.com/role/StockholdersEquityDetails", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r351", "r467", "r468", "r470" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails", "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r351", "r467", "r470", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails", "http://www.cinedigm.com/role/StockholdersEquityDetails", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r85" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Payments of notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r97", "r503", "r526" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r11", "r94", "r97", "r503", "r526" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails", "http://www.cinedigm.com/role/ScheduleoffairvaluemeasurementsoffinancialassetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashEquivalents": { "auth_ref": [ "r97", "r503", "r526", "r553", "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash equivalents restricted as to withdrawal or usage. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash Equivalents", "terseLabel": "Restricted Cash" } } }, "localname": "RestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofcashcashequivalentsandrestrictedcashTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r22", "r326", "r380", "r473", "r528", "r547", "r549" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAppropriated": { "auth_ref": [ "r53", "r104", "r303", "r304", "r522" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "A segregation of retained earnings which is unavailable for dividend distribution. Includes also retained earnings appropriated for loss contingencies.", "label": "Retained Earnings, Appropriated", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAppropriated", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NatureofOperationsandLiquidityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r112", "r113", "r114", "r116", "r122", "r124", "r218", "r377", "r378", "r379", "r393", "r394", "r436", "r544", "r546" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r166", "r167", "r180", "r186", "r187", "r193", "r194", "r196", "r333", "r334", "r487" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Total Cinema Equipment Business revenue", "verboseLabel": "Digital cinema servicing revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails", "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "REVENUE RECOGNITION" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r68", "r106", "r166", "r167", "r180", "r186", "r187", "r193", "r194", "r196", "r216", "r254", "r255", "r256", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r444", "r517" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenues", "verboseLabel": "Total Content & Entertainment Business revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement", "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Shares of common stock" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of supplemental cash flows" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SupplementalCashFlowInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r44", "r110", "r295", "r297", "r321", "r323", "r324", "r325", "r455", "r456", "r459", "r520" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of notes payable" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of debt outstanding" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r228", "r233", "r488" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r228", "r233" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of amortization expense per year for the intangible assets acquired in the business combination" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of goodwill and accumulated impairment charges" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfImpairedFinancingReceivableTable": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Schedule of the recorded investment, unpaid principal balance, associated allowance, average recorded investment, accounting policies, and interest income recognized on the accrual and cash basis for impaired financing receivables by class of financing receivable.", "label": "Schedule of Impaired Financing Receivable [Table]" } } }, "localname": "ScheduleOfImpairedFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofbusinesscombinationTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r33", "r560" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of public utility physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, deprecation expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Public Utility Property, Plant, and Equipment [Table Text Block]", "terseLabel": "Schedule of estimated useful lives of property and equipment" } } }, "localname": "ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r11", "r97", "r503", "r526" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of cash, cash equivalents and restricted cash" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r175", "r178", "r184", "r224" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r175", "r178", "r184", "r224" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of segment reporting, statement of operations" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of employee stock purchase plan activity.", "label": "Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]", "terseLabel": "Schedule of stock-based compensation expense" } } }, "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of analysis of option activity" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.", "label": "Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]", "terseLabel": "Schedule of stock appreciation rights outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r329", "r357" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of amortization expense per year for the developed technology acquired in the business combination" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r16", "r507", "r525" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "terseLabel": "Notes Payable, Non-Recourse" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuredDebtCurrent": { "auth_ref": [ "r14", "r506", "r524" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt, Current", "terseLabel": "Current portion of notes payable, non-recourse (see Note 5)" } } }, "localname": "SecuredDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r162", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r180", "r181", "r182", "r183", "r185", "r186", "r187", "r188", "r189", "r191", "r196", "r246", "r247", "r540" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r162", "r164", "r165", "r175", "r179", "r185", "r189", "r190", "r191", "r192", "r193", "r195", "r196", "r197" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]" } } }, "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r79" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement", "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable", "http://www.cinedigm.com/role/ScheduleofstockbasedcompensationexpenseTable" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A preferred stock", "verboseLabel": "Series A" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Services [Member]" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r91" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Total SARs Outstanding December 31, 2021", "periodStartLabel": "SARs Outstanding March 31, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofSARsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "terseLabel": "Options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares under option, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r376" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value (in Dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r366", "r376" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "terseLabel": "Options, outstanding shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period", "terseLabel": "Issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofSARsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r357", "r363" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, granted (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r360", "r364" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "STOCK-BASED COMPENSATION" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r373" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "http://www.cinedigm.com/role/ScheduleofstockappreciationrightsoutstandingTable" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Range of Prices, Minimum" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Options Exercisable (in Shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Options Outstanding (in Shares)", "verboseLabel": "Share-based Payment arrangement, option, exercise price range, shares outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "terseLabel": "Range of Prices, Maximum" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Aware expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "negatedLabel": "Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofSARsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Life in Years", "verboseLabel": "Options outstanding, weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price", "verboseLabel": "Share-based payment arrangement, option, exercise price range, outstanding, weighted average exercise price (in Dollars per share)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofanalysisofoptionactivityTable", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Shares owned (in Shares)", "verboseLabel": "Shares issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "auth_ref": [ "r36", "r533" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "Short-term Bank Loans and Notes Payable", "terseLabel": "Short-term payable" } } }, "localname": "ShortTermBankLoansAndNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r39" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofnotespayableTable" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r99", "r111" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r3", "r162", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r180", "r181", "r182", "r183", "r185", "r186", "r187", "r188", "r189", "r191", "r196", "r224", "r243", "r246", "r247", "r540" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofrevenuecategoriesTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingassetsanddebtTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingemployeestockbasedcompensationexpenseTable", "http://www.cinedigm.com/role/ScheduleofsegmentreportingstatementofoperationsTable", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r17", "r18", "r19", "r103", "r106", "r128", "r131", "r139", "r142", "r144", "r150", "r151", "r152", "r216", "r254", "r258", "r259", "r260", "r263", "r264", "r306", "r307", "r310", "r314", "r320", "r444", "r566" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.cinedigm.com/role/ShareholdersEquityType2or3", "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r49", "r64", "r65", "r66", "r112", "r113", "r114", "r116", "r122", "r124", "r149", "r218", "r320", "r326", "r377", "r378", "r379", "r393", "r394", "r436", "r446", "r447", "r448", "r449", "r450", "r451", "r544", "r545", "r546", "r568" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3", "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r112", "r113", "r114", "r149", "r487" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockAppreciationRightsSARSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs) [Member]", "verboseLabel": "SARs [Member]" } } }, "localname": "StockAppreciationRightsSARSMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockDividendsShares": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits.", "label": "Stock Dividends, Shares", "terseLabel": "Stock Dividends" } } }, "localname": "StockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r18", "r19", "r326" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Issuance of common stock in connection with equity line purchase commitment (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r48", "r283", "r320", "r321", "r326" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Common stock issued in connection with conversion of Convertible Notes (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r18", "r19", "r320", "r321", "r326" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "Issuance of common stock in connection with performance stock units (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "auth_ref": [ "r18", "r19", "r320", "r326", "r382" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.", "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan", "terseLabel": "Treasury stock in connection with taxes withheld from employees (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Issuance of common stock for third party professional service (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r18", "r19", "r320", "r326" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "July 2020 issuance of Class A common stock, net of $695 in issuance costs (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Issuance of Class A common stock to management and employees (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r18", "r19", "r320", "r326" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r18", "r19", "r320", "r326", "r367" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "terseLabel": "Options expired" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r49", "r320", "r326" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Issuance of Class A common stock for business combination" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r49", "r320", "r326" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Common stock issued in connection with conversion of Convertible Notes" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Issuance of common stock for third party professional service" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r18", "r19", "r320", "r326" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "July 2020 issuance of Class A common stock, net of $695 in issuance costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Treasury stock in connection with taxes withheld from employees" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r18", "r19", "r326", "r359", "r371" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockDividend": { "auth_ref": [ "r49", "r320", "r326" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued to shareholders as a dividend during the period.", "label": "Stock Issued During Period, Value, Stock Dividend", "terseLabel": "Accrued dividends on preferred stock" } } }, "localname": "StockIssuedDuringPeriodValueStockDividend", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofsupplementalcashflowsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r24", "r25", "r106", "r207", "r216", "r444", "r473" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total stockholders\u2019 equity of Cinedigm Corp." } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r65", "r106", "r112", "r113", "r114", "r116", "r122", "r216", "r218", "r326", "r377", "r378", "r379", "r393", "r394", "r415", "r416", "r429", "r436", "r444", "r446", "r447", "r451", "r545", "r546", "r568" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet", "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r104", "r307", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r326", "r330" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityForeignCurrencyTranslationAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to temporary equity resulting from foreign currency translation adjustments.", "label": "Temporary Equity, Foreign Currency Translation Adjustments", "terseLabel": "Foreign exchange translation" } } }, "localname": "TemporaryEquityForeignCurrencyTranslationAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r201", "r202", "r203", "r205", "r206", "r208" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "ACCOUNTS RECEIVABLE" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade Name [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ScheduleofamortizationexpenseperyearfortheintangibleassetsacquiredinthebusinesscombinationTable" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury stock shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r47", "r327" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r47", "r327" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury stock" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r47", "r327", "r328" ], "calculation": { "http://www.cinedigm.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost; 1,315,851 and 1,313,836 Class A common shares at December 31, 2021 and March 31, 2021, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_UpFrontPaymentArrangementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of deferred revenue by arrangement wherein all amount due is received from customer before delivery of goods or services, and revenue will be recognized upon customer acceptance of delivered goods or services.", "label": "Up-front Payment Arrangement [Member]", "terseLabel": "Up-front Payment Arrangement [Member]" } } }, "localname": "UpFrontPaymentArrangementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r154", "r155", "r156", "r157", "r158", "r159", "r160" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "USE OF ESTIMATES" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "VariableInterestEntityOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/OtherInterestsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r127", "r144" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average number of Class A common stock outstanding: diluted (in Shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r125", "r144" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average number of Class A common stock outstanding: basic (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.cinedigm.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r111": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1828-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2062-109256" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "48", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2538-109256" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "48", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2538-109256" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2574-109256" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2597-109256" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2600-109256" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "54", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2603-109256" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r161": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r197": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r252": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r301": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "63", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=117411753&loc=d3e23176-110880" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21332-112643" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21346-112643" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r402": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255" }, "r414": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90198-114008" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r475": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(23)(a)(4)(i))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(30)(a)(3)(ii))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "980", "URI": "http://asc.fasb.org/extlink&oid=84167750&loc=d3e42232-110370" }, "r561": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r562": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r563": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r564": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r565": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r566": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r567": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "http://asc.fasb.org/topic&trid=2134446" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" } }, "version": "2.1" } ZIP 76 0001213900-22-007623-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-007623-xbrl.zip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�@3L HGH!\39)8\[\#/C!,XZ!"?1!&-(]WL:=."]@BV7S$YK6+:(#Q' MXG/R .6G#**38-S,&),9,PQ#[Y'Y/BPVXKJ3 )% X6 , XU#ZXXPL%<[95HU MT7!XV*\8Q%8Q:S*$4J3D,#ISD$Z*/HTQX C.,E-*Q ^0"G8?7PXWG@Q=4<\],/AE+APQ!'0(D:+M9P>:^M. MK]E7+(2M)E<>M).B=@"V@[@= .X ,F<&W9EC=S+P&'2'A3;S=$WS%&8'X4,& M4R$Y2ZUSDB[65Z.9<[]BYES#+)UC3P^=BT_1S22M>EC4WG+4?&_:#2O&SY*7 MA4:%V3"E*#DXCMPXY^&B6/759.3[57A\I2S2RL6.+J'9\V MQ[\V>AVQHBF96-9#4H[Q[^3[IVL M_\UFV:C(%VETD,@@U'<60H>DUK-TV!BK6MW120,)P\#B2)_(FJIT&;5"\2?A6#%$-ON@;7TKSY8=&0RJHO,U/S8?<\QGI,Y_%#??29G4;S185 MXY(A>TLK5Z+93N',K(E0/8=H<\8RG1)N&.EE) MVIR+]T!/T@&FY].JR^H*^@OO@XK1RB361*4RYZM*#UF)X_5K5?(ABW]_N;P[ M^,^_?W''DZ=?^<$'[Z_W#\-?I_SV>/)X]EY\>/_SWA^WO6GDOW]P_WKC_Q3O MQ%WZTU_O]^^?=MV+^,UOIZ=[W9]W'IX.CWY]\^!U13]VQ=W[77X9GXQ'?_TB M:!_J_WG=_UW[X*;#^Y?T<7YP>&8?!@]QF[OZL_'RP]G/X[Y MP;U__W:O.[A\<\3_KWOXQPZ/Z0#/?[U8/+E M["Q\"L*W.^^>O'^YW=.CW_[\_)O[KO?;X1]>9R^XZO_,?[K_]!_GJ'N3O?:Q MS,JHA.74&OZ4I9H%7=7P5Q>_L]%26LBP9 %'>.E(A_.M VT=VME67/%!NWS MH!J_JN-F68JE96< _I'73!#$YNC?FOM1EG,6+;I90%6;6:!IH$E;/:@8 Y>< M#C,LB84X0[.YAUMD9M!@[(=32AH-8L<5 -PUUNVF3 %C$M;J:1G$:Y M%%9U&D#-9SV+*_;#?)ZK3>"?89!G,:E5?3AG?1D]=RIVP4KZJPV+C%AT'+H3 ME$8=[IW >3V>5C+U:4LT;;!OI)D@;2'_)[3F),W]EV7N^WZG\/P<_IC\5'BH M3OX,O[( ]PB'USXDJ'C_SDG>0;P(7=F_N;>_O?OL4>=E; M7BU1(-')8V+M4&3U%D&A?\BP#D>4O4^8KSHD9"QK[E _CF:-;<\;FR%J.3*U MKQJJ<#75E/^.3 XB+V; M62@X?NOTX5_$!7XDS_W)5RX_8@D^/(>C!,J.+8>DI3YMQ6*"#_7)4G"\8*'7 MD_6\B4AE-L?8PSX^X9>4C6!G!#D[P:]G(IR,LTX8-)_;BA?$G1M\U3B<9,'- MMS*V^0)#FZ\&UVE@,^XK65BSC:.Q /J"B%"-RBEAX@Y#=R]SD;OPCIIR,0Y MA^\O9)C626:S^&CJ_7P6EI)*IE":,:Z3NJS?#6XDA[+G=1AV49*&[&:R%SI(=;).>C>2/]U]#<"-B*=".N9K8!HMJ*_I%Z--E)6P=:\?5]0^7J\5)S3 MS0L3-<[_]UD-WJS M*8%;MY44&P$VDK:EEF9/R%[E,J^^A"'0 S=:Q^4F3])KW9>W&2]%B$KD'\$A M)" S8P7F)BP*2:,6TJ="4H5B=<3X8Z \=>"N19-V7I8 M*B(ZOI]:^J\&EA+4#%&W]];6>//UJ5+@4N\OC<-@ 5$&&)6JP^>0HQ?T.7_ MS*^P_W(O-9_#W\FAURK-MR5>U0*\Y: @^]3+C,<3(>!CD;P@Y#0F8EI'X(#X M42V%R25VG'WJ$Q^OM(%RVF?QXF0K\"K9FA:XQET3I\4Q'5#X!0.E(N:E2L45 MSV;+U:"3"> UCH&+V8.6&(0EB-+)JG*S)T3P'P4=P;&1/= +*'X:"LJ&<)2$Y<^'M"<( MCWRR(AFV-HI;TZ*TAJ(8.(^B"?6.)ZC>74OXTLL"?T:XYQQF#J MB':O.S8/SQ)4M1RH[HC .FHS4E%28[%Q6O& &*%7:PA91=@F\4&"#D;BACSI MJZ8MF!^"14"NF5#7)5ML-XQ;,O)63I%7M3D[QA=%^0M/APMN]0-\3J%\HL0 -@\(U=-JGJ5K[BG1.98,#/7 M0Y?VADJS+9T\@?K-HMQ-ILVSKR4ERO-$M2SH,!5!P;@UDZ8E8"7A]>>PZ)HP M+YEZL[:LG@=MR%A@T^N%EX3#@30+ \K"*&T>DD7(4=OURC*J%W9I'/NT*'QL M'@]3$EIL0/4M6"0EVB+67?(J-'?\.7\7BO,IN0ZU>G4L0HYR=1@N-9O'PY2$ MA0YA^18L6AUM$6M61ZXI];FBT[N\(;!GHT7WATF;RMB>6Q>3P6)VII M=:.F48O$RO(TF,PEZ;9=H^"]$!5,!U]'_AEA7-[$B3 X#<60/5 NH[:OK_' M)T\UZ,8$>_ H$+#5JH8. MMD9XX!A&.(A7O#Q8Z/QN,\5-T#5FSO"!H04=)LUQ..G'@XF?/A,<]<*8^!;/ M^6;LK3=5:1_OC9A(;K.@AP'(6.B"^%TJ'IA+3U^.=;,U61JO6]!2*':=>?1[ M'MK,:AW^+)XQKZ]^.-HBKZHDSX]+_G5&<#5^0]J MJ^/I'/LKGXF^1I"!(5#E');N>#.?2NOX6 ?/D!:+N*0"IML]:HZQUG%'B5') MHIH:%O%)BT[KA1WRRU3&Y_R_HNO09^ZT1Y_B0Q^4S;P+?9S]^,PV%$.D:A4O M/2Y:2)H*FI*68R:H&Z>BDP^EY<1"NDQ@-J>,P-?9KDIOPEE%IBE4\_000IUL MPF;R6V)7ZVPWZ++A0JTTXK*0L0#5OS1F7<971#"C/.S2OJ%9"1WJE!23( !I M& ZZ;,C9@+F$QZFQ!)T\<*'-GVJ;)\H?$"8>T'H0Y#(ZPL]91L?DE0OKMNQG MH%;K1[K.[BW2))Z)3O7:SY)L L@HZM/AD'$^M/A46H]7M:T52E.Y2[P4VE*T M:J-">NWKR;AX>^.\2SA5G)+FYD*HO[TDU6#5*!LU"3KM):T.K)9ERDP-]M+8 M@%MCP_=D@ 0H73)@!\]#(S9>9]#\LA9J!6#-;(7#'LJ=S_ />^G*@]1I$:?X M#@7%M.)>)8EK->DK9GSMLB=[R5Z,' VS%V@0C?JO:H0D0>HUW[[%$TPN^IJ& M*"%HE4/T&133US1"DA[5-MF^N=[K6F(]JO4XTS3X(D=!K;*W&[J;)(_%*]N5 M2E2M2JKDFWU-6U2%KM5/KM58\4O_A-:[)E+"UC-D(3KKT57=5<%G/[W/PB=:I:/NRQN6]B1J M(N9I^#J8C?7)ARJ8'5; MHQP(@"+D@]8P6O)^NQ<>D]ABM5B+6L-)2P3 TOF\VRUS=2J84>A[5$1)A'/% M]2'"(B3WF)>0CWF%)3\PJWQI5D>5VCMI%7W8Y!BS6GJTOD88\UMY>26)!.Y, MXE$H<%+?A(]4)'^Q@,VN@=)DV++-Y_87 M7"-UZMFH[M2L3SKO]'8\?CE#NC1UBPQI Q^KG7Z>!'TJK@8YY]FD^/+1^TNG M;W\F.C7O;V%7_3* #J9"3+(V'4[G1=)=OO-(A)OL"T6)1+W. Q5D2&]H M0!B7KMEYBH1DM+G-6L"4L&HZ6 JDZ@P_H)E(,%1P50."+FRJAK>U7>M5&L"UU8@WA, MO^ 0O.IMH(9.S39@J(#*9>GF,-+$@/]B3R%Z@I8^@*B:?X%GCV92M#L3Z;UU^ZDW(E6\Y8ES"+*WTEBE_/XK32@<[5CL;ZLK,O099A5 MJIR:#OI*M6B9E>REY6]=DC*SI(W59+G9@S//]A+1DMO' L3HUA_:'/"!.#A( MD#&+B2_/#"_\L:8EJ-(\M#U["B:7V7#7\F&HQZSQ%S'/)@VC^4KS9-=1IK,Y ME')>]4(8Z./PD=^!8 K%6H7NLD>5)NCJF=(3<@^;IC8''"K@$$AJ'$$\'[MVES(M393^IR^YVOZ?7@M0U$"RHT*Z$NM]^+&PIS(M3&GB21QCD?A"*0 M#50M)$D10"5JK+K8JH\\ MBTUS:LPZ^_K\_M5Z JM8-^]6A4L_%FDRQF3="\4ANP;,YYEAUC[F&_#KUD?KZ M?E-%./IWJQ.S:4)H8C5;V::P-N.6&K3>RHN^7D,00$,24[M6EQY?@[=.9L*8 MR5:[:&O&J.+:#74IQ@TGS,6CR F)XB\TB@\)O[=7XVS K8EG3MX;P)BR(4=' M+WR>QUXZZ^'JY$WU^3Y+)ZTA4/5A(C&[IH^!Y'PC$>#OQV&08RQN%)[\Y7G/ M@68@E3%+;5*X6G?P7P"][J:H36L660(6Q&WP/FFR-Z.7Q NZ2C2!KY-NF)Y8 M>C)?$G%/8_3$77/FW64I5B#6.1:,4$B<\].LIL6*8A6K1I.2-Z:9:AE="0_. M MD%H@6G%#V^UG2MG76K>7!*@5NY)\G1@)./"[^18?DHAK]^C?"B/")E5F%T M7!G(0V?A>&/!U%-"T]BBI.:;^J7T0OL=)A2 U13.GPK%,&_8-.&SD$]2Y)(: M64RP&7Z]7(E>P$-]!9R:?4V:6"6$4TK3\FA"@?Y7DEUK;03J@>M>YJS6DV%# MEXRS8!)8?"O0"'T1JLG3BZ4ZA:[+X)X/5,$G6^_&@V4WQ^7O FI1-3P9"O]( M"\\WU:O!W?7I-1[2S[\Z4080#8T&5CM35; JSX2W,D@L&C#JP7!([QD\8O5] M-DPNGRU>EQ(*+?:?/7"?V MP+E#K;U&67,2]%&:6 A-Q^&*#&"H?GZ-'M' M*N?EEU2R6$8M0U6;=TAME5]-4%6S05W/(DEF E+[!M/LJ@(/[W7WE%R(>PLP7VYPLM(]7MN]5,T!;O.'5H M-7$DN=E=,P%L6X!U$!L>SJ+X(E7F)7,;T<'$]R_8H,3"KY3@20M0:\$L\W@- MS[0\XPRM?:]%F;07YZ$KPRRC48?+_T.=X8'X4 K$\SB,J!VWV*VPZA.3SU/4 MVJKL*#$:)1"V3[_1HFM*E8N^)PH]QJI]L(I5+7:P[!WH[=C/#8DQ%12+3OTP M%%_=LJ6!9I[4.+55)M3:1[B0 8\- M$A"S_EET2>,4W^L9\!8TKS2#993/@7HFTWR=(_=AB.0SWA:X+:R%+/7./0N0 MJ"3K_TH'GP(@Y2N=F6M4+H'&R@(9EJ=!"T]%TUV(CSYC2BZ;/(%J4>EL=ZDU M"%4MF^A0X&J(4:B(.IN#NE6(M:='&3(4#DZ"L1].*8U^"M/DS\&8\.EIZ/OA MHPSE4[C",A[3(17/S,U%8&NR#,U7Z3!/GU=CU2GKZMJ MVJ2O-V-4&SRRV+UIA 7Q[$9\OSP3O^9JJ\&F2W+'W3"@/?)D5X!,+2QM:I/: M.!I;R-&A6]I0VGEBS[^H0'AX#*!&J>;9VF0J4>M\RC!B$8X>0N;90X5YQ,9P MX, I_K6-PGIPVLO$D\LS?*6A8+"S@R@=-.4M-\SI8_2QPZR)T'YVNV,)17IT M:O<$RGJ$64)#'HN2#7X8>E,@=3B)9"K=BR-+T"N!J8/=CX]^M -\#HD:[=7G M^,$2N#DHN@@K6 (>&P;%EU,M(4&'37,N2*O5&+#LHDL-4$]<0+#F6%J5K)*P M>G"ZC5!1\XI3JRF;X]/D@HC1HLJ]$W01A7,%QZ_IF<,2XDPP-J1_AG\5*ELV M,9L1:F>GIKH]4]0(I'*>)H\)7*,G1VB+G*S#I'9]8D-,N9:LU&L1_I&D8DY/ MOW909(11:Z:5]9/R,MC,*KJJN+3I.:JOIMFREG30E [?E3IX,V8M07EP[;C4 M>PRM)6H&K8E+N0=73\.)L(N@>G Z+D$Q[LG>>W>@4-I!3CTHC7@[(XP$G0! MN 13]H%&(G^"/\_N3NP@R@BCAL8?DWSPE@CN$AI]."0H%ISXMQ'MAH/XD0A+ M9)L:F%)70&=Q-&Y9I>[4@]+E5NWUNK&@),#TW]Q+-V$[B-%BT[U.)LVGNTYQRI0J52! MI+BE5-22T7@O).^=I5>1)?N+#IKZ7EQ&D%I"00F-27Y32X 7T>B!2W<%5V:P MNAK\"!O1S_#?!0N@3<\6<@PPZD*''L/>*)Q@]ODNAN[&E')[3,(-Z)2*3*Y> M;\2$K";": SRW-)[Q040+T-]]/+(KT#6&81"5X8*)+9;>9LP\V+II.1\?0\; M(Y2X'7R_ Q1&H)4$1.YV_P]02P,$% @ "XE.5$+);\5&#@ _J@ !4 M !C:61M+3(P,C$Q,C,Q7V-A;"YX;6SM7=MRXS82?=^OT#HON[6ED2W?QJYQ M4K)\B2>^*)+LS"252D$D*&%, 1J E"5__0*\V))(D!0)B-1F'U*9T9#HYCGL M1G>C 7[Z:3:V:U-(&2+X;&?OP^Y.#6*#F @/SW8>>_56KWUSL_/3C[7:/S[] MLUZO74,,*7"@61O,:VTRGO0,5.M3@)E%Z+CV+V?\[UJ]-G*IT/& [9IE ,>%J[([AV!0>UO8-:<_>TN7]Z<%A[[+?Y M7YI-_Y9_?+(1?AX !FM<;\S.=A8DS0;4_D#HL-'>SL0/2]>_ M['M7[YVXTO=[<]8P3'H(XP

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end